CAP Cancer Protocol Thyroid Gland



Protocol for the Examination of Specimens From Patients With Carcinomas of the Thyroid GlandVersion: Thyroid 4.0.0.0Protocol Posting Date: June 2017Includes pTNM requirements from the 8th Edition, AJCC Staging ManualFor accreditation purposes, this protocol should be used for the following procedures AND tumor types:ProcedureDescriptionResectionIncludes specimens designated thyroidectomy, lobectomy and partial excisionTumor TypeDescriptionCarcinomaIncludes papillary, follicular, anaplastic, poorly differentiated, and medullary cancersThis protocol is NOT required for accreditation purposes for the following:ProcedureBiopsyPrimary resection specimen with no residual cancer (e.g. following neoadjuvant therapy)Cytologic specimensTumor TypeNoninvasive follicular thyroid neoplasm with papillary like nuclear features (NIFTP)Thyroid carcinomas arising from struma ovariiThyroid carcinomas arising in thyroglossal duct cystsThe following tumor types should NOT be reported using this protocol:Tumor TypeLymphoma (consider the Hodgkin or non-Hodgkin Lymphoma protocols)Sarcoma (consider the Soft Tissue protocol)AuthorsRaja R. Seethala, MD*; Sylvia L. Asa, MD, PhD; Martin J. Bullock, MD; Sally E. Carty, MD; Steven P. Hodak, MD; Jonathan B. McHugh, MD; Yuri E. Nikiforov, MD, PhD; Jason Pettus, MD; Mary S. Richardson, MD, DDS; Jatin Shah, MD; Lester D.R. Thompson, MD With guidance from the CAP Cancer and CAP Pathology Electronic Reporting Committees.* Denotes primary author. All other contributing authors are listed alphabetically.Accreditation RequirementsThis protocol can be utilized for a variety of procedures and tumor types for clinical care purposes. For accreditation purposes, only the definitive primary cancer resection specimen is required to have the core and conditional data elements reported in a synoptic format. Core data elements are required in reports to adequately describe appropriate malignancies. For accreditation purposes, essential data elements must be reported in all instances, even if the response is “not applicable” or “cannot be determined.”Conditional data elements are only required to be reported if applicable as delineated in the protocol. For instance, the total number of lymph nodes examined must be reported, but only if nodes are present in the specimen.Optional data elements are identified with “+” and although not required for CAP accreditation purposes, may be considered for reporting as determined by local practice standards.The use of this protocol is not required for recurrent tumors or for metastatic tumors that are resected at a different time than the primary tumor. Use of this protocol is also not required for pathology reviews performed at a second institution (ie, secondary consultation, second opinion, or review of outside case at second institution).Synoptic ReportingAll core and conditionally required data elements outlined on the surgical case summary from this cancer protocol must be displayed in synoptic report format. Synoptic format is defined as:Data element: followed by its answer (response), outline format without the paired "Data element: Response" format is NOT considered synoptic.The data element must be represented in the report as it is listed in the case summary. The response for any data element may be modified from those listed in the case summary, including “Cannot be determined” if appropriate. Each diagnostic parameter pair (Data element: Response) is listed on a separate line or in a tabular format to achieve visual separation. The following exceptions are allowed to be listed on one line:Anatomic site or specimen, laterality, and procedurePathologic Stage Classification (pTNM) elementsNegative margins, as long as all negative margins are specifically enumerated where applicableThe synoptic portion of the report can appear in the diagnosis section of the pathology report, at the end of the report or in a separate section, but all Data element: Responses must be listed together in one locationOrganizations and pathologists may choose to list the required elements in any order, use additional methods in order to enhance or achieve visual separation, or add optional items within the synoptic report. The report may have required elements in a summary format elsewhere in the report IN ADDITION TO but not as replacement for the synoptic report i.e. all required elements must be in the synoptic portion of the report in the format defined above.CAP Laboratory Accreditation Program Protocol Required Use Date: March 2018** Beginning January 1, 2018, the 8th edition AJCC Staging Manual should be used for reporting pTNM. CAP Thyroid Protocol Summary of ChangesThe following data elements were modified:Pathologic Stage Classification (pTNM, AJCC 8th Edition)Histologic TypeSurgical Pathology Cancer Case SummaryProtocol posting date: June 2017THYROID GLAND: Select a single response unless otherwise indicated.Procedure (Note A)___ Completion thyroidectomy (reoperative)___ Right partial excision#___ Left partial excision#___ Partial excision# (specify type, if possible): _______________________________ Right lobectomy___ Left lobectomy___ Right lobectomy with isthmusectomy (hemithyroidectomy) ___ Left lobectomy with isthmusectomy (hemithyroidectomy) ___ Right lobe with partial left lobectomy (subtotal or near total thyroidectomy)___ Left lobe with partial right lobectomy (subtotal or near total thyroidectomy)___ Total thyroidectomy# Anything less than a lobectomy, including substernal excisionTumor Focality (Note B)___ Unifocal___ Multifocal ___ Cannot be determinedTumor Site (select all that apply) (Note B)___ Right lobe___ Left lobe___ Isthmus___ Pyramidal lobe ___ Other (specify): ____________________________Tumor Size (Note C)Greatest dimension (centimeters): ___ cm+ Additional dimensions (centimeters): ___ x ___ cm___ Cannot be determined (explain): ________________________________________Histologic Type (Notes D through H)Papillary Carcinomas___ Papillary carcinoma, classic (usual, conventional)___ Papillary carcinoma, follicular variant, encapsulated/well demarcated, with tumor capsular invasion___ Papillary carcinoma, follicular variant, encapsulated/well demarcated, noninvasive#___ Papillary carcinoma, follicular variant, infiltrative___ Papillary carcinoma, tall cell variant___ Papillary carcinoma, cribriform-morular variant___ Papillary carcinoma, diffuse sclerosing variant___ Papillary carcinoma, other variant (specify): _______________________________ Papillary carcinoma# A subset of noninvasive tumors can now be reclassified as NIFTP.+____ Noninvasive follicular thyroid neoplasm with papillary like nuclear features (NIFTP)#### This category is not overtly malignant; reporting is optional and only size, laterality, and margin status are reported.Follicular Carcinomas___ Follicular carcinoma, minimally invasive___ Follicular carcinoma, encapsulated angioinvasive___ Follicular carcinoma, widely invasive___ Follicular carcinoma, minimally invasive, oncocytic (Hürthle cell)___ Follicular carcinoma, encapsulated angioinvasive, oncocytic (Hürthle cell)___ Follicular carcinoma, widely invasive, oncocytic (Hürthle cell)___ Follicular carcinoma, minimally invasive, other variant (specify): _______________________________ Follicular carcinoma, encapsulated angioinvasive, other variant (specify): _______________________________ Follicular carcinoma, widely invasive, other variant (specify): _______________________________ Follicular carcinoma___ Poorly differentiated thyroid carcinoma___ Undifferentiated (anaplastic) carcinoma, focal or minor component without extrathyroidal extension___ Undifferentiated (anaplastic) carcinoma, major component___ Undifferentiated (anaplastic) carcinoma, not otherwise specified___ Medullary carcinoma___ Carcinoma, type cannot be determined___ Other histologic type not listed (specify): ____________________________Margins (Note I) ___ Cannot be assessed___ Uninvolved by carcinoma + Distance of invasive carcinoma from closest margin (millimeters): ___ mm___ Involved by carcinoma+ Site(s) of involvement: ____________________________Angioinvasion (Vascular Invasion) (Note J)___ Not identified ___ Present+ Extent: + ___ Focal (less than 4 vessels)+ ___ Extensive (4 or more vessels)___ Cannot be determinedLymphatic Invasion (Note J)___ Not identified ___ Present___ Cannot be determined+ Mitotic Rate + Mitotic Rate: ____ per 2 mm2Note: Mitoses should be counted in 10 consecutive high power fields (HPF) at 400x in the most mitotically active area. For most microscopes, 10 HPF is roughly equivalent to 2.5 mm2 + Perineural Invasion+___ Not identified +___ Present+___ Cannot be determinedExtrathyroidal Extension (Note K) ___ Not identified___ PresentExtent (requires clinical/macroscopic AND microscopic tumor invasion):___Invading only strap muscles (ie, pT3b)___ Invading subcutaneous soft tissues, larynx, trachea, esophagus or recurrent laryngeal nerve (ie, pT4a)___Invading prevertebral fascia or encasing the carotid artery or mediastinal vessels (ie, pT4b)___ Cannot be determinedRegional Lymph Nodes (Note L)___ No lymph nodes submitted or foundLymph Node Examination (required only if lymph nodes present in specimen)Number of Lymph Nodes Involved: ___________ Number cannot be determined (explain): ____________________________Specify Nodal Levels (select all apply) (required only if lymph nodes involved)___ Level VI - pretracheal, paratracheal and prelaryngeal/Delphian, perithyroidal (central compartment dissection)___ Level VII (superior mediastinal lymph nodes)___ Level I-V (lateral neck dissection)+ ___ Right+ ___ Left ___ Other (specify): ____________________________Number of Lymph Nodes Examined: __________ Number cannot be determined (explain): ____________________________Specify Nodal Levels (select all apply)___ Level VI - pretracheal, paratracheal and prelaryngeal/Delphian, perithyroidal (central compartment dissection)___ Level VII (superior mediastinal lymph nodes)___ Level I-V (lateral neck dissection)+ ___ Right+ ___ Left ___ Other (specify): ____________________________Lymph Node Metastasis (required only if lymph nodes involved) Size of Largest Metastatic Deposit (centimeters): ____ cm Extranodal Extension (ENE)___ Not identified ___ Present___ Cannot be determinedPathologic Stage Classification (pTNM, AJCC 8th Edition) (Note M)Note: Reporting of pT, pN, and (when applicable) pM categories is based on information available to the pathologist at the time the report is issued. Only the applicable T, N, or M category is required for reporting; their definitions need not be included in the report. The categories (with modifiers when applicable) can be listed on 1 line or more than 1 line.TNM Descriptors (required only if applicable) (select all that apply)___ m (multiple primary tumors)___ r (recurrent)___ y (posttreatment)For Papillary, Follicular, Poorly Differentiated, Hurthle Cell and Anaplastic Thyroid Carcinoma Primary Tumor (pT) ___ pTX:Primary tumor cannot be assessed___ pT0:No evidence of primary tumor___ pT1:Tumor ≤2 in greatest dimension, limited to the thyroid___ pT1a: Tumor ≤1 cm in greatest dimension limited to the thyroid___ pT1b: Tumor >1 cm but ≤2 cm in greatest dimension, limited to the thyroid___ pT2:Tumor >2 cm, but ≤4 cm in greatest dimension, limited to thyroid___ pT3:Tumor >4 cm limited to the thyroid, or gross extrathyroidal extension invading only strap muscles___ pT3a:Tumor >4 cm limited to the thyroid ___ pT3b:Gross extrathyroidal extension invading only strap muscles (sternohyoid, sternothyroid, thyrohyoid, or omohyoid muscles) from a tumor of any size___ pT4:Includes gross extrathyroidal extension beyond the strap muscles___ pT4a:Gross extrathyroidal extension invading subcutaneous soft tissues, larynx, trachea, esophagus, or recurrent laryngeal nerve from a tumor of any size___ pT4b: Gross extrathyroidal extension invading prevertebral fascia or encasing the carotid artery or mediastinal vessels from a tumor of any sizeNote: There is no category of carcinoma in situ (pTis) relative to carcinomas of thyroid gland.For Medullary Thyroid CarcinomaPrimary Tumor (pT) ___ pTX:Primary tumor cannot be assessed___ pT0:No evidence of primary tumor___ pT1:Tumor ≤2 in greatest dimension, limited to the thyroid___ pT1a: Tumor ≤1 cm in greatest dimension limited to the thyroid___ pT1b: Tumor >1 cm but ≤2 cm in greatest dimension, limited to the thyroid___ pT2:Tumor >2 cm, but ≤4 cm in greatest dimension, limited to thyroid___ pT3:Tumor >4 cm or with extrathyroidal extension___ pT3a:Tumor >4 cm in greatest dimension limited to the thyroid ___ pT3b:Tumor of any size with gross extrathyroidal extension invading only strap muscles (sternohyoid, sternothyroid, thyrohyoid or omohyoid muscles)___pT4: Advanced disease___pT4a: Moderately advanced disease; tumor of any size with gross extrathyroidal extension into the nearby tissues of the neck, including subcutaneous soft tissue, larynx, trachea, esophagus, or recurrent laryngeal nerve ___pT4b: Very advanced disease; tumor of any size with extension toward the spine or into nearby large blood vessels, gross extrathyroidal extension invading the prevertebral fascia, or encasing the carotid artery or mediastinal vesselsFor All Carcinomas of the ThyroidRegional Lymph Nodes (pN)# ___ pNX:Regional lymph nodes cannot be assessed___ pN0:No evidence of locoregional lymph node metastasis#___ pN0a:One or more cytologically or histologically confirmed benign lymph nodes___ pN1:Metastasis to regional nodes___ pN1a:Metastasis to level VI or VII (pretracheal, paratracheal, or prelaryngeal/Delphian, or upper mediastinal) lymph nodes. This can be unilateral or bilateral disease. ___ pN1b:Metastasis to unilateral, bilateral, or contralateral lateral neck lymph nodes (levels I, II, III, IV, or V) or retropharyngeal lymph nodes# N0b is defined as no radiologic or clinical evidence of locoregional lymph node metastasis.For All Carcinomas of the Thyroid Distant Metastasis (pM) (required only if confirmed pathologically in this case)___ pM1:Distant metastasisSpecify site(s), if known: ____________________________+ Additional Pathologic Findings (select all that apply)+ ___ Adenoma+ ___ Adenomatoid nodule(s) or nodular follicular disease (eg, nodular hyperplasia, goitrous thyroid)+ ___ Diffuse hyperplasia (Graves’ disease)+ ___ Thyroiditis (specify type):_____________________+ ___ Parathyroid gland(s) present (specify number, location, and findings): ____________________________+ ___ C-cell hyperplasia (specify type and focality if applicable:__________________________+ ___ None identified+ ___ Other (specify): ____________________________+ Ancillary Studies Note: For reporting molecular testing and other cancer biomarker testing results, the CAP Thyroid Biomarker Template should be used. Pending biomarker studies should be listed in the Comments section of this report. + Clinical History (select all that apply)+ ___ Radiation exposure (specify type): ____________________________+ ___ No known radiation exposure+ ___ Family history + ___ Postoperative serum marker (specify type and result): _________________+ ___ Other (specify): ____________________________+ Comment(s)Explanatory NotesScope of GuidelinesThe reporting of thyroid cancer is facilitated by the provision of a case summary illustrating the features required for comprehensive patient care. However, there are many cases in which the individual practicalities of applying such a case summary may not be straightforward. Common examples include finding the prescribed number of lymph nodes, trying to determine the compartments of the radical neck dissection, and determining if isolated tumor cells in a lymph node represent metastatic disease. Case summaries have evolved to include clinical, radiographic, morphologic, immunohistochemical, and molecular results in an effort to guide clinical management. This case summary tries to remain simple while still incorporating important pathologic features as proposed by the American Joint Committee on Cancer (AJCC) Cancer Staging Manual ADDIN EN.CITE <EndNote><Cite><Author>Tuttle</Author><Year>2017</Year><RecNum>1</RecNum><DisplayText><style face="superscript">1,2</style></DisplayText><record><rec-number>1</rec-number><foreign-keys><key app="EN" db-id="ps2wwdsfra2r5ee9zasxs5t8zwdwxrswe5xa" timestamp="1473117135">1</key></foreign-keys><ref-type name="Book Section">5</ref-type><contributors><authors><author>Tuttle, R.M.</author><author>Morris, L.F.</author><author>Haugen, B.R. </author><author>Shah, J.P </author><author>Sosa, J.A.</author><author>Rohren, E.</author><author>Subramaniam, R. M.</author><author>Hunt, J.L.</author><author>Perrier, N.D</author></authors><secondary-authors><author>Amin, M.B.</author></secondary-authors></contributors><titles><title>Thyroid- differentiated and anaplastic carcinoma</title><secondary-title>AJCC Cancer Staging Manual</secondary-title></titles><edition>8th</edition><dates><year>2017</year></dates><pub-location>New York, NY</pub-location><publisher>Springer</publisher><urls></urls></record></Cite><Cite><Author>Rosen</Author><Year>2017</Year><RecNum>46</RecNum><record><rec-number>46</rec-number><foreign-keys><key app="EN" db-id="ps2wwdsfra2r5ee9zasxs5t8zwdwxrswe5xa" timestamp="1473120927">46</key></foreign-keys><ref-type name="Book Section">5</ref-type><contributors><authors><author>Rosen, J.E.</author><author>Lloyd, R.V.</author><author>Brierley, J.D.</author><author>Grogan, R.H.</author><author>Haddad, R.</author><author>Hunt, J.L.</author><author>Ridge, J.A.</author><author>Seethala, R.R.</author><author>Sosa, J.A.</author><author>Subramaniam, R.M.</author><author>Wang, T.S.</author><author>Wirth, L.J. </author><author>Perrier, N.D.</author></authors><secondary-authors><author>Amin, M.B.</author></secondary-authors></contributors><titles><title>Thyroid- Medullary</title><secondary-title>AJCC Cancer Staging Manual</secondary-title></titles><edition>8th</edition><dates><year>2017</year></dates><pub-location>New York, NY</pub-location><publisher>Springer</publisher><urls></urls></record></Cite></EndNote>1,2 and the World Health Organization Classification of Tumours. ADDIN EN.CITE <EndNote><Cite><Author>DeLellis</Author><Year>2004</Year><RecNum>2</RecNum><DisplayText><style face="superscript">3</style></DisplayText><record><rec-number>2</rec-number><foreign-keys><key app="EN" db-id="ps2wwdsfra2r5ee9zasxs5t8zwdwxrswe5xa" timestamp="1473117135">2</key></foreign-keys><ref-type name="Edited Book">28</ref-type><contributors><authors><author>DeLellis, R.A.</author><author>Lloyd, R.V.</author><author>Heitz, P.U. </author><author>Eng,C</author></authors></contributors><titles><title>Pathology and Genetics of Tumours of the Endocrine Organs</title><secondary-title>World Health Organization Classification of Tumours</secondary-title></titles><dates><year>2004</year></dates><pub-location>Lyons</pub-location><publisher>IARC PRess</publisher><urls></urls></record></Cite></EndNote>3 This protocol is to be used as a guide and resource, an adjunct to diagnosing and managing cancers of the thyroid gland in a standardized manner. It should not be used as a substitute for dissection or grossing techniques and does not give histologic parameters to reach the diagnosis. Subjectivity is always a factor, and elements listed are not meant to be arbitrary but are meant to provide uniformity of reporting across all the disciplines that use the information. It is a foundation of practical information that will help to meet the requirements of daily practice to benefit both clinicians and patients alike. A. Anatomical Sites of the Thyroid Gland (Figure 1)The thyroid gland ordinarily is composed of a right and a left lobe lying adjacent and lateral to the upper trachea and esophagus. An isthmus connects the 2 lobes, and in some cases a pyramidal lobe is present extending cephalad anterior to the thyroid cartilage. Typically, surgical management of thyroid tumors consists of either a lobe with isthmusectomy (sometimes called hemithyroidectomy) or total thyroidectomy. Cases with lobectomy followed by completion thyroidectomy in the same operative procedure should be classified as total thyroidectomies. Other procedures include subtotal thyroidectomy and level VI central node dissection. Figure 1. Anatomy of the thyroid gland and adjacent structures. From Kini SR. Thyroid Cytopathology: An Atlas and Text. Philadelphia, PA: Lippincott Williams & Wilkins; 2008. Modified with permission.B. Tumor Site The thyroid may give rise to multiple foci of carcinoma in the same gland, designated as per AJCC guidelines with the descriptor “(m).” This protocol is applicable to the dominant excised tumor. The dominant tumor can be defined as the most aggressive tumor, specifically the tumor that imparts the highest stage and dictates patient management. As such, it is often but not necessarily the largest tumor. In cases of multiple lesions, the tumor characteristics of a second or rarely third focus may be relevant and contribute to the patient management, particularly if they are of a different histologic type (ie, tumor 1 is papillary carcinoma, and tumor 2 is medullary carcinoma). A second synoptic report can be generated for these instances. The features of additional foci that do not necessarily alter management can be detailed under the section on Additional Pathologic Findings.C. Tumor SizeTumor size has a significant impact on prognosis and is a component of TNM staging. Papillary carcinomas measuring less than 1 cm are associated with an excellent prognosis, while tumors measuring over 4 cm are associated with a worse prognosis. For follicular carcinomas, tumor size over 3.5?cm is associated with a worse prognosis. ADDIN EN.CITE <EndNote><Cite><Author>Chan</Author><Year>2007</Year><RecNum>4</RecNum><DisplayText><style face="superscript">4</style></DisplayText><record><rec-number>4</rec-number><foreign-keys><key app="EN" db-id="ps2wwdsfra2r5ee9zasxs5t8zwdwxrswe5xa" timestamp="1473117136">4</key></foreign-keys><ref-type name="Book Section">5</ref-type><contributors><authors><author>Chan, J. K.</author></authors><secondary-authors><author>Fletcher, C.D.M.</author></secondary-authors></contributors><titles><title>The thyroid gland</title><secondary-title>Diagnostic histopathology of tumours</secondary-title></titles><pages>1018</pages><dates><year>2007</year></dates><pub-location>Edinburgh</pub-location><publisher>Churchill Livingstone Elsevier</publisher><urls></urls></record></Cite></EndNote>4 For medullary carcinomas, size is a staging component, though a recent epidemiologic survey shows that even small tumors (microcarcinomas <1.0 cm) have a 20% rate of regional spread and a 5% distant metastatic rate. ADDIN EN.CITE <EndNote><Cite><Author>Kazaure</Author><Year>2012</Year><RecNum>5</RecNum><DisplayText><style face="superscript">5</style></DisplayText><record><rec-number>5</rec-number><foreign-keys><key app="EN" db-id="ps2wwdsfra2r5ee9zasxs5t8zwdwxrswe5xa" timestamp="1473117136">5</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kazaure, H. S.</author><author>Roman, S. A.</author><author>Sosa, J. A.</author></authors></contributors><auth-address>Department of Surgery, Yale University School of Medicine, New Haven, Connecticut 06520, USA.</auth-address><titles><title>Medullary thyroid microcarcinoma: a population-level analysis of 310 patients</title><secondary-title>Cancer</secondary-title></titles><periodical><full-title>Cancer</full-title></periodical><pages>620-7</pages><volume>118</volume><number>3</number><edition>2011/07/01</edition><keywords><keyword>Aged</keyword><keyword>Carcinoma, Medullary/epidemiology/*secondary/therapy</keyword><keyword>Connecticut/epidemiology</keyword><keyword>Disease-Free Survival</keyword><keyword>Female</keyword><keyword>Humans</keyword><keyword>Incidence</keyword><keyword>Lymph Nodes/pathology/surgery</keyword><keyword>Lymphatic Metastasis</keyword><keyword>Male</keyword><keyword>Middle Aged</keyword><keyword>Multiple Endocrine Neoplasia/epidemiology/*pathology/therapy</keyword><keyword>Neoplasm Recurrence, Local/epidemiology/*pathology/therapy</keyword><keyword>SEER Program</keyword><keyword>Thyroid Neoplasms/epidemiology/*pathology/therapy</keyword></keywords><dates><year>2012</year><pub-dates><date>Feb 1</date></pub-dates></dates><isbn>1097-0142 (Electronic)&#xD;0008-543X (Linking)</isbn><accession-num>21717441</accession-num><urls><related-urls><url>. Histologic TypeThe histologic classification recommended below in notes F through H is modified from the World Health Organization (WHO) published recommendations with a few important alterations based on subsequently published studies. ADDIN EN.CITE <EndNote><Cite><Author>DeLellis</Author><Year>2004</Year><RecNum>2</RecNum><DisplayText><style face="superscript">3</style></DisplayText><record><rec-number>2</rec-number><foreign-keys><key app="EN" db-id="ps2wwdsfra2r5ee9zasxs5t8zwdwxrswe5xa" timestamp="1473117135">2</key></foreign-keys><ref-type name="Edited Book">28</ref-type><contributors><authors><author>DeLellis, R.A.</author><author>Lloyd, R.V.</author><author>Heitz, P.U. </author><author>Eng,C</author></authors></contributors><titles><title>Pathology and Genetics of Tumours of the Endocrine Organs</title><secondary-title>World Health Organization Classification of Tumours</secondary-title></titles><dates><year>2004</year></dates><pub-location>Lyons</pub-location><publisher>IARC PRess</publisher><urls></urls></record></Cite></EndNote>3 This protocol applies only to carcinomas and does not apply to lymphomas, sarcomas, or metastatic tumors to the thyroid gland. WHO Classification of Carcinoma of the ThyroidPapillary carcinomaVariants (in alphabetical order):Classic (usual) Clear cell variant Columnar cell variantCribriform-morular variantDiffuse sclerosing variantFollicular variant Hobnail variant#Macrofollicular variant Microcarcinoma (occult, latent, small, microtumor)Oncocytic or oxyphilic variant (follicular variant, nonfollicular variant) Solid variantTall cell variantWarthin-like variant Follicular carcinomaVariants:Clear cell variantOncocytic (Hürthle cell) variant##Poorly differentiated thyroid carcinomas including insular carcinomaMedullary carcinomaUndifferentiated (anaplastic) carcinomaCarcinoma, type cannot be determined#Upcoming unpublished 4th edition of WHO Classification.## Hürthle cell tumors will have their own chapter in the upcoming WHO Classification 4th edtion.E. Histologic Grade While AJCC includes a generic 4-tiered scheme for thyroid cancers as with other cancers, application of this to the current classification of thyroid cancers is difficult and not particularly relevant, as there is no grading system beyond what is implied by each specific histologic variant. F. Papillary CarcinomaPapillary carcinoma is the most common carcinoma type and consists of numerous named variants, though only a few of these currently have sufficient evidence to be considered clinically and biologically relevant. Thus effort should be made to flag or document the following variants when present: Classic (usual, conventional)Follicular variant, encapsulated/well demarcatedFollicular variant, infiltrativeTall cell variantCribriform-morular variantDiffuse sclerosing variantClassic (usual, conventional) papillary carcinoma is the most common and “default” variant of papillary carcinoma. Tall cell variant of papillary carcinoma is a more aggressive variant that has a higher prevalence of BRAF mutations and is more frequently refractory to radioactive Iodine therapy.PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Nb3JyaXM8L0F1dGhvcj48WWVhcj4yMDEwPC9ZZWFyPjxS

ZWNOdW0+NjwvUmVjTnVtPjxEaXNwbGF5VGV4dD48c3R5bGUgZmFjZT0ic3VwZXJzY3JpcHQiPjYt

ODwvc3R5bGU+PC9EaXNwbGF5VGV4dD48cmVjb3JkPjxyZWMtbnVtYmVyPjY8L3JlYy1udW1iZXI+

PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRiLWlkPSJwczJ3d2RzZnJhMnI1ZWU5emFzeHM1

dDh6d2R3eHJzd2U1eGEiIHRpbWVzdGFtcD0iMTQ3MzExNzEzNiI+Njwva2V5PjwvZm9yZWlnbi1r

ZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9yZWYtdHlwZT48Y29udHJp

YnV0b3JzPjxhdXRob3JzPjxhdXRob3I+TW9ycmlzLCBMLiBHLjwvYXV0aG9yPjxhdXRob3I+U2hh

aGEsIEEuIFIuPC9hdXRob3I+PGF1dGhvcj5UdXR0bGUsIFIuIE0uPC9hdXRob3I+PGF1dGhvcj5T

aWtvcmEsIEEuIEcuPC9hdXRob3I+PGF1dGhvcj5HYW5seSwgSS48L2F1dGhvcj48L2F1dGhvcnM+

PC9jb250cmlidXRvcnM+PGF1dGgtYWRkcmVzcz5IZWFkIGFuZCBOZWNrIFNlcnZpY2UsIERlcGFy

dG1lbnQgb2YgU3VyZ2VyeSwgTWVtb3JpYWwgU2xvYW4tS2V0dGVyaW5nIENhbmNlciBDZW50ZXIs

IE5ldyBZb3JrLCBOZXcgWW9yayAxMDAyMSwgVVNBLjwvYXV0aC1hZGRyZXNzPjx0aXRsZXM+PHRp

dGxlPlRhbGwtY2VsbCB2YXJpYW50IG9mIHBhcGlsbGFyeSB0aHlyb2lkIGNhcmNpbm9tYTogYSBt

YXRjaGVkLXBhaXIgYW5hbHlzaXMgb2Ygc3Vydml2YWw8L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+

VGh5cm9pZDwvc2Vjb25kYXJ5LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxl

PlRoeXJvaWQ8L2Z1bGwtdGl0bGU+PC9wZXJpb2RpY2FsPjxwYWdlcz4xNTMtODwvcGFnZXM+PHZv

bHVtZT4yMDwvdm9sdW1lPjxudW1iZXI+MjwvbnVtYmVyPjxlZGl0aW9uPjIwMTAvMDIvMTY8L2Vk

aXRpb24+PGtleXdvcmRzPjxrZXl3b3JkPkNhcmNpbm9tYSwgUGFwaWxsYXJ5Lyptb3J0YWxpdHkv

KnBhdGhvbG9neTwva2V5d29yZD48a2V5d29yZD5IdW1hbnM8L2tleXdvcmQ+PGtleXdvcmQ+TWF0

Y2hlZC1QYWlyIEFuYWx5c2lzPC9rZXl3b3JkPjxrZXl3b3JkPk1pZGRsZSBBZ2VkPC9rZXl3b3Jk

PjxrZXl3b3JkPlByb2dub3Npczwva2V5d29yZD48a2V5d29yZD5TRUVSIFByb2dyYW08L2tleXdv

cmQ+PGtleXdvcmQ+VGh5cm9pZCBHbGFuZC8qcGF0aG9sb2d5PC9rZXl3b3JkPjxrZXl3b3JkPlRo

eXJvaWQgTmVvcGxhc21zLyptb3J0YWxpdHkvKnBhdGhvbG9neTwva2V5d29yZD48a2V5d29yZD5U

cmVhdG1lbnQgT3V0Y29tZTwva2V5d29yZD48L2tleXdvcmRzPjxkYXRlcz48eWVhcj4yMDEwPC95

ZWFyPjxwdWItZGF0ZXM+PGRhdGU+RmViPC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+

MTU1Ny05MDc3IChFbGVjdHJvbmljKSYjeEQ7MTA1MC03MjU2IChMaW5raW5nKTwvaXNibj48YWNj

ZXNzaW9uLW51bT4yMDE1MTgyMjwvYWNjZXNzaW9uLW51bT48dXJscz48cmVsYXRlZC11cmxzPjx1

cmw+aHR0cDovL3d3dy5uY2JpLm5sbS5uaWguZ292L3B1Ym1lZC8yMDE1MTgyMjwvdXJsPjwvcmVs

YXRlZC11cmxzPjwvdXJscz48ZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+MTAuMTA4OS90aHkuMjAw

OS4wMzUyPC9lbGVjdHJvbmljLXJlc291cmNlLW51bT48bGFuZ3VhZ2U+ZW5nPC9sYW5ndWFnZT48

L3JlY29yZD48L0NpdGU+PENpdGU+PEF1dGhvcj5OaWtpZm9yb3Y8L0F1dGhvcj48WWVhcj4yMDEx

PC9ZZWFyPjxSZWNOdW0+NzwvUmVjTnVtPjxyZWNvcmQ+PHJlYy1udW1iZXI+NzwvcmVjLW51bWJl

cj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9InBzMnd3ZHNmcmEycjVlZTl6YXN4

czV0OHp3ZHd4cnN3ZTV4YSIgdGltZXN0YW1wPSIxNDczMTE3MTM2Ij43PC9rZXk+PC9mb3JlaWdu

LWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxjb250

cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5OaWtpZm9yb3YsIFkuIEUuPC9hdXRob3I+PGF1dGhv

cj5OaWtpZm9yb3ZhLCBNLiBOLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48YXV0

aC1hZGRyZXNzPkRlcGFydG1lbnQgb2YgUGF0aG9sb2d5IGFuZCBMYWJvcmF0b3J5IE1lZGljaW5l

LCBVbml2ZXJzaXR5IG9mIFBpdHRzYnVyZ2ggU2Nob29sIG9mIE1lZGljaW5lLCBQVUggQy02MDYs

IDIwMCBMb3Rocm9wIFN0cmVldCwgUGl0dHNidXJnaCwgUEEgMTUyMTMsIFVTQS4gbmlraWZvcm92

eWVAdXBtYy5lZHU8L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5Nb2xlY3VsYXIgZ2VuZXRp

Y3MgYW5kIGRpYWdub3NpcyBvZiB0aHlyb2lkIGNhbmNlcjwvdGl0bGU+PHNlY29uZGFyeS10aXRs

ZT5OYXQgUmV2IEVuZG9jcmlub2w8L3NlY29uZGFyeS10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNh

bD48ZnVsbC10aXRsZT5OYXQgUmV2IEVuZG9jcmlub2w8L2Z1bGwtdGl0bGU+PC9wZXJpb2RpY2Fs

PjxwYWdlcz41NjktODA8L3BhZ2VzPjx2b2x1bWU+Nzwvdm9sdW1lPjxudW1iZXI+MTA8L251bWJl

cj48ZWRpdGlvbj4yMDExLzA5LzAxPC9lZGl0aW9uPjxrZXl3b3Jkcz48a2V5d29yZD5DYXJjaW5v

bWEsIFBhcGlsbGFyeSwgRm9sbGljdWxhci8qZGlhZ25vc2lzL2Vuenltb2xvZ3kvKmdlbmV0aWNz

PC9rZXl3b3JkPjxrZXl3b3JkPkh1bWFuczwva2V5d29yZD48a2V5d29yZD5Nb2xlY3VsYXIgQmlv

bG9neS9tZXRob2RzPC9rZXl3b3JkPjxrZXl3b3JkPlRoeXJvaWQgTmVvcGxhc21zLypkaWFnbm9z

aXMvZW56eW1vbG9neS8qZ2VuZXRpY3M8L2tleXdvcmQ+PGtleXdvcmQ+VHVtb3IgTWFya2Vycywg

QmlvbG9naWNhbC9hbmFseXNpcy9nZW5ldGljczwva2V5d29yZD48L2tleXdvcmRzPjxkYXRlcz48

eWVhcj4yMDExPC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+T2N0PC9kYXRlPjwvcHViLWRhdGVzPjwv

ZGF0ZXM+PGlzYm4+MTc1OS01MDM3IChFbGVjdHJvbmljKSYjeEQ7MTc1OS01MDI5IChMaW5raW5n

KTwvaXNibj48YWNjZXNzaW9uLW51bT4yMTg3ODg5NjwvYWNjZXNzaW9uLW51bT48dXJscz48cmVs

YXRlZC11cmxzPjx1cmw+aHR0cDovL3d3dy5uY2JpLm5sbS5uaWguZ292L3B1Ym1lZC8yMTg3ODg5

NjwvdXJsPjwvcmVsYXRlZC11cmxzPjwvdXJscz48ZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+MTAu

MTAzOC9ucmVuZG8uMjAxMS4xNDImI3hEO25yZW5kby4yMDExLjE0MiBbcGlpXTwvZWxlY3Ryb25p

Yy1yZXNvdXJjZS1udW0+PGxhbmd1YWdlPmVuZzwvbGFuZ3VhZ2U+PC9yZWNvcmQ+PC9DaXRlPjxD

aXRlPjxBdXRob3I+Uml2ZXJhPC9BdXRob3I+PFllYXI+MjAwODwvWWVhcj48UmVjTnVtPjg8L1Jl

Y051bT48cmVjb3JkPjxyZWMtbnVtYmVyPjg8L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5

IGFwcD0iRU4iIGRiLWlkPSJwczJ3d2RzZnJhMnI1ZWU5emFzeHM1dDh6d2R3eHJzd2U1eGEiIHRp

bWVzdGFtcD0iMTQ3MzExNzEzNiI+ODwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1l

PSJKb3VybmFsIEFydGljbGUiPjE3PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxh

dXRob3I+Uml2ZXJhLCBNLjwvYXV0aG9yPjxhdXRob3I+R2hvc3NlaW4sIFIuIEEuPC9hdXRob3I+

PGF1dGhvcj5TY2hvZGVyLCBILjwvYXV0aG9yPjxhdXRob3I+R29tZXosIEQuPC9hdXRob3I+PGF1

dGhvcj5MYXJzb24sIFMuIE0uPC9hdXRob3I+PGF1dGhvcj5UdXR0bGUsIFIuIE0uPC9hdXRob3I+

PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjxhdXRoLWFkZHJlc3M+RGVwYXJ0bWVudCBvZiBQYXRo

b2xvZ3ksIE1lbW9yaWFsIFNsb2FuLUtldHRlcmluZyBDYW5jZXIgQ2VudGVyLCBOZXcgWW9yaywg

TlkgMTAwMjEsIFVTQS48L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5IaXN0b3BhdGhvbG9n

aWMgY2hhcmFjdGVyaXphdGlvbiBvZiByYWRpb2FjdGl2ZSBpb2RpbmUtcmVmcmFjdG9yeSBmbHVv

cm9kZW94eWdsdWNvc2UtcG9zaXRyb24gZW1pc3Npb24gdG9tb2dyYXBoeS1wb3NpdGl2ZSB0aHly

b2lkIGNhcmNpbm9tYTwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5DYW5jZXI8L3NlY29uZGFyeS10

aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5DYW5jZXI8L2Z1bGwtdGl0bGU+

PC9wZXJpb2RpY2FsPjxwYWdlcz40OC01NjwvcGFnZXM+PHZvbHVtZT4xMTM8L3ZvbHVtZT48bnVt

YmVyPjE8L251bWJlcj48ZWRpdGlvbj4yMDA4LzA1LzIwPC9lZGl0aW9uPjxrZXl3b3Jkcz48a2V5

d29yZD5BZHVsdDwva2V5d29yZD48a2V5d29yZD5BZ2VkPC9rZXl3b3JkPjxrZXl3b3JkPkRpc2Vh

c2UtRnJlZSBTdXJ2aXZhbDwva2V5d29yZD48a2V5d29yZD5GZW1hbGU8L2tleXdvcmQ+PGtleXdv

cmQ+Rmx1b3JvZGVveHlnbHVjb3NlIEYxOC9kaWFnbm9zdGljIHVzZTwva2V5d29yZD48a2V5d29y

ZD5IdW1hbnM8L2tleXdvcmQ+PGtleXdvcmQ+SW9kaW5lIFJhZGlvaXNvdG9wZXMvZGlhZ25vc3Rp

YyB1c2U8L2tleXdvcmQ+PGtleXdvcmQ+TWFsZTwva2V5d29yZD48a2V5d29yZD5NaWRkbGUgQWdl

ZDwva2V5d29yZD48a2V5d29yZD5OZW9wbGFzbSBNZXRhc3Rhc2lzPC9rZXl3b3JkPjxrZXl3b3Jk

Pk5lb3BsYXNtIFJlY3VycmVuY2UsIExvY2FsPC9rZXl3b3JkPjxrZXl3b3JkPlBvc2l0cm9uLUVt

aXNzaW9uIFRvbW9ncmFwaHk8L2tleXdvcmQ+PGtleXdvcmQ+UmFkaW9waGFybWFjZXV0aWNhbHM8

L2tleXdvcmQ+PGtleXdvcmQ+U3Vydml2YWwgQW5hbHlzaXM8L2tleXdvcmQ+PGtleXdvcmQ+VGh5

cm9pZCBOZW9wbGFzbXMvKnBhdGhvbG9neTwva2V5d29yZD48L2tleXdvcmRzPjxkYXRlcz48eWVh

cj4yMDA4PC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+SnVsIDE8L2RhdGU+PC9wdWItZGF0ZXM+PC9k

YXRlcz48aXNibj4wMDA4LTU0M1ggKFByaW50KSYjeEQ7MDAwOC01NDNYIChMaW5raW5nKTwvaXNi

bj48YWNjZXNzaW9uLW51bT4xODQ4NDU4NDwvYWNjZXNzaW9uLW51bT48dXJscz48cmVsYXRlZC11

cmxzPjx1cmw+aHR0cDovL3d3dy5uY2JpLm5sbS5uaWguZ292L3B1Ym1lZC8xODQ4NDU4NDwvdXJs

PjwvcmVsYXRlZC11cmxzPjwvdXJscz48ZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+MTAuMTAwMi9j

bmNyLjIzNTE1PC9lbGVjdHJvbmljLXJlc291cmNlLW51bT48bGFuZ3VhZ2U+ZW5nPC9sYW5ndWFn

ZT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPgB=

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Nb3JyaXM8L0F1dGhvcj48WWVhcj4yMDEwPC9ZZWFyPjxS

ZWNOdW0+NjwvUmVjTnVtPjxEaXNwbGF5VGV4dD48c3R5bGUgZmFjZT0ic3VwZXJzY3JpcHQiPjYt

ODwvc3R5bGU+PC9EaXNwbGF5VGV4dD48cmVjb3JkPjxyZWMtbnVtYmVyPjY8L3JlYy1udW1iZXI+

PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRiLWlkPSJwczJ3d2RzZnJhMnI1ZWU5emFzeHM1

dDh6d2R3eHJzd2U1eGEiIHRpbWVzdGFtcD0iMTQ3MzExNzEzNiI+Njwva2V5PjwvZm9yZWlnbi1r

ZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9yZWYtdHlwZT48Y29udHJp

YnV0b3JzPjxhdXRob3JzPjxhdXRob3I+TW9ycmlzLCBMLiBHLjwvYXV0aG9yPjxhdXRob3I+U2hh

aGEsIEEuIFIuPC9hdXRob3I+PGF1dGhvcj5UdXR0bGUsIFIuIE0uPC9hdXRob3I+PGF1dGhvcj5T

aWtvcmEsIEEuIEcuPC9hdXRob3I+PGF1dGhvcj5HYW5seSwgSS48L2F1dGhvcj48L2F1dGhvcnM+

PC9jb250cmlidXRvcnM+PGF1dGgtYWRkcmVzcz5IZWFkIGFuZCBOZWNrIFNlcnZpY2UsIERlcGFy

dG1lbnQgb2YgU3VyZ2VyeSwgTWVtb3JpYWwgU2xvYW4tS2V0dGVyaW5nIENhbmNlciBDZW50ZXIs

IE5ldyBZb3JrLCBOZXcgWW9yayAxMDAyMSwgVVNBLjwvYXV0aC1hZGRyZXNzPjx0aXRsZXM+PHRp

dGxlPlRhbGwtY2VsbCB2YXJpYW50IG9mIHBhcGlsbGFyeSB0aHlyb2lkIGNhcmNpbm9tYTogYSBt

YXRjaGVkLXBhaXIgYW5hbHlzaXMgb2Ygc3Vydml2YWw8L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+

VGh5cm9pZDwvc2Vjb25kYXJ5LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxl

PlRoeXJvaWQ8L2Z1bGwtdGl0bGU+PC9wZXJpb2RpY2FsPjxwYWdlcz4xNTMtODwvcGFnZXM+PHZv

bHVtZT4yMDwvdm9sdW1lPjxudW1iZXI+MjwvbnVtYmVyPjxlZGl0aW9uPjIwMTAvMDIvMTY8L2Vk

aXRpb24+PGtleXdvcmRzPjxrZXl3b3JkPkNhcmNpbm9tYSwgUGFwaWxsYXJ5Lyptb3J0YWxpdHkv

KnBhdGhvbG9neTwva2V5d29yZD48a2V5d29yZD5IdW1hbnM8L2tleXdvcmQ+PGtleXdvcmQ+TWF0

Y2hlZC1QYWlyIEFuYWx5c2lzPC9rZXl3b3JkPjxrZXl3b3JkPk1pZGRsZSBBZ2VkPC9rZXl3b3Jk

PjxrZXl3b3JkPlByb2dub3Npczwva2V5d29yZD48a2V5d29yZD5TRUVSIFByb2dyYW08L2tleXdv

cmQ+PGtleXdvcmQ+VGh5cm9pZCBHbGFuZC8qcGF0aG9sb2d5PC9rZXl3b3JkPjxrZXl3b3JkPlRo

eXJvaWQgTmVvcGxhc21zLyptb3J0YWxpdHkvKnBhdGhvbG9neTwva2V5d29yZD48a2V5d29yZD5U

cmVhdG1lbnQgT3V0Y29tZTwva2V5d29yZD48L2tleXdvcmRzPjxkYXRlcz48eWVhcj4yMDEwPC95

ZWFyPjxwdWItZGF0ZXM+PGRhdGU+RmViPC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+

MTU1Ny05MDc3IChFbGVjdHJvbmljKSYjeEQ7MTA1MC03MjU2IChMaW5raW5nKTwvaXNibj48YWNj

ZXNzaW9uLW51bT4yMDE1MTgyMjwvYWNjZXNzaW9uLW51bT48dXJscz48cmVsYXRlZC11cmxzPjx1

cmw+aHR0cDovL3d3dy5uY2JpLm5sbS5uaWguZ292L3B1Ym1lZC8yMDE1MTgyMjwvdXJsPjwvcmVs

YXRlZC11cmxzPjwvdXJscz48ZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+MTAuMTA4OS90aHkuMjAw

OS4wMzUyPC9lbGVjdHJvbmljLXJlc291cmNlLW51bT48bGFuZ3VhZ2U+ZW5nPC9sYW5ndWFnZT48

L3JlY29yZD48L0NpdGU+PENpdGU+PEF1dGhvcj5OaWtpZm9yb3Y8L0F1dGhvcj48WWVhcj4yMDEx

PC9ZZWFyPjxSZWNOdW0+NzwvUmVjTnVtPjxyZWNvcmQ+PHJlYy1udW1iZXI+NzwvcmVjLW51bWJl

cj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9InBzMnd3ZHNmcmEycjVlZTl6YXN4

czV0OHp3ZHd4cnN3ZTV4YSIgdGltZXN0YW1wPSIxNDczMTE3MTM2Ij43PC9rZXk+PC9mb3JlaWdu

LWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxjb250

cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5OaWtpZm9yb3YsIFkuIEUuPC9hdXRob3I+PGF1dGhv

cj5OaWtpZm9yb3ZhLCBNLiBOLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48YXV0

aC1hZGRyZXNzPkRlcGFydG1lbnQgb2YgUGF0aG9sb2d5IGFuZCBMYWJvcmF0b3J5IE1lZGljaW5l

LCBVbml2ZXJzaXR5IG9mIFBpdHRzYnVyZ2ggU2Nob29sIG9mIE1lZGljaW5lLCBQVUggQy02MDYs

IDIwMCBMb3Rocm9wIFN0cmVldCwgUGl0dHNidXJnaCwgUEEgMTUyMTMsIFVTQS4gbmlraWZvcm92

eWVAdXBtYy5lZHU8L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5Nb2xlY3VsYXIgZ2VuZXRp

Y3MgYW5kIGRpYWdub3NpcyBvZiB0aHlyb2lkIGNhbmNlcjwvdGl0bGU+PHNlY29uZGFyeS10aXRs

ZT5OYXQgUmV2IEVuZG9jcmlub2w8L3NlY29uZGFyeS10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNh

bD48ZnVsbC10aXRsZT5OYXQgUmV2IEVuZG9jcmlub2w8L2Z1bGwtdGl0bGU+PC9wZXJpb2RpY2Fs

PjxwYWdlcz41NjktODA8L3BhZ2VzPjx2b2x1bWU+Nzwvdm9sdW1lPjxudW1iZXI+MTA8L251bWJl

cj48ZWRpdGlvbj4yMDExLzA5LzAxPC9lZGl0aW9uPjxrZXl3b3Jkcz48a2V5d29yZD5DYXJjaW5v

bWEsIFBhcGlsbGFyeSwgRm9sbGljdWxhci8qZGlhZ25vc2lzL2Vuenltb2xvZ3kvKmdlbmV0aWNz

PC9rZXl3b3JkPjxrZXl3b3JkPkh1bWFuczwva2V5d29yZD48a2V5d29yZD5Nb2xlY3VsYXIgQmlv

bG9neS9tZXRob2RzPC9rZXl3b3JkPjxrZXl3b3JkPlRoeXJvaWQgTmVvcGxhc21zLypkaWFnbm9z

aXMvZW56eW1vbG9neS8qZ2VuZXRpY3M8L2tleXdvcmQ+PGtleXdvcmQ+VHVtb3IgTWFya2Vycywg

QmlvbG9naWNhbC9hbmFseXNpcy9nZW5ldGljczwva2V5d29yZD48L2tleXdvcmRzPjxkYXRlcz48

eWVhcj4yMDExPC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+T2N0PC9kYXRlPjwvcHViLWRhdGVzPjwv

ZGF0ZXM+PGlzYm4+MTc1OS01MDM3IChFbGVjdHJvbmljKSYjeEQ7MTc1OS01MDI5IChMaW5raW5n

KTwvaXNibj48YWNjZXNzaW9uLW51bT4yMTg3ODg5NjwvYWNjZXNzaW9uLW51bT48dXJscz48cmVs

YXRlZC11cmxzPjx1cmw+aHR0cDovL3d3dy5uY2JpLm5sbS5uaWguZ292L3B1Ym1lZC8yMTg3ODg5

NjwvdXJsPjwvcmVsYXRlZC11cmxzPjwvdXJscz48ZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+MTAu

MTAzOC9ucmVuZG8uMjAxMS4xNDImI3hEO25yZW5kby4yMDExLjE0MiBbcGlpXTwvZWxlY3Ryb25p

Yy1yZXNvdXJjZS1udW0+PGxhbmd1YWdlPmVuZzwvbGFuZ3VhZ2U+PC9yZWNvcmQ+PC9DaXRlPjxD

aXRlPjxBdXRob3I+Uml2ZXJhPC9BdXRob3I+PFllYXI+MjAwODwvWWVhcj48UmVjTnVtPjg8L1Jl

Y051bT48cmVjb3JkPjxyZWMtbnVtYmVyPjg8L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5

IGFwcD0iRU4iIGRiLWlkPSJwczJ3d2RzZnJhMnI1ZWU5emFzeHM1dDh6d2R3eHJzd2U1eGEiIHRp

bWVzdGFtcD0iMTQ3MzExNzEzNiI+ODwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1l

PSJKb3VybmFsIEFydGljbGUiPjE3PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxh

dXRob3I+Uml2ZXJhLCBNLjwvYXV0aG9yPjxhdXRob3I+R2hvc3NlaW4sIFIuIEEuPC9hdXRob3I+

PGF1dGhvcj5TY2hvZGVyLCBILjwvYXV0aG9yPjxhdXRob3I+R29tZXosIEQuPC9hdXRob3I+PGF1

dGhvcj5MYXJzb24sIFMuIE0uPC9hdXRob3I+PGF1dGhvcj5UdXR0bGUsIFIuIE0uPC9hdXRob3I+

PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjxhdXRoLWFkZHJlc3M+RGVwYXJ0bWVudCBvZiBQYXRo

b2xvZ3ksIE1lbW9yaWFsIFNsb2FuLUtldHRlcmluZyBDYW5jZXIgQ2VudGVyLCBOZXcgWW9yaywg

TlkgMTAwMjEsIFVTQS48L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5IaXN0b3BhdGhvbG9n

aWMgY2hhcmFjdGVyaXphdGlvbiBvZiByYWRpb2FjdGl2ZSBpb2RpbmUtcmVmcmFjdG9yeSBmbHVv

cm9kZW94eWdsdWNvc2UtcG9zaXRyb24gZW1pc3Npb24gdG9tb2dyYXBoeS1wb3NpdGl2ZSB0aHly

b2lkIGNhcmNpbm9tYTwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5DYW5jZXI8L3NlY29uZGFyeS10

aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5DYW5jZXI8L2Z1bGwtdGl0bGU+

PC9wZXJpb2RpY2FsPjxwYWdlcz40OC01NjwvcGFnZXM+PHZvbHVtZT4xMTM8L3ZvbHVtZT48bnVt

YmVyPjE8L251bWJlcj48ZWRpdGlvbj4yMDA4LzA1LzIwPC9lZGl0aW9uPjxrZXl3b3Jkcz48a2V5

d29yZD5BZHVsdDwva2V5d29yZD48a2V5d29yZD5BZ2VkPC9rZXl3b3JkPjxrZXl3b3JkPkRpc2Vh

c2UtRnJlZSBTdXJ2aXZhbDwva2V5d29yZD48a2V5d29yZD5GZW1hbGU8L2tleXdvcmQ+PGtleXdv

cmQ+Rmx1b3JvZGVveHlnbHVjb3NlIEYxOC9kaWFnbm9zdGljIHVzZTwva2V5d29yZD48a2V5d29y

ZD5IdW1hbnM8L2tleXdvcmQ+PGtleXdvcmQ+SW9kaW5lIFJhZGlvaXNvdG9wZXMvZGlhZ25vc3Rp

YyB1c2U8L2tleXdvcmQ+PGtleXdvcmQ+TWFsZTwva2V5d29yZD48a2V5d29yZD5NaWRkbGUgQWdl

ZDwva2V5d29yZD48a2V5d29yZD5OZW9wbGFzbSBNZXRhc3Rhc2lzPC9rZXl3b3JkPjxrZXl3b3Jk

Pk5lb3BsYXNtIFJlY3VycmVuY2UsIExvY2FsPC9rZXl3b3JkPjxrZXl3b3JkPlBvc2l0cm9uLUVt

aXNzaW9uIFRvbW9ncmFwaHk8L2tleXdvcmQ+PGtleXdvcmQ+UmFkaW9waGFybWFjZXV0aWNhbHM8

L2tleXdvcmQ+PGtleXdvcmQ+U3Vydml2YWwgQW5hbHlzaXM8L2tleXdvcmQ+PGtleXdvcmQ+VGh5

cm9pZCBOZW9wbGFzbXMvKnBhdGhvbG9neTwva2V5d29yZD48L2tleXdvcmRzPjxkYXRlcz48eWVh

cj4yMDA4PC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+SnVsIDE8L2RhdGU+PC9wdWItZGF0ZXM+PC9k

YXRlcz48aXNibj4wMDA4LTU0M1ggKFByaW50KSYjeEQ7MDAwOC01NDNYIChMaW5raW5nKTwvaXNi

bj48YWNjZXNzaW9uLW51bT4xODQ4NDU4NDwvYWNjZXNzaW9uLW51bT48dXJscz48cmVsYXRlZC11

cmxzPjx1cmw+aHR0cDovL3d3dy5uY2JpLm5sbS5uaWguZ292L3B1Ym1lZC8xODQ4NDU4NDwvdXJs

PjwvcmVsYXRlZC11cmxzPjwvdXJscz48ZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+MTAuMTAwMi9j

bmNyLjIzNTE1PC9lbGVjdHJvbmljLXJlc291cmNlLW51bT48bGFuZ3VhZ2U+ZW5nPC9sYW5ndWFn

ZT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPgB=

ADDIN EN.CITE.DATA 6-8 The cribriform morular variant is a biologically distinct variant characterized by APC or beta catenin mutations and shows an association with familial adenomatous polyposis coli, in some cases preceding recognition of colon polyps or other extracolonic manifestations. ADDIN EN.CITE <EndNote><Cite><Author>Cameselle-Teijeiro</Author><Year>1999</Year><RecNum>9</RecNum><DisplayText><style face="superscript">9</style></DisplayText><record><rec-number>9</rec-number><foreign-keys><key app="EN" db-id="ps2wwdsfra2r5ee9zasxs5t8zwdwxrswe5xa" timestamp="1473117136">9</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Cameselle-Teijeiro, J.</author><author>Chan, J. K.</author></authors></contributors><auth-address>Department of Pathology, Hospital Xeral de Galicia, Santiago de Compostela, Spain. apjocame@usc.es</auth-address><titles><title>Cribriform-morular variant of papillary carcinoma: a distinctive variant representing the sporadic counterpart of familial adenomatous polyposis-associated thyroid carcinoma?</title><secondary-title>Mod Pathol</secondary-title></titles><periodical><full-title>Mod Pathol</full-title></periodical><pages>400-11</pages><volume>12</volume><number>4</number><edition>1999/05/06</edition><keywords><keyword>Adenomatous Polyposis Coli/pathology</keyword><keyword>Adolescent</keyword><keyword>Adult</keyword><keyword>Carcinoma, Papillary/metabolism/*pathology</keyword><keyword>Female</keyword><keyword>Humans</keyword><keyword>Immunohistochemistry</keyword><keyword>Keratins/analysis</keyword><keyword>Mucin-1/analysis</keyword><keyword>Phosphopyruvate Hydratase/analysis</keyword><keyword>Thyroglobulin/analysis</keyword><keyword>Thyroid Neoplasms/metabolism/*pathology</keyword><keyword>Vimentin/analysis</keyword></keywords><dates><year>1999</year><pub-dates><date>Apr</date></pub-dates></dates><isbn>0893-3952 (Print)&#xD;0893-3952 (Linking)</isbn><accession-num>10229505</accession-num><urls><related-urls><url> Diffuse sclerosing variant is a locoregionally aggressive variant with a high rate of nodal metastasis and locoregional recurrence, though overall survival when corrected for other high-risk parameters is not entirely clear. Nonetheless, this variant appears to necessitate more aggressive initial surgical management including extent of node dissection.PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5SZWdhbGJ1dG88L0F1dGhvcj48WWVhcj4yMDExPC9ZZWFy

PjxSZWNOdW0+MTA8L1JlY051bT48RGlzcGxheVRleHQ+PHN0eWxlIGZhY2U9InN1cGVyc2NyaXB0

Ij4xMDwvc3R5bGU+PC9EaXNwbGF5VGV4dD48cmVjb3JkPjxyZWMtbnVtYmVyPjEwPC9yZWMtbnVt

YmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0icHMyd3dkc2ZyYTJyNWVlOXph

c3hzNXQ4endkd3hyc3dlNXhhIiB0aW1lc3RhbXA9IjE0NzMxMTcxMzYiPjEwPC9rZXk+PC9mb3Jl

aWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxj

b250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5SZWdhbGJ1dG8sIEMuPC9hdXRob3I+PGF1dGhv

cj5NYWxhbmRyaW5vLCBQLjwvYXV0aG9yPjxhdXRob3I+VHVtbWluaWEsIEEuPC9hdXRob3I+PGF1

dGhvcj5MZSBNb2xpLCBSLjwvYXV0aG9yPjxhdXRob3I+VmlnbmVyaSwgUi48L2F1dGhvcj48YXV0

aG9yPlBlenppbm8sIFYuPC9hdXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjxhdXRoLWFk

ZHJlc3M+RW5kb2NyaW5vbG9neSwgRGVwYXJ0bWVudCBvZiBDbGluaWNhbCBhbmQgTW9sZWN1bGFy

IE1lZGljaW5lIG9mIHRoZSBVbml2ZXJzaXR5IG9mIENhdGFuaWEsIEdhcmliYWxkaS1OZXNpbWEg

SG9zcGl0YWwsIENhdGFuaWEsIEl0YWx5LjwvYXV0aC1hZGRyZXNzPjx0aXRsZXM+PHRpdGxlPkEg

ZGlmZnVzZSBzY2xlcm9zaW5nIHZhcmlhbnQgb2YgcGFwaWxsYXJ5IHRoeXJvaWQgY2FyY2lub21h

OiBjbGluaWNhbCBhbmQgcGF0aG9sb2dpYyBmZWF0dXJlcyBhbmQgb3V0Y29tZXMgb2YgMzQgY29u

c2VjdXRpdmUgY2FzZXM8L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+VGh5cm9pZDwvc2Vjb25kYXJ5

LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPlRoeXJvaWQ8L2Z1bGwtdGl0

bGU+PC9wZXJpb2RpY2FsPjxwYWdlcz4zODMtOTwvcGFnZXM+PHZvbHVtZT4yMTwvdm9sdW1lPjxu

dW1iZXI+NDwvbnVtYmVyPjxlZGl0aW9uPjIwMTEvMDIvMTI8L2VkaXRpb24+PGtleXdvcmRzPjxr

ZXl3b3JkPkFkdWx0PC9rZXl3b3JkPjxrZXl3b3JkPkNhcmNpbm9tYTwva2V5d29yZD48a2V5d29y

ZD5DYXJjaW5vbWEsIFBhcGlsbGFyeS9lcGlkZW1pb2xvZ3kvKnBhdGhvbG9neS9zdXJnZXJ5PC9r

ZXl3b3JkPjxrZXl3b3JkPkZlbWFsZTwva2V5d29yZD48a2V5d29yZD5IdW1hbnM8L2tleXdvcmQ+

PGtleXdvcmQ+SXRhbHkvZXBpZGVtaW9sb2d5PC9rZXl3b3JkPjxrZXl3b3JkPkx5bXBoYXRpYyBN

ZXRhc3Rhc2lzPC9rZXl3b3JkPjxrZXl3b3JkPk1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+TWlkZGxl

IEFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+TmVvcGxhc20gUmVjdXJyZW5jZSwgTG9jYWwvZXBpZGVt

aW9sb2d5PC9rZXl3b3JkPjxrZXl3b3JkPlByb3BvcnRpb25hbCBIYXphcmRzIE1vZGVsczwva2V5

d29yZD48a2V5d29yZD5SZXRyb3NwZWN0aXZlIFN0dWRpZXM8L2tleXdvcmQ+PGtleXdvcmQ+Umlz

azwva2V5d29yZD48a2V5d29yZD5TY2xlcm9kZXJtYSwgRGlmZnVzZS9lcGlkZW1pb2xvZ3kvcGF0

aG9sb2d5L3N1cmdlcnk8L2tleXdvcmQ+PGtleXdvcmQ+VGh5cm9pZCBOZW9wbGFzbXMvZXBpZGVt

aW9sb2d5L3BhdGhvbG9neS9zdXJnZXJ5PC9rZXl3b3JkPjxrZXl3b3JkPlRoeXJvaWRlY3RvbXk8

L2tleXdvcmQ+PGtleXdvcmQ+VHJlYXRtZW50IE91dGNvbWU8L2tleXdvcmQ+PC9rZXl3b3Jkcz48

ZGF0ZXM+PHllYXI+MjAxMTwveWVhcj48cHViLWRhdGVzPjxkYXRlPkFwcjwvZGF0ZT48L3B1Yi1k

YXRlcz48L2RhdGVzPjxpc2JuPjE1NTctOTA3NyAoRWxlY3Ryb25pYykmI3hEOzEwNTAtNzI1NiAo

TGlua2luZyk8L2lzYm4+PGFjY2Vzc2lvbi1udW0+MjEzMDk3MjI8L2FjY2Vzc2lvbi1udW0+PHVy

bHM+PHJlbGF0ZWQtdXJscz48dXJsPmh0dHA6Ly93d3cubmNiaS5ubG0ubmloLmdvdi9wdWJtZWQv

MjEzMDk3MjI8L3VybD48L3JlbGF0ZWQtdXJscz48L3VybHM+PGVsZWN0cm9uaWMtcmVzb3VyY2Ut

bnVtPjEwLjEwODkvdGh5LjIwMTAuMDMzMTwvZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+PGxhbmd1

YWdlPmVuZzwvbGFuZ3VhZ2U+PC9yZWNvcmQ+PC9DaXRlPjwvRW5kTm90ZT4A

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5SZWdhbGJ1dG88L0F1dGhvcj48WWVhcj4yMDExPC9ZZWFy

PjxSZWNOdW0+MTA8L1JlY051bT48RGlzcGxheVRleHQ+PHN0eWxlIGZhY2U9InN1cGVyc2NyaXB0

Ij4xMDwvc3R5bGU+PC9EaXNwbGF5VGV4dD48cmVjb3JkPjxyZWMtbnVtYmVyPjEwPC9yZWMtbnVt

YmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0icHMyd3dkc2ZyYTJyNWVlOXph

c3hzNXQ4endkd3hyc3dlNXhhIiB0aW1lc3RhbXA9IjE0NzMxMTcxMzYiPjEwPC9rZXk+PC9mb3Jl

aWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxj

b250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5SZWdhbGJ1dG8sIEMuPC9hdXRob3I+PGF1dGhv

cj5NYWxhbmRyaW5vLCBQLjwvYXV0aG9yPjxhdXRob3I+VHVtbWluaWEsIEEuPC9hdXRob3I+PGF1

dGhvcj5MZSBNb2xpLCBSLjwvYXV0aG9yPjxhdXRob3I+VmlnbmVyaSwgUi48L2F1dGhvcj48YXV0

aG9yPlBlenppbm8sIFYuPC9hdXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjxhdXRoLWFk

ZHJlc3M+RW5kb2NyaW5vbG9neSwgRGVwYXJ0bWVudCBvZiBDbGluaWNhbCBhbmQgTW9sZWN1bGFy

IE1lZGljaW5lIG9mIHRoZSBVbml2ZXJzaXR5IG9mIENhdGFuaWEsIEdhcmliYWxkaS1OZXNpbWEg

SG9zcGl0YWwsIENhdGFuaWEsIEl0YWx5LjwvYXV0aC1hZGRyZXNzPjx0aXRsZXM+PHRpdGxlPkEg

ZGlmZnVzZSBzY2xlcm9zaW5nIHZhcmlhbnQgb2YgcGFwaWxsYXJ5IHRoeXJvaWQgY2FyY2lub21h

OiBjbGluaWNhbCBhbmQgcGF0aG9sb2dpYyBmZWF0dXJlcyBhbmQgb3V0Y29tZXMgb2YgMzQgY29u

c2VjdXRpdmUgY2FzZXM8L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+VGh5cm9pZDwvc2Vjb25kYXJ5

LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPlRoeXJvaWQ8L2Z1bGwtdGl0

bGU+PC9wZXJpb2RpY2FsPjxwYWdlcz4zODMtOTwvcGFnZXM+PHZvbHVtZT4yMTwvdm9sdW1lPjxu

dW1iZXI+NDwvbnVtYmVyPjxlZGl0aW9uPjIwMTEvMDIvMTI8L2VkaXRpb24+PGtleXdvcmRzPjxr

ZXl3b3JkPkFkdWx0PC9rZXl3b3JkPjxrZXl3b3JkPkNhcmNpbm9tYTwva2V5d29yZD48a2V5d29y

ZD5DYXJjaW5vbWEsIFBhcGlsbGFyeS9lcGlkZW1pb2xvZ3kvKnBhdGhvbG9neS9zdXJnZXJ5PC9r

ZXl3b3JkPjxrZXl3b3JkPkZlbWFsZTwva2V5d29yZD48a2V5d29yZD5IdW1hbnM8L2tleXdvcmQ+

PGtleXdvcmQ+SXRhbHkvZXBpZGVtaW9sb2d5PC9rZXl3b3JkPjxrZXl3b3JkPkx5bXBoYXRpYyBN

ZXRhc3Rhc2lzPC9rZXl3b3JkPjxrZXl3b3JkPk1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+TWlkZGxl

IEFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+TmVvcGxhc20gUmVjdXJyZW5jZSwgTG9jYWwvZXBpZGVt

aW9sb2d5PC9rZXl3b3JkPjxrZXl3b3JkPlByb3BvcnRpb25hbCBIYXphcmRzIE1vZGVsczwva2V5

d29yZD48a2V5d29yZD5SZXRyb3NwZWN0aXZlIFN0dWRpZXM8L2tleXdvcmQ+PGtleXdvcmQ+Umlz

azwva2V5d29yZD48a2V5d29yZD5TY2xlcm9kZXJtYSwgRGlmZnVzZS9lcGlkZW1pb2xvZ3kvcGF0

aG9sb2d5L3N1cmdlcnk8L2tleXdvcmQ+PGtleXdvcmQ+VGh5cm9pZCBOZW9wbGFzbXMvZXBpZGVt

aW9sb2d5L3BhdGhvbG9neS9zdXJnZXJ5PC9rZXl3b3JkPjxrZXl3b3JkPlRoeXJvaWRlY3RvbXk8

L2tleXdvcmQ+PGtleXdvcmQ+VHJlYXRtZW50IE91dGNvbWU8L2tleXdvcmQ+PC9rZXl3b3Jkcz48

ZGF0ZXM+PHllYXI+MjAxMTwveWVhcj48cHViLWRhdGVzPjxkYXRlPkFwcjwvZGF0ZT48L3B1Yi1k

YXRlcz48L2RhdGVzPjxpc2JuPjE1NTctOTA3NyAoRWxlY3Ryb25pYykmI3hEOzEwNTAtNzI1NiAo

TGlua2luZyk8L2lzYm4+PGFjY2Vzc2lvbi1udW0+MjEzMDk3MjI8L2FjY2Vzc2lvbi1udW0+PHVy

bHM+PHJlbGF0ZWQtdXJscz48dXJsPmh0dHA6Ly93d3cubmNiaS5ubG0ubmloLmdvdi9wdWJtZWQv

MjEzMDk3MjI8L3VybD48L3JlbGF0ZWQtdXJscz48L3VybHM+PGVsZWN0cm9uaWMtcmVzb3VyY2Ut

bnVtPjEwLjEwODkvdGh5LjIwMTAuMDMzMTwvZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+PGxhbmd1

YWdlPmVuZzwvbGFuZ3VhZ2U+PC9yZWNvcmQ+PC9DaXRlPjwvRW5kTm90ZT4A

ADDIN EN.CITE.DATA 10 Follicular variant of papillary carcinoma is important to document because it has recently been substratified based on outcome into noninvasive (encapsulated/well demarcated) and infiltrative follicular variants. Unencapsulated follicular variants have a behavior similar to classic papillary carcinoma, particularly in terms of propensity for nodal metastasis, while the behavior of encapsulated follicular variant is more indolent.PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5SaXZlcmE8L0F1dGhvcj48WWVhcj4yMDA5PC9ZZWFyPjxS

ZWNOdW0+MTE8L1JlY051bT48RGlzcGxheVRleHQ+PHN0eWxlIGZhY2U9InN1cGVyc2NyaXB0Ij4x

MSwxMjwvc3R5bGU+PC9EaXNwbGF5VGV4dD48cmVjb3JkPjxyZWMtbnVtYmVyPjExPC9yZWMtbnVt

YmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0icHMyd3dkc2ZyYTJyNWVlOXph

c3hzNXQ4endkd3hyc3dlNXhhIiB0aW1lc3RhbXA9IjE0NzMxMTcxMzYiPjExPC9rZXk+PC9mb3Jl

aWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxj

b250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5SaXZlcmEsIE0uPC9hdXRob3I+PGF1dGhvcj5U

dXR0bGUsIFIuIE0uPC9hdXRob3I+PGF1dGhvcj5QYXRlbCwgUy48L2F1dGhvcj48YXV0aG9yPlNo

YWhhLCBBLjwvYXV0aG9yPjxhdXRob3I+U2hhaCwgSi4gUC48L2F1dGhvcj48YXV0aG9yPkdob3Nz

ZWluLCBSLiBBLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48YXV0aC1hZGRyZXNz

PkRlcGFydG1lbnQgb2YgUGF0aG9sb2d5LCBNZW1vcmlhbCBTbG9hbi1LZXR0ZXJpbmcgQ2FuY2Vy

IENlbnRlciAsIE5ldyBZb3JrLCBOZXcgWW9yaywgVVNBLjwvYXV0aC1hZGRyZXNzPjx0aXRsZXM+

PHRpdGxlPkVuY2Fwc3VsYXRlZCBwYXBpbGxhcnkgdGh5cm9pZCBjYXJjaW5vbWE6IGEgY2xpbmlj

by1wYXRob2xvZ2ljIHN0dWR5IG9mIDEwNiBjYXNlcyB3aXRoIGVtcGhhc2lzIG9uIGl0cyBtb3Jw

aG9sb2dpYyBzdWJ0eXBlcyAoaGlzdG9sb2dpYyBncm93dGggcGF0dGVybik8L3RpdGxlPjxzZWNv

bmRhcnktdGl0bGU+VGh5cm9pZDwvc2Vjb25kYXJ5LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2Fs

PjxmdWxsLXRpdGxlPlRoeXJvaWQ8L2Z1bGwtdGl0bGU+PC9wZXJpb2RpY2FsPjxwYWdlcz4xMTkt

Mjc8L3BhZ2VzPjx2b2x1bWU+MTk8L3ZvbHVtZT48bnVtYmVyPjI8L251bWJlcj48ZWRpdGlvbj4y

MDA5LzAyLzA1PC9lZGl0aW9uPjxrZXl3b3Jkcz48a2V5d29yZD5BZGVub2NhcmNpbm9tYSwgRm9s

bGljdWxhci9wYXRob2xvZ3k8L2tleXdvcmQ+PGtleXdvcmQ+QWRlbm9jYXJjaW5vbWEsIFBhcGls

bGFyeS9wYXRob2xvZ3k8L2tleXdvcmQ+PGtleXdvcmQ+QWR1bHQ8L2tleXdvcmQ+PGtleXdvcmQ+

QWdlZCwgODAgYW5kIG92ZXI8L2tleXdvcmQ+PGtleXdvcmQ+Q2FyY2lub21hLCBQYXBpbGxhcnkv

cGF0aG9sb2d5PC9rZXl3b3JkPjxrZXl3b3JkPkZlbWFsZTwva2V5d29yZD48a2V5d29yZD5IdW1h

bnM8L2tleXdvcmQ+PGtleXdvcmQ+THltcGhhdGljIE1ldGFzdGFzaXMvcGF0aG9sb2d5PC9rZXl3

b3JkPjxrZXl3b3JkPk1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+TWlkZGxlIEFnZWQ8L2tleXdvcmQ+

PGtleXdvcmQ+TmVvcGxhc20gSW52YXNpdmVuZXNzL3BhdGhvbG9neTwva2V5d29yZD48a2V5d29y

ZD5SZXRyb3NwZWN0aXZlIFN0dWRpZXM8L2tleXdvcmQ+PGtleXdvcmQ+VGh5cm9pZCBHbGFuZC8q

cGF0aG9sb2d5PC9rZXl3b3JkPjxrZXl3b3JkPlRoeXJvaWQgTmVvcGxhc21zLypwYXRob2xvZ3kv

c3VyZ2VyeTwva2V5d29yZD48a2V5d29yZD5UcmVhdG1lbnQgT3V0Y29tZTwva2V5d29yZD48L2tl

eXdvcmRzPjxkYXRlcz48eWVhcj4yMDA5PC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+RmViPC9kYXRl

PjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+MTU1Ny05MDc3IChFbGVjdHJvbmljKSYjeEQ7MTA1

MC03MjU2IChMaW5raW5nKTwvaXNibj48YWNjZXNzaW9uLW51bT4xOTE5MTc0NDwvYWNjZXNzaW9u

LW51bT48dXJscz48cmVsYXRlZC11cmxzPjx1cmw+aHR0cDovL3d3dy5uY2JpLm5sbS5uaWguZ292

L3B1Ym1lZC8xOTE5MTc0NDwvdXJsPjwvcmVsYXRlZC11cmxzPjwvdXJscz48ZWxlY3Ryb25pYy1y

ZXNvdXJjZS1udW0+MTAuMTA4OS90aHkuMjAwOC4wMzAzJiN4RDsxMC4xMDg5L3RoeS4yMDA4LjAz

MDMgW3BpaV08L2VsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjxsYW5ndWFnZT5lbmc8L2xhbmd1YWdl

PjwvcmVjb3JkPjwvQ2l0ZT48Q2l0ZT48QXV0aG9yPkxpdTwvQXV0aG9yPjxZZWFyPjIwMDY8L1ll

YXI+PFJlY051bT4xMjwvUmVjTnVtPjxyZWNvcmQ+PHJlYy1udW1iZXI+MTI8L3JlYy1udW1iZXI+

PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRiLWlkPSJwczJ3d2RzZnJhMnI1ZWU5emFzeHM1

dDh6d2R3eHJzd2U1eGEiIHRpbWVzdGFtcD0iMTQ3MzExNzEzNiI+MTI8L2tleT48L2ZvcmVpZ24t

a2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5cGU+PGNvbnRy

aWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPkxpdSwgSi48L2F1dGhvcj48YXV0aG9yPlNpbmdoLCBC

LjwvYXV0aG9yPjxhdXRob3I+VGFsbGluaSwgRy48L2F1dGhvcj48YXV0aG9yPkNhcmxzb24sIEQu

IEwuPC9hdXRob3I+PGF1dGhvcj5LYXRhYmksIE4uPC9hdXRob3I+PGF1dGhvcj5TaGFoYSwgQS48

L2F1dGhvcj48YXV0aG9yPlR1dHRsZSwgUi4gTS48L2F1dGhvcj48YXV0aG9yPkdob3NzZWluLCBS

LiBBLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48YXV0aC1hZGRyZXNzPkRlcGFy

dG1lbnQgb2YgT3RvbGFyeW5nb2xvZ3ktSGVhZCBhbmQgTmVjayBTdXJnZXJ5LCBDb2x1bWJpYSBV

bml2ZXJzaXR5LCBOZXcgWW9yaywgTmV3IFlvcmssIFVTQS48L2F1dGgtYWRkcmVzcz48dGl0bGVz

Pjx0aXRsZT5Gb2xsaWN1bGFyIHZhcmlhbnQgb2YgcGFwaWxsYXJ5IHRoeXJvaWQgY2FyY2lub21h

OiBhIGNsaW5pY29wYXRob2xvZ2ljIHN0dWR5IG9mIGEgcHJvYmxlbWF0aWMgZW50aXR5PC90aXRs

ZT48c2Vjb25kYXJ5LXRpdGxlPkNhbmNlcjwvc2Vjb25kYXJ5LXRpdGxlPjwvdGl0bGVzPjxwZXJp

b2RpY2FsPjxmdWxsLXRpdGxlPkNhbmNlcjwvZnVsbC10aXRsZT48L3BlcmlvZGljYWw+PHBhZ2Vz

PjEyNTUtNjQ8L3BhZ2VzPjx2b2x1bWU+MTA3PC92b2x1bWU+PG51bWJlcj42PC9udW1iZXI+PGVk

aXRpb24+MjAwNi8wOC8xMTwvZWRpdGlvbj48a2V5d29yZHM+PGtleXdvcmQ+QWRlbm9jYXJjaW5v

bWEsIEZvbGxpY3VsYXIvcGF0aG9sb2d5PC9rZXl3b3JkPjxrZXl3b3JkPkFkZW5vY2FyY2lub21h

LCBQYXBpbGxhcnkvcGF0aG9sb2d5PC9rZXl3b3JkPjxrZXl3b3JkPkFkb2xlc2NlbnQ8L2tleXdv

cmQ+PGtleXdvcmQ+QWR1bHQ8L2tleXdvcmQ+PGtleXdvcmQ+QWdlZDwva2V5d29yZD48a2V5d29y

ZD5DYXJjaW5vbWEsIFBhcGlsbGFyeSwgRm9sbGljdWxhci9jbGFzc2lmaWNhdGlvbi8qcGF0aG9s

b2d5PC9rZXl3b3JkPjxrZXl3b3JkPkNoaWxkPC9rZXl3b3JkPjxrZXl3b3JkPkRpYWdub3Npcywg

RGlmZmVyZW50aWFsPC9rZXl3b3JkPjxrZXl3b3JkPkZlbWFsZTwva2V5d29yZD48a2V5d29yZD5I

dW1hbnM8L2tleXdvcmQ+PGtleXdvcmQ+TWFsZTwva2V5d29yZD48a2V5d29yZD5NaWRkbGUgQWdl

ZDwva2V5d29yZD48a2V5d29yZD5Nb2RlbHMsIEJpb2xvZ2ljYWw8L2tleXdvcmQ+PGtleXdvcmQ+

TmVvcGxhc20gSW52YXNpdmVuZXNzPC9rZXl3b3JkPjxrZXl3b3JkPk5lb3BsYXNtIFN0YWdpbmc8

L2tleXdvcmQ+PGtleXdvcmQ+VGh5cm9pZCBOZW9wbGFzbXMvY2xhc3NpZmljYXRpb24vKnBhdGhv

bG9neTwva2V5d29yZD48L2tleXdvcmRzPjxkYXRlcz48eWVhcj4yMDA2PC95ZWFyPjxwdWItZGF0

ZXM+PGRhdGU+U2VwIDE1PC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+MDAwOC01NDNY

IChQcmludCkmI3hEOzAwMDgtNTQzWCAoTGlua2luZyk8L2lzYm4+PGFjY2Vzc2lvbi1udW0+MTY5

MDA1MTk8L2FjY2Vzc2lvbi1udW0+PHVybHM+PHJlbGF0ZWQtdXJscz48dXJsPmh0dHA6Ly93d3cu

bmNiaS5ubG0ubmloLmdvdi9wdWJtZWQvMTY5MDA1MTk8L3VybD48L3JlbGF0ZWQtdXJscz48L3Vy

bHM+PGVsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjEwLjEwMDIvY25jci4yMjEzODwvZWxlY3Ryb25p

Yy1yZXNvdXJjZS1udW0+PGxhbmd1YWdlPmVuZzwvbGFuZ3VhZ2U+PC9yZWNvcmQ+PC9DaXRlPjwv

RW5kTm90ZT4A

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5SaXZlcmE8L0F1dGhvcj48WWVhcj4yMDA5PC9ZZWFyPjxS

ZWNOdW0+MTE8L1JlY051bT48RGlzcGxheVRleHQ+PHN0eWxlIGZhY2U9InN1cGVyc2NyaXB0Ij4x

MSwxMjwvc3R5bGU+PC9EaXNwbGF5VGV4dD48cmVjb3JkPjxyZWMtbnVtYmVyPjExPC9yZWMtbnVt

YmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0icHMyd3dkc2ZyYTJyNWVlOXph

c3hzNXQ4endkd3hyc3dlNXhhIiB0aW1lc3RhbXA9IjE0NzMxMTcxMzYiPjExPC9rZXk+PC9mb3Jl

aWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxj

b250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5SaXZlcmEsIE0uPC9hdXRob3I+PGF1dGhvcj5U

dXR0bGUsIFIuIE0uPC9hdXRob3I+PGF1dGhvcj5QYXRlbCwgUy48L2F1dGhvcj48YXV0aG9yPlNo

YWhhLCBBLjwvYXV0aG9yPjxhdXRob3I+U2hhaCwgSi4gUC48L2F1dGhvcj48YXV0aG9yPkdob3Nz

ZWluLCBSLiBBLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48YXV0aC1hZGRyZXNz

PkRlcGFydG1lbnQgb2YgUGF0aG9sb2d5LCBNZW1vcmlhbCBTbG9hbi1LZXR0ZXJpbmcgQ2FuY2Vy

IENlbnRlciAsIE5ldyBZb3JrLCBOZXcgWW9yaywgVVNBLjwvYXV0aC1hZGRyZXNzPjx0aXRsZXM+

PHRpdGxlPkVuY2Fwc3VsYXRlZCBwYXBpbGxhcnkgdGh5cm9pZCBjYXJjaW5vbWE6IGEgY2xpbmlj

by1wYXRob2xvZ2ljIHN0dWR5IG9mIDEwNiBjYXNlcyB3aXRoIGVtcGhhc2lzIG9uIGl0cyBtb3Jw

aG9sb2dpYyBzdWJ0eXBlcyAoaGlzdG9sb2dpYyBncm93dGggcGF0dGVybik8L3RpdGxlPjxzZWNv

bmRhcnktdGl0bGU+VGh5cm9pZDwvc2Vjb25kYXJ5LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2Fs

PjxmdWxsLXRpdGxlPlRoeXJvaWQ8L2Z1bGwtdGl0bGU+PC9wZXJpb2RpY2FsPjxwYWdlcz4xMTkt

Mjc8L3BhZ2VzPjx2b2x1bWU+MTk8L3ZvbHVtZT48bnVtYmVyPjI8L251bWJlcj48ZWRpdGlvbj4y

MDA5LzAyLzA1PC9lZGl0aW9uPjxrZXl3b3Jkcz48a2V5d29yZD5BZGVub2NhcmNpbm9tYSwgRm9s

bGljdWxhci9wYXRob2xvZ3k8L2tleXdvcmQ+PGtleXdvcmQ+QWRlbm9jYXJjaW5vbWEsIFBhcGls

bGFyeS9wYXRob2xvZ3k8L2tleXdvcmQ+PGtleXdvcmQ+QWR1bHQ8L2tleXdvcmQ+PGtleXdvcmQ+

QWdlZCwgODAgYW5kIG92ZXI8L2tleXdvcmQ+PGtleXdvcmQ+Q2FyY2lub21hLCBQYXBpbGxhcnkv

cGF0aG9sb2d5PC9rZXl3b3JkPjxrZXl3b3JkPkZlbWFsZTwva2V5d29yZD48a2V5d29yZD5IdW1h

bnM8L2tleXdvcmQ+PGtleXdvcmQ+THltcGhhdGljIE1ldGFzdGFzaXMvcGF0aG9sb2d5PC9rZXl3

b3JkPjxrZXl3b3JkPk1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+TWlkZGxlIEFnZWQ8L2tleXdvcmQ+

PGtleXdvcmQ+TmVvcGxhc20gSW52YXNpdmVuZXNzL3BhdGhvbG9neTwva2V5d29yZD48a2V5d29y

ZD5SZXRyb3NwZWN0aXZlIFN0dWRpZXM8L2tleXdvcmQ+PGtleXdvcmQ+VGh5cm9pZCBHbGFuZC8q

cGF0aG9sb2d5PC9rZXl3b3JkPjxrZXl3b3JkPlRoeXJvaWQgTmVvcGxhc21zLypwYXRob2xvZ3kv

c3VyZ2VyeTwva2V5d29yZD48a2V5d29yZD5UcmVhdG1lbnQgT3V0Y29tZTwva2V5d29yZD48L2tl

eXdvcmRzPjxkYXRlcz48eWVhcj4yMDA5PC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+RmViPC9kYXRl

PjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+MTU1Ny05MDc3IChFbGVjdHJvbmljKSYjeEQ7MTA1

MC03MjU2IChMaW5raW5nKTwvaXNibj48YWNjZXNzaW9uLW51bT4xOTE5MTc0NDwvYWNjZXNzaW9u

LW51bT48dXJscz48cmVsYXRlZC11cmxzPjx1cmw+aHR0cDovL3d3dy5uY2JpLm5sbS5uaWguZ292

L3B1Ym1lZC8xOTE5MTc0NDwvdXJsPjwvcmVsYXRlZC11cmxzPjwvdXJscz48ZWxlY3Ryb25pYy1y

ZXNvdXJjZS1udW0+MTAuMTA4OS90aHkuMjAwOC4wMzAzJiN4RDsxMC4xMDg5L3RoeS4yMDA4LjAz

MDMgW3BpaV08L2VsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjxsYW5ndWFnZT5lbmc8L2xhbmd1YWdl

PjwvcmVjb3JkPjwvQ2l0ZT48Q2l0ZT48QXV0aG9yPkxpdTwvQXV0aG9yPjxZZWFyPjIwMDY8L1ll

YXI+PFJlY051bT4xMjwvUmVjTnVtPjxyZWNvcmQ+PHJlYy1udW1iZXI+MTI8L3JlYy1udW1iZXI+

PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRiLWlkPSJwczJ3d2RzZnJhMnI1ZWU5emFzeHM1

dDh6d2R3eHJzd2U1eGEiIHRpbWVzdGFtcD0iMTQ3MzExNzEzNiI+MTI8L2tleT48L2ZvcmVpZ24t

a2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5cGU+PGNvbnRy

aWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPkxpdSwgSi48L2F1dGhvcj48YXV0aG9yPlNpbmdoLCBC

LjwvYXV0aG9yPjxhdXRob3I+VGFsbGluaSwgRy48L2F1dGhvcj48YXV0aG9yPkNhcmxzb24sIEQu

IEwuPC9hdXRob3I+PGF1dGhvcj5LYXRhYmksIE4uPC9hdXRob3I+PGF1dGhvcj5TaGFoYSwgQS48

L2F1dGhvcj48YXV0aG9yPlR1dHRsZSwgUi4gTS48L2F1dGhvcj48YXV0aG9yPkdob3NzZWluLCBS

LiBBLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48YXV0aC1hZGRyZXNzPkRlcGFy

dG1lbnQgb2YgT3RvbGFyeW5nb2xvZ3ktSGVhZCBhbmQgTmVjayBTdXJnZXJ5LCBDb2x1bWJpYSBV

bml2ZXJzaXR5LCBOZXcgWW9yaywgTmV3IFlvcmssIFVTQS48L2F1dGgtYWRkcmVzcz48dGl0bGVz

Pjx0aXRsZT5Gb2xsaWN1bGFyIHZhcmlhbnQgb2YgcGFwaWxsYXJ5IHRoeXJvaWQgY2FyY2lub21h

OiBhIGNsaW5pY29wYXRob2xvZ2ljIHN0dWR5IG9mIGEgcHJvYmxlbWF0aWMgZW50aXR5PC90aXRs

ZT48c2Vjb25kYXJ5LXRpdGxlPkNhbmNlcjwvc2Vjb25kYXJ5LXRpdGxlPjwvdGl0bGVzPjxwZXJp

b2RpY2FsPjxmdWxsLXRpdGxlPkNhbmNlcjwvZnVsbC10aXRsZT48L3BlcmlvZGljYWw+PHBhZ2Vz

PjEyNTUtNjQ8L3BhZ2VzPjx2b2x1bWU+MTA3PC92b2x1bWU+PG51bWJlcj42PC9udW1iZXI+PGVk

aXRpb24+MjAwNi8wOC8xMTwvZWRpdGlvbj48a2V5d29yZHM+PGtleXdvcmQ+QWRlbm9jYXJjaW5v

bWEsIEZvbGxpY3VsYXIvcGF0aG9sb2d5PC9rZXl3b3JkPjxrZXl3b3JkPkFkZW5vY2FyY2lub21h

LCBQYXBpbGxhcnkvcGF0aG9sb2d5PC9rZXl3b3JkPjxrZXl3b3JkPkFkb2xlc2NlbnQ8L2tleXdv

cmQ+PGtleXdvcmQ+QWR1bHQ8L2tleXdvcmQ+PGtleXdvcmQ+QWdlZDwva2V5d29yZD48a2V5d29y

ZD5DYXJjaW5vbWEsIFBhcGlsbGFyeSwgRm9sbGljdWxhci9jbGFzc2lmaWNhdGlvbi8qcGF0aG9s

b2d5PC9rZXl3b3JkPjxrZXl3b3JkPkNoaWxkPC9rZXl3b3JkPjxrZXl3b3JkPkRpYWdub3Npcywg

RGlmZmVyZW50aWFsPC9rZXl3b3JkPjxrZXl3b3JkPkZlbWFsZTwva2V5d29yZD48a2V5d29yZD5I

dW1hbnM8L2tleXdvcmQ+PGtleXdvcmQ+TWFsZTwva2V5d29yZD48a2V5d29yZD5NaWRkbGUgQWdl

ZDwva2V5d29yZD48a2V5d29yZD5Nb2RlbHMsIEJpb2xvZ2ljYWw8L2tleXdvcmQ+PGtleXdvcmQ+

TmVvcGxhc20gSW52YXNpdmVuZXNzPC9rZXl3b3JkPjxrZXl3b3JkPk5lb3BsYXNtIFN0YWdpbmc8

L2tleXdvcmQ+PGtleXdvcmQ+VGh5cm9pZCBOZW9wbGFzbXMvY2xhc3NpZmljYXRpb24vKnBhdGhv

bG9neTwva2V5d29yZD48L2tleXdvcmRzPjxkYXRlcz48eWVhcj4yMDA2PC95ZWFyPjxwdWItZGF0

ZXM+PGRhdGU+U2VwIDE1PC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+MDAwOC01NDNY

IChQcmludCkmI3hEOzAwMDgtNTQzWCAoTGlua2luZyk8L2lzYm4+PGFjY2Vzc2lvbi1udW0+MTY5

MDA1MTk8L2FjY2Vzc2lvbi1udW0+PHVybHM+PHJlbGF0ZWQtdXJscz48dXJsPmh0dHA6Ly93d3cu

bmNiaS5ubG0ubmloLmdvdi9wdWJtZWQvMTY5MDA1MTk8L3VybD48L3JlbGF0ZWQtdXJscz48L3Vy

bHM+PGVsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjEwLjEwMDIvY25jci4yMjEzODwvZWxlY3Ryb25p

Yy1yZXNvdXJjZS1udW0+PGxhbmd1YWdlPmVuZzwvbGFuZ3VhZ2U+PC9yZWNvcmQ+PC9DaXRlPjwv

RW5kTm90ZT4A

ADDIN EN.CITE.DATA 11,12Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP) A subset of noninvasive follicular variants of papillary thyroid carcinoma can now be reclassified under the new designation noninvasive follicular thyroid neoplasm with papillary like nuclear features (NIFTP). This shift in nomenclature arose as an effort to encourage conservative management of these lesions given their extremely low risk of structural and chemical recurrence.PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5OaWtpZm9yb3Y8L0F1dGhvcj48WWVhcj4yMDE2PC9ZZWFy

PjxSZWNOdW0+NDg8L1JlY051bT48RGlzcGxheVRleHQ+PHN0eWxlIGZhY2U9InN1cGVyc2NyaXB0

Ij4xMzwvc3R5bGU+PC9EaXNwbGF5VGV4dD48cmVjb3JkPjxyZWMtbnVtYmVyPjQ4PC9yZWMtbnVt

YmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0icHMyd3dkc2ZyYTJyNWVlOXph

c3hzNXQ4endkd3hyc3dlNXhhIiB0aW1lc3RhbXA9IjE0OTUyNDM5MzAiPjQ4PC9rZXk+PC9mb3Jl

aWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxj

b250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5OaWtpZm9yb3YsIFkuIEUuPC9hdXRob3I+PGF1

dGhvcj5TZWV0aGFsYSwgUi4gUi48L2F1dGhvcj48YXV0aG9yPlRhbGxpbmksIEcuPC9hdXRob3I+

PGF1dGhvcj5CYWxvY2gsIFouIFcuPC9hdXRob3I+PGF1dGhvcj5CYXNvbG8sIEYuPC9hdXRob3I+

PGF1dGhvcj5UaG9tcHNvbiwgTC4gRC48L2F1dGhvcj48YXV0aG9yPkJhcmxldHRhLCBKLiBBLjwv

YXV0aG9yPjxhdXRob3I+V2VuaWcsIEIuIE0uPC9hdXRob3I+PGF1dGhvcj5BbCBHaHV6bGFuLCBB

LjwvYXV0aG9yPjxhdXRob3I+S2FrdWRvLCBLLjwvYXV0aG9yPjxhdXRob3I+R2lvcmRhbm8sIFQu

IEouPC9hdXRob3I+PGF1dGhvcj5BbHZlcywgVi4gQS48L2F1dGhvcj48YXV0aG9yPktoYW5hZnNo

YXIsIEUuPC9hdXRob3I+PGF1dGhvcj5Bc2EsIFMuIEwuPC9hdXRob3I+PGF1dGhvcj5FbC1OYWdn

YXIsIEEuIEsuPC9hdXRob3I+PGF1dGhvcj5Hb29kaW5nLCBXLiBFLjwvYXV0aG9yPjxhdXRob3I+

SG9kYWssIFMuIFAuPC9hdXRob3I+PGF1dGhvcj5MbG95ZCwgUi4gVi48L2F1dGhvcj48YXV0aG9y

Pk1heXRhbCwgRy48L2F1dGhvcj48YXV0aG9yPk1ldGUsIE8uPC9hdXRob3I+PGF1dGhvcj5OaWtp

Zm9yb3ZhLCBNLiBOLjwvYXV0aG9yPjxhdXRob3I+Tm9zZSwgVi48L2F1dGhvcj48YXV0aG9yPlBh

cG90dGksIE0uPC9hdXRob3I+PGF1dGhvcj5Qb2xsZXIsIEQuIE4uPC9hdXRob3I+PGF1dGhvcj5T

YWRvdywgUC4gTS48L2F1dGhvcj48YXV0aG9yPlRpc2NobGVyLCBBLiBTLjwvYXV0aG9yPjxhdXRo

b3I+VHV0dGxlLCBSLiBNLjwvYXV0aG9yPjxhdXRob3I+V2FsbCwgSy4gQi48L2F1dGhvcj48YXV0

aG9yPkxpVm9sc2ksIFYuIEEuPC9hdXRob3I+PGF1dGhvcj5SYW5kb2xwaCwgRy4gVy48L2F1dGhv

cj48YXV0aG9yPkdob3NzZWluLCBSLiBBLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9y

cz48YXV0aC1hZGRyZXNzPkRlcGFydG1lbnQgb2YgUGF0aG9sb2d5LCBVbml2ZXJzaXR5IG9mIFBp

dHRzYnVyZ2gsIFBpdHRzYnVyZ2gsIFBlbm5zeWx2YW5pYS4mI3hEO0FuYXRvbWljIFBhdGhvbG9n

eSwgRGVwYXJ0bWVudCBvZiBNZWRpY2luZSAoRElNRVMpLCBVbml2ZXJzaXR5IG9mIEJvbG9nbmEg

U2Nob29sIG9mIE1lZGljaW5lLCBCb2xvZ25hLCBJdGFseS4mI3hEO0RlcGFydG1lbnQgb2YgUGF0

aG9sb2d5IGFuZCBMYWJvcmF0b3J5IE1lZGljaW5lLCBIb3NwaXRhbCBvZiB0aGUgVW5pdmVyc2l0

eSBvZiBQZW5uc3lsdmFuaWEsIFBlcmVsbWFuIFNjaG9vbCBvZiBNZWRpY2luZSwgUGhpbGFkZWxw

aGlhLiYjeEQ7RGVwYXJ0bWVudCBvZiBTdXJnaWNhbCwgTWVkaWNhbCBhbmQgTW9sZWN1bGFyIFBh

dGhvbG9neSwgVW5pdmVyc2l0eSBvZiBQaXNhLCBQaXNhLCBJdGFseS4mI3hEO1NvdXRoZXJuIENh

bGlmb3JuaWEgUGVybWFuZW50ZSBNZWRpY2FsIEdyb3VwLCBXb29kbGFuZCBIaWxscy4mI3hEO0Rl

cGFydG1lbnQgb2YgUGF0aG9sb2d5LCBCcmlnaGFtIGFuZCBXb21lbiZhcG9zO3MgSG9zcGl0YWws

IEhhcnZhcmQgTWVkaWNhbCBTY2hvb2wsIEJvc3RvbiwgTWFzc2FjaHVzZXR0cy4mI3hEO0RlcGFy

dG1lbnQgb2YgUGF0aG9sb2d5LCBNb3VudCBTaW5haSBIZWFsdGggU3lzdGVtLCBOZXcgWW9yaywg

TmV3IFlvcmsuJiN4RDtEZXBhcnRtZW50IG9mIE1lZGljYWwgQmlvbG9neSBhbmQgUGF0aG9sb2d5

LCBHdXN0YXZlIFJvdXNzeSBDYW5jZXIgQ2FtcHVzIEdyYW5kIFBhcmlzLCBWaWxsZWp1aWYsIEZy

YW5jZS4mI3hEO0RlcGFydG1lbnQgb2YgUGF0aG9sb2d5IGFuZCBMYWJvcmF0b3J5IE1lZGljaW5l

LCBOYXJhIEhvc3BpdGFsLCBLaW5kYWkgVW5pdmVyc2l0eSBGYWN1bHR5IG9mIE1lZGljaW5lLCBJ

a29tYS1jaXR5LCBKYXBhbi4mI3hEO0RlcGFydG1lbnQgb2YgUGF0aG9sb2d5LCBVbml2ZXJzaXR5

IG9mIE1pY2hpZ2FuLCBBbm4gQXJib3IxMUNvbXByZWhlbnNpdmUgQ2FuY2VyIENlbnRlciwgVW5p

dmVyc2l0eSBvZiBNaWNoaWdhbiwgQW5uIEFyYm9yLiYjeEQ7RGVwYXJ0bWVudCBvZiBQYXRob2xv

Z3ksIFVuaXZlcnNpdHkgb2YgU2FvIFBhdWxvIFNjaG9vbCBvZiBNZWRpY2luZSwgU2FvIFBhdWxv

LCBCcmF6aWwxM0RlcGFydG1lbnQgb2YgUGF0aG9sb2d5LCBIb3NwaXRhbCBBbGVtYW8gT3N3YWxk

byBDcnV6LCBTYW8gUGF1bG8sIEJyYXppbC4mI3hEO0RlcGFydG1lbnQgb2YgUGF0aG9sb2d5LCBV

bml2ZXJzaXR5IG9mIENhbGlmb3JuaWEgU2FuIEZyYW5jaXNjby4mI3hEO0RlcGFydG1lbnQgb2Yg

UGF0aG9sb2d5LCBVbml2ZXJzaXR5IEhlYWx0aCBOZXR3b3JrLCBUb3JvbnRvLCBPbnRhcmlvLCBD

YW5hZGEuJiN4RDtEZXBhcnRtZW50IG9mIFBhdGhvbG9neSwgVW5pdmVyc2l0eSBvZiBUZXhhcyBN

LkQuIEFuZGVyc29uIENhbmNlciBDZW50ZXIsIEhvdXN0b24uJiN4RDtCaW9zdGF0aXN0aWNzIEZh

Y2lsaXR5LCBVbml2ZXJzaXR5IG9mIFBpdHRzYnVyZ2ggQ2FuY2VyIEluc3RpdHV0ZSwgUGl0dHNi

dXJnaCwgUGVubnN5bHZhbmlhLiYjeEQ7RGl2aXNpb24gb2YgRW5kb2NyaW5vbG9neSBhbmQgTWV0

YWJvbGlzbSwgTmV3IFlvcmsgVW5pdmVyc2l0eSBTY2hvb2wgb2YgTWVkaWNpbmUsIE5ldyBZb3Jr

LiYjeEQ7VW5pdmVyc2l0eSBvZiBXaXNjb25zaW4gU2Nob29sIG9mIE1lZGljaW5lIGFuZCBQdWJs

aWMgSGVhbHRoLCBNYWRpc29uLiYjeEQ7RGVwYXJ0bWVudCBvZiBQc3ljaGlhdHJ5LCBNYXNzYWNo

dXNldHRzIEdlbmVyYWwgSG9zcGl0YWwsIEJvc3Rvbi4mI3hEO0RlcGFydG1lbnQgb2YgUGF0aG9s

b2d5LCBNYXNzYWNodXNldHRzIEdlbmVyYWwgSG9zcGl0YWwsIEJvc3RvbjIyRGVwYXJ0bWVudCBv

ZiBQYXRob2xvZ3kgSGFydmFyZCBNZWRpY2FsIFNjaG9vbCwgQm9zdG9uLCBNYXNzYWNodXNldHRz

LiYjeEQ7RGVwYXJ0bWVudCBvZiBPbmNvbG9neSwgVW5pdmVyc2l0eSBvZiBUdXJpbiwgVG9yaW5v

LCBJdGFseS4mI3hEO1VuaXZlcnNpdHkgb2YgUG9ydHNtb3V0aCwgRGVwYXJ0bWVudCBvZiBQYXRo

b2xvZ3ksIFF1ZWVuIEFsZXhhbmRyYSBIb3NwaXRhbCwgQ29zaGFtLCBQb3J0c21vdXRoLCBVbml0

ZWQgS2luZ2RvbS4mI3hEO0RlcGFydG1lbnQgb2YgUGF0aG9sb2d5IGFuZCBMYWJvcmF0b3J5IE1l

ZGljaW5lLCBUdWZ0cyBVbml2ZXJzaXR5IFNjaG9vbCBvZiBNZWRpY2luZSwgVHVmdHMgTWVkaWNh

bCBDZW50ZXIsIEJvc3RvbiwgTWFzc2FjaHVzZXR0cy4mI3hEO0RlcGFydG1lbnQgb2YgRW5kb2Ny

aW5vbG9neSwgTWVtb3JpYWwgU2xvYW4gS2V0dGVyaW5nIENhbmNlciBDZW50ZXIsIE5ldyBZb3Jr

LCBOZXcgWW9yay4mI3hEO1RoeXJvaWQgQ2FuY2VyIFN1cnZpdm9ycyBBc3NvY2lhdGlvbiBJbmMs

IFJhbGVpZ2gsIE5vcnRoIENhcm9saW5hLiYjeEQ7R2VuZXJhbCBhbmQgVGh5cm9pZCBhbmQgUGFy

YXRoeXJvaWQgRW5kb2NyaW5lIFN1cmdlcnkgRGl2aXNpb24sIE1hc3NhY2h1c2V0dHMgRXllIGFu

ZCBFYXIgSW5maXJtYXJ5LCBCb3N0b24uJiN4RDtEZXBhcnRtZW50IG9mIFBhdGhvbG9neSwgTWVt

b3JpYWwgU2xvYW4gS2V0dGVyaW5nIENhbmNlciBDZW50ZXIsIE5ldyBZb3JrLCBOZXcgWW9yay48

L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5Ob21lbmNsYXR1cmUgUmV2aXNpb24gZm9yIEVu

Y2Fwc3VsYXRlZCBGb2xsaWN1bGFyIFZhcmlhbnQgb2YgUGFwaWxsYXJ5IFRoeXJvaWQgQ2FyY2lu

b21hOiBBIFBhcmFkaWdtIFNoaWZ0IHRvIFJlZHVjZSBPdmVydHJlYXRtZW50IG9mIEluZG9sZW50

IFR1bW9yczwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5KQU1BIE9uY29sPC9zZWNvbmRhcnktdGl0

bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+SkFNQSBPbmNvbDwvZnVsbC10aXRs

ZT48L3BlcmlvZGljYWw+PHBhZ2VzPjEwMjMtOTwvcGFnZXM+PHZvbHVtZT4yPC92b2x1bWU+PG51

bWJlcj44PC9udW1iZXI+PGtleXdvcmRzPjxrZXl3b3JkPkFkZW5vY2FyY2lub21hLCBGb2xsaWN1

bGFyL2NsYXNzaWZpY2F0aW9uL2RpYWdub3Npcy8qcGF0aG9sb2d5PC9rZXl3b3JkPjxrZXl3b3Jk

PkFkdWx0PC9rZXl3b3JkPjxrZXl3b3JkPkFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+QWdlZCwgODAg

YW5kIG92ZXI8L2tleXdvcmQ+PGtleXdvcmQ+Q2FyY2lub21hL2NsYXNzaWZpY2F0aW9uL2RpYWdu

b3Npcy8qcGF0aG9sb2d5PC9rZXl3b3JkPjxrZXl3b3JkPkZlbWFsZTwva2V5d29yZD48a2V5d29y

ZD5IdW1hbnM8L2tleXdvcmQ+PGtleXdvcmQ+TWFsZTwva2V5d29yZD48a2V5d29yZD5NZWRpY2Fs

IE92ZXJ1c2UvKnByZXZlbnRpb24gJmFtcDsgY29udHJvbDwva2V5d29yZD48a2V5d29yZD5NaWRk

bGUgQWdlZDwva2V5d29yZD48a2V5d29yZD5OZW9wbGFzbSBJbnZhc2l2ZW5lc3M8L2tleXdvcmQ+

PGtleXdvcmQ+UmV0cm9zcGVjdGl2ZSBTdHVkaWVzPC9rZXl3b3JkPjxrZXl3b3JkPipUZXJtaW5v

bG9neSBhcyBUb3BpYzwva2V5d29yZD48a2V5d29yZD5UaHlyb2lkIE5lb3BsYXNtcy9jbGFzc2lm

aWNhdGlvbi9kaWFnbm9zaXMvKnBhdGhvbG9neTwva2V5d29yZD48a2V5d29yZD5UaHlyb2lkIE5v

ZHVsZS9jbGFzc2lmaWNhdGlvbi9kaWFnbm9zaXMvKnBhdGhvbG9neTwva2V5d29yZD48a2V5d29y

ZD5Zb3VuZyBBZHVsdDwva2V5d29yZD48L2tleXdvcmRzPjxkYXRlcz48eWVhcj4yMDE2PC95ZWFy

PjxwdWItZGF0ZXM+PGRhdGU+QXVnIDAxPC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+

MjM3NC0yNDQ1IChFbGVjdHJvbmljKSYjeEQ7MjM3NC0yNDM3IChMaW5raW5nKTwvaXNibj48YWNj

ZXNzaW9uLW51bT4yNzA3ODE0NTwvYWNjZXNzaW9uLW51bT48dXJscz48cmVsYXRlZC11cmxzPjx1

cmw+aHR0cHM6Ly93d3cubmNiaS5ubG0ubmloLmdvdi9wdWJtZWQvMjcwNzgxNDU8L3VybD48L3Jl

bGF0ZWQtdXJscz48L3VybHM+PGVsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjEwLjEwMDEvamFtYW9u

Y29sLjIwMTYuMDM4NjwvZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+PC9yZWNvcmQ+PC9DaXRlPjwv

RW5kTm90ZT5=

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5OaWtpZm9yb3Y8L0F1dGhvcj48WWVhcj4yMDE2PC9ZZWFy

PjxSZWNOdW0+NDg8L1JlY051bT48RGlzcGxheVRleHQ+PHN0eWxlIGZhY2U9InN1cGVyc2NyaXB0

Ij4xMzwvc3R5bGU+PC9EaXNwbGF5VGV4dD48cmVjb3JkPjxyZWMtbnVtYmVyPjQ4PC9yZWMtbnVt

YmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0icHMyd3dkc2ZyYTJyNWVlOXph

c3hzNXQ4endkd3hyc3dlNXhhIiB0aW1lc3RhbXA9IjE0OTUyNDM5MzAiPjQ4PC9rZXk+PC9mb3Jl

aWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxj

b250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5OaWtpZm9yb3YsIFkuIEUuPC9hdXRob3I+PGF1

dGhvcj5TZWV0aGFsYSwgUi4gUi48L2F1dGhvcj48YXV0aG9yPlRhbGxpbmksIEcuPC9hdXRob3I+

PGF1dGhvcj5CYWxvY2gsIFouIFcuPC9hdXRob3I+PGF1dGhvcj5CYXNvbG8sIEYuPC9hdXRob3I+

PGF1dGhvcj5UaG9tcHNvbiwgTC4gRC48L2F1dGhvcj48YXV0aG9yPkJhcmxldHRhLCBKLiBBLjwv

YXV0aG9yPjxhdXRob3I+V2VuaWcsIEIuIE0uPC9hdXRob3I+PGF1dGhvcj5BbCBHaHV6bGFuLCBB

LjwvYXV0aG9yPjxhdXRob3I+S2FrdWRvLCBLLjwvYXV0aG9yPjxhdXRob3I+R2lvcmRhbm8sIFQu

IEouPC9hdXRob3I+PGF1dGhvcj5BbHZlcywgVi4gQS48L2F1dGhvcj48YXV0aG9yPktoYW5hZnNo

YXIsIEUuPC9hdXRob3I+PGF1dGhvcj5Bc2EsIFMuIEwuPC9hdXRob3I+PGF1dGhvcj5FbC1OYWdn

YXIsIEEuIEsuPC9hdXRob3I+PGF1dGhvcj5Hb29kaW5nLCBXLiBFLjwvYXV0aG9yPjxhdXRob3I+

SG9kYWssIFMuIFAuPC9hdXRob3I+PGF1dGhvcj5MbG95ZCwgUi4gVi48L2F1dGhvcj48YXV0aG9y

Pk1heXRhbCwgRy48L2F1dGhvcj48YXV0aG9yPk1ldGUsIE8uPC9hdXRob3I+PGF1dGhvcj5OaWtp

Zm9yb3ZhLCBNLiBOLjwvYXV0aG9yPjxhdXRob3I+Tm9zZSwgVi48L2F1dGhvcj48YXV0aG9yPlBh

cG90dGksIE0uPC9hdXRob3I+PGF1dGhvcj5Qb2xsZXIsIEQuIE4uPC9hdXRob3I+PGF1dGhvcj5T

YWRvdywgUC4gTS48L2F1dGhvcj48YXV0aG9yPlRpc2NobGVyLCBBLiBTLjwvYXV0aG9yPjxhdXRo

b3I+VHV0dGxlLCBSLiBNLjwvYXV0aG9yPjxhdXRob3I+V2FsbCwgSy4gQi48L2F1dGhvcj48YXV0

aG9yPkxpVm9sc2ksIFYuIEEuPC9hdXRob3I+PGF1dGhvcj5SYW5kb2xwaCwgRy4gVy48L2F1dGhv

cj48YXV0aG9yPkdob3NzZWluLCBSLiBBLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9y

cz48YXV0aC1hZGRyZXNzPkRlcGFydG1lbnQgb2YgUGF0aG9sb2d5LCBVbml2ZXJzaXR5IG9mIFBp

dHRzYnVyZ2gsIFBpdHRzYnVyZ2gsIFBlbm5zeWx2YW5pYS4mI3hEO0FuYXRvbWljIFBhdGhvbG9n

eSwgRGVwYXJ0bWVudCBvZiBNZWRpY2luZSAoRElNRVMpLCBVbml2ZXJzaXR5IG9mIEJvbG9nbmEg

U2Nob29sIG9mIE1lZGljaW5lLCBCb2xvZ25hLCBJdGFseS4mI3hEO0RlcGFydG1lbnQgb2YgUGF0

aG9sb2d5IGFuZCBMYWJvcmF0b3J5IE1lZGljaW5lLCBIb3NwaXRhbCBvZiB0aGUgVW5pdmVyc2l0

eSBvZiBQZW5uc3lsdmFuaWEsIFBlcmVsbWFuIFNjaG9vbCBvZiBNZWRpY2luZSwgUGhpbGFkZWxw

aGlhLiYjeEQ7RGVwYXJ0bWVudCBvZiBTdXJnaWNhbCwgTWVkaWNhbCBhbmQgTW9sZWN1bGFyIFBh

dGhvbG9neSwgVW5pdmVyc2l0eSBvZiBQaXNhLCBQaXNhLCBJdGFseS4mI3hEO1NvdXRoZXJuIENh

bGlmb3JuaWEgUGVybWFuZW50ZSBNZWRpY2FsIEdyb3VwLCBXb29kbGFuZCBIaWxscy4mI3hEO0Rl

cGFydG1lbnQgb2YgUGF0aG9sb2d5LCBCcmlnaGFtIGFuZCBXb21lbiZhcG9zO3MgSG9zcGl0YWws

IEhhcnZhcmQgTWVkaWNhbCBTY2hvb2wsIEJvc3RvbiwgTWFzc2FjaHVzZXR0cy4mI3hEO0RlcGFy

dG1lbnQgb2YgUGF0aG9sb2d5LCBNb3VudCBTaW5haSBIZWFsdGggU3lzdGVtLCBOZXcgWW9yaywg

TmV3IFlvcmsuJiN4RDtEZXBhcnRtZW50IG9mIE1lZGljYWwgQmlvbG9neSBhbmQgUGF0aG9sb2d5

LCBHdXN0YXZlIFJvdXNzeSBDYW5jZXIgQ2FtcHVzIEdyYW5kIFBhcmlzLCBWaWxsZWp1aWYsIEZy

YW5jZS4mI3hEO0RlcGFydG1lbnQgb2YgUGF0aG9sb2d5IGFuZCBMYWJvcmF0b3J5IE1lZGljaW5l

LCBOYXJhIEhvc3BpdGFsLCBLaW5kYWkgVW5pdmVyc2l0eSBGYWN1bHR5IG9mIE1lZGljaW5lLCBJ

a29tYS1jaXR5LCBKYXBhbi4mI3hEO0RlcGFydG1lbnQgb2YgUGF0aG9sb2d5LCBVbml2ZXJzaXR5

IG9mIE1pY2hpZ2FuLCBBbm4gQXJib3IxMUNvbXByZWhlbnNpdmUgQ2FuY2VyIENlbnRlciwgVW5p

dmVyc2l0eSBvZiBNaWNoaWdhbiwgQW5uIEFyYm9yLiYjeEQ7RGVwYXJ0bWVudCBvZiBQYXRob2xv

Z3ksIFVuaXZlcnNpdHkgb2YgU2FvIFBhdWxvIFNjaG9vbCBvZiBNZWRpY2luZSwgU2FvIFBhdWxv

LCBCcmF6aWwxM0RlcGFydG1lbnQgb2YgUGF0aG9sb2d5LCBIb3NwaXRhbCBBbGVtYW8gT3N3YWxk

byBDcnV6LCBTYW8gUGF1bG8sIEJyYXppbC4mI3hEO0RlcGFydG1lbnQgb2YgUGF0aG9sb2d5LCBV

bml2ZXJzaXR5IG9mIENhbGlmb3JuaWEgU2FuIEZyYW5jaXNjby4mI3hEO0RlcGFydG1lbnQgb2Yg

UGF0aG9sb2d5LCBVbml2ZXJzaXR5IEhlYWx0aCBOZXR3b3JrLCBUb3JvbnRvLCBPbnRhcmlvLCBD

YW5hZGEuJiN4RDtEZXBhcnRtZW50IG9mIFBhdGhvbG9neSwgVW5pdmVyc2l0eSBvZiBUZXhhcyBN

LkQuIEFuZGVyc29uIENhbmNlciBDZW50ZXIsIEhvdXN0b24uJiN4RDtCaW9zdGF0aXN0aWNzIEZh

Y2lsaXR5LCBVbml2ZXJzaXR5IG9mIFBpdHRzYnVyZ2ggQ2FuY2VyIEluc3RpdHV0ZSwgUGl0dHNi

dXJnaCwgUGVubnN5bHZhbmlhLiYjeEQ7RGl2aXNpb24gb2YgRW5kb2NyaW5vbG9neSBhbmQgTWV0

YWJvbGlzbSwgTmV3IFlvcmsgVW5pdmVyc2l0eSBTY2hvb2wgb2YgTWVkaWNpbmUsIE5ldyBZb3Jr

LiYjeEQ7VW5pdmVyc2l0eSBvZiBXaXNjb25zaW4gU2Nob29sIG9mIE1lZGljaW5lIGFuZCBQdWJs

aWMgSGVhbHRoLCBNYWRpc29uLiYjeEQ7RGVwYXJ0bWVudCBvZiBQc3ljaGlhdHJ5LCBNYXNzYWNo

dXNldHRzIEdlbmVyYWwgSG9zcGl0YWwsIEJvc3Rvbi4mI3hEO0RlcGFydG1lbnQgb2YgUGF0aG9s

b2d5LCBNYXNzYWNodXNldHRzIEdlbmVyYWwgSG9zcGl0YWwsIEJvc3RvbjIyRGVwYXJ0bWVudCBv

ZiBQYXRob2xvZ3kgSGFydmFyZCBNZWRpY2FsIFNjaG9vbCwgQm9zdG9uLCBNYXNzYWNodXNldHRz

LiYjeEQ7RGVwYXJ0bWVudCBvZiBPbmNvbG9neSwgVW5pdmVyc2l0eSBvZiBUdXJpbiwgVG9yaW5v

LCBJdGFseS4mI3hEO1VuaXZlcnNpdHkgb2YgUG9ydHNtb3V0aCwgRGVwYXJ0bWVudCBvZiBQYXRo

b2xvZ3ksIFF1ZWVuIEFsZXhhbmRyYSBIb3NwaXRhbCwgQ29zaGFtLCBQb3J0c21vdXRoLCBVbml0

ZWQgS2luZ2RvbS4mI3hEO0RlcGFydG1lbnQgb2YgUGF0aG9sb2d5IGFuZCBMYWJvcmF0b3J5IE1l

ZGljaW5lLCBUdWZ0cyBVbml2ZXJzaXR5IFNjaG9vbCBvZiBNZWRpY2luZSwgVHVmdHMgTWVkaWNh

bCBDZW50ZXIsIEJvc3RvbiwgTWFzc2FjaHVzZXR0cy4mI3hEO0RlcGFydG1lbnQgb2YgRW5kb2Ny

aW5vbG9neSwgTWVtb3JpYWwgU2xvYW4gS2V0dGVyaW5nIENhbmNlciBDZW50ZXIsIE5ldyBZb3Jr

LCBOZXcgWW9yay4mI3hEO1RoeXJvaWQgQ2FuY2VyIFN1cnZpdm9ycyBBc3NvY2lhdGlvbiBJbmMs

IFJhbGVpZ2gsIE5vcnRoIENhcm9saW5hLiYjeEQ7R2VuZXJhbCBhbmQgVGh5cm9pZCBhbmQgUGFy

YXRoeXJvaWQgRW5kb2NyaW5lIFN1cmdlcnkgRGl2aXNpb24sIE1hc3NhY2h1c2V0dHMgRXllIGFu

ZCBFYXIgSW5maXJtYXJ5LCBCb3N0b24uJiN4RDtEZXBhcnRtZW50IG9mIFBhdGhvbG9neSwgTWVt

b3JpYWwgU2xvYW4gS2V0dGVyaW5nIENhbmNlciBDZW50ZXIsIE5ldyBZb3JrLCBOZXcgWW9yay48

L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5Ob21lbmNsYXR1cmUgUmV2aXNpb24gZm9yIEVu

Y2Fwc3VsYXRlZCBGb2xsaWN1bGFyIFZhcmlhbnQgb2YgUGFwaWxsYXJ5IFRoeXJvaWQgQ2FyY2lu

b21hOiBBIFBhcmFkaWdtIFNoaWZ0IHRvIFJlZHVjZSBPdmVydHJlYXRtZW50IG9mIEluZG9sZW50

IFR1bW9yczwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5KQU1BIE9uY29sPC9zZWNvbmRhcnktdGl0

bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+SkFNQSBPbmNvbDwvZnVsbC10aXRs

ZT48L3BlcmlvZGljYWw+PHBhZ2VzPjEwMjMtOTwvcGFnZXM+PHZvbHVtZT4yPC92b2x1bWU+PG51

bWJlcj44PC9udW1iZXI+PGtleXdvcmRzPjxrZXl3b3JkPkFkZW5vY2FyY2lub21hLCBGb2xsaWN1

bGFyL2NsYXNzaWZpY2F0aW9uL2RpYWdub3Npcy8qcGF0aG9sb2d5PC9rZXl3b3JkPjxrZXl3b3Jk

PkFkdWx0PC9rZXl3b3JkPjxrZXl3b3JkPkFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+QWdlZCwgODAg

YW5kIG92ZXI8L2tleXdvcmQ+PGtleXdvcmQ+Q2FyY2lub21hL2NsYXNzaWZpY2F0aW9uL2RpYWdu

b3Npcy8qcGF0aG9sb2d5PC9rZXl3b3JkPjxrZXl3b3JkPkZlbWFsZTwva2V5d29yZD48a2V5d29y

ZD5IdW1hbnM8L2tleXdvcmQ+PGtleXdvcmQ+TWFsZTwva2V5d29yZD48a2V5d29yZD5NZWRpY2Fs

IE92ZXJ1c2UvKnByZXZlbnRpb24gJmFtcDsgY29udHJvbDwva2V5d29yZD48a2V5d29yZD5NaWRk

bGUgQWdlZDwva2V5d29yZD48a2V5d29yZD5OZW9wbGFzbSBJbnZhc2l2ZW5lc3M8L2tleXdvcmQ+

PGtleXdvcmQ+UmV0cm9zcGVjdGl2ZSBTdHVkaWVzPC9rZXl3b3JkPjxrZXl3b3JkPipUZXJtaW5v

bG9neSBhcyBUb3BpYzwva2V5d29yZD48a2V5d29yZD5UaHlyb2lkIE5lb3BsYXNtcy9jbGFzc2lm

aWNhdGlvbi9kaWFnbm9zaXMvKnBhdGhvbG9neTwva2V5d29yZD48a2V5d29yZD5UaHlyb2lkIE5v

ZHVsZS9jbGFzc2lmaWNhdGlvbi9kaWFnbm9zaXMvKnBhdGhvbG9neTwva2V5d29yZD48a2V5d29y

ZD5Zb3VuZyBBZHVsdDwva2V5d29yZD48L2tleXdvcmRzPjxkYXRlcz48eWVhcj4yMDE2PC95ZWFy

PjxwdWItZGF0ZXM+PGRhdGU+QXVnIDAxPC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+

MjM3NC0yNDQ1IChFbGVjdHJvbmljKSYjeEQ7MjM3NC0yNDM3IChMaW5raW5nKTwvaXNibj48YWNj

ZXNzaW9uLW51bT4yNzA3ODE0NTwvYWNjZXNzaW9uLW51bT48dXJscz48cmVsYXRlZC11cmxzPjx1

cmw+aHR0cHM6Ly93d3cubmNiaS5ubG0ubmloLmdvdi9wdWJtZWQvMjcwNzgxNDU8L3VybD48L3Jl

bGF0ZWQtdXJscz48L3VybHM+PGVsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjEwLjEwMDEvamFtYW9u

Y29sLjIwMTYuMDM4NjwvZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+PC9yZWNvcmQ+PC9DaXRlPjwv

RW5kTm90ZT5=

ADDIN EN.CITE.DATA 13 NIFTP is still not entirely considered benign and remains an actionable surgical disease, albeit with a more conservative approach. As NIFTP is not overtly malignant, it is technically not required to report these under this cancer protocol. However it is encouraged to report these, though only limited parameters are relevant, namely size, laterality, and margin status.It must be noted that not all tumors previously designated as noninvasive follicular variant of papillary thyroid carcinoma would qualify as NIFTP.PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5OaWtpZm9yb3Y8L0F1dGhvcj48WWVhcj4yMDE2PC9ZZWFy

PjxSZWNOdW0+NDg8L1JlY051bT48RGlzcGxheVRleHQ+PHN0eWxlIGZhY2U9InN1cGVyc2NyaXB0

Ij4xMzwvc3R5bGU+PC9EaXNwbGF5VGV4dD48cmVjb3JkPjxyZWMtbnVtYmVyPjQ4PC9yZWMtbnVt

YmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0icHMyd3dkc2ZyYTJyNWVlOXph

c3hzNXQ4endkd3hyc3dlNXhhIiB0aW1lc3RhbXA9IjE0OTUyNDM5MzAiPjQ4PC9rZXk+PC9mb3Jl

aWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxj

b250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5OaWtpZm9yb3YsIFkuIEUuPC9hdXRob3I+PGF1

dGhvcj5TZWV0aGFsYSwgUi4gUi48L2F1dGhvcj48YXV0aG9yPlRhbGxpbmksIEcuPC9hdXRob3I+

PGF1dGhvcj5CYWxvY2gsIFouIFcuPC9hdXRob3I+PGF1dGhvcj5CYXNvbG8sIEYuPC9hdXRob3I+

PGF1dGhvcj5UaG9tcHNvbiwgTC4gRC48L2F1dGhvcj48YXV0aG9yPkJhcmxldHRhLCBKLiBBLjwv

YXV0aG9yPjxhdXRob3I+V2VuaWcsIEIuIE0uPC9hdXRob3I+PGF1dGhvcj5BbCBHaHV6bGFuLCBB

LjwvYXV0aG9yPjxhdXRob3I+S2FrdWRvLCBLLjwvYXV0aG9yPjxhdXRob3I+R2lvcmRhbm8sIFQu

IEouPC9hdXRob3I+PGF1dGhvcj5BbHZlcywgVi4gQS48L2F1dGhvcj48YXV0aG9yPktoYW5hZnNo

YXIsIEUuPC9hdXRob3I+PGF1dGhvcj5Bc2EsIFMuIEwuPC9hdXRob3I+PGF1dGhvcj5FbC1OYWdn

YXIsIEEuIEsuPC9hdXRob3I+PGF1dGhvcj5Hb29kaW5nLCBXLiBFLjwvYXV0aG9yPjxhdXRob3I+

SG9kYWssIFMuIFAuPC9hdXRob3I+PGF1dGhvcj5MbG95ZCwgUi4gVi48L2F1dGhvcj48YXV0aG9y

Pk1heXRhbCwgRy48L2F1dGhvcj48YXV0aG9yPk1ldGUsIE8uPC9hdXRob3I+PGF1dGhvcj5OaWtp

Zm9yb3ZhLCBNLiBOLjwvYXV0aG9yPjxhdXRob3I+Tm9zZSwgVi48L2F1dGhvcj48YXV0aG9yPlBh

cG90dGksIE0uPC9hdXRob3I+PGF1dGhvcj5Qb2xsZXIsIEQuIE4uPC9hdXRob3I+PGF1dGhvcj5T

YWRvdywgUC4gTS48L2F1dGhvcj48YXV0aG9yPlRpc2NobGVyLCBBLiBTLjwvYXV0aG9yPjxhdXRo

b3I+VHV0dGxlLCBSLiBNLjwvYXV0aG9yPjxhdXRob3I+V2FsbCwgSy4gQi48L2F1dGhvcj48YXV0

aG9yPkxpVm9sc2ksIFYuIEEuPC9hdXRob3I+PGF1dGhvcj5SYW5kb2xwaCwgRy4gVy48L2F1dGhv

cj48YXV0aG9yPkdob3NzZWluLCBSLiBBLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9y

cz48YXV0aC1hZGRyZXNzPkRlcGFydG1lbnQgb2YgUGF0aG9sb2d5LCBVbml2ZXJzaXR5IG9mIFBp

dHRzYnVyZ2gsIFBpdHRzYnVyZ2gsIFBlbm5zeWx2YW5pYS4mI3hEO0FuYXRvbWljIFBhdGhvbG9n

eSwgRGVwYXJ0bWVudCBvZiBNZWRpY2luZSAoRElNRVMpLCBVbml2ZXJzaXR5IG9mIEJvbG9nbmEg

U2Nob29sIG9mIE1lZGljaW5lLCBCb2xvZ25hLCBJdGFseS4mI3hEO0RlcGFydG1lbnQgb2YgUGF0

aG9sb2d5IGFuZCBMYWJvcmF0b3J5IE1lZGljaW5lLCBIb3NwaXRhbCBvZiB0aGUgVW5pdmVyc2l0

eSBvZiBQZW5uc3lsdmFuaWEsIFBlcmVsbWFuIFNjaG9vbCBvZiBNZWRpY2luZSwgUGhpbGFkZWxw

aGlhLiYjeEQ7RGVwYXJ0bWVudCBvZiBTdXJnaWNhbCwgTWVkaWNhbCBhbmQgTW9sZWN1bGFyIFBh

dGhvbG9neSwgVW5pdmVyc2l0eSBvZiBQaXNhLCBQaXNhLCBJdGFseS4mI3hEO1NvdXRoZXJuIENh

bGlmb3JuaWEgUGVybWFuZW50ZSBNZWRpY2FsIEdyb3VwLCBXb29kbGFuZCBIaWxscy4mI3hEO0Rl

cGFydG1lbnQgb2YgUGF0aG9sb2d5LCBCcmlnaGFtIGFuZCBXb21lbiZhcG9zO3MgSG9zcGl0YWws

IEhhcnZhcmQgTWVkaWNhbCBTY2hvb2wsIEJvc3RvbiwgTWFzc2FjaHVzZXR0cy4mI3hEO0RlcGFy

dG1lbnQgb2YgUGF0aG9sb2d5LCBNb3VudCBTaW5haSBIZWFsdGggU3lzdGVtLCBOZXcgWW9yaywg

TmV3IFlvcmsuJiN4RDtEZXBhcnRtZW50IG9mIE1lZGljYWwgQmlvbG9neSBhbmQgUGF0aG9sb2d5

LCBHdXN0YXZlIFJvdXNzeSBDYW5jZXIgQ2FtcHVzIEdyYW5kIFBhcmlzLCBWaWxsZWp1aWYsIEZy

YW5jZS4mI3hEO0RlcGFydG1lbnQgb2YgUGF0aG9sb2d5IGFuZCBMYWJvcmF0b3J5IE1lZGljaW5l

LCBOYXJhIEhvc3BpdGFsLCBLaW5kYWkgVW5pdmVyc2l0eSBGYWN1bHR5IG9mIE1lZGljaW5lLCBJ

a29tYS1jaXR5LCBKYXBhbi4mI3hEO0RlcGFydG1lbnQgb2YgUGF0aG9sb2d5LCBVbml2ZXJzaXR5

IG9mIE1pY2hpZ2FuLCBBbm4gQXJib3IxMUNvbXByZWhlbnNpdmUgQ2FuY2VyIENlbnRlciwgVW5p

dmVyc2l0eSBvZiBNaWNoaWdhbiwgQW5uIEFyYm9yLiYjeEQ7RGVwYXJ0bWVudCBvZiBQYXRob2xv

Z3ksIFVuaXZlcnNpdHkgb2YgU2FvIFBhdWxvIFNjaG9vbCBvZiBNZWRpY2luZSwgU2FvIFBhdWxv

LCBCcmF6aWwxM0RlcGFydG1lbnQgb2YgUGF0aG9sb2d5LCBIb3NwaXRhbCBBbGVtYW8gT3N3YWxk

byBDcnV6LCBTYW8gUGF1bG8sIEJyYXppbC4mI3hEO0RlcGFydG1lbnQgb2YgUGF0aG9sb2d5LCBV

bml2ZXJzaXR5IG9mIENhbGlmb3JuaWEgU2FuIEZyYW5jaXNjby4mI3hEO0RlcGFydG1lbnQgb2Yg

UGF0aG9sb2d5LCBVbml2ZXJzaXR5IEhlYWx0aCBOZXR3b3JrLCBUb3JvbnRvLCBPbnRhcmlvLCBD

YW5hZGEuJiN4RDtEZXBhcnRtZW50IG9mIFBhdGhvbG9neSwgVW5pdmVyc2l0eSBvZiBUZXhhcyBN

LkQuIEFuZGVyc29uIENhbmNlciBDZW50ZXIsIEhvdXN0b24uJiN4RDtCaW9zdGF0aXN0aWNzIEZh

Y2lsaXR5LCBVbml2ZXJzaXR5IG9mIFBpdHRzYnVyZ2ggQ2FuY2VyIEluc3RpdHV0ZSwgUGl0dHNi

dXJnaCwgUGVubnN5bHZhbmlhLiYjeEQ7RGl2aXNpb24gb2YgRW5kb2NyaW5vbG9neSBhbmQgTWV0

YWJvbGlzbSwgTmV3IFlvcmsgVW5pdmVyc2l0eSBTY2hvb2wgb2YgTWVkaWNpbmUsIE5ldyBZb3Jr

LiYjeEQ7VW5pdmVyc2l0eSBvZiBXaXNjb25zaW4gU2Nob29sIG9mIE1lZGljaW5lIGFuZCBQdWJs

aWMgSGVhbHRoLCBNYWRpc29uLiYjeEQ7RGVwYXJ0bWVudCBvZiBQc3ljaGlhdHJ5LCBNYXNzYWNo

dXNldHRzIEdlbmVyYWwgSG9zcGl0YWwsIEJvc3Rvbi4mI3hEO0RlcGFydG1lbnQgb2YgUGF0aG9s

b2d5LCBNYXNzYWNodXNldHRzIEdlbmVyYWwgSG9zcGl0YWwsIEJvc3RvbjIyRGVwYXJ0bWVudCBv

ZiBQYXRob2xvZ3kgSGFydmFyZCBNZWRpY2FsIFNjaG9vbCwgQm9zdG9uLCBNYXNzYWNodXNldHRz

LiYjeEQ7RGVwYXJ0bWVudCBvZiBPbmNvbG9neSwgVW5pdmVyc2l0eSBvZiBUdXJpbiwgVG9yaW5v

LCBJdGFseS4mI3hEO1VuaXZlcnNpdHkgb2YgUG9ydHNtb3V0aCwgRGVwYXJ0bWVudCBvZiBQYXRo

b2xvZ3ksIFF1ZWVuIEFsZXhhbmRyYSBIb3NwaXRhbCwgQ29zaGFtLCBQb3J0c21vdXRoLCBVbml0

ZWQgS2luZ2RvbS4mI3hEO0RlcGFydG1lbnQgb2YgUGF0aG9sb2d5IGFuZCBMYWJvcmF0b3J5IE1l

ZGljaW5lLCBUdWZ0cyBVbml2ZXJzaXR5IFNjaG9vbCBvZiBNZWRpY2luZSwgVHVmdHMgTWVkaWNh

bCBDZW50ZXIsIEJvc3RvbiwgTWFzc2FjaHVzZXR0cy4mI3hEO0RlcGFydG1lbnQgb2YgRW5kb2Ny

aW5vbG9neSwgTWVtb3JpYWwgU2xvYW4gS2V0dGVyaW5nIENhbmNlciBDZW50ZXIsIE5ldyBZb3Jr

LCBOZXcgWW9yay4mI3hEO1RoeXJvaWQgQ2FuY2VyIFN1cnZpdm9ycyBBc3NvY2lhdGlvbiBJbmMs

IFJhbGVpZ2gsIE5vcnRoIENhcm9saW5hLiYjeEQ7R2VuZXJhbCBhbmQgVGh5cm9pZCBhbmQgUGFy

YXRoeXJvaWQgRW5kb2NyaW5lIFN1cmdlcnkgRGl2aXNpb24sIE1hc3NhY2h1c2V0dHMgRXllIGFu

ZCBFYXIgSW5maXJtYXJ5LCBCb3N0b24uJiN4RDtEZXBhcnRtZW50IG9mIFBhdGhvbG9neSwgTWVt

b3JpYWwgU2xvYW4gS2V0dGVyaW5nIENhbmNlciBDZW50ZXIsIE5ldyBZb3JrLCBOZXcgWW9yay48

L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5Ob21lbmNsYXR1cmUgUmV2aXNpb24gZm9yIEVu

Y2Fwc3VsYXRlZCBGb2xsaWN1bGFyIFZhcmlhbnQgb2YgUGFwaWxsYXJ5IFRoeXJvaWQgQ2FyY2lu

b21hOiBBIFBhcmFkaWdtIFNoaWZ0IHRvIFJlZHVjZSBPdmVydHJlYXRtZW50IG9mIEluZG9sZW50

IFR1bW9yczwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5KQU1BIE9uY29sPC9zZWNvbmRhcnktdGl0

bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+SkFNQSBPbmNvbDwvZnVsbC10aXRs

ZT48L3BlcmlvZGljYWw+PHBhZ2VzPjEwMjMtOTwvcGFnZXM+PHZvbHVtZT4yPC92b2x1bWU+PG51

bWJlcj44PC9udW1iZXI+PGtleXdvcmRzPjxrZXl3b3JkPkFkZW5vY2FyY2lub21hLCBGb2xsaWN1

bGFyL2NsYXNzaWZpY2F0aW9uL2RpYWdub3Npcy8qcGF0aG9sb2d5PC9rZXl3b3JkPjxrZXl3b3Jk

PkFkdWx0PC9rZXl3b3JkPjxrZXl3b3JkPkFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+QWdlZCwgODAg

YW5kIG92ZXI8L2tleXdvcmQ+PGtleXdvcmQ+Q2FyY2lub21hL2NsYXNzaWZpY2F0aW9uL2RpYWdu

b3Npcy8qcGF0aG9sb2d5PC9rZXl3b3JkPjxrZXl3b3JkPkZlbWFsZTwva2V5d29yZD48a2V5d29y

ZD5IdW1hbnM8L2tleXdvcmQ+PGtleXdvcmQ+TWFsZTwva2V5d29yZD48a2V5d29yZD5NZWRpY2Fs

IE92ZXJ1c2UvKnByZXZlbnRpb24gJmFtcDsgY29udHJvbDwva2V5d29yZD48a2V5d29yZD5NaWRk

bGUgQWdlZDwva2V5d29yZD48a2V5d29yZD5OZW9wbGFzbSBJbnZhc2l2ZW5lc3M8L2tleXdvcmQ+

PGtleXdvcmQ+UmV0cm9zcGVjdGl2ZSBTdHVkaWVzPC9rZXl3b3JkPjxrZXl3b3JkPipUZXJtaW5v

bG9neSBhcyBUb3BpYzwva2V5d29yZD48a2V5d29yZD5UaHlyb2lkIE5lb3BsYXNtcy9jbGFzc2lm

aWNhdGlvbi9kaWFnbm9zaXMvKnBhdGhvbG9neTwva2V5d29yZD48a2V5d29yZD5UaHlyb2lkIE5v

ZHVsZS9jbGFzc2lmaWNhdGlvbi9kaWFnbm9zaXMvKnBhdGhvbG9neTwva2V5d29yZD48a2V5d29y

ZD5Zb3VuZyBBZHVsdDwva2V5d29yZD48L2tleXdvcmRzPjxkYXRlcz48eWVhcj4yMDE2PC95ZWFy

PjxwdWItZGF0ZXM+PGRhdGU+QXVnIDAxPC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+

MjM3NC0yNDQ1IChFbGVjdHJvbmljKSYjeEQ7MjM3NC0yNDM3IChMaW5raW5nKTwvaXNibj48YWNj

ZXNzaW9uLW51bT4yNzA3ODE0NTwvYWNjZXNzaW9uLW51bT48dXJscz48cmVsYXRlZC11cmxzPjx1

cmw+aHR0cHM6Ly93d3cubmNiaS5ubG0ubmloLmdvdi9wdWJtZWQvMjcwNzgxNDU8L3VybD48L3Jl

bGF0ZWQtdXJscz48L3VybHM+PGVsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjEwLjEwMDEvamFtYW9u

Y29sLjIwMTYuMDM4NjwvZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+PC9yZWNvcmQ+PC9DaXRlPjwv

RW5kTm90ZT5=

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5OaWtpZm9yb3Y8L0F1dGhvcj48WWVhcj4yMDE2PC9ZZWFy

PjxSZWNOdW0+NDg8L1JlY051bT48RGlzcGxheVRleHQ+PHN0eWxlIGZhY2U9InN1cGVyc2NyaXB0

Ij4xMzwvc3R5bGU+PC9EaXNwbGF5VGV4dD48cmVjb3JkPjxyZWMtbnVtYmVyPjQ4PC9yZWMtbnVt

YmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0icHMyd3dkc2ZyYTJyNWVlOXph

c3hzNXQ4endkd3hyc3dlNXhhIiB0aW1lc3RhbXA9IjE0OTUyNDM5MzAiPjQ4PC9rZXk+PC9mb3Jl

aWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxj

b250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5OaWtpZm9yb3YsIFkuIEUuPC9hdXRob3I+PGF1

dGhvcj5TZWV0aGFsYSwgUi4gUi48L2F1dGhvcj48YXV0aG9yPlRhbGxpbmksIEcuPC9hdXRob3I+

PGF1dGhvcj5CYWxvY2gsIFouIFcuPC9hdXRob3I+PGF1dGhvcj5CYXNvbG8sIEYuPC9hdXRob3I+

PGF1dGhvcj5UaG9tcHNvbiwgTC4gRC48L2F1dGhvcj48YXV0aG9yPkJhcmxldHRhLCBKLiBBLjwv

YXV0aG9yPjxhdXRob3I+V2VuaWcsIEIuIE0uPC9hdXRob3I+PGF1dGhvcj5BbCBHaHV6bGFuLCBB

LjwvYXV0aG9yPjxhdXRob3I+S2FrdWRvLCBLLjwvYXV0aG9yPjxhdXRob3I+R2lvcmRhbm8sIFQu

IEouPC9hdXRob3I+PGF1dGhvcj5BbHZlcywgVi4gQS48L2F1dGhvcj48YXV0aG9yPktoYW5hZnNo

YXIsIEUuPC9hdXRob3I+PGF1dGhvcj5Bc2EsIFMuIEwuPC9hdXRob3I+PGF1dGhvcj5FbC1OYWdn

YXIsIEEuIEsuPC9hdXRob3I+PGF1dGhvcj5Hb29kaW5nLCBXLiBFLjwvYXV0aG9yPjxhdXRob3I+

SG9kYWssIFMuIFAuPC9hdXRob3I+PGF1dGhvcj5MbG95ZCwgUi4gVi48L2F1dGhvcj48YXV0aG9y

Pk1heXRhbCwgRy48L2F1dGhvcj48YXV0aG9yPk1ldGUsIE8uPC9hdXRob3I+PGF1dGhvcj5OaWtp

Zm9yb3ZhLCBNLiBOLjwvYXV0aG9yPjxhdXRob3I+Tm9zZSwgVi48L2F1dGhvcj48YXV0aG9yPlBh

cG90dGksIE0uPC9hdXRob3I+PGF1dGhvcj5Qb2xsZXIsIEQuIE4uPC9hdXRob3I+PGF1dGhvcj5T

YWRvdywgUC4gTS48L2F1dGhvcj48YXV0aG9yPlRpc2NobGVyLCBBLiBTLjwvYXV0aG9yPjxhdXRo

b3I+VHV0dGxlLCBSLiBNLjwvYXV0aG9yPjxhdXRob3I+V2FsbCwgSy4gQi48L2F1dGhvcj48YXV0

aG9yPkxpVm9sc2ksIFYuIEEuPC9hdXRob3I+PGF1dGhvcj5SYW5kb2xwaCwgRy4gVy48L2F1dGhv

cj48YXV0aG9yPkdob3NzZWluLCBSLiBBLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9y

cz48YXV0aC1hZGRyZXNzPkRlcGFydG1lbnQgb2YgUGF0aG9sb2d5LCBVbml2ZXJzaXR5IG9mIFBp

dHRzYnVyZ2gsIFBpdHRzYnVyZ2gsIFBlbm5zeWx2YW5pYS4mI3hEO0FuYXRvbWljIFBhdGhvbG9n

eSwgRGVwYXJ0bWVudCBvZiBNZWRpY2luZSAoRElNRVMpLCBVbml2ZXJzaXR5IG9mIEJvbG9nbmEg

U2Nob29sIG9mIE1lZGljaW5lLCBCb2xvZ25hLCBJdGFseS4mI3hEO0RlcGFydG1lbnQgb2YgUGF0

aG9sb2d5IGFuZCBMYWJvcmF0b3J5IE1lZGljaW5lLCBIb3NwaXRhbCBvZiB0aGUgVW5pdmVyc2l0

eSBvZiBQZW5uc3lsdmFuaWEsIFBlcmVsbWFuIFNjaG9vbCBvZiBNZWRpY2luZSwgUGhpbGFkZWxw

aGlhLiYjeEQ7RGVwYXJ0bWVudCBvZiBTdXJnaWNhbCwgTWVkaWNhbCBhbmQgTW9sZWN1bGFyIFBh

dGhvbG9neSwgVW5pdmVyc2l0eSBvZiBQaXNhLCBQaXNhLCBJdGFseS4mI3hEO1NvdXRoZXJuIENh

bGlmb3JuaWEgUGVybWFuZW50ZSBNZWRpY2FsIEdyb3VwLCBXb29kbGFuZCBIaWxscy4mI3hEO0Rl

cGFydG1lbnQgb2YgUGF0aG9sb2d5LCBCcmlnaGFtIGFuZCBXb21lbiZhcG9zO3MgSG9zcGl0YWws

IEhhcnZhcmQgTWVkaWNhbCBTY2hvb2wsIEJvc3RvbiwgTWFzc2FjaHVzZXR0cy4mI3hEO0RlcGFy

dG1lbnQgb2YgUGF0aG9sb2d5LCBNb3VudCBTaW5haSBIZWFsdGggU3lzdGVtLCBOZXcgWW9yaywg

TmV3IFlvcmsuJiN4RDtEZXBhcnRtZW50IG9mIE1lZGljYWwgQmlvbG9neSBhbmQgUGF0aG9sb2d5

LCBHdXN0YXZlIFJvdXNzeSBDYW5jZXIgQ2FtcHVzIEdyYW5kIFBhcmlzLCBWaWxsZWp1aWYsIEZy

YW5jZS4mI3hEO0RlcGFydG1lbnQgb2YgUGF0aG9sb2d5IGFuZCBMYWJvcmF0b3J5IE1lZGljaW5l

LCBOYXJhIEhvc3BpdGFsLCBLaW5kYWkgVW5pdmVyc2l0eSBGYWN1bHR5IG9mIE1lZGljaW5lLCBJ

a29tYS1jaXR5LCBKYXBhbi4mI3hEO0RlcGFydG1lbnQgb2YgUGF0aG9sb2d5LCBVbml2ZXJzaXR5

IG9mIE1pY2hpZ2FuLCBBbm4gQXJib3IxMUNvbXByZWhlbnNpdmUgQ2FuY2VyIENlbnRlciwgVW5p

dmVyc2l0eSBvZiBNaWNoaWdhbiwgQW5uIEFyYm9yLiYjeEQ7RGVwYXJ0bWVudCBvZiBQYXRob2xv

Z3ksIFVuaXZlcnNpdHkgb2YgU2FvIFBhdWxvIFNjaG9vbCBvZiBNZWRpY2luZSwgU2FvIFBhdWxv

LCBCcmF6aWwxM0RlcGFydG1lbnQgb2YgUGF0aG9sb2d5LCBIb3NwaXRhbCBBbGVtYW8gT3N3YWxk

byBDcnV6LCBTYW8gUGF1bG8sIEJyYXppbC4mI3hEO0RlcGFydG1lbnQgb2YgUGF0aG9sb2d5LCBV

bml2ZXJzaXR5IG9mIENhbGlmb3JuaWEgU2FuIEZyYW5jaXNjby4mI3hEO0RlcGFydG1lbnQgb2Yg

UGF0aG9sb2d5LCBVbml2ZXJzaXR5IEhlYWx0aCBOZXR3b3JrLCBUb3JvbnRvLCBPbnRhcmlvLCBD

YW5hZGEuJiN4RDtEZXBhcnRtZW50IG9mIFBhdGhvbG9neSwgVW5pdmVyc2l0eSBvZiBUZXhhcyBN

LkQuIEFuZGVyc29uIENhbmNlciBDZW50ZXIsIEhvdXN0b24uJiN4RDtCaW9zdGF0aXN0aWNzIEZh

Y2lsaXR5LCBVbml2ZXJzaXR5IG9mIFBpdHRzYnVyZ2ggQ2FuY2VyIEluc3RpdHV0ZSwgUGl0dHNi

dXJnaCwgUGVubnN5bHZhbmlhLiYjeEQ7RGl2aXNpb24gb2YgRW5kb2NyaW5vbG9neSBhbmQgTWV0

YWJvbGlzbSwgTmV3IFlvcmsgVW5pdmVyc2l0eSBTY2hvb2wgb2YgTWVkaWNpbmUsIE5ldyBZb3Jr

LiYjeEQ7VW5pdmVyc2l0eSBvZiBXaXNjb25zaW4gU2Nob29sIG9mIE1lZGljaW5lIGFuZCBQdWJs

aWMgSGVhbHRoLCBNYWRpc29uLiYjeEQ7RGVwYXJ0bWVudCBvZiBQc3ljaGlhdHJ5LCBNYXNzYWNo

dXNldHRzIEdlbmVyYWwgSG9zcGl0YWwsIEJvc3Rvbi4mI3hEO0RlcGFydG1lbnQgb2YgUGF0aG9s

b2d5LCBNYXNzYWNodXNldHRzIEdlbmVyYWwgSG9zcGl0YWwsIEJvc3RvbjIyRGVwYXJ0bWVudCBv

ZiBQYXRob2xvZ3kgSGFydmFyZCBNZWRpY2FsIFNjaG9vbCwgQm9zdG9uLCBNYXNzYWNodXNldHRz

LiYjeEQ7RGVwYXJ0bWVudCBvZiBPbmNvbG9neSwgVW5pdmVyc2l0eSBvZiBUdXJpbiwgVG9yaW5v

LCBJdGFseS4mI3hEO1VuaXZlcnNpdHkgb2YgUG9ydHNtb3V0aCwgRGVwYXJ0bWVudCBvZiBQYXRo

b2xvZ3ksIFF1ZWVuIEFsZXhhbmRyYSBIb3NwaXRhbCwgQ29zaGFtLCBQb3J0c21vdXRoLCBVbml0

ZWQgS2luZ2RvbS4mI3hEO0RlcGFydG1lbnQgb2YgUGF0aG9sb2d5IGFuZCBMYWJvcmF0b3J5IE1l

ZGljaW5lLCBUdWZ0cyBVbml2ZXJzaXR5IFNjaG9vbCBvZiBNZWRpY2luZSwgVHVmdHMgTWVkaWNh

bCBDZW50ZXIsIEJvc3RvbiwgTWFzc2FjaHVzZXR0cy4mI3hEO0RlcGFydG1lbnQgb2YgRW5kb2Ny

aW5vbG9neSwgTWVtb3JpYWwgU2xvYW4gS2V0dGVyaW5nIENhbmNlciBDZW50ZXIsIE5ldyBZb3Jr

LCBOZXcgWW9yay4mI3hEO1RoeXJvaWQgQ2FuY2VyIFN1cnZpdm9ycyBBc3NvY2lhdGlvbiBJbmMs

IFJhbGVpZ2gsIE5vcnRoIENhcm9saW5hLiYjeEQ7R2VuZXJhbCBhbmQgVGh5cm9pZCBhbmQgUGFy

YXRoeXJvaWQgRW5kb2NyaW5lIFN1cmdlcnkgRGl2aXNpb24sIE1hc3NhY2h1c2V0dHMgRXllIGFu

ZCBFYXIgSW5maXJtYXJ5LCBCb3N0b24uJiN4RDtEZXBhcnRtZW50IG9mIFBhdGhvbG9neSwgTWVt

b3JpYWwgU2xvYW4gS2V0dGVyaW5nIENhbmNlciBDZW50ZXIsIE5ldyBZb3JrLCBOZXcgWW9yay48

L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5Ob21lbmNsYXR1cmUgUmV2aXNpb24gZm9yIEVu

Y2Fwc3VsYXRlZCBGb2xsaWN1bGFyIFZhcmlhbnQgb2YgUGFwaWxsYXJ5IFRoeXJvaWQgQ2FyY2lu

b21hOiBBIFBhcmFkaWdtIFNoaWZ0IHRvIFJlZHVjZSBPdmVydHJlYXRtZW50IG9mIEluZG9sZW50

IFR1bW9yczwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5KQU1BIE9uY29sPC9zZWNvbmRhcnktdGl0

bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+SkFNQSBPbmNvbDwvZnVsbC10aXRs

ZT48L3BlcmlvZGljYWw+PHBhZ2VzPjEwMjMtOTwvcGFnZXM+PHZvbHVtZT4yPC92b2x1bWU+PG51

bWJlcj44PC9udW1iZXI+PGtleXdvcmRzPjxrZXl3b3JkPkFkZW5vY2FyY2lub21hLCBGb2xsaWN1

bGFyL2NsYXNzaWZpY2F0aW9uL2RpYWdub3Npcy8qcGF0aG9sb2d5PC9rZXl3b3JkPjxrZXl3b3Jk

PkFkdWx0PC9rZXl3b3JkPjxrZXl3b3JkPkFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+QWdlZCwgODAg

YW5kIG92ZXI8L2tleXdvcmQ+PGtleXdvcmQ+Q2FyY2lub21hL2NsYXNzaWZpY2F0aW9uL2RpYWdu

b3Npcy8qcGF0aG9sb2d5PC9rZXl3b3JkPjxrZXl3b3JkPkZlbWFsZTwva2V5d29yZD48a2V5d29y

ZD5IdW1hbnM8L2tleXdvcmQ+PGtleXdvcmQ+TWFsZTwva2V5d29yZD48a2V5d29yZD5NZWRpY2Fs

IE92ZXJ1c2UvKnByZXZlbnRpb24gJmFtcDsgY29udHJvbDwva2V5d29yZD48a2V5d29yZD5NaWRk

bGUgQWdlZDwva2V5d29yZD48a2V5d29yZD5OZW9wbGFzbSBJbnZhc2l2ZW5lc3M8L2tleXdvcmQ+

PGtleXdvcmQ+UmV0cm9zcGVjdGl2ZSBTdHVkaWVzPC9rZXl3b3JkPjxrZXl3b3JkPipUZXJtaW5v

bG9neSBhcyBUb3BpYzwva2V5d29yZD48a2V5d29yZD5UaHlyb2lkIE5lb3BsYXNtcy9jbGFzc2lm

aWNhdGlvbi9kaWFnbm9zaXMvKnBhdGhvbG9neTwva2V5d29yZD48a2V5d29yZD5UaHlyb2lkIE5v

ZHVsZS9jbGFzc2lmaWNhdGlvbi9kaWFnbm9zaXMvKnBhdGhvbG9neTwva2V5d29yZD48a2V5d29y

ZD5Zb3VuZyBBZHVsdDwva2V5d29yZD48L2tleXdvcmRzPjxkYXRlcz48eWVhcj4yMDE2PC95ZWFy

PjxwdWItZGF0ZXM+PGRhdGU+QXVnIDAxPC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+

MjM3NC0yNDQ1IChFbGVjdHJvbmljKSYjeEQ7MjM3NC0yNDM3IChMaW5raW5nKTwvaXNibj48YWNj

ZXNzaW9uLW51bT4yNzA3ODE0NTwvYWNjZXNzaW9uLW51bT48dXJscz48cmVsYXRlZC11cmxzPjx1

cmw+aHR0cHM6Ly93d3cubmNiaS5ubG0ubmloLmdvdi9wdWJtZWQvMjcwNzgxNDU8L3VybD48L3Jl

bGF0ZWQtdXJscz48L3VybHM+PGVsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjEwLjEwMDEvamFtYW9u

Y29sLjIwMTYuMDM4NjwvZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+PC9yZWNvcmQ+PC9DaXRlPjwv

RW5kTm90ZT5=

ADDIN EN.CITE.DATA 13 Main inclusion criteria require that the tumor is: Encapsulated or well demarcatedFollicular patternedDemonstrating at least focal nuclear features of papillary thyroid carcinoma Another key requirement for this designation is that the entire lesional border has been submitted for histologic evaluation. However, several exclusionary criteria exist as well in order to ensure that the NIFTP category remains indolent and are as followsPEVuZE5vdGU+PENpdGU+PEF1dGhvcj5OaWtpZm9yb3Y8L0F1dGhvcj48WWVhcj4yMDE2PC9ZZWFy

PjxSZWNOdW0+NDg8L1JlY051bT48RGlzcGxheVRleHQ+PHN0eWxlIGZhY2U9InN1cGVyc2NyaXB0

Ij4xMzwvc3R5bGU+PC9EaXNwbGF5VGV4dD48cmVjb3JkPjxyZWMtbnVtYmVyPjQ4PC9yZWMtbnVt

YmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0icHMyd3dkc2ZyYTJyNWVlOXph

c3hzNXQ4endkd3hyc3dlNXhhIiB0aW1lc3RhbXA9IjE0OTUyNDM5MzAiPjQ4PC9rZXk+PC9mb3Jl

aWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxj

b250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5OaWtpZm9yb3YsIFkuIEUuPC9hdXRob3I+PGF1

dGhvcj5TZWV0aGFsYSwgUi4gUi48L2F1dGhvcj48YXV0aG9yPlRhbGxpbmksIEcuPC9hdXRob3I+

PGF1dGhvcj5CYWxvY2gsIFouIFcuPC9hdXRob3I+PGF1dGhvcj5CYXNvbG8sIEYuPC9hdXRob3I+

PGF1dGhvcj5UaG9tcHNvbiwgTC4gRC48L2F1dGhvcj48YXV0aG9yPkJhcmxldHRhLCBKLiBBLjwv

YXV0aG9yPjxhdXRob3I+V2VuaWcsIEIuIE0uPC9hdXRob3I+PGF1dGhvcj5BbCBHaHV6bGFuLCBB

LjwvYXV0aG9yPjxhdXRob3I+S2FrdWRvLCBLLjwvYXV0aG9yPjxhdXRob3I+R2lvcmRhbm8sIFQu

IEouPC9hdXRob3I+PGF1dGhvcj5BbHZlcywgVi4gQS48L2F1dGhvcj48YXV0aG9yPktoYW5hZnNo

YXIsIEUuPC9hdXRob3I+PGF1dGhvcj5Bc2EsIFMuIEwuPC9hdXRob3I+PGF1dGhvcj5FbC1OYWdn

YXIsIEEuIEsuPC9hdXRob3I+PGF1dGhvcj5Hb29kaW5nLCBXLiBFLjwvYXV0aG9yPjxhdXRob3I+

SG9kYWssIFMuIFAuPC9hdXRob3I+PGF1dGhvcj5MbG95ZCwgUi4gVi48L2F1dGhvcj48YXV0aG9y

Pk1heXRhbCwgRy48L2F1dGhvcj48YXV0aG9yPk1ldGUsIE8uPC9hdXRob3I+PGF1dGhvcj5OaWtp

Zm9yb3ZhLCBNLiBOLjwvYXV0aG9yPjxhdXRob3I+Tm9zZSwgVi48L2F1dGhvcj48YXV0aG9yPlBh

cG90dGksIE0uPC9hdXRob3I+PGF1dGhvcj5Qb2xsZXIsIEQuIE4uPC9hdXRob3I+PGF1dGhvcj5T

YWRvdywgUC4gTS48L2F1dGhvcj48YXV0aG9yPlRpc2NobGVyLCBBLiBTLjwvYXV0aG9yPjxhdXRo

b3I+VHV0dGxlLCBSLiBNLjwvYXV0aG9yPjxhdXRob3I+V2FsbCwgSy4gQi48L2F1dGhvcj48YXV0

aG9yPkxpVm9sc2ksIFYuIEEuPC9hdXRob3I+PGF1dGhvcj5SYW5kb2xwaCwgRy4gVy48L2F1dGhv

cj48YXV0aG9yPkdob3NzZWluLCBSLiBBLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9y

cz48YXV0aC1hZGRyZXNzPkRlcGFydG1lbnQgb2YgUGF0aG9sb2d5LCBVbml2ZXJzaXR5IG9mIFBp

dHRzYnVyZ2gsIFBpdHRzYnVyZ2gsIFBlbm5zeWx2YW5pYS4mI3hEO0FuYXRvbWljIFBhdGhvbG9n

eSwgRGVwYXJ0bWVudCBvZiBNZWRpY2luZSAoRElNRVMpLCBVbml2ZXJzaXR5IG9mIEJvbG9nbmEg

U2Nob29sIG9mIE1lZGljaW5lLCBCb2xvZ25hLCBJdGFseS4mI3hEO0RlcGFydG1lbnQgb2YgUGF0

aG9sb2d5IGFuZCBMYWJvcmF0b3J5IE1lZGljaW5lLCBIb3NwaXRhbCBvZiB0aGUgVW5pdmVyc2l0

eSBvZiBQZW5uc3lsdmFuaWEsIFBlcmVsbWFuIFNjaG9vbCBvZiBNZWRpY2luZSwgUGhpbGFkZWxw

aGlhLiYjeEQ7RGVwYXJ0bWVudCBvZiBTdXJnaWNhbCwgTWVkaWNhbCBhbmQgTW9sZWN1bGFyIFBh

dGhvbG9neSwgVW5pdmVyc2l0eSBvZiBQaXNhLCBQaXNhLCBJdGFseS4mI3hEO1NvdXRoZXJuIENh

bGlmb3JuaWEgUGVybWFuZW50ZSBNZWRpY2FsIEdyb3VwLCBXb29kbGFuZCBIaWxscy4mI3hEO0Rl

cGFydG1lbnQgb2YgUGF0aG9sb2d5LCBCcmlnaGFtIGFuZCBXb21lbiZhcG9zO3MgSG9zcGl0YWws

IEhhcnZhcmQgTWVkaWNhbCBTY2hvb2wsIEJvc3RvbiwgTWFzc2FjaHVzZXR0cy4mI3hEO0RlcGFy

dG1lbnQgb2YgUGF0aG9sb2d5LCBNb3VudCBTaW5haSBIZWFsdGggU3lzdGVtLCBOZXcgWW9yaywg

TmV3IFlvcmsuJiN4RDtEZXBhcnRtZW50IG9mIE1lZGljYWwgQmlvbG9neSBhbmQgUGF0aG9sb2d5

LCBHdXN0YXZlIFJvdXNzeSBDYW5jZXIgQ2FtcHVzIEdyYW5kIFBhcmlzLCBWaWxsZWp1aWYsIEZy

YW5jZS4mI3hEO0RlcGFydG1lbnQgb2YgUGF0aG9sb2d5IGFuZCBMYWJvcmF0b3J5IE1lZGljaW5l

LCBOYXJhIEhvc3BpdGFsLCBLaW5kYWkgVW5pdmVyc2l0eSBGYWN1bHR5IG9mIE1lZGljaW5lLCBJ

a29tYS1jaXR5LCBKYXBhbi4mI3hEO0RlcGFydG1lbnQgb2YgUGF0aG9sb2d5LCBVbml2ZXJzaXR5

IG9mIE1pY2hpZ2FuLCBBbm4gQXJib3IxMUNvbXByZWhlbnNpdmUgQ2FuY2VyIENlbnRlciwgVW5p

dmVyc2l0eSBvZiBNaWNoaWdhbiwgQW5uIEFyYm9yLiYjeEQ7RGVwYXJ0bWVudCBvZiBQYXRob2xv

Z3ksIFVuaXZlcnNpdHkgb2YgU2FvIFBhdWxvIFNjaG9vbCBvZiBNZWRpY2luZSwgU2FvIFBhdWxv

LCBCcmF6aWwxM0RlcGFydG1lbnQgb2YgUGF0aG9sb2d5LCBIb3NwaXRhbCBBbGVtYW8gT3N3YWxk

byBDcnV6LCBTYW8gUGF1bG8sIEJyYXppbC4mI3hEO0RlcGFydG1lbnQgb2YgUGF0aG9sb2d5LCBV

bml2ZXJzaXR5IG9mIENhbGlmb3JuaWEgU2FuIEZyYW5jaXNjby4mI3hEO0RlcGFydG1lbnQgb2Yg

UGF0aG9sb2d5LCBVbml2ZXJzaXR5IEhlYWx0aCBOZXR3b3JrLCBUb3JvbnRvLCBPbnRhcmlvLCBD

YW5hZGEuJiN4RDtEZXBhcnRtZW50IG9mIFBhdGhvbG9neSwgVW5pdmVyc2l0eSBvZiBUZXhhcyBN

LkQuIEFuZGVyc29uIENhbmNlciBDZW50ZXIsIEhvdXN0b24uJiN4RDtCaW9zdGF0aXN0aWNzIEZh

Y2lsaXR5LCBVbml2ZXJzaXR5IG9mIFBpdHRzYnVyZ2ggQ2FuY2VyIEluc3RpdHV0ZSwgUGl0dHNi

dXJnaCwgUGVubnN5bHZhbmlhLiYjeEQ7RGl2aXNpb24gb2YgRW5kb2NyaW5vbG9neSBhbmQgTWV0

YWJvbGlzbSwgTmV3IFlvcmsgVW5pdmVyc2l0eSBTY2hvb2wgb2YgTWVkaWNpbmUsIE5ldyBZb3Jr

LiYjeEQ7VW5pdmVyc2l0eSBvZiBXaXNjb25zaW4gU2Nob29sIG9mIE1lZGljaW5lIGFuZCBQdWJs

aWMgSGVhbHRoLCBNYWRpc29uLiYjeEQ7RGVwYXJ0bWVudCBvZiBQc3ljaGlhdHJ5LCBNYXNzYWNo

dXNldHRzIEdlbmVyYWwgSG9zcGl0YWwsIEJvc3Rvbi4mI3hEO0RlcGFydG1lbnQgb2YgUGF0aG9s

b2d5LCBNYXNzYWNodXNldHRzIEdlbmVyYWwgSG9zcGl0YWwsIEJvc3RvbjIyRGVwYXJ0bWVudCBv

ZiBQYXRob2xvZ3kgSGFydmFyZCBNZWRpY2FsIFNjaG9vbCwgQm9zdG9uLCBNYXNzYWNodXNldHRz

LiYjeEQ7RGVwYXJ0bWVudCBvZiBPbmNvbG9neSwgVW5pdmVyc2l0eSBvZiBUdXJpbiwgVG9yaW5v

LCBJdGFseS4mI3hEO1VuaXZlcnNpdHkgb2YgUG9ydHNtb3V0aCwgRGVwYXJ0bWVudCBvZiBQYXRo

b2xvZ3ksIFF1ZWVuIEFsZXhhbmRyYSBIb3NwaXRhbCwgQ29zaGFtLCBQb3J0c21vdXRoLCBVbml0

ZWQgS2luZ2RvbS4mI3hEO0RlcGFydG1lbnQgb2YgUGF0aG9sb2d5IGFuZCBMYWJvcmF0b3J5IE1l

ZGljaW5lLCBUdWZ0cyBVbml2ZXJzaXR5IFNjaG9vbCBvZiBNZWRpY2luZSwgVHVmdHMgTWVkaWNh

bCBDZW50ZXIsIEJvc3RvbiwgTWFzc2FjaHVzZXR0cy4mI3hEO0RlcGFydG1lbnQgb2YgRW5kb2Ny

aW5vbG9neSwgTWVtb3JpYWwgU2xvYW4gS2V0dGVyaW5nIENhbmNlciBDZW50ZXIsIE5ldyBZb3Jr

LCBOZXcgWW9yay4mI3hEO1RoeXJvaWQgQ2FuY2VyIFN1cnZpdm9ycyBBc3NvY2lhdGlvbiBJbmMs

IFJhbGVpZ2gsIE5vcnRoIENhcm9saW5hLiYjeEQ7R2VuZXJhbCBhbmQgVGh5cm9pZCBhbmQgUGFy

YXRoeXJvaWQgRW5kb2NyaW5lIFN1cmdlcnkgRGl2aXNpb24sIE1hc3NhY2h1c2V0dHMgRXllIGFu

ZCBFYXIgSW5maXJtYXJ5LCBCb3N0b24uJiN4RDtEZXBhcnRtZW50IG9mIFBhdGhvbG9neSwgTWVt

b3JpYWwgU2xvYW4gS2V0dGVyaW5nIENhbmNlciBDZW50ZXIsIE5ldyBZb3JrLCBOZXcgWW9yay48

L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5Ob21lbmNsYXR1cmUgUmV2aXNpb24gZm9yIEVu

Y2Fwc3VsYXRlZCBGb2xsaWN1bGFyIFZhcmlhbnQgb2YgUGFwaWxsYXJ5IFRoeXJvaWQgQ2FyY2lu

b21hOiBBIFBhcmFkaWdtIFNoaWZ0IHRvIFJlZHVjZSBPdmVydHJlYXRtZW50IG9mIEluZG9sZW50

IFR1bW9yczwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5KQU1BIE9uY29sPC9zZWNvbmRhcnktdGl0

bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+SkFNQSBPbmNvbDwvZnVsbC10aXRs

ZT48L3BlcmlvZGljYWw+PHBhZ2VzPjEwMjMtOTwvcGFnZXM+PHZvbHVtZT4yPC92b2x1bWU+PG51

bWJlcj44PC9udW1iZXI+PGtleXdvcmRzPjxrZXl3b3JkPkFkZW5vY2FyY2lub21hLCBGb2xsaWN1

bGFyL2NsYXNzaWZpY2F0aW9uL2RpYWdub3Npcy8qcGF0aG9sb2d5PC9rZXl3b3JkPjxrZXl3b3Jk

PkFkdWx0PC9rZXl3b3JkPjxrZXl3b3JkPkFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+QWdlZCwgODAg

YW5kIG92ZXI8L2tleXdvcmQ+PGtleXdvcmQ+Q2FyY2lub21hL2NsYXNzaWZpY2F0aW9uL2RpYWdu

b3Npcy8qcGF0aG9sb2d5PC9rZXl3b3JkPjxrZXl3b3JkPkZlbWFsZTwva2V5d29yZD48a2V5d29y

ZD5IdW1hbnM8L2tleXdvcmQ+PGtleXdvcmQ+TWFsZTwva2V5d29yZD48a2V5d29yZD5NZWRpY2Fs

IE92ZXJ1c2UvKnByZXZlbnRpb24gJmFtcDsgY29udHJvbDwva2V5d29yZD48a2V5d29yZD5NaWRk

bGUgQWdlZDwva2V5d29yZD48a2V5d29yZD5OZW9wbGFzbSBJbnZhc2l2ZW5lc3M8L2tleXdvcmQ+

PGtleXdvcmQ+UmV0cm9zcGVjdGl2ZSBTdHVkaWVzPC9rZXl3b3JkPjxrZXl3b3JkPipUZXJtaW5v

bG9neSBhcyBUb3BpYzwva2V5d29yZD48a2V5d29yZD5UaHlyb2lkIE5lb3BsYXNtcy9jbGFzc2lm

aWNhdGlvbi9kaWFnbm9zaXMvKnBhdGhvbG9neTwva2V5d29yZD48a2V5d29yZD5UaHlyb2lkIE5v

ZHVsZS9jbGFzc2lmaWNhdGlvbi9kaWFnbm9zaXMvKnBhdGhvbG9neTwva2V5d29yZD48a2V5d29y

ZD5Zb3VuZyBBZHVsdDwva2V5d29yZD48L2tleXdvcmRzPjxkYXRlcz48eWVhcj4yMDE2PC95ZWFy

PjxwdWItZGF0ZXM+PGRhdGU+QXVnIDAxPC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+

MjM3NC0yNDQ1IChFbGVjdHJvbmljKSYjeEQ7MjM3NC0yNDM3IChMaW5raW5nKTwvaXNibj48YWNj

ZXNzaW9uLW51bT4yNzA3ODE0NTwvYWNjZXNzaW9uLW51bT48dXJscz48cmVsYXRlZC11cmxzPjx1

cmw+aHR0cHM6Ly93d3cubmNiaS5ubG0ubmloLmdvdi9wdWJtZWQvMjcwNzgxNDU8L3VybD48L3Jl

bGF0ZWQtdXJscz48L3VybHM+PGVsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjEwLjEwMDEvamFtYW9u

Y29sLjIwMTYuMDM4NjwvZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+PC9yZWNvcmQ+PC9DaXRlPjwv

RW5kTm90ZT5=

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5OaWtpZm9yb3Y8L0F1dGhvcj48WWVhcj4yMDE2PC9ZZWFy

PjxSZWNOdW0+NDg8L1JlY051bT48RGlzcGxheVRleHQ+PHN0eWxlIGZhY2U9InN1cGVyc2NyaXB0

Ij4xMzwvc3R5bGU+PC9EaXNwbGF5VGV4dD48cmVjb3JkPjxyZWMtbnVtYmVyPjQ4PC9yZWMtbnVt

YmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0icHMyd3dkc2ZyYTJyNWVlOXph

c3hzNXQ4endkd3hyc3dlNXhhIiB0aW1lc3RhbXA9IjE0OTUyNDM5MzAiPjQ4PC9rZXk+PC9mb3Jl

aWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxj

b250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5OaWtpZm9yb3YsIFkuIEUuPC9hdXRob3I+PGF1

dGhvcj5TZWV0aGFsYSwgUi4gUi48L2F1dGhvcj48YXV0aG9yPlRhbGxpbmksIEcuPC9hdXRob3I+

PGF1dGhvcj5CYWxvY2gsIFouIFcuPC9hdXRob3I+PGF1dGhvcj5CYXNvbG8sIEYuPC9hdXRob3I+

PGF1dGhvcj5UaG9tcHNvbiwgTC4gRC48L2F1dGhvcj48YXV0aG9yPkJhcmxldHRhLCBKLiBBLjwv

YXV0aG9yPjxhdXRob3I+V2VuaWcsIEIuIE0uPC9hdXRob3I+PGF1dGhvcj5BbCBHaHV6bGFuLCBB

LjwvYXV0aG9yPjxhdXRob3I+S2FrdWRvLCBLLjwvYXV0aG9yPjxhdXRob3I+R2lvcmRhbm8sIFQu

IEouPC9hdXRob3I+PGF1dGhvcj5BbHZlcywgVi4gQS48L2F1dGhvcj48YXV0aG9yPktoYW5hZnNo

YXIsIEUuPC9hdXRob3I+PGF1dGhvcj5Bc2EsIFMuIEwuPC9hdXRob3I+PGF1dGhvcj5FbC1OYWdn

YXIsIEEuIEsuPC9hdXRob3I+PGF1dGhvcj5Hb29kaW5nLCBXLiBFLjwvYXV0aG9yPjxhdXRob3I+

SG9kYWssIFMuIFAuPC9hdXRob3I+PGF1dGhvcj5MbG95ZCwgUi4gVi48L2F1dGhvcj48YXV0aG9y

Pk1heXRhbCwgRy48L2F1dGhvcj48YXV0aG9yPk1ldGUsIE8uPC9hdXRob3I+PGF1dGhvcj5OaWtp

Zm9yb3ZhLCBNLiBOLjwvYXV0aG9yPjxhdXRob3I+Tm9zZSwgVi48L2F1dGhvcj48YXV0aG9yPlBh

cG90dGksIE0uPC9hdXRob3I+PGF1dGhvcj5Qb2xsZXIsIEQuIE4uPC9hdXRob3I+PGF1dGhvcj5T

YWRvdywgUC4gTS48L2F1dGhvcj48YXV0aG9yPlRpc2NobGVyLCBBLiBTLjwvYXV0aG9yPjxhdXRo

b3I+VHV0dGxlLCBSLiBNLjwvYXV0aG9yPjxhdXRob3I+V2FsbCwgSy4gQi48L2F1dGhvcj48YXV0

aG9yPkxpVm9sc2ksIFYuIEEuPC9hdXRob3I+PGF1dGhvcj5SYW5kb2xwaCwgRy4gVy48L2F1dGhv

cj48YXV0aG9yPkdob3NzZWluLCBSLiBBLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9y

cz48YXV0aC1hZGRyZXNzPkRlcGFydG1lbnQgb2YgUGF0aG9sb2d5LCBVbml2ZXJzaXR5IG9mIFBp

dHRzYnVyZ2gsIFBpdHRzYnVyZ2gsIFBlbm5zeWx2YW5pYS4mI3hEO0FuYXRvbWljIFBhdGhvbG9n

eSwgRGVwYXJ0bWVudCBvZiBNZWRpY2luZSAoRElNRVMpLCBVbml2ZXJzaXR5IG9mIEJvbG9nbmEg

U2Nob29sIG9mIE1lZGljaW5lLCBCb2xvZ25hLCBJdGFseS4mI3hEO0RlcGFydG1lbnQgb2YgUGF0

aG9sb2d5IGFuZCBMYWJvcmF0b3J5IE1lZGljaW5lLCBIb3NwaXRhbCBvZiB0aGUgVW5pdmVyc2l0

eSBvZiBQZW5uc3lsdmFuaWEsIFBlcmVsbWFuIFNjaG9vbCBvZiBNZWRpY2luZSwgUGhpbGFkZWxw

aGlhLiYjeEQ7RGVwYXJ0bWVudCBvZiBTdXJnaWNhbCwgTWVkaWNhbCBhbmQgTW9sZWN1bGFyIFBh

dGhvbG9neSwgVW5pdmVyc2l0eSBvZiBQaXNhLCBQaXNhLCBJdGFseS4mI3hEO1NvdXRoZXJuIENh

bGlmb3JuaWEgUGVybWFuZW50ZSBNZWRpY2FsIEdyb3VwLCBXb29kbGFuZCBIaWxscy4mI3hEO0Rl

cGFydG1lbnQgb2YgUGF0aG9sb2d5LCBCcmlnaGFtIGFuZCBXb21lbiZhcG9zO3MgSG9zcGl0YWws

IEhhcnZhcmQgTWVkaWNhbCBTY2hvb2wsIEJvc3RvbiwgTWFzc2FjaHVzZXR0cy4mI3hEO0RlcGFy

dG1lbnQgb2YgUGF0aG9sb2d5LCBNb3VudCBTaW5haSBIZWFsdGggU3lzdGVtLCBOZXcgWW9yaywg

TmV3IFlvcmsuJiN4RDtEZXBhcnRtZW50IG9mIE1lZGljYWwgQmlvbG9neSBhbmQgUGF0aG9sb2d5

LCBHdXN0YXZlIFJvdXNzeSBDYW5jZXIgQ2FtcHVzIEdyYW5kIFBhcmlzLCBWaWxsZWp1aWYsIEZy

YW5jZS4mI3hEO0RlcGFydG1lbnQgb2YgUGF0aG9sb2d5IGFuZCBMYWJvcmF0b3J5IE1lZGljaW5l

LCBOYXJhIEhvc3BpdGFsLCBLaW5kYWkgVW5pdmVyc2l0eSBGYWN1bHR5IG9mIE1lZGljaW5lLCBJ

a29tYS1jaXR5LCBKYXBhbi4mI3hEO0RlcGFydG1lbnQgb2YgUGF0aG9sb2d5LCBVbml2ZXJzaXR5

IG9mIE1pY2hpZ2FuLCBBbm4gQXJib3IxMUNvbXByZWhlbnNpdmUgQ2FuY2VyIENlbnRlciwgVW5p

dmVyc2l0eSBvZiBNaWNoaWdhbiwgQW5uIEFyYm9yLiYjeEQ7RGVwYXJ0bWVudCBvZiBQYXRob2xv

Z3ksIFVuaXZlcnNpdHkgb2YgU2FvIFBhdWxvIFNjaG9vbCBvZiBNZWRpY2luZSwgU2FvIFBhdWxv

LCBCcmF6aWwxM0RlcGFydG1lbnQgb2YgUGF0aG9sb2d5LCBIb3NwaXRhbCBBbGVtYW8gT3N3YWxk

byBDcnV6LCBTYW8gUGF1bG8sIEJyYXppbC4mI3hEO0RlcGFydG1lbnQgb2YgUGF0aG9sb2d5LCBV

bml2ZXJzaXR5IG9mIENhbGlmb3JuaWEgU2FuIEZyYW5jaXNjby4mI3hEO0RlcGFydG1lbnQgb2Yg

UGF0aG9sb2d5LCBVbml2ZXJzaXR5IEhlYWx0aCBOZXR3b3JrLCBUb3JvbnRvLCBPbnRhcmlvLCBD

YW5hZGEuJiN4RDtEZXBhcnRtZW50IG9mIFBhdGhvbG9neSwgVW5pdmVyc2l0eSBvZiBUZXhhcyBN

LkQuIEFuZGVyc29uIENhbmNlciBDZW50ZXIsIEhvdXN0b24uJiN4RDtCaW9zdGF0aXN0aWNzIEZh

Y2lsaXR5LCBVbml2ZXJzaXR5IG9mIFBpdHRzYnVyZ2ggQ2FuY2VyIEluc3RpdHV0ZSwgUGl0dHNi

dXJnaCwgUGVubnN5bHZhbmlhLiYjeEQ7RGl2aXNpb24gb2YgRW5kb2NyaW5vbG9neSBhbmQgTWV0

YWJvbGlzbSwgTmV3IFlvcmsgVW5pdmVyc2l0eSBTY2hvb2wgb2YgTWVkaWNpbmUsIE5ldyBZb3Jr

LiYjeEQ7VW5pdmVyc2l0eSBvZiBXaXNjb25zaW4gU2Nob29sIG9mIE1lZGljaW5lIGFuZCBQdWJs

aWMgSGVhbHRoLCBNYWRpc29uLiYjeEQ7RGVwYXJ0bWVudCBvZiBQc3ljaGlhdHJ5LCBNYXNzYWNo

dXNldHRzIEdlbmVyYWwgSG9zcGl0YWwsIEJvc3Rvbi4mI3hEO0RlcGFydG1lbnQgb2YgUGF0aG9s

b2d5LCBNYXNzYWNodXNldHRzIEdlbmVyYWwgSG9zcGl0YWwsIEJvc3RvbjIyRGVwYXJ0bWVudCBv

ZiBQYXRob2xvZ3kgSGFydmFyZCBNZWRpY2FsIFNjaG9vbCwgQm9zdG9uLCBNYXNzYWNodXNldHRz

LiYjeEQ7RGVwYXJ0bWVudCBvZiBPbmNvbG9neSwgVW5pdmVyc2l0eSBvZiBUdXJpbiwgVG9yaW5v

LCBJdGFseS4mI3hEO1VuaXZlcnNpdHkgb2YgUG9ydHNtb3V0aCwgRGVwYXJ0bWVudCBvZiBQYXRo

b2xvZ3ksIFF1ZWVuIEFsZXhhbmRyYSBIb3NwaXRhbCwgQ29zaGFtLCBQb3J0c21vdXRoLCBVbml0

ZWQgS2luZ2RvbS4mI3hEO0RlcGFydG1lbnQgb2YgUGF0aG9sb2d5IGFuZCBMYWJvcmF0b3J5IE1l

ZGljaW5lLCBUdWZ0cyBVbml2ZXJzaXR5IFNjaG9vbCBvZiBNZWRpY2luZSwgVHVmdHMgTWVkaWNh

bCBDZW50ZXIsIEJvc3RvbiwgTWFzc2FjaHVzZXR0cy4mI3hEO0RlcGFydG1lbnQgb2YgRW5kb2Ny

aW5vbG9neSwgTWVtb3JpYWwgU2xvYW4gS2V0dGVyaW5nIENhbmNlciBDZW50ZXIsIE5ldyBZb3Jr

LCBOZXcgWW9yay4mI3hEO1RoeXJvaWQgQ2FuY2VyIFN1cnZpdm9ycyBBc3NvY2lhdGlvbiBJbmMs

IFJhbGVpZ2gsIE5vcnRoIENhcm9saW5hLiYjeEQ7R2VuZXJhbCBhbmQgVGh5cm9pZCBhbmQgUGFy

YXRoeXJvaWQgRW5kb2NyaW5lIFN1cmdlcnkgRGl2aXNpb24sIE1hc3NhY2h1c2V0dHMgRXllIGFu

ZCBFYXIgSW5maXJtYXJ5LCBCb3N0b24uJiN4RDtEZXBhcnRtZW50IG9mIFBhdGhvbG9neSwgTWVt

b3JpYWwgU2xvYW4gS2V0dGVyaW5nIENhbmNlciBDZW50ZXIsIE5ldyBZb3JrLCBOZXcgWW9yay48

L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5Ob21lbmNsYXR1cmUgUmV2aXNpb24gZm9yIEVu

Y2Fwc3VsYXRlZCBGb2xsaWN1bGFyIFZhcmlhbnQgb2YgUGFwaWxsYXJ5IFRoeXJvaWQgQ2FyY2lu

b21hOiBBIFBhcmFkaWdtIFNoaWZ0IHRvIFJlZHVjZSBPdmVydHJlYXRtZW50IG9mIEluZG9sZW50

IFR1bW9yczwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5KQU1BIE9uY29sPC9zZWNvbmRhcnktdGl0

bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+SkFNQSBPbmNvbDwvZnVsbC10aXRs

ZT48L3BlcmlvZGljYWw+PHBhZ2VzPjEwMjMtOTwvcGFnZXM+PHZvbHVtZT4yPC92b2x1bWU+PG51

bWJlcj44PC9udW1iZXI+PGtleXdvcmRzPjxrZXl3b3JkPkFkZW5vY2FyY2lub21hLCBGb2xsaWN1

bGFyL2NsYXNzaWZpY2F0aW9uL2RpYWdub3Npcy8qcGF0aG9sb2d5PC9rZXl3b3JkPjxrZXl3b3Jk

PkFkdWx0PC9rZXl3b3JkPjxrZXl3b3JkPkFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+QWdlZCwgODAg

YW5kIG92ZXI8L2tleXdvcmQ+PGtleXdvcmQ+Q2FyY2lub21hL2NsYXNzaWZpY2F0aW9uL2RpYWdu

b3Npcy8qcGF0aG9sb2d5PC9rZXl3b3JkPjxrZXl3b3JkPkZlbWFsZTwva2V5d29yZD48a2V5d29y

ZD5IdW1hbnM8L2tleXdvcmQ+PGtleXdvcmQ+TWFsZTwva2V5d29yZD48a2V5d29yZD5NZWRpY2Fs

IE92ZXJ1c2UvKnByZXZlbnRpb24gJmFtcDsgY29udHJvbDwva2V5d29yZD48a2V5d29yZD5NaWRk

bGUgQWdlZDwva2V5d29yZD48a2V5d29yZD5OZW9wbGFzbSBJbnZhc2l2ZW5lc3M8L2tleXdvcmQ+

PGtleXdvcmQ+UmV0cm9zcGVjdGl2ZSBTdHVkaWVzPC9rZXl3b3JkPjxrZXl3b3JkPipUZXJtaW5v

bG9neSBhcyBUb3BpYzwva2V5d29yZD48a2V5d29yZD5UaHlyb2lkIE5lb3BsYXNtcy9jbGFzc2lm

aWNhdGlvbi9kaWFnbm9zaXMvKnBhdGhvbG9neTwva2V5d29yZD48a2V5d29yZD5UaHlyb2lkIE5v

ZHVsZS9jbGFzc2lmaWNhdGlvbi9kaWFnbm9zaXMvKnBhdGhvbG9neTwva2V5d29yZD48a2V5d29y

ZD5Zb3VuZyBBZHVsdDwva2V5d29yZD48L2tleXdvcmRzPjxkYXRlcz48eWVhcj4yMDE2PC95ZWFy

PjxwdWItZGF0ZXM+PGRhdGU+QXVnIDAxPC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+

MjM3NC0yNDQ1IChFbGVjdHJvbmljKSYjeEQ7MjM3NC0yNDM3IChMaW5raW5nKTwvaXNibj48YWNj

ZXNzaW9uLW51bT4yNzA3ODE0NTwvYWNjZXNzaW9uLW51bT48dXJscz48cmVsYXRlZC11cmxzPjx1

cmw+aHR0cHM6Ly93d3cubmNiaS5ubG0ubmloLmdvdi9wdWJtZWQvMjcwNzgxNDU8L3VybD48L3Jl

bGF0ZWQtdXJscz48L3VybHM+PGVsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjEwLjEwMDEvamFtYW9u

Y29sLjIwMTYuMDM4NjwvZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+PC9yZWNvcmQ+PC9DaXRlPjwv

RW5kTm90ZT5=

ADDIN EN.CITE.DATA 13: Infiltration/tumoral capsular invasion.Solid/trabecular or insular growth >30%True papillary growth (with fibrovascular cores) (even 1 well formed papillary structure)Psammoma bodiesTall cell, columnar, or cribriform morular morphologyNecrosisMitoses >3 per 10 consecutive high power fields (HPF) (in solid/microfollicular areas)When a tumor fulfills these inclusion and exclusion criteria, NIFTP designation is appropriate. Of note, NIFTP is not well validated in oncocytic, sub centimeter, and multifocal lesions. In these scenarios, the designation NIFTP is not absolutely contraindicated but there are inadequate data to substantiate this designation. It must be emphasized that in order for NIFTP to accurately reflect an indolent tumor type, rigorous application of the inclusion and exclusion criteria should be employed – specifically complete submission of tumor normal interface, adequate sampling of the tumor center (ie, at least 1 section per centimeter of tumor) and strict observation of histologic criteria. NIFTP is still an evolving diagnosis, and certain problematic areas have already been noted. For instance, it is challenging to evaluate for invasion in well-circumscribed unencapsulated tumors. The recommendation for qualification as NIFTP in this scenario is to demonstrate a complete rim of compressed thyroid parenchyma with absolutely no mingling of normal and neoplastic follicles. Another problematic area is recognition of exclusionary papillae. A papilla in this context is well formed, demonstrates a fibrovascular core (unlike the follicles seen in Sanderson polsters), and shows overt nuclear features of papillary carcinoma. Initial criterion of <1%PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5OaWtpZm9yb3Y8L0F1dGhvcj48WWVhcj4yMDE2PC9ZZWFy

PjxSZWNOdW0+NDg8L1JlY051bT48RGlzcGxheVRleHQ+PHN0eWxlIGZhY2U9InN1cGVyc2NyaXB0

Ij4xMzwvc3R5bGU+PC9EaXNwbGF5VGV4dD48cmVjb3JkPjxyZWMtbnVtYmVyPjQ4PC9yZWMtbnVt

YmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0icHMyd3dkc2ZyYTJyNWVlOXph

c3hzNXQ4endkd3hyc3dlNXhhIiB0aW1lc3RhbXA9IjE0OTUyNDM5MzAiPjQ4PC9rZXk+PC9mb3Jl

aWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxj

b250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5OaWtpZm9yb3YsIFkuIEUuPC9hdXRob3I+PGF1

dGhvcj5TZWV0aGFsYSwgUi4gUi48L2F1dGhvcj48YXV0aG9yPlRhbGxpbmksIEcuPC9hdXRob3I+

PGF1dGhvcj5CYWxvY2gsIFouIFcuPC9hdXRob3I+PGF1dGhvcj5CYXNvbG8sIEYuPC9hdXRob3I+

PGF1dGhvcj5UaG9tcHNvbiwgTC4gRC48L2F1dGhvcj48YXV0aG9yPkJhcmxldHRhLCBKLiBBLjwv

YXV0aG9yPjxhdXRob3I+V2VuaWcsIEIuIE0uPC9hdXRob3I+PGF1dGhvcj5BbCBHaHV6bGFuLCBB

LjwvYXV0aG9yPjxhdXRob3I+S2FrdWRvLCBLLjwvYXV0aG9yPjxhdXRob3I+R2lvcmRhbm8sIFQu

IEouPC9hdXRob3I+PGF1dGhvcj5BbHZlcywgVi4gQS48L2F1dGhvcj48YXV0aG9yPktoYW5hZnNo

YXIsIEUuPC9hdXRob3I+PGF1dGhvcj5Bc2EsIFMuIEwuPC9hdXRob3I+PGF1dGhvcj5FbC1OYWdn

YXIsIEEuIEsuPC9hdXRob3I+PGF1dGhvcj5Hb29kaW5nLCBXLiBFLjwvYXV0aG9yPjxhdXRob3I+

SG9kYWssIFMuIFAuPC9hdXRob3I+PGF1dGhvcj5MbG95ZCwgUi4gVi48L2F1dGhvcj48YXV0aG9y

Pk1heXRhbCwgRy48L2F1dGhvcj48YXV0aG9yPk1ldGUsIE8uPC9hdXRob3I+PGF1dGhvcj5OaWtp

Zm9yb3ZhLCBNLiBOLjwvYXV0aG9yPjxhdXRob3I+Tm9zZSwgVi48L2F1dGhvcj48YXV0aG9yPlBh

cG90dGksIE0uPC9hdXRob3I+PGF1dGhvcj5Qb2xsZXIsIEQuIE4uPC9hdXRob3I+PGF1dGhvcj5T

YWRvdywgUC4gTS48L2F1dGhvcj48YXV0aG9yPlRpc2NobGVyLCBBLiBTLjwvYXV0aG9yPjxhdXRo

b3I+VHV0dGxlLCBSLiBNLjwvYXV0aG9yPjxhdXRob3I+V2FsbCwgSy4gQi48L2F1dGhvcj48YXV0

aG9yPkxpVm9sc2ksIFYuIEEuPC9hdXRob3I+PGF1dGhvcj5SYW5kb2xwaCwgRy4gVy48L2F1dGhv

cj48YXV0aG9yPkdob3NzZWluLCBSLiBBLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9y

cz48YXV0aC1hZGRyZXNzPkRlcGFydG1lbnQgb2YgUGF0aG9sb2d5LCBVbml2ZXJzaXR5IG9mIFBp

dHRzYnVyZ2gsIFBpdHRzYnVyZ2gsIFBlbm5zeWx2YW5pYS4mI3hEO0FuYXRvbWljIFBhdGhvbG9n

eSwgRGVwYXJ0bWVudCBvZiBNZWRpY2luZSAoRElNRVMpLCBVbml2ZXJzaXR5IG9mIEJvbG9nbmEg

U2Nob29sIG9mIE1lZGljaW5lLCBCb2xvZ25hLCBJdGFseS4mI3hEO0RlcGFydG1lbnQgb2YgUGF0

aG9sb2d5IGFuZCBMYWJvcmF0b3J5IE1lZGljaW5lLCBIb3NwaXRhbCBvZiB0aGUgVW5pdmVyc2l0

eSBvZiBQZW5uc3lsdmFuaWEsIFBlcmVsbWFuIFNjaG9vbCBvZiBNZWRpY2luZSwgUGhpbGFkZWxw

aGlhLiYjeEQ7RGVwYXJ0bWVudCBvZiBTdXJnaWNhbCwgTWVkaWNhbCBhbmQgTW9sZWN1bGFyIFBh

dGhvbG9neSwgVW5pdmVyc2l0eSBvZiBQaXNhLCBQaXNhLCBJdGFseS4mI3hEO1NvdXRoZXJuIENh

bGlmb3JuaWEgUGVybWFuZW50ZSBNZWRpY2FsIEdyb3VwLCBXb29kbGFuZCBIaWxscy4mI3hEO0Rl

cGFydG1lbnQgb2YgUGF0aG9sb2d5LCBCcmlnaGFtIGFuZCBXb21lbiZhcG9zO3MgSG9zcGl0YWws

IEhhcnZhcmQgTWVkaWNhbCBTY2hvb2wsIEJvc3RvbiwgTWFzc2FjaHVzZXR0cy4mI3hEO0RlcGFy

dG1lbnQgb2YgUGF0aG9sb2d5LCBNb3VudCBTaW5haSBIZWFsdGggU3lzdGVtLCBOZXcgWW9yaywg

TmV3IFlvcmsuJiN4RDtEZXBhcnRtZW50IG9mIE1lZGljYWwgQmlvbG9neSBhbmQgUGF0aG9sb2d5

LCBHdXN0YXZlIFJvdXNzeSBDYW5jZXIgQ2FtcHVzIEdyYW5kIFBhcmlzLCBWaWxsZWp1aWYsIEZy

YW5jZS4mI3hEO0RlcGFydG1lbnQgb2YgUGF0aG9sb2d5IGFuZCBMYWJvcmF0b3J5IE1lZGljaW5l

LCBOYXJhIEhvc3BpdGFsLCBLaW5kYWkgVW5pdmVyc2l0eSBGYWN1bHR5IG9mIE1lZGljaW5lLCBJ

a29tYS1jaXR5LCBKYXBhbi4mI3hEO0RlcGFydG1lbnQgb2YgUGF0aG9sb2d5LCBVbml2ZXJzaXR5

IG9mIE1pY2hpZ2FuLCBBbm4gQXJib3IxMUNvbXByZWhlbnNpdmUgQ2FuY2VyIENlbnRlciwgVW5p

dmVyc2l0eSBvZiBNaWNoaWdhbiwgQW5uIEFyYm9yLiYjeEQ7RGVwYXJ0bWVudCBvZiBQYXRob2xv

Z3ksIFVuaXZlcnNpdHkgb2YgU2FvIFBhdWxvIFNjaG9vbCBvZiBNZWRpY2luZSwgU2FvIFBhdWxv

LCBCcmF6aWwxM0RlcGFydG1lbnQgb2YgUGF0aG9sb2d5LCBIb3NwaXRhbCBBbGVtYW8gT3N3YWxk

byBDcnV6LCBTYW8gUGF1bG8sIEJyYXppbC4mI3hEO0RlcGFydG1lbnQgb2YgUGF0aG9sb2d5LCBV

bml2ZXJzaXR5IG9mIENhbGlmb3JuaWEgU2FuIEZyYW5jaXNjby4mI3hEO0RlcGFydG1lbnQgb2Yg

UGF0aG9sb2d5LCBVbml2ZXJzaXR5IEhlYWx0aCBOZXR3b3JrLCBUb3JvbnRvLCBPbnRhcmlvLCBD

YW5hZGEuJiN4RDtEZXBhcnRtZW50IG9mIFBhdGhvbG9neSwgVW5pdmVyc2l0eSBvZiBUZXhhcyBN

LkQuIEFuZGVyc29uIENhbmNlciBDZW50ZXIsIEhvdXN0b24uJiN4RDtCaW9zdGF0aXN0aWNzIEZh

Y2lsaXR5LCBVbml2ZXJzaXR5IG9mIFBpdHRzYnVyZ2ggQ2FuY2VyIEluc3RpdHV0ZSwgUGl0dHNi

dXJnaCwgUGVubnN5bHZhbmlhLiYjeEQ7RGl2aXNpb24gb2YgRW5kb2NyaW5vbG9neSBhbmQgTWV0

YWJvbGlzbSwgTmV3IFlvcmsgVW5pdmVyc2l0eSBTY2hvb2wgb2YgTWVkaWNpbmUsIE5ldyBZb3Jr

LiYjeEQ7VW5pdmVyc2l0eSBvZiBXaXNjb25zaW4gU2Nob29sIG9mIE1lZGljaW5lIGFuZCBQdWJs

aWMgSGVhbHRoLCBNYWRpc29uLiYjeEQ7RGVwYXJ0bWVudCBvZiBQc3ljaGlhdHJ5LCBNYXNzYWNo

dXNldHRzIEdlbmVyYWwgSG9zcGl0YWwsIEJvc3Rvbi4mI3hEO0RlcGFydG1lbnQgb2YgUGF0aG9s

b2d5LCBNYXNzYWNodXNldHRzIEdlbmVyYWwgSG9zcGl0YWwsIEJvc3RvbjIyRGVwYXJ0bWVudCBv

ZiBQYXRob2xvZ3kgSGFydmFyZCBNZWRpY2FsIFNjaG9vbCwgQm9zdG9uLCBNYXNzYWNodXNldHRz

LiYjeEQ7RGVwYXJ0bWVudCBvZiBPbmNvbG9neSwgVW5pdmVyc2l0eSBvZiBUdXJpbiwgVG9yaW5v

LCBJdGFseS4mI3hEO1VuaXZlcnNpdHkgb2YgUG9ydHNtb3V0aCwgRGVwYXJ0bWVudCBvZiBQYXRo

b2xvZ3ksIFF1ZWVuIEFsZXhhbmRyYSBIb3NwaXRhbCwgQ29zaGFtLCBQb3J0c21vdXRoLCBVbml0

ZWQgS2luZ2RvbS4mI3hEO0RlcGFydG1lbnQgb2YgUGF0aG9sb2d5IGFuZCBMYWJvcmF0b3J5IE1l

ZGljaW5lLCBUdWZ0cyBVbml2ZXJzaXR5IFNjaG9vbCBvZiBNZWRpY2luZSwgVHVmdHMgTWVkaWNh

bCBDZW50ZXIsIEJvc3RvbiwgTWFzc2FjaHVzZXR0cy4mI3hEO0RlcGFydG1lbnQgb2YgRW5kb2Ny

aW5vbG9neSwgTWVtb3JpYWwgU2xvYW4gS2V0dGVyaW5nIENhbmNlciBDZW50ZXIsIE5ldyBZb3Jr

LCBOZXcgWW9yay4mI3hEO1RoeXJvaWQgQ2FuY2VyIFN1cnZpdm9ycyBBc3NvY2lhdGlvbiBJbmMs

IFJhbGVpZ2gsIE5vcnRoIENhcm9saW5hLiYjeEQ7R2VuZXJhbCBhbmQgVGh5cm9pZCBhbmQgUGFy

YXRoeXJvaWQgRW5kb2NyaW5lIFN1cmdlcnkgRGl2aXNpb24sIE1hc3NhY2h1c2V0dHMgRXllIGFu

ZCBFYXIgSW5maXJtYXJ5LCBCb3N0b24uJiN4RDtEZXBhcnRtZW50IG9mIFBhdGhvbG9neSwgTWVt

b3JpYWwgU2xvYW4gS2V0dGVyaW5nIENhbmNlciBDZW50ZXIsIE5ldyBZb3JrLCBOZXcgWW9yay48

L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5Ob21lbmNsYXR1cmUgUmV2aXNpb24gZm9yIEVu

Y2Fwc3VsYXRlZCBGb2xsaWN1bGFyIFZhcmlhbnQgb2YgUGFwaWxsYXJ5IFRoeXJvaWQgQ2FyY2lu

b21hOiBBIFBhcmFkaWdtIFNoaWZ0IHRvIFJlZHVjZSBPdmVydHJlYXRtZW50IG9mIEluZG9sZW50

IFR1bW9yczwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5KQU1BIE9uY29sPC9zZWNvbmRhcnktdGl0

bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+SkFNQSBPbmNvbDwvZnVsbC10aXRs

ZT48L3BlcmlvZGljYWw+PHBhZ2VzPjEwMjMtOTwvcGFnZXM+PHZvbHVtZT4yPC92b2x1bWU+PG51

bWJlcj44PC9udW1iZXI+PGtleXdvcmRzPjxrZXl3b3JkPkFkZW5vY2FyY2lub21hLCBGb2xsaWN1

bGFyL2NsYXNzaWZpY2F0aW9uL2RpYWdub3Npcy8qcGF0aG9sb2d5PC9rZXl3b3JkPjxrZXl3b3Jk

PkFkdWx0PC9rZXl3b3JkPjxrZXl3b3JkPkFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+QWdlZCwgODAg

YW5kIG92ZXI8L2tleXdvcmQ+PGtleXdvcmQ+Q2FyY2lub21hL2NsYXNzaWZpY2F0aW9uL2RpYWdu

b3Npcy8qcGF0aG9sb2d5PC9rZXl3b3JkPjxrZXl3b3JkPkZlbWFsZTwva2V5d29yZD48a2V5d29y

ZD5IdW1hbnM8L2tleXdvcmQ+PGtleXdvcmQ+TWFsZTwva2V5d29yZD48a2V5d29yZD5NZWRpY2Fs

IE92ZXJ1c2UvKnByZXZlbnRpb24gJmFtcDsgY29udHJvbDwva2V5d29yZD48a2V5d29yZD5NaWRk

bGUgQWdlZDwva2V5d29yZD48a2V5d29yZD5OZW9wbGFzbSBJbnZhc2l2ZW5lc3M8L2tleXdvcmQ+

PGtleXdvcmQ+UmV0cm9zcGVjdGl2ZSBTdHVkaWVzPC9rZXl3b3JkPjxrZXl3b3JkPipUZXJtaW5v

bG9neSBhcyBUb3BpYzwva2V5d29yZD48a2V5d29yZD5UaHlyb2lkIE5lb3BsYXNtcy9jbGFzc2lm

aWNhdGlvbi9kaWFnbm9zaXMvKnBhdGhvbG9neTwva2V5d29yZD48a2V5d29yZD5UaHlyb2lkIE5v

ZHVsZS9jbGFzc2lmaWNhdGlvbi9kaWFnbm9zaXMvKnBhdGhvbG9neTwva2V5d29yZD48a2V5d29y

ZD5Zb3VuZyBBZHVsdDwva2V5d29yZD48L2tleXdvcmRzPjxkYXRlcz48eWVhcj4yMDE2PC95ZWFy

PjxwdWItZGF0ZXM+PGRhdGU+QXVnIDAxPC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+

MjM3NC0yNDQ1IChFbGVjdHJvbmljKSYjeEQ7MjM3NC0yNDM3IChMaW5raW5nKTwvaXNibj48YWNj

ZXNzaW9uLW51bT4yNzA3ODE0NTwvYWNjZXNzaW9uLW51bT48dXJscz48cmVsYXRlZC11cmxzPjx1

cmw+aHR0cHM6Ly93d3cubmNiaS5ubG0ubmloLmdvdi9wdWJtZWQvMjcwNzgxNDU8L3VybD48L3Jl

bGF0ZWQtdXJscz48L3VybHM+PGVsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjEwLjEwMDEvamFtYW9u

Y29sLjIwMTYuMDM4NjwvZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+PC9yZWNvcmQ+PC9DaXRlPjwv

RW5kTm90ZT5=

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5OaWtpZm9yb3Y8L0F1dGhvcj48WWVhcj4yMDE2PC9ZZWFy

PjxSZWNOdW0+NDg8L1JlY051bT48RGlzcGxheVRleHQ+PHN0eWxlIGZhY2U9InN1cGVyc2NyaXB0

Ij4xMzwvc3R5bGU+PC9EaXNwbGF5VGV4dD48cmVjb3JkPjxyZWMtbnVtYmVyPjQ4PC9yZWMtbnVt

YmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0icHMyd3dkc2ZyYTJyNWVlOXph

c3hzNXQ4endkd3hyc3dlNXhhIiB0aW1lc3RhbXA9IjE0OTUyNDM5MzAiPjQ4PC9rZXk+PC9mb3Jl

aWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxj

b250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5OaWtpZm9yb3YsIFkuIEUuPC9hdXRob3I+PGF1

dGhvcj5TZWV0aGFsYSwgUi4gUi48L2F1dGhvcj48YXV0aG9yPlRhbGxpbmksIEcuPC9hdXRob3I+

PGF1dGhvcj5CYWxvY2gsIFouIFcuPC9hdXRob3I+PGF1dGhvcj5CYXNvbG8sIEYuPC9hdXRob3I+

PGF1dGhvcj5UaG9tcHNvbiwgTC4gRC48L2F1dGhvcj48YXV0aG9yPkJhcmxldHRhLCBKLiBBLjwv

YXV0aG9yPjxhdXRob3I+V2VuaWcsIEIuIE0uPC9hdXRob3I+PGF1dGhvcj5BbCBHaHV6bGFuLCBB

LjwvYXV0aG9yPjxhdXRob3I+S2FrdWRvLCBLLjwvYXV0aG9yPjxhdXRob3I+R2lvcmRhbm8sIFQu

IEouPC9hdXRob3I+PGF1dGhvcj5BbHZlcywgVi4gQS48L2F1dGhvcj48YXV0aG9yPktoYW5hZnNo

YXIsIEUuPC9hdXRob3I+PGF1dGhvcj5Bc2EsIFMuIEwuPC9hdXRob3I+PGF1dGhvcj5FbC1OYWdn

YXIsIEEuIEsuPC9hdXRob3I+PGF1dGhvcj5Hb29kaW5nLCBXLiBFLjwvYXV0aG9yPjxhdXRob3I+

SG9kYWssIFMuIFAuPC9hdXRob3I+PGF1dGhvcj5MbG95ZCwgUi4gVi48L2F1dGhvcj48YXV0aG9y

Pk1heXRhbCwgRy48L2F1dGhvcj48YXV0aG9yPk1ldGUsIE8uPC9hdXRob3I+PGF1dGhvcj5OaWtp

Zm9yb3ZhLCBNLiBOLjwvYXV0aG9yPjxhdXRob3I+Tm9zZSwgVi48L2F1dGhvcj48YXV0aG9yPlBh

cG90dGksIE0uPC9hdXRob3I+PGF1dGhvcj5Qb2xsZXIsIEQuIE4uPC9hdXRob3I+PGF1dGhvcj5T

YWRvdywgUC4gTS48L2F1dGhvcj48YXV0aG9yPlRpc2NobGVyLCBBLiBTLjwvYXV0aG9yPjxhdXRo

b3I+VHV0dGxlLCBSLiBNLjwvYXV0aG9yPjxhdXRob3I+V2FsbCwgSy4gQi48L2F1dGhvcj48YXV0

aG9yPkxpVm9sc2ksIFYuIEEuPC9hdXRob3I+PGF1dGhvcj5SYW5kb2xwaCwgRy4gVy48L2F1dGhv

cj48YXV0aG9yPkdob3NzZWluLCBSLiBBLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9y

cz48YXV0aC1hZGRyZXNzPkRlcGFydG1lbnQgb2YgUGF0aG9sb2d5LCBVbml2ZXJzaXR5IG9mIFBp

dHRzYnVyZ2gsIFBpdHRzYnVyZ2gsIFBlbm5zeWx2YW5pYS4mI3hEO0FuYXRvbWljIFBhdGhvbG9n

eSwgRGVwYXJ0bWVudCBvZiBNZWRpY2luZSAoRElNRVMpLCBVbml2ZXJzaXR5IG9mIEJvbG9nbmEg

U2Nob29sIG9mIE1lZGljaW5lLCBCb2xvZ25hLCBJdGFseS4mI3hEO0RlcGFydG1lbnQgb2YgUGF0

aG9sb2d5IGFuZCBMYWJvcmF0b3J5IE1lZGljaW5lLCBIb3NwaXRhbCBvZiB0aGUgVW5pdmVyc2l0

eSBvZiBQZW5uc3lsdmFuaWEsIFBlcmVsbWFuIFNjaG9vbCBvZiBNZWRpY2luZSwgUGhpbGFkZWxw

aGlhLiYjeEQ7RGVwYXJ0bWVudCBvZiBTdXJnaWNhbCwgTWVkaWNhbCBhbmQgTW9sZWN1bGFyIFBh

dGhvbG9neSwgVW5pdmVyc2l0eSBvZiBQaXNhLCBQaXNhLCBJdGFseS4mI3hEO1NvdXRoZXJuIENh

bGlmb3JuaWEgUGVybWFuZW50ZSBNZWRpY2FsIEdyb3VwLCBXb29kbGFuZCBIaWxscy4mI3hEO0Rl

cGFydG1lbnQgb2YgUGF0aG9sb2d5LCBCcmlnaGFtIGFuZCBXb21lbiZhcG9zO3MgSG9zcGl0YWws

IEhhcnZhcmQgTWVkaWNhbCBTY2hvb2wsIEJvc3RvbiwgTWFzc2FjaHVzZXR0cy4mI3hEO0RlcGFy

dG1lbnQgb2YgUGF0aG9sb2d5LCBNb3VudCBTaW5haSBIZWFsdGggU3lzdGVtLCBOZXcgWW9yaywg

TmV3IFlvcmsuJiN4RDtEZXBhcnRtZW50IG9mIE1lZGljYWwgQmlvbG9neSBhbmQgUGF0aG9sb2d5

LCBHdXN0YXZlIFJvdXNzeSBDYW5jZXIgQ2FtcHVzIEdyYW5kIFBhcmlzLCBWaWxsZWp1aWYsIEZy

YW5jZS4mI3hEO0RlcGFydG1lbnQgb2YgUGF0aG9sb2d5IGFuZCBMYWJvcmF0b3J5IE1lZGljaW5l

LCBOYXJhIEhvc3BpdGFsLCBLaW5kYWkgVW5pdmVyc2l0eSBGYWN1bHR5IG9mIE1lZGljaW5lLCBJ

a29tYS1jaXR5LCBKYXBhbi4mI3hEO0RlcGFydG1lbnQgb2YgUGF0aG9sb2d5LCBVbml2ZXJzaXR5

IG9mIE1pY2hpZ2FuLCBBbm4gQXJib3IxMUNvbXByZWhlbnNpdmUgQ2FuY2VyIENlbnRlciwgVW5p

dmVyc2l0eSBvZiBNaWNoaWdhbiwgQW5uIEFyYm9yLiYjeEQ7RGVwYXJ0bWVudCBvZiBQYXRob2xv

Z3ksIFVuaXZlcnNpdHkgb2YgU2FvIFBhdWxvIFNjaG9vbCBvZiBNZWRpY2luZSwgU2FvIFBhdWxv

LCBCcmF6aWwxM0RlcGFydG1lbnQgb2YgUGF0aG9sb2d5LCBIb3NwaXRhbCBBbGVtYW8gT3N3YWxk

byBDcnV6LCBTYW8gUGF1bG8sIEJyYXppbC4mI3hEO0RlcGFydG1lbnQgb2YgUGF0aG9sb2d5LCBV

bml2ZXJzaXR5IG9mIENhbGlmb3JuaWEgU2FuIEZyYW5jaXNjby4mI3hEO0RlcGFydG1lbnQgb2Yg

UGF0aG9sb2d5LCBVbml2ZXJzaXR5IEhlYWx0aCBOZXR3b3JrLCBUb3JvbnRvLCBPbnRhcmlvLCBD

YW5hZGEuJiN4RDtEZXBhcnRtZW50IG9mIFBhdGhvbG9neSwgVW5pdmVyc2l0eSBvZiBUZXhhcyBN

LkQuIEFuZGVyc29uIENhbmNlciBDZW50ZXIsIEhvdXN0b24uJiN4RDtCaW9zdGF0aXN0aWNzIEZh

Y2lsaXR5LCBVbml2ZXJzaXR5IG9mIFBpdHRzYnVyZ2ggQ2FuY2VyIEluc3RpdHV0ZSwgUGl0dHNi

dXJnaCwgUGVubnN5bHZhbmlhLiYjeEQ7RGl2aXNpb24gb2YgRW5kb2NyaW5vbG9neSBhbmQgTWV0

YWJvbGlzbSwgTmV3IFlvcmsgVW5pdmVyc2l0eSBTY2hvb2wgb2YgTWVkaWNpbmUsIE5ldyBZb3Jr

LiYjeEQ7VW5pdmVyc2l0eSBvZiBXaXNjb25zaW4gU2Nob29sIG9mIE1lZGljaW5lIGFuZCBQdWJs

aWMgSGVhbHRoLCBNYWRpc29uLiYjeEQ7RGVwYXJ0bWVudCBvZiBQc3ljaGlhdHJ5LCBNYXNzYWNo

dXNldHRzIEdlbmVyYWwgSG9zcGl0YWwsIEJvc3Rvbi4mI3hEO0RlcGFydG1lbnQgb2YgUGF0aG9s

b2d5LCBNYXNzYWNodXNldHRzIEdlbmVyYWwgSG9zcGl0YWwsIEJvc3RvbjIyRGVwYXJ0bWVudCBv

ZiBQYXRob2xvZ3kgSGFydmFyZCBNZWRpY2FsIFNjaG9vbCwgQm9zdG9uLCBNYXNzYWNodXNldHRz

LiYjeEQ7RGVwYXJ0bWVudCBvZiBPbmNvbG9neSwgVW5pdmVyc2l0eSBvZiBUdXJpbiwgVG9yaW5v

LCBJdGFseS4mI3hEO1VuaXZlcnNpdHkgb2YgUG9ydHNtb3V0aCwgRGVwYXJ0bWVudCBvZiBQYXRo

b2xvZ3ksIFF1ZWVuIEFsZXhhbmRyYSBIb3NwaXRhbCwgQ29zaGFtLCBQb3J0c21vdXRoLCBVbml0

ZWQgS2luZ2RvbS4mI3hEO0RlcGFydG1lbnQgb2YgUGF0aG9sb2d5IGFuZCBMYWJvcmF0b3J5IE1l

ZGljaW5lLCBUdWZ0cyBVbml2ZXJzaXR5IFNjaG9vbCBvZiBNZWRpY2luZSwgVHVmdHMgTWVkaWNh

bCBDZW50ZXIsIEJvc3RvbiwgTWFzc2FjaHVzZXR0cy4mI3hEO0RlcGFydG1lbnQgb2YgRW5kb2Ny

aW5vbG9neSwgTWVtb3JpYWwgU2xvYW4gS2V0dGVyaW5nIENhbmNlciBDZW50ZXIsIE5ldyBZb3Jr

LCBOZXcgWW9yay4mI3hEO1RoeXJvaWQgQ2FuY2VyIFN1cnZpdm9ycyBBc3NvY2lhdGlvbiBJbmMs

IFJhbGVpZ2gsIE5vcnRoIENhcm9saW5hLiYjeEQ7R2VuZXJhbCBhbmQgVGh5cm9pZCBhbmQgUGFy

YXRoeXJvaWQgRW5kb2NyaW5lIFN1cmdlcnkgRGl2aXNpb24sIE1hc3NhY2h1c2V0dHMgRXllIGFu

ZCBFYXIgSW5maXJtYXJ5LCBCb3N0b24uJiN4RDtEZXBhcnRtZW50IG9mIFBhdGhvbG9neSwgTWVt

b3JpYWwgU2xvYW4gS2V0dGVyaW5nIENhbmNlciBDZW50ZXIsIE5ldyBZb3JrLCBOZXcgWW9yay48

L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5Ob21lbmNsYXR1cmUgUmV2aXNpb24gZm9yIEVu

Y2Fwc3VsYXRlZCBGb2xsaWN1bGFyIFZhcmlhbnQgb2YgUGFwaWxsYXJ5IFRoeXJvaWQgQ2FyY2lu

b21hOiBBIFBhcmFkaWdtIFNoaWZ0IHRvIFJlZHVjZSBPdmVydHJlYXRtZW50IG9mIEluZG9sZW50

IFR1bW9yczwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5KQU1BIE9uY29sPC9zZWNvbmRhcnktdGl0

bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+SkFNQSBPbmNvbDwvZnVsbC10aXRs

ZT48L3BlcmlvZGljYWw+PHBhZ2VzPjEwMjMtOTwvcGFnZXM+PHZvbHVtZT4yPC92b2x1bWU+PG51

bWJlcj44PC9udW1iZXI+PGtleXdvcmRzPjxrZXl3b3JkPkFkZW5vY2FyY2lub21hLCBGb2xsaWN1

bGFyL2NsYXNzaWZpY2F0aW9uL2RpYWdub3Npcy8qcGF0aG9sb2d5PC9rZXl3b3JkPjxrZXl3b3Jk

PkFkdWx0PC9rZXl3b3JkPjxrZXl3b3JkPkFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+QWdlZCwgODAg

YW5kIG92ZXI8L2tleXdvcmQ+PGtleXdvcmQ+Q2FyY2lub21hL2NsYXNzaWZpY2F0aW9uL2RpYWdu

b3Npcy8qcGF0aG9sb2d5PC9rZXl3b3JkPjxrZXl3b3JkPkZlbWFsZTwva2V5d29yZD48a2V5d29y

ZD5IdW1hbnM8L2tleXdvcmQ+PGtleXdvcmQ+TWFsZTwva2V5d29yZD48a2V5d29yZD5NZWRpY2Fs

IE92ZXJ1c2UvKnByZXZlbnRpb24gJmFtcDsgY29udHJvbDwva2V5d29yZD48a2V5d29yZD5NaWRk

bGUgQWdlZDwva2V5d29yZD48a2V5d29yZD5OZW9wbGFzbSBJbnZhc2l2ZW5lc3M8L2tleXdvcmQ+

PGtleXdvcmQ+UmV0cm9zcGVjdGl2ZSBTdHVkaWVzPC9rZXl3b3JkPjxrZXl3b3JkPipUZXJtaW5v

bG9neSBhcyBUb3BpYzwva2V5d29yZD48a2V5d29yZD5UaHlyb2lkIE5lb3BsYXNtcy9jbGFzc2lm

aWNhdGlvbi9kaWFnbm9zaXMvKnBhdGhvbG9neTwva2V5d29yZD48a2V5d29yZD5UaHlyb2lkIE5v

ZHVsZS9jbGFzc2lmaWNhdGlvbi9kaWFnbm9zaXMvKnBhdGhvbG9neTwva2V5d29yZD48a2V5d29y

ZD5Zb3VuZyBBZHVsdDwva2V5d29yZD48L2tleXdvcmRzPjxkYXRlcz48eWVhcj4yMDE2PC95ZWFy

PjxwdWItZGF0ZXM+PGRhdGU+QXVnIDAxPC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+

MjM3NC0yNDQ1IChFbGVjdHJvbmljKSYjeEQ7MjM3NC0yNDM3IChMaW5raW5nKTwvaXNibj48YWNj

ZXNzaW9uLW51bT4yNzA3ODE0NTwvYWNjZXNzaW9uLW51bT48dXJscz48cmVsYXRlZC11cmxzPjx1

cmw+aHR0cHM6Ly93d3cubmNiaS5ubG0ubmloLmdvdi9wdWJtZWQvMjcwNzgxNDU8L3VybD48L3Jl

bGF0ZWQtdXJscz48L3VybHM+PGVsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjEwLjEwMDEvamFtYW9u

Y29sLjIwMTYuMDM4NjwvZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+PC9yZWNvcmQ+PC9DaXRlPjwv

RW5kTm90ZT5=

ADDIN EN.CITE.DATA 13 is noted to be subjective and difficult to apply. Additionally, this cut-off was already shown to be inferior to a 0% cut-off in ensuring indolent outcome. Thus even 1 well-formed papilla as defined above should be considered exclusionary. ADDIN EN.CITE <EndNote><Cite><Author>Cho</Author><Year>2017</Year><RecNum>47</RecNum><DisplayText><style face="superscript">14</style></DisplayText><record><rec-number>47</rec-number><foreign-keys><key app="EN" db-id="ps2wwdsfra2r5ee9zasxs5t8zwdwxrswe5xa" timestamp="1495243857">47</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Cho, U.</author><author>Mete, O.</author><author>Kim, M. H.</author><author>Bae, J. S.</author><author>Jung, C. K.</author></authors></contributors><auth-address>Department of Hospital Pathology, Seoul St Mary&apos;s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.&#xD;Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.&#xD;Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.&#xD;Department of Surgery, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.&#xD;Cancer Research Institute, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.</auth-address><titles><title>Molecular correlates and rate of lymph node metastasis of non-invasive follicular thyroid neoplasm with papillary-like nuclear features and invasive follicular variant papillary thyroid carcinoma: the impact of rigid criteria to distinguish non-invasive follicular thyroid neoplasm with papillary-like nuclear features</title><secondary-title>Mod Pathol</secondary-title></titles><periodical><full-title>Mod Pathol</full-title></periodical><dates><year>2017</year><pub-dates><date>Mar 10</date></pub-dates></dates><isbn>1530-0285 (Electronic)&#xD;0893-3952 (Linking)</isbn><accession-num>28281551</accession-num><urls><related-urls><url> Other variants that may have prognostic and therapeutic value but are rare and not well validated include: Clear cellColumnar cellHobnail cell#MacrofollicularOncocytic or oxyphilicSolidWarthin-like# To be present in the upcoming unpublished WHO classification.Reporting of these is optional but recommended.Papillary microcarcinomas (also historically referred to as papillary microtumor, occult, latent, or small papillary carcinoma) are not technically a specific variant but refer to papillary carcinomas that are found incidentally measuring 1 cm or less. ADDIN EN.CITE <EndNote><Cite><Author>DeLellis</Author><Year>2004</Year><RecNum>2</RecNum><DisplayText><style face="superscript">3</style></DisplayText><record><rec-number>2</rec-number><foreign-keys><key app="EN" db-id="ps2wwdsfra2r5ee9zasxs5t8zwdwxrswe5xa" timestamp="1473117135">2</key></foreign-keys><ref-type name="Edited Book">28</ref-type><contributors><authors><author>DeLellis, R.A.</author><author>Lloyd, R.V.</author><author>Heitz, P.U. </author><author>Eng,C</author></authors></contributors><titles><title>Pathology and Genetics of Tumours of the Endocrine Organs</title><secondary-title>World Health Organization Classification of Tumours</secondary-title></titles><dates><year>2004</year></dates><pub-location>Lyons</pub-location><publisher>IARC PRess</publisher><urls></urls></record></Cite></EndNote>3 In spite of their rather common identification in thyroid gland resectionsPEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Lb21vcm93c2tpPC9BdXRob3I+PFllYXI+MTk4ODwvWWVh

cj48UmVjTnVtPjEzPC9SZWNOdW0+PERpc3BsYXlUZXh0PjxzdHlsZSBmYWNlPSJzdXBlcnNjcmlw

dCI+MTQsMTU8L3N0eWxlPjwvRGlzcGxheVRleHQ+PHJlY29yZD48cmVjLW51bWJlcj4xMzwvcmVj

LW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9InBzMnd3ZHNmcmEycjVl

ZTl6YXN4czV0OHp3ZHd4cnN3ZTV4YSIgdGltZXN0YW1wPSIxNDczMTE3MTM3Ij4xMzwva2V5Pjwv

Zm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9yZWYtdHlw

ZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+S29tb3Jvd3NraSwgUi4gQS48L2F1dGhv

cj48YXV0aG9yPkhhbnNvbiwgRy4gQS48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+

PGF1dGgtYWRkcmVzcz5EZXBhcnRtZW50IG9mIFBhdGhvbG9neSwgTWVkaWNhbCBDb2xsZWdlIG9m

IFdpc2NvbnNpbiwgTWlsd2F1a2VlIDUzMjI2LjwvYXV0aC1hZGRyZXNzPjx0aXRsZXM+PHRpdGxl

Pk9jY3VsdCB0aHlyb2lkIHBhdGhvbG9neSBpbiB0aGUgeW91bmcgYWR1bHQ6IGFuIGF1dG9wc3kg

c3R1ZHkgb2YgMTM4IHBhdGllbnRzIHdpdGhvdXQgY2xpbmljYWwgdGh5cm9pZCBkaXNlYXNlPC90

aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkh1bSBQYXRob2w8L3NlY29uZGFyeS10aXRsZT48L3RpdGxl

cz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5IdW0gUGF0aG9sPC9mdWxsLXRpdGxlPjwvcGVyaW9k

aWNhbD48cGFnZXM+Njg5LTk2PC9wYWdlcz48dm9sdW1lPjE5PC92b2x1bWU+PG51bWJlcj42PC9u

dW1iZXI+PGVkaXRpb24+MTk4OC8wNi8wMTwvZWRpdGlvbj48a2V5d29yZHM+PGtleXdvcmQ+QWRl

bm9tYS9kaWFnbm9zaXMvcGF0aG9sb2d5PC9rZXl3b3JkPjxrZXl3b3JkPkFkdWx0PC9rZXl3b3Jk

PjxrZXl3b3JkPkNhcmNpbm9tYSwgUGFwaWxsYXJ5L2RpYWdub3Npcy9wYXRob2xvZ3k8L2tleXdv

cmQ+PGtleXdvcmQ+RmVtYWxlPC9rZXl3b3JkPjxrZXl3b3JkPkZpYnJvc2lzL3BhdGhvbG9neTwv

a2V5d29yZD48a2V5d29yZD5IdW1hbnM8L2tleXdvcmQ+PGtleXdvcmQ+THltcGhvY3l0ZXMvcGF0

aG9sb2d5PC9rZXl3b3JkPjxrZXl3b3JkPk1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+VGh5cm9pZCBE

aXNlYXNlcy9kaWFnbm9zaXMvKnBhdGhvbG9neTwva2V5d29yZD48a2V5d29yZD5UaHlyb2lkIEds

YW5kLypwYXRob2xvZ3k8L2tleXdvcmQ+PGtleXdvcmQ+VGh5cm9pZCBOZW9wbGFzbXMvZGlhZ25v

c2lzL3BhdGhvbG9neS9zZWNvbmRhcnk8L2tleXdvcmQ+PC9rZXl3b3Jkcz48ZGF0ZXM+PHllYXI+

MTk4ODwveWVhcj48cHViLWRhdGVzPjxkYXRlPkp1bjwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVz

Pjxpc2JuPjAwNDYtODE3NyAoUHJpbnQpJiN4RDswMDQ2LTgxNzcgKExpbmtpbmcpPC9pc2JuPjxh

Y2Nlc3Npb24tbnVtPjMzNzg3ODg8L2FjY2Vzc2lvbi1udW0+PHVybHM+PHJlbGF0ZWQtdXJscz48

dXJsPmh0dHA6Ly93d3cubmNiaS5ubG0ubmloLmdvdi9wdWJtZWQvMzM3ODc4ODwvdXJsPjwvcmVs

YXRlZC11cmxzPjwvdXJscz48bGFuZ3VhZ2U+ZW5nPC9sYW5ndWFnZT48L3JlY29yZD48L0NpdGU+

PENpdGU+PEF1dGhvcj5GaW5rPC9BdXRob3I+PFllYXI+MTk5NjwvWWVhcj48UmVjTnVtPjE0PC9S

ZWNOdW0+PHJlY29yZD48cmVjLW51bWJlcj4xNDwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxr

ZXkgYXBwPSJFTiIgZGItaWQ9InBzMnd3ZHNmcmEycjVlZTl6YXN4czV0OHp3ZHd4cnN3ZTV4YSIg

dGltZXN0YW1wPSIxNDczMTE3MTM3Ij4xNDwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBu

YW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3Jz

PjxhdXRob3I+RmluaywgQS48L2F1dGhvcj48YXV0aG9yPlRvbWxpbnNvbiwgRy48L2F1dGhvcj48

YXV0aG9yPkZyZWVtYW4sIEouIEwuPC9hdXRob3I+PGF1dGhvcj5Sb3NlbiwgSS4gQi48L2F1dGhv

cj48YXV0aG9yPkFzYSwgUy4gTC48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PGF1

dGgtYWRkcmVzcz5EZXBhcnRtZW50IG9mIFBhdGhvbG9neSwgTW91bnQgU2luYWkgSG9zcGl0YWws

IFVuaXZlcnNpdHkgb2YgVG9yb250bywgT250YXJpbywgQ2FuYWRhLjwvYXV0aC1hZGRyZXNzPjx0

aXRsZXM+PHRpdGxlPk9jY3VsdCBtaWNyb3BhcGlsbGFyeSBjYXJjaW5vbWEgYXNzb2NpYXRlZCB3

aXRoIGJlbmlnbiBmb2xsaWN1bGFyIHRoeXJvaWQgZGlzZWFzZSBhbmQgdW5yZWxhdGVkIHRoeXJv

aWQgbmVvcGxhc21zPC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPk1vZCBQYXRob2w8L3NlY29uZGFy

eS10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5Nb2QgUGF0aG9sPC9mdWxs

LXRpdGxlPjwvcGVyaW9kaWNhbD48cGFnZXM+ODE2LTIwPC9wYWdlcz48dm9sdW1lPjk8L3ZvbHVt

ZT48bnVtYmVyPjg8L251bWJlcj48ZWRpdGlvbj4xOTk2LzA4LzAxPC9lZGl0aW9uPjxrZXl3b3Jk

cz48a2V5d29yZD5BZG9sZXNjZW50PC9rZXl3b3JkPjxrZXl3b3JkPkFkdWx0PC9rZXl3b3JkPjxr

ZXl3b3JkPkFnZSBGYWN0b3JzPC9rZXl3b3JkPjxrZXl3b3JkPkFnZWQ8L2tleXdvcmQ+PGtleXdv

cmQ+QWdlZCwgODAgYW5kIG92ZXI8L2tleXdvcmQ+PGtleXdvcmQ+Q2FyY2lub21hLCBQYXBpbGxh

cnkvZXBpZGVtaW9sb2d5LypwYXRob2xvZ3k8L2tleXdvcmQ+PGtleXdvcmQ+RmVtYWxlPC9rZXl3

b3JkPjxrZXl3b3JkPkh1bWFuczwva2V5d29yZD48a2V5d29yZD5JbmNpZGVuY2U8L2tleXdvcmQ+

PGtleXdvcmQ+TG9naXN0aWMgTW9kZWxzPC9rZXl3b3JkPjxrZXl3b3JkPk1hbGU8L2tleXdvcmQ+

PGtleXdvcmQ+TWlkZGxlIEFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+U2V4IEZhY3RvcnM8L2tleXdv

cmQ+PGtleXdvcmQ+VGh5cm9pZCBEaXNlYXNlcy8qcGF0aG9sb2d5L3N1cmdlcnk8L2tleXdvcmQ+

PGtleXdvcmQ+VGh5cm9pZCBOZW9wbGFzbXMvZXBpZGVtaW9sb2d5LypwYXRob2xvZ3k8L2tleXdv

cmQ+PC9rZXl3b3Jkcz48ZGF0ZXM+PHllYXI+MTk5NjwveWVhcj48cHViLWRhdGVzPjxkYXRlPkF1

ZzwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxpc2JuPjA4OTMtMzk1MiAoUHJpbnQpJiN4RDsw

ODkzLTM5NTIgKExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Npb24tbnVtPjg4NzE5MjI8L2FjY2Vzc2lv

bi1udW0+PHVybHM+PHJlbGF0ZWQtdXJscz48dXJsPmh0dHA6Ly93d3cubmNiaS5ubG0ubmloLmdv

di9wdWJtZWQvODg3MTkyMjwvdXJsPjwvcmVsYXRlZC11cmxzPjwvdXJscz48bGFuZ3VhZ2U+ZW5n

PC9sYW5ndWFnZT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPn==

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Lb21vcm93c2tpPC9BdXRob3I+PFllYXI+MTk4ODwvWWVh

cj48UmVjTnVtPjEzPC9SZWNOdW0+PERpc3BsYXlUZXh0PjxzdHlsZSBmYWNlPSJzdXBlcnNjcmlw

dCI+MTQsMTU8L3N0eWxlPjwvRGlzcGxheVRleHQ+PHJlY29yZD48cmVjLW51bWJlcj4xMzwvcmVj

LW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9InBzMnd3ZHNmcmEycjVl

ZTl6YXN4czV0OHp3ZHd4cnN3ZTV4YSIgdGltZXN0YW1wPSIxNDczMTE3MTM3Ij4xMzwva2V5Pjwv

Zm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9yZWYtdHlw

ZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+S29tb3Jvd3NraSwgUi4gQS48L2F1dGhv

cj48YXV0aG9yPkhhbnNvbiwgRy4gQS48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+

PGF1dGgtYWRkcmVzcz5EZXBhcnRtZW50IG9mIFBhdGhvbG9neSwgTWVkaWNhbCBDb2xsZWdlIG9m

IFdpc2NvbnNpbiwgTWlsd2F1a2VlIDUzMjI2LjwvYXV0aC1hZGRyZXNzPjx0aXRsZXM+PHRpdGxl

Pk9jY3VsdCB0aHlyb2lkIHBhdGhvbG9neSBpbiB0aGUgeW91bmcgYWR1bHQ6IGFuIGF1dG9wc3kg

c3R1ZHkgb2YgMTM4IHBhdGllbnRzIHdpdGhvdXQgY2xpbmljYWwgdGh5cm9pZCBkaXNlYXNlPC90

aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkh1bSBQYXRob2w8L3NlY29uZGFyeS10aXRsZT48L3RpdGxl

cz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5IdW0gUGF0aG9sPC9mdWxsLXRpdGxlPjwvcGVyaW9k

aWNhbD48cGFnZXM+Njg5LTk2PC9wYWdlcz48dm9sdW1lPjE5PC92b2x1bWU+PG51bWJlcj42PC9u

dW1iZXI+PGVkaXRpb24+MTk4OC8wNi8wMTwvZWRpdGlvbj48a2V5d29yZHM+PGtleXdvcmQ+QWRl

bm9tYS9kaWFnbm9zaXMvcGF0aG9sb2d5PC9rZXl3b3JkPjxrZXl3b3JkPkFkdWx0PC9rZXl3b3Jk

PjxrZXl3b3JkPkNhcmNpbm9tYSwgUGFwaWxsYXJ5L2RpYWdub3Npcy9wYXRob2xvZ3k8L2tleXdv

cmQ+PGtleXdvcmQ+RmVtYWxlPC9rZXl3b3JkPjxrZXl3b3JkPkZpYnJvc2lzL3BhdGhvbG9neTwv

a2V5d29yZD48a2V5d29yZD5IdW1hbnM8L2tleXdvcmQ+PGtleXdvcmQ+THltcGhvY3l0ZXMvcGF0

aG9sb2d5PC9rZXl3b3JkPjxrZXl3b3JkPk1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+VGh5cm9pZCBE

aXNlYXNlcy9kaWFnbm9zaXMvKnBhdGhvbG9neTwva2V5d29yZD48a2V5d29yZD5UaHlyb2lkIEds

YW5kLypwYXRob2xvZ3k8L2tleXdvcmQ+PGtleXdvcmQ+VGh5cm9pZCBOZW9wbGFzbXMvZGlhZ25v

c2lzL3BhdGhvbG9neS9zZWNvbmRhcnk8L2tleXdvcmQ+PC9rZXl3b3Jkcz48ZGF0ZXM+PHllYXI+

MTk4ODwveWVhcj48cHViLWRhdGVzPjxkYXRlPkp1bjwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVz

Pjxpc2JuPjAwNDYtODE3NyAoUHJpbnQpJiN4RDswMDQ2LTgxNzcgKExpbmtpbmcpPC9pc2JuPjxh

Y2Nlc3Npb24tbnVtPjMzNzg3ODg8L2FjY2Vzc2lvbi1udW0+PHVybHM+PHJlbGF0ZWQtdXJscz48

dXJsPmh0dHA6Ly93d3cubmNiaS5ubG0ubmloLmdvdi9wdWJtZWQvMzM3ODc4ODwvdXJsPjwvcmVs

YXRlZC11cmxzPjwvdXJscz48bGFuZ3VhZ2U+ZW5nPC9sYW5ndWFnZT48L3JlY29yZD48L0NpdGU+

PENpdGU+PEF1dGhvcj5GaW5rPC9BdXRob3I+PFllYXI+MTk5NjwvWWVhcj48UmVjTnVtPjE0PC9S

ZWNOdW0+PHJlY29yZD48cmVjLW51bWJlcj4xNDwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxr

ZXkgYXBwPSJFTiIgZGItaWQ9InBzMnd3ZHNmcmEycjVlZTl6YXN4czV0OHp3ZHd4cnN3ZTV4YSIg

dGltZXN0YW1wPSIxNDczMTE3MTM3Ij4xNDwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBu

YW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3Jz

PjxhdXRob3I+RmluaywgQS48L2F1dGhvcj48YXV0aG9yPlRvbWxpbnNvbiwgRy48L2F1dGhvcj48

YXV0aG9yPkZyZWVtYW4sIEouIEwuPC9hdXRob3I+PGF1dGhvcj5Sb3NlbiwgSS4gQi48L2F1dGhv

cj48YXV0aG9yPkFzYSwgUy4gTC48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PGF1

dGgtYWRkcmVzcz5EZXBhcnRtZW50IG9mIFBhdGhvbG9neSwgTW91bnQgU2luYWkgSG9zcGl0YWws

IFVuaXZlcnNpdHkgb2YgVG9yb250bywgT250YXJpbywgQ2FuYWRhLjwvYXV0aC1hZGRyZXNzPjx0

aXRsZXM+PHRpdGxlPk9jY3VsdCBtaWNyb3BhcGlsbGFyeSBjYXJjaW5vbWEgYXNzb2NpYXRlZCB3

aXRoIGJlbmlnbiBmb2xsaWN1bGFyIHRoeXJvaWQgZGlzZWFzZSBhbmQgdW5yZWxhdGVkIHRoeXJv

aWQgbmVvcGxhc21zPC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPk1vZCBQYXRob2w8L3NlY29uZGFy

eS10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5Nb2QgUGF0aG9sPC9mdWxs

LXRpdGxlPjwvcGVyaW9kaWNhbD48cGFnZXM+ODE2LTIwPC9wYWdlcz48dm9sdW1lPjk8L3ZvbHVt

ZT48bnVtYmVyPjg8L251bWJlcj48ZWRpdGlvbj4xOTk2LzA4LzAxPC9lZGl0aW9uPjxrZXl3b3Jk

cz48a2V5d29yZD5BZG9sZXNjZW50PC9rZXl3b3JkPjxrZXl3b3JkPkFkdWx0PC9rZXl3b3JkPjxr

ZXl3b3JkPkFnZSBGYWN0b3JzPC9rZXl3b3JkPjxrZXl3b3JkPkFnZWQ8L2tleXdvcmQ+PGtleXdv

cmQ+QWdlZCwgODAgYW5kIG92ZXI8L2tleXdvcmQ+PGtleXdvcmQ+Q2FyY2lub21hLCBQYXBpbGxh

cnkvZXBpZGVtaW9sb2d5LypwYXRob2xvZ3k8L2tleXdvcmQ+PGtleXdvcmQ+RmVtYWxlPC9rZXl3

b3JkPjxrZXl3b3JkPkh1bWFuczwva2V5d29yZD48a2V5d29yZD5JbmNpZGVuY2U8L2tleXdvcmQ+

PGtleXdvcmQ+TG9naXN0aWMgTW9kZWxzPC9rZXl3b3JkPjxrZXl3b3JkPk1hbGU8L2tleXdvcmQ+

PGtleXdvcmQ+TWlkZGxlIEFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+U2V4IEZhY3RvcnM8L2tleXdv

cmQ+PGtleXdvcmQ+VGh5cm9pZCBEaXNlYXNlcy8qcGF0aG9sb2d5L3N1cmdlcnk8L2tleXdvcmQ+

PGtleXdvcmQ+VGh5cm9pZCBOZW9wbGFzbXMvZXBpZGVtaW9sb2d5LypwYXRob2xvZ3k8L2tleXdv

cmQ+PC9rZXl3b3Jkcz48ZGF0ZXM+PHllYXI+MTk5NjwveWVhcj48cHViLWRhdGVzPjxkYXRlPkF1

ZzwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxpc2JuPjA4OTMtMzk1MiAoUHJpbnQpJiN4RDsw

ODkzLTM5NTIgKExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Npb24tbnVtPjg4NzE5MjI8L2FjY2Vzc2lv

bi1udW0+PHVybHM+PHJlbGF0ZWQtdXJscz48dXJsPmh0dHA6Ly93d3cubmNiaS5ubG0ubmloLmdv

di9wdWJtZWQvODg3MTkyMjwvdXJsPjwvcmVsYXRlZC11cmxzPjwvdXJscz48bGFuZ3VhZ2U+ZW5n

PC9sYW5ndWFnZT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPn==

ADDIN EN.CITE.DATA 14,15 and apparent indolent biologic behavior, it is the recommendation to issue a protocol for all cases in which papillary thyroid carcinoma is found, including subcentimeter carcinomas, whether incidentally found in a thyroid gland removed for other reasons (eg, multinodular goiter), discovered clinically (palpable, visible nodule), and/or discovered by imaging. Given the more sophisticated diagnostic (eg, imaging) modalities currently available, small (ie, less than 1 cm) lesions are being identified and resected. In an effort to have these papillary microcarcinomas reported and documented in tumor registries, thereby providing for long-term follow-up and better determination of their biologic nature, it is recommended that they should also be reported following this CAP thyroid protocol. More recently, certain histologic features have been shown to correlate with nodal metastasis in papillary microcarcinomas. A combined histologic-molecular scoring scheme has been proposed for microcarcinomas based on BRAF mutation status, subcapsular location, peri- and intratumoral fibrosis, and multifocality. This is not yet validated, but documentations of the aforementioned morphologic parameters (with or without mutational status) may be useful in management. ADDIN EN.CITE <EndNote><Cite><Author>Niemeier</Author><Year>2012</Year><RecNum>64</RecNum><DisplayText><style face="superscript">16</style></DisplayText><record><rec-number>15</rec-number><foreign-keys><key app="EN" db-id="ps2wwdsfra2r5ee9zasxs5t8zwdwxrswe5xa" timestamp="1473117137">15</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Niemeier, L. A.</author><author>Kuffner Akatsu, H.</author><author>Song, C.</author><author>Carty, S. E.</author><author>Hodak, S. P.</author><author>Yip, L.</author><author>Ferris, R. L.</author><author>Tseng, G. C.</author><author>Seethala, R. R.</author><author>Lebeau, S. O.</author><author>Stang, M. T.</author><author>Coyne, C.</author><author>Johnson, J. T.</author><author>Stewart, A. F.</author><author>Nikiforov, Y. E.</author></authors></contributors><auth-address>Department of Pathology and Laboratory Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.</auth-address><titles><title>A combined molecular-pathologic score improves risk stratification of thyroid papillary microcarcinoma</title><secondary-title>Cancer</secondary-title></titles><periodical><full-title>Cancer</full-title></periodical><pages>2069-77</pages><volume>118</volume><number>8</number><edition>2011/09/02</edition><keywords><keyword>Carcinoma</keyword><keyword>Humans</keyword><keyword>Lymphatic Metastasis</keyword><keyword>*Mutation</keyword><keyword>Proto-Oncogene Proteins B-raf/*genetics</keyword><keyword>Recurrence</keyword><keyword>Risk Assessment/*methods</keyword><keyword>Thyroid Neoplasms/*genetics/*pathology</keyword></keywords><dates><year>2012</year><pub-dates><date>Apr 15</date></pub-dates></dates><isbn>1097-0142 (Electronic)&#xD;0008-543X (Linking)</isbn><accession-num>21882177</accession-num><urls><related-urls><url> G. Follicular CarcinomaFollicular carcinoma is a well-differentiated carcinoma type defined by invasiveness in the absence of diagnostic nuclear features of papillary thyroid carcinoma. The diagnosis of follicular carcinoma and its distinction from follicular adenoma primarily depends on the identification of invasion of the tumor capsule and/or vascular spaces (see also note I).There are a few variants that are recognized in the WHO classification. The most commonly named variant is:Oncocytic variant (Hürthle cell carcinoma)Despite the current designation as a variant of follicular carcinoma, historically oncocytic carcinoma was considered a distinct entity. Even now the debate continues as to whether this tumor is sufficiently biologically distinct as to warrant categorization as a separate entity. This variant is often more aggressive and radioactive iodine resistant, and unlike follicular carcinoma, this variant can metastasize to lymph nodes. However, when controlled for stage and extent of invasion, this difference is diminished. ADDIN EN.CITE <EndNote><Cite><Author>Nikiforov</Author><Year>2012</Year><RecNum>16</RecNum><DisplayText><style face="superscript">17</style></DisplayText><record><rec-number>16</rec-number><foreign-keys><key app="EN" db-id="ps2wwdsfra2r5ee9zasxs5t8zwdwxrswe5xa" timestamp="1473117137">16</key></foreign-keys><ref-type name="Book Section">5</ref-type><contributors><authors><author>Nikiforov, Y. E.</author><author>Ohori, N. P.</author></authors><secondary-authors><author>Nikiforov, Y. E.</author><author>Biddinger, P.W.</author><author>Thompson, L.D.R.</author></secondary-authors></contributors><titles><title>Follicular carcinoma</title><secondary-title>Diagnostic pathology and molecular genetics of the thyroid</secondary-title></titles><pages>152-182</pages><edition>2nd</edition><section>10</section><dates><year>2012</year></dates><pub-location>Philadelphia</pub-location><publisher>Lippincott Williams and Wilkins</publisher><urls></urls></record></Cite></EndNote>17 Other proposed subtypes that are rare and of uncertain significance include:Clear cell variantMucinous variant#Follicular carcinoma with signet-ring cells*# Not part of the WHO classification.Criteria for Capsular InvasionWhile conceptually simple, there is no consensus as to the definition of capsular invasion. Some authorities require complete transgression of the capsule, while other authorities do not require complete transgression of the capsule. Figure 2 depicts the various histologic appearances for the presence or absence of capsular invasion. While a number of the illustrated representations of capsular invasion would be accepted by all pathologists (eg, C, D, E, H), other depictions listed as “Not yet” (eg, F, G, I) may be acceptable to some pathologists as representing capsular invasion. The impact of previous biopsy may confound the interpretation of capsular invasion and must be considered.42286006604000Figure 2. Capsular invasion (CI). Schematic drawing for the interpretation of the presence or absence of CI. The diagram depicts a follicular neoplasm (orange) surrounded by a fibrous capsule (green). A. Bosselation on the inner aspect of the capsule does not represent CI. B.?Sharp tumor bud invades into but not through the capsule suggesting invasion requiring deeper sections to exclude. C. Tumor totally transgresses the capsule invading beyond the outer contour of the capsule qualifying as CI. D. Tumor clothed by thin (probably new) fibrous capsule but already extending beyond an imaginary (dotted) line drawn through the outer contour of the capsule qualifying as CI. E. Satellite tumor nodule with similar features (architecture, cytomorphology) to the main tumor lying outside the capsule qualifying as CI. F. Follicles aligned perpendicular to the capsule suggesting invasion requiring deeper sections to exclude. G.?Follicles aligned parallel to the capsule do not represent CI. H.?Mushroom-shaped tumor with total transgression of the capsule qualifies as CI. I. Mushroom-shaped tumor within but not through the capsule suggests invasion requiring deeper sections to exclude invasion. J. Neoplastic follicles in the fibrous capsule with a degenerated appearance accompanied by lymphocytes and siderophages does not represent CI but rather capsular rupture related to prior fine-needle aspiration.From Fletcher CDM, ed. Diagnostic Histopathology of Tumours. 3rd ed. Edinburgh: Churchill Livingstone Elsevier; 2007. Modified with permission. ??Elsevier.The criteria defining minimally invasive follicular carcinoma are controversial. The upcoming WHO classification now separates encapsulated angioinvasive tumors into a distinct more aggressive category than minimally invasive carcinoma. Literature supports this separation.PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5OaWtpZm9yb3Y8L0F1dGhvcj48WWVhcj4yMDEyPC9ZZWFy

PjxSZWNOdW0+MTY8L1JlY051bT48RGlzcGxheVRleHQ+PHN0eWxlIGZhY2U9InN1cGVyc2NyaXB0

Ij4xNywxODwvc3R5bGU+PC9EaXNwbGF5VGV4dD48cmVjb3JkPjxyZWMtbnVtYmVyPjE2PC9yZWMt

bnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0icHMyd3dkc2ZyYTJyNWVl

OXphc3hzNXQ4endkd3hyc3dlNXhhIiB0aW1lc3RhbXA9IjE0NzMxMTcxMzciPjE2PC9rZXk+PC9m

b3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkJvb2sgU2VjdGlvbiI+NTwvcmVmLXR5cGU+PGNv

bnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPk5pa2lmb3JvdiwgWS4gRS48L2F1dGhvcj48YXV0

aG9yPk9ob3JpLCBOLiBQLjwvYXV0aG9yPjwvYXV0aG9ycz48c2Vjb25kYXJ5LWF1dGhvcnM+PGF1

dGhvcj5OaWtpZm9yb3YsIFkuIEUuPC9hdXRob3I+PGF1dGhvcj5CaWRkaW5nZXIsIFAuVy48L2F1

dGhvcj48YXV0aG9yPlRob21wc29uLCBMLkQuUi48L2F1dGhvcj48L3NlY29uZGFyeS1hdXRob3Jz

PjwvY29udHJpYnV0b3JzPjx0aXRsZXM+PHRpdGxlPkZvbGxpY3VsYXIgY2FyY2lub21hPC90aXRs

ZT48c2Vjb25kYXJ5LXRpdGxlPkRpYWdub3N0aWMgcGF0aG9sb2d5IGFuZCBtb2xlY3VsYXIgZ2Vu

ZXRpY3Mgb2YgdGhlIHRoeXJvaWQ8L3NlY29uZGFyeS10aXRsZT48L3RpdGxlcz48cGFnZXM+MTUy

LTE4MjwvcGFnZXM+PGVkaXRpb24+Mm5kPC9lZGl0aW9uPjxzZWN0aW9uPjEwPC9zZWN0aW9uPjxk

YXRlcz48eWVhcj4yMDEyPC95ZWFyPjwvZGF0ZXM+PHB1Yi1sb2NhdGlvbj5QaGlsYWRlbHBoaWE8

L3B1Yi1sb2NhdGlvbj48cHVibGlzaGVyPkxpcHBpbmNvdHQgV2lsbGlhbXMgYW5kIFdpbGtpbnM8

L3B1Ymxpc2hlcj48dXJscz48L3VybHM+PC9yZWNvcmQ+PC9DaXRlPjxDaXRlPjxBdXRob3I+dmFu

IEhlZXJkZW48L0F1dGhvcj48WWVhcj4xOTkyPC9ZZWFyPjxSZWNOdW0+MTc8L1JlY051bT48cmVj

b3JkPjxyZWMtbnVtYmVyPjE3PC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVO

IiBkYi1pZD0icHMyd3dkc2ZyYTJyNWVlOXphc3hzNXQ4endkd3hyc3dlNXhhIiB0aW1lc3RhbXA9

IjE0NzMxMTcxMzciPjE3PC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJu

YWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj52

YW4gSGVlcmRlbiwgSi4gQS48L2F1dGhvcj48YXV0aG9yPkhheSwgSS4gRC48L2F1dGhvcj48YXV0

aG9yPkdvZWxsbmVyLCBKLiBSLjwvYXV0aG9yPjxhdXRob3I+U2Fsb21hbywgRC48L2F1dGhvcj48

YXV0aG9yPkViZXJzb2xkLCBKLiBSLjwvYXV0aG9yPjxhdXRob3I+QmVyZ3N0cmFsaCwgRS4gSi48

L2F1dGhvcj48YXV0aG9yPkdyYW50LCBDLiBTLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1

dG9ycz48YXV0aC1hZGRyZXNzPkRlcGFydG1lbnQgb2YgU3VyZ2VyeSwgTWF5byBDbGluaWMsIFJv

Y2hlc3RlciwgTU4gNTU5MDUuPC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48dGl0bGU+Rm9sbGljdWxh

ciB0aHlyb2lkIGNhcmNpbm9tYSB3aXRoIGNhcHN1bGFyIGludmFzaW9uIGFsb25lOiBhIG5vbnRo

cmVhdGVuaW5nIG1hbGlnbmFuY3k8L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+U3VyZ2VyeTwvc2Vj

b25kYXJ5LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPlN1cmdlcnk8L2Z1

bGwtdGl0bGU+PC9wZXJpb2RpY2FsPjxwYWdlcz4xMTMwLTY7IGRpc2N1c3Npb24gMTEzNi04PC9w

YWdlcz48dm9sdW1lPjExMjwvdm9sdW1lPjxudW1iZXI+NjwvbnVtYmVyPjxlZGl0aW9uPjE5OTIv

MTIvMDE8L2VkaXRpb24+PGtleXdvcmRzPjxrZXl3b3JkPkFkZW5vY2FyY2lub21hLypwYXRob2xv

Z3kvc3VyZ2VyeTwva2V5d29yZD48a2V5d29yZD5BZHVsdDwva2V5d29yZD48a2V5d29yZD5BZ2Vk

PC9rZXl3b3JkPjxrZXl3b3JkPkFnZWQsIDgwIGFuZCBvdmVyPC9rZXl3b3JkPjxrZXl3b3JkPkZl

bWFsZTwva2V5d29yZD48a2V5d29yZD5IdW1hbnM8L2tleXdvcmQ+PGtleXdvcmQ+TWFsZTwva2V5

d29yZD48a2V5d29yZD5NaWRkbGUgQWdlZDwva2V5d29yZD48a2V5d29yZD5NdWx0aXZhcmlhdGUg

QW5hbHlzaXM8L2tleXdvcmQ+PGtleXdvcmQ+TmVvcGxhc20gSW52YXNpdmVuZXNzPC9rZXl3b3Jk

PjxrZXl3b3JkPlBvc3RvcGVyYXRpdmUgUGVyaW9kPC9rZXl3b3JkPjxrZXl3b3JkPlRoeXJvaWQg

TmVvcGxhc21zLypwYXRob2xvZ3kvc3VyZ2VyeTwva2V5d29yZD48a2V5d29yZD5UcmVhdG1lbnQg

T3V0Y29tZTwva2V5d29yZD48L2tleXdvcmRzPjxkYXRlcz48eWVhcj4xOTkyPC95ZWFyPjxwdWIt

ZGF0ZXM+PGRhdGU+RGVjPC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+MDAzOS02MDYw

IChQcmludCkmI3hEOzAwMzktNjA2MCAoTGlua2luZyk8L2lzYm4+PGFjY2Vzc2lvbi1udW0+MTQ1

NTMxNTwvYWNjZXNzaW9uLW51bT48dXJscz48cmVsYXRlZC11cmxzPjx1cmw+aHR0cDovL3d3dy5u

Y2JpLm5sbS5uaWguZ292L3B1Ym1lZC8xNDU1MzE1PC91cmw+PC9yZWxhdGVkLXVybHM+PC91cmxz

PjxlbGVjdHJvbmljLXJlc291cmNlLW51bT4wMDM5LTYwNjAoOTIpOTAzMTgtVCBbcGlpXTwvZWxl

Y3Ryb25pYy1yZXNvdXJjZS1udW0+PGxhbmd1YWdlPmVuZzwvbGFuZ3VhZ2U+PC9yZWNvcmQ+PC9D

aXRlPjwvRW5kTm90ZT5=

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5OaWtpZm9yb3Y8L0F1dGhvcj48WWVhcj4yMDEyPC9ZZWFy

PjxSZWNOdW0+MTY8L1JlY051bT48RGlzcGxheVRleHQ+PHN0eWxlIGZhY2U9InN1cGVyc2NyaXB0

Ij4xNywxODwvc3R5bGU+PC9EaXNwbGF5VGV4dD48cmVjb3JkPjxyZWMtbnVtYmVyPjE2PC9yZWMt

bnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0icHMyd3dkc2ZyYTJyNWVl

OXphc3hzNXQ4endkd3hyc3dlNXhhIiB0aW1lc3RhbXA9IjE0NzMxMTcxMzciPjE2PC9rZXk+PC9m

b3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkJvb2sgU2VjdGlvbiI+NTwvcmVmLXR5cGU+PGNv

bnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPk5pa2lmb3JvdiwgWS4gRS48L2F1dGhvcj48YXV0

aG9yPk9ob3JpLCBOLiBQLjwvYXV0aG9yPjwvYXV0aG9ycz48c2Vjb25kYXJ5LWF1dGhvcnM+PGF1

dGhvcj5OaWtpZm9yb3YsIFkuIEUuPC9hdXRob3I+PGF1dGhvcj5CaWRkaW5nZXIsIFAuVy48L2F1

dGhvcj48YXV0aG9yPlRob21wc29uLCBMLkQuUi48L2F1dGhvcj48L3NlY29uZGFyeS1hdXRob3Jz

PjwvY29udHJpYnV0b3JzPjx0aXRsZXM+PHRpdGxlPkZvbGxpY3VsYXIgY2FyY2lub21hPC90aXRs

ZT48c2Vjb25kYXJ5LXRpdGxlPkRpYWdub3N0aWMgcGF0aG9sb2d5IGFuZCBtb2xlY3VsYXIgZ2Vu

ZXRpY3Mgb2YgdGhlIHRoeXJvaWQ8L3NlY29uZGFyeS10aXRsZT48L3RpdGxlcz48cGFnZXM+MTUy

LTE4MjwvcGFnZXM+PGVkaXRpb24+Mm5kPC9lZGl0aW9uPjxzZWN0aW9uPjEwPC9zZWN0aW9uPjxk

YXRlcz48eWVhcj4yMDEyPC95ZWFyPjwvZGF0ZXM+PHB1Yi1sb2NhdGlvbj5QaGlsYWRlbHBoaWE8

L3B1Yi1sb2NhdGlvbj48cHVibGlzaGVyPkxpcHBpbmNvdHQgV2lsbGlhbXMgYW5kIFdpbGtpbnM8

L3B1Ymxpc2hlcj48dXJscz48L3VybHM+PC9yZWNvcmQ+PC9DaXRlPjxDaXRlPjxBdXRob3I+dmFu

IEhlZXJkZW48L0F1dGhvcj48WWVhcj4xOTkyPC9ZZWFyPjxSZWNOdW0+MTc8L1JlY051bT48cmVj

b3JkPjxyZWMtbnVtYmVyPjE3PC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVO

IiBkYi1pZD0icHMyd3dkc2ZyYTJyNWVlOXphc3hzNXQ4endkd3hyc3dlNXhhIiB0aW1lc3RhbXA9

IjE0NzMxMTcxMzciPjE3PC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJu

YWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj52

YW4gSGVlcmRlbiwgSi4gQS48L2F1dGhvcj48YXV0aG9yPkhheSwgSS4gRC48L2F1dGhvcj48YXV0

aG9yPkdvZWxsbmVyLCBKLiBSLjwvYXV0aG9yPjxhdXRob3I+U2Fsb21hbywgRC48L2F1dGhvcj48

YXV0aG9yPkViZXJzb2xkLCBKLiBSLjwvYXV0aG9yPjxhdXRob3I+QmVyZ3N0cmFsaCwgRS4gSi48

L2F1dGhvcj48YXV0aG9yPkdyYW50LCBDLiBTLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1

dG9ycz48YXV0aC1hZGRyZXNzPkRlcGFydG1lbnQgb2YgU3VyZ2VyeSwgTWF5byBDbGluaWMsIFJv

Y2hlc3RlciwgTU4gNTU5MDUuPC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48dGl0bGU+Rm9sbGljdWxh

ciB0aHlyb2lkIGNhcmNpbm9tYSB3aXRoIGNhcHN1bGFyIGludmFzaW9uIGFsb25lOiBhIG5vbnRo

cmVhdGVuaW5nIG1hbGlnbmFuY3k8L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+U3VyZ2VyeTwvc2Vj

b25kYXJ5LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPlN1cmdlcnk8L2Z1

bGwtdGl0bGU+PC9wZXJpb2RpY2FsPjxwYWdlcz4xMTMwLTY7IGRpc2N1c3Npb24gMTEzNi04PC9w

YWdlcz48dm9sdW1lPjExMjwvdm9sdW1lPjxudW1iZXI+NjwvbnVtYmVyPjxlZGl0aW9uPjE5OTIv

MTIvMDE8L2VkaXRpb24+PGtleXdvcmRzPjxrZXl3b3JkPkFkZW5vY2FyY2lub21hLypwYXRob2xv

Z3kvc3VyZ2VyeTwva2V5d29yZD48a2V5d29yZD5BZHVsdDwva2V5d29yZD48a2V5d29yZD5BZ2Vk

PC9rZXl3b3JkPjxrZXl3b3JkPkFnZWQsIDgwIGFuZCBvdmVyPC9rZXl3b3JkPjxrZXl3b3JkPkZl

bWFsZTwva2V5d29yZD48a2V5d29yZD5IdW1hbnM8L2tleXdvcmQ+PGtleXdvcmQ+TWFsZTwva2V5

d29yZD48a2V5d29yZD5NaWRkbGUgQWdlZDwva2V5d29yZD48a2V5d29yZD5NdWx0aXZhcmlhdGUg

QW5hbHlzaXM8L2tleXdvcmQ+PGtleXdvcmQ+TmVvcGxhc20gSW52YXNpdmVuZXNzPC9rZXl3b3Jk

PjxrZXl3b3JkPlBvc3RvcGVyYXRpdmUgUGVyaW9kPC9rZXl3b3JkPjxrZXl3b3JkPlRoeXJvaWQg

TmVvcGxhc21zLypwYXRob2xvZ3kvc3VyZ2VyeTwva2V5d29yZD48a2V5d29yZD5UcmVhdG1lbnQg

T3V0Y29tZTwva2V5d29yZD48L2tleXdvcmRzPjxkYXRlcz48eWVhcj4xOTkyPC95ZWFyPjxwdWIt

ZGF0ZXM+PGRhdGU+RGVjPC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+MDAzOS02MDYw

IChQcmludCkmI3hEOzAwMzktNjA2MCAoTGlua2luZyk8L2lzYm4+PGFjY2Vzc2lvbi1udW0+MTQ1

NTMxNTwvYWNjZXNzaW9uLW51bT48dXJscz48cmVsYXRlZC11cmxzPjx1cmw+aHR0cDovL3d3dy5u

Y2JpLm5sbS5uaWguZ292L3B1Ym1lZC8xNDU1MzE1PC91cmw+PC9yZWxhdGVkLXVybHM+PC91cmxz

PjxlbGVjdHJvbmljLXJlc291cmNlLW51bT4wMDM5LTYwNjAoOTIpOTAzMTgtVCBbcGlpXTwvZWxl

Y3Ryb25pYy1yZXNvdXJjZS1udW0+PGxhbmd1YWdlPmVuZzwvbGFuZ3VhZ2U+PC9yZWNvcmQ+PC9D

aXRlPjwvRW5kTm90ZT5=

ADDIN EN.CITE.DATA 17,18 Even 1 focus of angioinvasion places a tumor into this new category. Thus minimally invasive carcinomas are now restricted to tumoral capsular invasion only. Widely invasive follicular carcinomas have similarly nebulous definition and consist of those tumors with grossly apparent invasion of thyroid and/or soft tissue (ie, extrathyroidal invasion). ADDIN EN.CITE <EndNote><Cite><Author>DeLellis</Author><Year>2004</Year><RecNum>2</RecNum><DisplayText><style face="superscript">3</style></DisplayText><record><rec-number>2</rec-number><foreign-keys><key app="EN" db-id="ps2wwdsfra2r5ee9zasxs5t8zwdwxrswe5xa" timestamp="1473117135">2</key></foreign-keys><ref-type name="Edited Book">28</ref-type><contributors><authors><author>DeLellis, R.A.</author><author>Lloyd, R.V.</author><author>Heitz, P.U. </author><author>Eng,C</author></authors></contributors><titles><title>Pathology and Genetics of Tumours of the Endocrine Organs</title><secondary-title>World Health Organization Classification of Tumours</secondary-title></titles><dates><year>2004</year></dates><pub-location>Lyons</pub-location><publisher>IARC PRess</publisher><urls></urls></record></Cite></EndNote>3 The term is usually assigned to tumors with loss of encapsulation and multiple fronts of tumor invasion radiating from the epicenter of the tumor. These tumors are typically accompanied by other markers of aggressiveness such as extrathyroidal extension and extensive vascular invasion. H. Poorly Differentiated and Undifferentiated (Anaplastic) CarcinomaWhile the majority of thyroid cancers are well differentiated, a subset are poorly differentiated (historically known as insular, or trabecular, carcinoma) or undifferentiated (anaplastic). These tumor types represent progression to a more aggressive phenotype and are often seen with co-existent or antecedent well-differentiated carcinoma. While detailed histomorphologic review is beyond the scope of this protocol, salient features of both tumor types are listed below. Briefly, poorly differentiated carcinomas are tumors that display a solid, trabecular, and/or insular growth pattern, and show 1 or more of the following: greater than 3 mitoses per 10 HPF, necrosis, and nuclear convolution (without other features seen in papillary carcinoma).PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Wb2xhbnRlPC9BdXRob3I+PFllYXI+MjAwNzwvWWVhcj48

UmVjTnVtPjE4PC9SZWNOdW0+PERpc3BsYXlUZXh0PjxzdHlsZSBmYWNlPSJzdXBlcnNjcmlwdCI+

MTk8L3N0eWxlPjwvRGlzcGxheVRleHQ+PHJlY29yZD48cmVjLW51bWJlcj4xODwvcmVjLW51bWJl

cj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9InBzMnd3ZHNmcmEycjVlZTl6YXN4

czV0OHp3ZHd4cnN3ZTV4YSIgdGltZXN0YW1wPSIxNDczMTE3MTM3Ij4xODwva2V5PjwvZm9yZWln

bi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9yZWYtdHlwZT48Y29u

dHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+Vm9sYW50ZSwgTS48L2F1dGhvcj48YXV0aG9yPkNv

bGxpbmksIFAuPC9hdXRob3I+PGF1dGhvcj5OaWtpZm9yb3YsIFkuIEUuPC9hdXRob3I+PGF1dGhv

cj5TYWthbW90bywgQS48L2F1dGhvcj48YXV0aG9yPktha3VkbywgSy48L2F1dGhvcj48YXV0aG9y

PkthdG9oLCBSLjwvYXV0aG9yPjxhdXRob3I+TGxveWQsIFIuIFYuPC9hdXRob3I+PGF1dGhvcj5M

aVZvbHNpLCBWLiBBLjwvYXV0aG9yPjxhdXRob3I+UGFwb3R0aSwgTS48L2F1dGhvcj48YXV0aG9y

PlNvYnJpbmhvLVNpbW9lcywgTS48L2F1dGhvcj48YXV0aG9yPkJ1c3NvbGF0aSwgRy48L2F1dGhv

cj48YXV0aG9yPlJvc2FpLCBKLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48YXV0

aC1hZGRyZXNzPkRlcGFydG1lbnQgb2YgQ2xpbmljYWwgYW5kIEJpb2xvZ2ljYWwgU2NpZW5jZXMg

YXQgU2FuIEx1aWdpIEhvc3BpdGFsLCBVbml2ZXJzaXR5IG9mIFR1cmluLCBUdXJpbiwgSXRhbHku

IG1hcmNvLnZvbGFudGVAdW5pdG8uaXQ8L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5Qb29y

bHkgZGlmZmVyZW50aWF0ZWQgdGh5cm9pZCBjYXJjaW5vbWE6IHRoZSBUdXJpbiBwcm9wb3NhbCBm

b3IgdGhlIHVzZSBvZiB1bmlmb3JtIGRpYWdub3N0aWMgY3JpdGVyaWEgYW5kIGFuIGFsZ29yaXRo

bWljIGRpYWdub3N0aWMgYXBwcm9hY2g8L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+QW0gSiBTdXJn

IFBhdGhvbDwvc2Vjb25kYXJ5LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxl

PkFtIEogU3VyZyBQYXRob2w8L2Z1bGwtdGl0bGU+PC9wZXJpb2RpY2FsPjxwYWdlcz4xMjU2LTY0

PC9wYWdlcz48dm9sdW1lPjMxPC92b2x1bWU+PG51bWJlcj44PC9udW1iZXI+PGVkaXRpb24+MjAw

Ny8wOC8wMjwvZWRpdGlvbj48a2V5d29yZHM+PGtleXdvcmQ+QWRlbm9jYXJjaW5vbWEvY2hlbWlz

dHJ5L2NsYXNzaWZpY2F0aW9uLypkaWFnbm9zaXMvbW9ydGFsaXR5PC9rZXl3b3JkPjxrZXl3b3Jk

PkFkb2xlc2NlbnQ8L2tleXdvcmQ+PGtleXdvcmQ+QWR1bHQ8L2tleXdvcmQ+PGtleXdvcmQ+QWdl

ZDwva2V5d29yZD48a2V5d29yZD5BZ2VkLCA4MCBhbmQgb3Zlcjwva2V5d29yZD48a2V5d29yZD4q

QWxnb3JpdGhtczwva2V5d29yZD48a2V5d29yZD5DZWxsIE51Y2xldXMvcGF0aG9sb2d5PC9rZXl3

b3JkPjxrZXl3b3JkPkNoaWxkPC9rZXl3b3JkPjxrZXl3b3JkPkNoaWxkLCBQcmVzY2hvb2w8L2tl

eXdvcmQ+PGtleXdvcmQ+RmVtYWxlPC9rZXl3b3JkPjxrZXl3b3JkPkh1bWFuczwva2V5d29yZD48

a2V5d29yZD5JbW11bm9oaXN0b2NoZW1pc3RyeTwva2V5d29yZD48a2V5d29yZD5NYWxlPC9rZXl3

b3JkPjxrZXl3b3JkPk1pZGRsZSBBZ2VkPC9rZXl3b3JkPjxrZXl3b3JkPk1pdG9zaXM8L2tleXdv

cmQ+PGtleXdvcmQ+TmVjcm9zaXM8L2tleXdvcmQ+PGtleXdvcmQ+U3Vydml2YWwgUmF0ZTwva2V5

d29yZD48a2V5d29yZD5UaHlyb2lkIE5lb3BsYXNtcy9jaGVtaXN0cnkvY2xhc3NpZmljYXRpb24v

KmRpYWdub3Npcy9tb3J0YWxpdHk8L2tleXdvcmQ+PGtleXdvcmQ+VHVtb3IgTWFya2VycywgQmlv

bG9naWNhbC9hbmFseXNpczwva2V5d29yZD48L2tleXdvcmRzPjxkYXRlcz48eWVhcj4yMDA3PC95

ZWFyPjxwdWItZGF0ZXM+PGRhdGU+QXVnPC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+

MDE0Ny01MTg1IChQcmludCkmI3hEOzAxNDctNTE4NSAoTGlua2luZyk8L2lzYm4+PGFjY2Vzc2lv

bi1udW0+MTc2Njc1NTE8L2FjY2Vzc2lvbi1udW0+PHVybHM+PHJlbGF0ZWQtdXJscz48dXJsPmh0

dHA6Ly93d3cubmNiaS5ubG0ubmloLmdvdi9wdWJtZWQvMTc2Njc1NTE8L3VybD48L3JlbGF0ZWQt

dXJscz48L3VybHM+PGVsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjEwLjEwOTcvUEFTLjBiMDEzZTMx

ODAzMDllNmEmI3hEOzAwMDAwNDc4LTIwMDcwODAwMC0wMDAxNyBbcGlpXTwvZWxlY3Ryb25pYy1y

ZXNvdXJjZS1udW0+PGxhbmd1YWdlPmVuZzwvbGFuZ3VhZ2U+PC9yZWNvcmQ+PC9DaXRlPjwvRW5k

Tm90ZT4A

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Wb2xhbnRlPC9BdXRob3I+PFllYXI+MjAwNzwvWWVhcj48

UmVjTnVtPjE4PC9SZWNOdW0+PERpc3BsYXlUZXh0PjxzdHlsZSBmYWNlPSJzdXBlcnNjcmlwdCI+

MTk8L3N0eWxlPjwvRGlzcGxheVRleHQ+PHJlY29yZD48cmVjLW51bWJlcj4xODwvcmVjLW51bWJl

cj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9InBzMnd3ZHNmcmEycjVlZTl6YXN4

czV0OHp3ZHd4cnN3ZTV4YSIgdGltZXN0YW1wPSIxNDczMTE3MTM3Ij4xODwva2V5PjwvZm9yZWln

bi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9yZWYtdHlwZT48Y29u

dHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+Vm9sYW50ZSwgTS48L2F1dGhvcj48YXV0aG9yPkNv

bGxpbmksIFAuPC9hdXRob3I+PGF1dGhvcj5OaWtpZm9yb3YsIFkuIEUuPC9hdXRob3I+PGF1dGhv

cj5TYWthbW90bywgQS48L2F1dGhvcj48YXV0aG9yPktha3VkbywgSy48L2F1dGhvcj48YXV0aG9y

PkthdG9oLCBSLjwvYXV0aG9yPjxhdXRob3I+TGxveWQsIFIuIFYuPC9hdXRob3I+PGF1dGhvcj5M

aVZvbHNpLCBWLiBBLjwvYXV0aG9yPjxhdXRob3I+UGFwb3R0aSwgTS48L2F1dGhvcj48YXV0aG9y

PlNvYnJpbmhvLVNpbW9lcywgTS48L2F1dGhvcj48YXV0aG9yPkJ1c3NvbGF0aSwgRy48L2F1dGhv

cj48YXV0aG9yPlJvc2FpLCBKLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48YXV0

aC1hZGRyZXNzPkRlcGFydG1lbnQgb2YgQ2xpbmljYWwgYW5kIEJpb2xvZ2ljYWwgU2NpZW5jZXMg

YXQgU2FuIEx1aWdpIEhvc3BpdGFsLCBVbml2ZXJzaXR5IG9mIFR1cmluLCBUdXJpbiwgSXRhbHku

IG1hcmNvLnZvbGFudGVAdW5pdG8uaXQ8L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5Qb29y

bHkgZGlmZmVyZW50aWF0ZWQgdGh5cm9pZCBjYXJjaW5vbWE6IHRoZSBUdXJpbiBwcm9wb3NhbCBm

b3IgdGhlIHVzZSBvZiB1bmlmb3JtIGRpYWdub3N0aWMgY3JpdGVyaWEgYW5kIGFuIGFsZ29yaXRo

bWljIGRpYWdub3N0aWMgYXBwcm9hY2g8L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+QW0gSiBTdXJn

IFBhdGhvbDwvc2Vjb25kYXJ5LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxl

PkFtIEogU3VyZyBQYXRob2w8L2Z1bGwtdGl0bGU+PC9wZXJpb2RpY2FsPjxwYWdlcz4xMjU2LTY0

PC9wYWdlcz48dm9sdW1lPjMxPC92b2x1bWU+PG51bWJlcj44PC9udW1iZXI+PGVkaXRpb24+MjAw

Ny8wOC8wMjwvZWRpdGlvbj48a2V5d29yZHM+PGtleXdvcmQ+QWRlbm9jYXJjaW5vbWEvY2hlbWlz

dHJ5L2NsYXNzaWZpY2F0aW9uLypkaWFnbm9zaXMvbW9ydGFsaXR5PC9rZXl3b3JkPjxrZXl3b3Jk

PkFkb2xlc2NlbnQ8L2tleXdvcmQ+PGtleXdvcmQ+QWR1bHQ8L2tleXdvcmQ+PGtleXdvcmQ+QWdl

ZDwva2V5d29yZD48a2V5d29yZD5BZ2VkLCA4MCBhbmQgb3Zlcjwva2V5d29yZD48a2V5d29yZD4q

QWxnb3JpdGhtczwva2V5d29yZD48a2V5d29yZD5DZWxsIE51Y2xldXMvcGF0aG9sb2d5PC9rZXl3

b3JkPjxrZXl3b3JkPkNoaWxkPC9rZXl3b3JkPjxrZXl3b3JkPkNoaWxkLCBQcmVzY2hvb2w8L2tl

eXdvcmQ+PGtleXdvcmQ+RmVtYWxlPC9rZXl3b3JkPjxrZXl3b3JkPkh1bWFuczwva2V5d29yZD48

a2V5d29yZD5JbW11bm9oaXN0b2NoZW1pc3RyeTwva2V5d29yZD48a2V5d29yZD5NYWxlPC9rZXl3

b3JkPjxrZXl3b3JkPk1pZGRsZSBBZ2VkPC9rZXl3b3JkPjxrZXl3b3JkPk1pdG9zaXM8L2tleXdv

cmQ+PGtleXdvcmQ+TmVjcm9zaXM8L2tleXdvcmQ+PGtleXdvcmQ+U3Vydml2YWwgUmF0ZTwva2V5

d29yZD48a2V5d29yZD5UaHlyb2lkIE5lb3BsYXNtcy9jaGVtaXN0cnkvY2xhc3NpZmljYXRpb24v

KmRpYWdub3Npcy9tb3J0YWxpdHk8L2tleXdvcmQ+PGtleXdvcmQ+VHVtb3IgTWFya2VycywgQmlv

bG9naWNhbC9hbmFseXNpczwva2V5d29yZD48L2tleXdvcmRzPjxkYXRlcz48eWVhcj4yMDA3PC95

ZWFyPjxwdWItZGF0ZXM+PGRhdGU+QXVnPC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+

MDE0Ny01MTg1IChQcmludCkmI3hEOzAxNDctNTE4NSAoTGlua2luZyk8L2lzYm4+PGFjY2Vzc2lv

bi1udW0+MTc2Njc1NTE8L2FjY2Vzc2lvbi1udW0+PHVybHM+PHJlbGF0ZWQtdXJscz48dXJsPmh0

dHA6Ly93d3cubmNiaS5ubG0ubmloLmdvdi9wdWJtZWQvMTc2Njc1NTE8L3VybD48L3JlbGF0ZWQt

dXJscz48L3VybHM+PGVsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjEwLjEwOTcvUEFTLjBiMDEzZTMx

ODAzMDllNmEmI3hEOzAwMDAwNDc4LTIwMDcwODAwMC0wMDAxNyBbcGlpXTwvZWxlY3Ryb25pYy1y

ZXNvdXJjZS1udW0+PGxhbmd1YWdlPmVuZzwvbGFuZ3VhZ2U+PC9yZWNvcmQ+PC9DaXRlPjwvRW5k

Tm90ZT4A

ADDIN EN.CITE.DATA 19 As noted above, poorly differentiated thyroid carcinoma may be seen as a component of well-differentiated carcinoma, and as little as 10% of a poorly differentiated component is sufficient to confer an aggressive biologic behavior. ADDIN EN.CITE <EndNote><Cite><Author>Dettmer</Author><Year>2011</Year><RecNum>19</RecNum><DisplayText><style face="superscript">20</style></DisplayText><record><rec-number>19</rec-number><foreign-keys><key app="EN" db-id="ps2wwdsfra2r5ee9zasxs5t8zwdwxrswe5xa" timestamp="1473117137">19</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Dettmer, M.</author><author>Schmitt, A.</author><author>Steinert, H.</author><author>Haldemann, A.</author><author>Meili, A.</author><author>Moch, H.</author><author>Komminoth, P.</author><author>Perren, A.</author></authors></contributors><auth-address>Institute of Pathology, University of Bern, Triemlispital, Zurich. dettmerms@upmc.edu</auth-address><titles><title>Poorly differentiated thyroid carcinomas: how much poorly differentiated is needed?</title><secondary-title>Am J Surg Pathol</secondary-title></titles><periodical><full-title>Am J Surg Pathol</full-title></periodical><pages>1866-72</pages><volume>35</volume><number>12</number><edition>2011/10/13</edition><keywords><keyword>Adenocarcinoma, Follicular/pathology</keyword><keyword>Carcinoma, Papillary/pathology</keyword><keyword>*Cell Differentiation</keyword><keyword>Female</keyword><keyword>Humans</keyword><keyword>Kaplan-Meier Estimate</keyword><keyword>Male</keyword><keyword>Middle Aged</keyword><keyword>Neoplasm Staging</keyword><keyword>Prognosis</keyword><keyword>Proportional Hazards Models</keyword><keyword>Thyroid Neoplasms/mortality/*pathology</keyword></keywords><dates><year>2011</year><pub-dates><date>Dec</date></pub-dates></dates><isbn>1532-0979 (Electronic)&#xD;0147-5185 (Linking)</isbn><accession-num>21989341</accession-num><urls><related-urls><url> On the other hand, encapsulated tumors appear to have a more favorable prognosis than unencapsulated tumors, particularly if they show no capsular or vascular invasion with adequate sampling.PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5IaWx0emlrPC9BdXRob3I+PFllYXI+MjAwNjwvWWVhcj48

UmVjTnVtPjIzPC9SZWNOdW0+PERpc3BsYXlUZXh0PjxzdHlsZSBmYWNlPSJzdXBlcnNjcmlwdCI+

MjEsMjI8L3N0eWxlPjwvRGlzcGxheVRleHQ+PHJlY29yZD48cmVjLW51bWJlcj4yMDwvcmVjLW51

bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9InBzMnd3ZHNmcmEycjVlZTl6

YXN4czV0OHp3ZHd4cnN3ZTV4YSIgdGltZXN0YW1wPSIxNDczMTE3MTM3Ij4yMDwva2V5PjwvZm9y

ZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9yZWYtdHlwZT48

Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+SGlsdHppaywgRC48L2F1dGhvcj48YXV0aG9y

PkNhcmxzb24sIEQuIEwuPC9hdXRob3I+PGF1dGhvcj5UdXR0bGUsIFIuIE0uPC9hdXRob3I+PGF1

dGhvcj5DaHVhaSwgUy48L2F1dGhvcj48YXV0aG9yPklzaGlsbCwgTi48L2F1dGhvcj48YXV0aG9y

PlNoYWhhLCBBLjwvYXV0aG9yPjxhdXRob3I+U2hhaCwgSi4gUC48L2F1dGhvcj48YXV0aG9yPlNp

bmdoLCBCLjwvYXV0aG9yPjxhdXRob3I+R2hvc3NlaW4sIFIuIEEuPC9hdXRob3I+PC9hdXRob3Jz

PjwvY29udHJpYnV0b3JzPjxhdXRoLWFkZHJlc3M+RGVwYXJ0bWVudCBvZiBPdG9sYXJ5bmdvbG9n

eS1IZWFkIGFuZCBOZWNrIFN1cmdlcnksIENvbHVtYmlhIFVuaXZlcnNpdHksIE5ldyBZb3JrLCBO

WSwgVVNBLjwvYXV0aC1hZGRyZXNzPjx0aXRsZXM+PHRpdGxlPlBvb3JseSBkaWZmZXJlbnRpYXRl

ZCB0aHlyb2lkIGNhcmNpbm9tYXMgZGVmaW5lZCBvbiB0aGUgYmFzaXMgb2YgbWl0b3NpcyBhbmQg

bmVjcm9zaXM6IGEgY2xpbmljb3BhdGhvbG9naWMgc3R1ZHkgb2YgNTggcGF0aWVudHM8L3RpdGxl

PjxzZWNvbmRhcnktdGl0bGU+Q2FuY2VyPC9zZWNvbmRhcnktdGl0bGU+PC90aXRsZXM+PHBlcmlv

ZGljYWw+PGZ1bGwtdGl0bGU+Q2FuY2VyPC9mdWxsLXRpdGxlPjwvcGVyaW9kaWNhbD48cGFnZXM+

MTI4Ni05NTwvcGFnZXM+PHZvbHVtZT4xMDY8L3ZvbHVtZT48bnVtYmVyPjY8L251bWJlcj48ZWRp

dGlvbj4yMDA2LzAyLzE0PC9lZGl0aW9uPjxrZXl3b3Jkcz48a2V5d29yZD5BZGVub2NhcmNpbm9t

YSwgRm9sbGljdWxhci9wYXRob2xvZ3kvc3VyZ2VyeTwva2V5d29yZD48a2V5d29yZD5BZG9sZXNj

ZW50PC9rZXl3b3JkPjxrZXl3b3JkPkFkdWx0PC9rZXl3b3JkPjxrZXl3b3JkPkFnZWQ8L2tleXdv

cmQ+PGtleXdvcmQ+QWdlZCwgODAgYW5kIG92ZXI8L2tleXdvcmQ+PGtleXdvcmQ+Q2FyY2lub21h

LCBQYXBpbGxhcnkvcGF0aG9sb2d5L3N1cmdlcnk8L2tleXdvcmQ+PGtleXdvcmQ+KkNlbGwgRGlm

ZmVyZW50aWF0aW9uPC9rZXl3b3JkPjxrZXl3b3JkPkNoaWxkPC9rZXl3b3JkPjxrZXl3b3JkPkRp

c2Vhc2UtRnJlZSBTdXJ2aXZhbDwva2V5d29yZD48a2V5d29yZD5GZW1hbGU8L2tleXdvcmQ+PGtl

eXdvcmQ+SHVtYW5zPC9rZXl3b3JkPjxrZXl3b3JkPk1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+TWlk

ZGxlIEFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+Kk1pdG9zaXM8L2tleXdvcmQ+PGtleXdvcmQ+TmVj

cm9zaXM8L2tleXdvcmQ+PGtleXdvcmQ+TmVvcGxhc20gSW52YXNpdmVuZXNzL3BhdGhvbG9neTwv

a2V5d29yZD48a2V5d29yZD5OZW9wbGFzbSBNZXRhc3Rhc2lzPC9rZXl3b3JkPjxrZXl3b3JkPk5l

b3BsYXNtIFJlY3VycmVuY2UsIExvY2FsL3BhdGhvbG9neS9zdXJnZXJ5PC9rZXl3b3JkPjxrZXl3

b3JkPk5lb3BsYXNtIFN0YWdpbmc8L2tleXdvcmQ+PGtleXdvcmQ+UHJvZ25vc2lzPC9rZXl3b3Jk

PjxrZXl3b3JkPlJldHJvc3BlY3RpdmUgU3R1ZGllczwva2V5d29yZD48a2V5d29yZD5SaXNrIEZh

Y3RvcnM8L2tleXdvcmQ+PGtleXdvcmQ+U3Vydml2YWwgUmF0ZTwva2V5d29yZD48a2V5d29yZD5U

aHlyb2lkIE5lb3BsYXNtcy8qcGF0aG9sb2d5L3N1cmdlcnk8L2tleXdvcmQ+PGtleXdvcmQ+VHJl

YXRtZW50IE91dGNvbWU8L2tleXdvcmQ+PC9rZXl3b3Jkcz48ZGF0ZXM+PHllYXI+MjAwNjwveWVh

cj48cHViLWRhdGVzPjxkYXRlPk1hciAxNTwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxpc2Ju

PjAwMDgtNTQzWCAoUHJpbnQpJiN4RDswMDA4LTU0M1ggKExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Np

b24tbnVtPjE2NDcwNjA1PC9hY2Nlc3Npb24tbnVtPjx1cmxzPjxyZWxhdGVkLXVybHM+PHVybD5o

dHRwOi8vd3d3Lm5jYmkubmxtLm5paC5nb3YvcHVibWVkLzE2NDcwNjA1PC91cmw+PC9yZWxhdGVk

LXVybHM+PC91cmxzPjxlbGVjdHJvbmljLXJlc291cmNlLW51bT4xMC4xMDAyL2NuY3IuMjE3Mzk8

L2VsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjxsYW5ndWFnZT5lbmc8L2xhbmd1YWdlPjwvcmVjb3Jk

PjwvQ2l0ZT48Q2l0ZT48QXV0aG9yPlJpdmVyYTwvQXV0aG9yPjxZZWFyPjIwMTA8L1llYXI+PFJl

Y051bT4yMTwvUmVjTnVtPjxyZWNvcmQ+PHJlYy1udW1iZXI+MjE8L3JlYy1udW1iZXI+PGZvcmVp

Z24ta2V5cz48a2V5IGFwcD0iRU4iIGRiLWlkPSJwczJ3d2RzZnJhMnI1ZWU5emFzeHM1dDh6d2R3

eHJzd2U1eGEiIHRpbWVzdGFtcD0iMTQ3MzExNzEzNyI+MjE8L2tleT48L2ZvcmVpZ24ta2V5cz48

cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5cGU+PGNvbnRyaWJ1dG9y

cz48YXV0aG9ycz48YXV0aG9yPlJpdmVyYSwgTS48L2F1dGhvcj48YXV0aG9yPlJpY2FydGUtRmls

aG8sIEouPC9hdXRob3I+PGF1dGhvcj5QYXRlbCwgUy48L2F1dGhvcj48YXV0aG9yPlR1dHRsZSwg

TS48L2F1dGhvcj48YXV0aG9yPlNoYWhhLCBBLjwvYXV0aG9yPjxhdXRob3I+U2hhaCwgSi4gUC48

L2F1dGhvcj48YXV0aG9yPkZhZ2luLCBKLiBBLjwvYXV0aG9yPjxhdXRob3I+R2hvc3NlaW4sIFIu

IEEuPC9hdXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjxhdXRoLWFkZHJlc3M+RGVwYXJ0

bWVudCBvZiBQYXRob2xvZ3ksIE1lbW9yaWFsIFNsb2FuLUtldHRlcmluZyBDYW5jZXIgQ2VudGVy

LCBOZXcgWW9yaywgTlkgMTAwNjUsIFVTQS48L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5F

bmNhcHN1bGF0ZWQgdGh5cm9pZCB0dW1vcnMgb2YgZm9sbGljdWxhciBjZWxsIG9yaWdpbiB3aXRo

IGhpZ2ggZ3JhZGUgZmVhdHVyZXMgKGhpZ2ggbWl0b3RpYyByYXRlL3R1bW9yIG5lY3Jvc2lzKTog

YSBjbGluaWNvcGF0aG9sb2dpYyBhbmQgbW9sZWN1bGFyIHN0dWR5PC90aXRsZT48c2Vjb25kYXJ5

LXRpdGxlPkh1bSBQYXRob2w8L3NlY29uZGFyeS10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48

ZnVsbC10aXRsZT5IdW0gUGF0aG9sPC9mdWxsLXRpdGxlPjwvcGVyaW9kaWNhbD48cGFnZXM+MTcy

LTgwPC9wYWdlcz48dm9sdW1lPjQxPC92b2x1bWU+PG51bWJlcj4yPC9udW1iZXI+PGVkaXRpb24+

MjAwOS8xMS8xNzwvZWRpdGlvbj48a2V5d29yZHM+PGtleXdvcmQ+QWRlbm9jYXJjaW5vbWEsIEZv

bGxpY3VsYXIvKmdlbmV0aWNzLypwYXRob2xvZ3k8L2tleXdvcmQ+PGtleXdvcmQ+QWRvbGVzY2Vu

dDwva2V5d29yZD48a2V5d29yZD5BZHVsdDwva2V5d29yZD48a2V5d29yZD5BZ2VkPC9rZXl3b3Jk

PjxrZXl3b3JkPkFnZWQsIDgwIGFuZCBvdmVyPC9rZXl3b3JkPjxrZXl3b3JkPkZlbWFsZTwva2V5

d29yZD48a2V5d29yZD5HZW5vdHlwZTwva2V5d29yZD48a2V5d29yZD5IdW1hbnM8L2tleXdvcmQ+

PGtleXdvcmQ+TWFsZTwva2V5d29yZD48a2V5d29yZD5NYXNzIFNwZWN0cm9tZXRyeTwva2V5d29y

ZD48a2V5d29yZD5NaWRkbGUgQWdlZDwva2V5d29yZD48a2V5d29yZD5NaXRvc2lzPC9rZXl3b3Jk

PjxrZXl3b3JkPk1pdG90aWMgSW5kZXg8L2tleXdvcmQ+PGtleXdvcmQ+TXV0YXRpb248L2tleXdv

cmQ+PGtleXdvcmQ+TmVjcm9zaXMvZ2VuZXRpY3MvcGF0aG9sb2d5PC9rZXl3b3JkPjxrZXl3b3Jk

Pk5lb3BsYXNtIFJlY3VycmVuY2UsIExvY2FsL2dlbmV0aWNzL3BhdGhvbG9neTwva2V5d29yZD48

a2V5d29yZD5QYXRpZW50IFNlbGVjdGlvbjwva2V5d29yZD48a2V5d29yZD5UaHlyb2lkIE5lb3Bs

YXNtcy8qZ2VuZXRpY3MvKnBhdGhvbG9neTwva2V5d29yZD48a2V5d29yZD5UdW1vciBNYXJrZXJz

LCBCaW9sb2dpY2FsL2dlbmV0aWNzPC9rZXl3b3JkPjwva2V5d29yZHM+PGRhdGVzPjx5ZWFyPjIw

MTA8L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5GZWI8L2RhdGU+PC9wdWItZGF0ZXM+PC9kYXRlcz48

aXNibj4xNTMyLTgzOTIgKEVsZWN0cm9uaWMpJiN4RDswMDQ2LTgxNzcgKExpbmtpbmcpPC9pc2Ju

PjxhY2Nlc3Npb24tbnVtPjE5OTEzMjgwPC9hY2Nlc3Npb24tbnVtPjx1cmxzPjxyZWxhdGVkLXVy

bHM+PHVybD5odHRwOi8vd3d3Lm5jYmkubmxtLm5paC5nb3YvcHVibWVkLzE5OTEzMjgwPC91cmw+

PC9yZWxhdGVkLXVybHM+PC91cmxzPjxlbGVjdHJvbmljLXJlc291cmNlLW51bT4xMC4xMDE2L2ou

aHVtcGF0aC4yMDA5LjA4LjAxMSYjeEQ7UzAwNDYtODE3NygwOSkwMDI5OC02IFtwaWldPC9lbGVj

dHJvbmljLXJlc291cmNlLW51bT48bGFuZ3VhZ2U+ZW5nPC9sYW5ndWFnZT48L3JlY29yZD48L0Np

dGU+PC9FbmROb3RlPgB=

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5IaWx0emlrPC9BdXRob3I+PFllYXI+MjAwNjwvWWVhcj48

UmVjTnVtPjIzPC9SZWNOdW0+PERpc3BsYXlUZXh0PjxzdHlsZSBmYWNlPSJzdXBlcnNjcmlwdCI+

MjEsMjI8L3N0eWxlPjwvRGlzcGxheVRleHQ+PHJlY29yZD48cmVjLW51bWJlcj4yMDwvcmVjLW51

bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9InBzMnd3ZHNmcmEycjVlZTl6

YXN4czV0OHp3ZHd4cnN3ZTV4YSIgdGltZXN0YW1wPSIxNDczMTE3MTM3Ij4yMDwva2V5PjwvZm9y

ZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9yZWYtdHlwZT48

Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+SGlsdHppaywgRC48L2F1dGhvcj48YXV0aG9y

PkNhcmxzb24sIEQuIEwuPC9hdXRob3I+PGF1dGhvcj5UdXR0bGUsIFIuIE0uPC9hdXRob3I+PGF1

dGhvcj5DaHVhaSwgUy48L2F1dGhvcj48YXV0aG9yPklzaGlsbCwgTi48L2F1dGhvcj48YXV0aG9y

PlNoYWhhLCBBLjwvYXV0aG9yPjxhdXRob3I+U2hhaCwgSi4gUC48L2F1dGhvcj48YXV0aG9yPlNp

bmdoLCBCLjwvYXV0aG9yPjxhdXRob3I+R2hvc3NlaW4sIFIuIEEuPC9hdXRob3I+PC9hdXRob3Jz

PjwvY29udHJpYnV0b3JzPjxhdXRoLWFkZHJlc3M+RGVwYXJ0bWVudCBvZiBPdG9sYXJ5bmdvbG9n

eS1IZWFkIGFuZCBOZWNrIFN1cmdlcnksIENvbHVtYmlhIFVuaXZlcnNpdHksIE5ldyBZb3JrLCBO

WSwgVVNBLjwvYXV0aC1hZGRyZXNzPjx0aXRsZXM+PHRpdGxlPlBvb3JseSBkaWZmZXJlbnRpYXRl

ZCB0aHlyb2lkIGNhcmNpbm9tYXMgZGVmaW5lZCBvbiB0aGUgYmFzaXMgb2YgbWl0b3NpcyBhbmQg

bmVjcm9zaXM6IGEgY2xpbmljb3BhdGhvbG9naWMgc3R1ZHkgb2YgNTggcGF0aWVudHM8L3RpdGxl

PjxzZWNvbmRhcnktdGl0bGU+Q2FuY2VyPC9zZWNvbmRhcnktdGl0bGU+PC90aXRsZXM+PHBlcmlv

ZGljYWw+PGZ1bGwtdGl0bGU+Q2FuY2VyPC9mdWxsLXRpdGxlPjwvcGVyaW9kaWNhbD48cGFnZXM+

MTI4Ni05NTwvcGFnZXM+PHZvbHVtZT4xMDY8L3ZvbHVtZT48bnVtYmVyPjY8L251bWJlcj48ZWRp

dGlvbj4yMDA2LzAyLzE0PC9lZGl0aW9uPjxrZXl3b3Jkcz48a2V5d29yZD5BZGVub2NhcmNpbm9t

YSwgRm9sbGljdWxhci9wYXRob2xvZ3kvc3VyZ2VyeTwva2V5d29yZD48a2V5d29yZD5BZG9sZXNj

ZW50PC9rZXl3b3JkPjxrZXl3b3JkPkFkdWx0PC9rZXl3b3JkPjxrZXl3b3JkPkFnZWQ8L2tleXdv

cmQ+PGtleXdvcmQ+QWdlZCwgODAgYW5kIG92ZXI8L2tleXdvcmQ+PGtleXdvcmQ+Q2FyY2lub21h

LCBQYXBpbGxhcnkvcGF0aG9sb2d5L3N1cmdlcnk8L2tleXdvcmQ+PGtleXdvcmQ+KkNlbGwgRGlm

ZmVyZW50aWF0aW9uPC9rZXl3b3JkPjxrZXl3b3JkPkNoaWxkPC9rZXl3b3JkPjxrZXl3b3JkPkRp

c2Vhc2UtRnJlZSBTdXJ2aXZhbDwva2V5d29yZD48a2V5d29yZD5GZW1hbGU8L2tleXdvcmQ+PGtl

eXdvcmQ+SHVtYW5zPC9rZXl3b3JkPjxrZXl3b3JkPk1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+TWlk

ZGxlIEFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+Kk1pdG9zaXM8L2tleXdvcmQ+PGtleXdvcmQ+TmVj

cm9zaXM8L2tleXdvcmQ+PGtleXdvcmQ+TmVvcGxhc20gSW52YXNpdmVuZXNzL3BhdGhvbG9neTwv

a2V5d29yZD48a2V5d29yZD5OZW9wbGFzbSBNZXRhc3Rhc2lzPC9rZXl3b3JkPjxrZXl3b3JkPk5l

b3BsYXNtIFJlY3VycmVuY2UsIExvY2FsL3BhdGhvbG9neS9zdXJnZXJ5PC9rZXl3b3JkPjxrZXl3

b3JkPk5lb3BsYXNtIFN0YWdpbmc8L2tleXdvcmQ+PGtleXdvcmQ+UHJvZ25vc2lzPC9rZXl3b3Jk

PjxrZXl3b3JkPlJldHJvc3BlY3RpdmUgU3R1ZGllczwva2V5d29yZD48a2V5d29yZD5SaXNrIEZh

Y3RvcnM8L2tleXdvcmQ+PGtleXdvcmQ+U3Vydml2YWwgUmF0ZTwva2V5d29yZD48a2V5d29yZD5U

aHlyb2lkIE5lb3BsYXNtcy8qcGF0aG9sb2d5L3N1cmdlcnk8L2tleXdvcmQ+PGtleXdvcmQ+VHJl

YXRtZW50IE91dGNvbWU8L2tleXdvcmQ+PC9rZXl3b3Jkcz48ZGF0ZXM+PHllYXI+MjAwNjwveWVh

cj48cHViLWRhdGVzPjxkYXRlPk1hciAxNTwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxpc2Ju

PjAwMDgtNTQzWCAoUHJpbnQpJiN4RDswMDA4LTU0M1ggKExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Np

b24tbnVtPjE2NDcwNjA1PC9hY2Nlc3Npb24tbnVtPjx1cmxzPjxyZWxhdGVkLXVybHM+PHVybD5o

dHRwOi8vd3d3Lm5jYmkubmxtLm5paC5nb3YvcHVibWVkLzE2NDcwNjA1PC91cmw+PC9yZWxhdGVk

LXVybHM+PC91cmxzPjxlbGVjdHJvbmljLXJlc291cmNlLW51bT4xMC4xMDAyL2NuY3IuMjE3Mzk8

L2VsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjxsYW5ndWFnZT5lbmc8L2xhbmd1YWdlPjwvcmVjb3Jk

PjwvQ2l0ZT48Q2l0ZT48QXV0aG9yPlJpdmVyYTwvQXV0aG9yPjxZZWFyPjIwMTA8L1llYXI+PFJl

Y051bT4yMTwvUmVjTnVtPjxyZWNvcmQ+PHJlYy1udW1iZXI+MjE8L3JlYy1udW1iZXI+PGZvcmVp

Z24ta2V5cz48a2V5IGFwcD0iRU4iIGRiLWlkPSJwczJ3d2RzZnJhMnI1ZWU5emFzeHM1dDh6d2R3

eHJzd2U1eGEiIHRpbWVzdGFtcD0iMTQ3MzExNzEzNyI+MjE8L2tleT48L2ZvcmVpZ24ta2V5cz48

cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5cGU+PGNvbnRyaWJ1dG9y

cz48YXV0aG9ycz48YXV0aG9yPlJpdmVyYSwgTS48L2F1dGhvcj48YXV0aG9yPlJpY2FydGUtRmls

aG8sIEouPC9hdXRob3I+PGF1dGhvcj5QYXRlbCwgUy48L2F1dGhvcj48YXV0aG9yPlR1dHRsZSwg

TS48L2F1dGhvcj48YXV0aG9yPlNoYWhhLCBBLjwvYXV0aG9yPjxhdXRob3I+U2hhaCwgSi4gUC48

L2F1dGhvcj48YXV0aG9yPkZhZ2luLCBKLiBBLjwvYXV0aG9yPjxhdXRob3I+R2hvc3NlaW4sIFIu

IEEuPC9hdXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjxhdXRoLWFkZHJlc3M+RGVwYXJ0

bWVudCBvZiBQYXRob2xvZ3ksIE1lbW9yaWFsIFNsb2FuLUtldHRlcmluZyBDYW5jZXIgQ2VudGVy

LCBOZXcgWW9yaywgTlkgMTAwNjUsIFVTQS48L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5F

bmNhcHN1bGF0ZWQgdGh5cm9pZCB0dW1vcnMgb2YgZm9sbGljdWxhciBjZWxsIG9yaWdpbiB3aXRo

IGhpZ2ggZ3JhZGUgZmVhdHVyZXMgKGhpZ2ggbWl0b3RpYyByYXRlL3R1bW9yIG5lY3Jvc2lzKTog

YSBjbGluaWNvcGF0aG9sb2dpYyBhbmQgbW9sZWN1bGFyIHN0dWR5PC90aXRsZT48c2Vjb25kYXJ5

LXRpdGxlPkh1bSBQYXRob2w8L3NlY29uZGFyeS10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48

ZnVsbC10aXRsZT5IdW0gUGF0aG9sPC9mdWxsLXRpdGxlPjwvcGVyaW9kaWNhbD48cGFnZXM+MTcy

LTgwPC9wYWdlcz48dm9sdW1lPjQxPC92b2x1bWU+PG51bWJlcj4yPC9udW1iZXI+PGVkaXRpb24+

MjAwOS8xMS8xNzwvZWRpdGlvbj48a2V5d29yZHM+PGtleXdvcmQ+QWRlbm9jYXJjaW5vbWEsIEZv

bGxpY3VsYXIvKmdlbmV0aWNzLypwYXRob2xvZ3k8L2tleXdvcmQ+PGtleXdvcmQ+QWRvbGVzY2Vu

dDwva2V5d29yZD48a2V5d29yZD5BZHVsdDwva2V5d29yZD48a2V5d29yZD5BZ2VkPC9rZXl3b3Jk

PjxrZXl3b3JkPkFnZWQsIDgwIGFuZCBvdmVyPC9rZXl3b3JkPjxrZXl3b3JkPkZlbWFsZTwva2V5

d29yZD48a2V5d29yZD5HZW5vdHlwZTwva2V5d29yZD48a2V5d29yZD5IdW1hbnM8L2tleXdvcmQ+

PGtleXdvcmQ+TWFsZTwva2V5d29yZD48a2V5d29yZD5NYXNzIFNwZWN0cm9tZXRyeTwva2V5d29y

ZD48a2V5d29yZD5NaWRkbGUgQWdlZDwva2V5d29yZD48a2V5d29yZD5NaXRvc2lzPC9rZXl3b3Jk

PjxrZXl3b3JkPk1pdG90aWMgSW5kZXg8L2tleXdvcmQ+PGtleXdvcmQ+TXV0YXRpb248L2tleXdv

cmQ+PGtleXdvcmQ+TmVjcm9zaXMvZ2VuZXRpY3MvcGF0aG9sb2d5PC9rZXl3b3JkPjxrZXl3b3Jk

Pk5lb3BsYXNtIFJlY3VycmVuY2UsIExvY2FsL2dlbmV0aWNzL3BhdGhvbG9neTwva2V5d29yZD48

a2V5d29yZD5QYXRpZW50IFNlbGVjdGlvbjwva2V5d29yZD48a2V5d29yZD5UaHlyb2lkIE5lb3Bs

YXNtcy8qZ2VuZXRpY3MvKnBhdGhvbG9neTwva2V5d29yZD48a2V5d29yZD5UdW1vciBNYXJrZXJz

LCBCaW9sb2dpY2FsL2dlbmV0aWNzPC9rZXl3b3JkPjwva2V5d29yZHM+PGRhdGVzPjx5ZWFyPjIw

MTA8L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5GZWI8L2RhdGU+PC9wdWItZGF0ZXM+PC9kYXRlcz48

aXNibj4xNTMyLTgzOTIgKEVsZWN0cm9uaWMpJiN4RDswMDQ2LTgxNzcgKExpbmtpbmcpPC9pc2Ju

PjxhY2Nlc3Npb24tbnVtPjE5OTEzMjgwPC9hY2Nlc3Npb24tbnVtPjx1cmxzPjxyZWxhdGVkLXVy

bHM+PHVybD5odHRwOi8vd3d3Lm5jYmkubmxtLm5paC5nb3YvcHVibWVkLzE5OTEzMjgwPC91cmw+

PC9yZWxhdGVkLXVybHM+PC91cmxzPjxlbGVjdHJvbmljLXJlc291cmNlLW51bT4xMC4xMDE2L2ou

aHVtcGF0aC4yMDA5LjA4LjAxMSYjeEQ7UzAwNDYtODE3NygwOSkwMDI5OC02IFtwaWldPC9lbGVj

dHJvbmljLXJlc291cmNlLW51bT48bGFuZ3VhZ2U+ZW5nPC9sYW5ndWFnZT48L3JlY29yZD48L0Np

dGU+PC9FbmROb3RlPgB=

ADDIN EN.CITE.DATA 21,22 Undifferentiated carcinoma represents the most extreme form of tumor progression and consists of a high-grade malignancy with spindled, pleomorphic, squamoid, or even rhabdoid morphology. ADDIN EN.CITE <EndNote><Cite><Author>Nikiforov</Author><Year>2012</Year><RecNum>22</RecNum><DisplayText><style face="superscript">23</style></DisplayText><record><rec-number>22</rec-number><foreign-keys><key app="EN" db-id="ps2wwdsfra2r5ee9zasxs5t8zwdwxrswe5xa" timestamp="1473117137">22</key></foreign-keys><ref-type name="Book Section">5</ref-type><contributors><authors><author>Nikiforov, Y. E.</author><author>Seethala, R. R.</author></authors><secondary-authors><author>Nikiforov, Y. E.</author><author>Biddinger, P.W.</author><author>Thompson, L.D.R.</author></secondary-authors></contributors><titles><title>Anaplastic (undifferentiated) carcinoma</title><secondary-title>Diagnostic pathology and molecular genetics of the thyroid</secondary-title></titles><pages>263-284</pages><edition>2nd</edition><section>10</section><dates><year>2012</year></dates><pub-location>Philadelphia</pub-location><publisher>Lippincott Williams and Wilkins</publisher><urls></urls></record></Cite></EndNote>23 Undifferentiated carcinoma is almost invariably rapidly lethal. The few exceptions are noteworthy as they mainly consist of well-differentiated tumor with only focal anaplastic transformation.PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5TdWdpdGFuaTwvQXV0aG9yPjxZZWFyPjIwMDE8L1llYXI+

PFJlY051bT4yMzwvUmVjTnVtPjxEaXNwbGF5VGV4dD48c3R5bGUgZmFjZT0ic3VwZXJzY3JpcHQi

PjIzLTI1PC9zdHlsZT48L0Rpc3BsYXlUZXh0PjxyZWNvcmQ+PHJlYy1udW1iZXI+MjM8L3JlYy1u

dW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRiLWlkPSJwczJ3d2RzZnJhMnI1ZWU5

emFzeHM1dDh6d2R3eHJzd2U1eGEiIHRpbWVzdGFtcD0iMTQ3MzExNzEzNyI+MjM8L2tleT48L2Zv

cmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5cGU+

PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPlN1Z2l0YW5pLCBJLjwvYXV0aG9yPjxhdXRo

b3I+S2FzYWksIE4uPC9hdXRob3I+PGF1dGhvcj5GdWppbW90bywgWS48L2F1dGhvcj48YXV0aG9y

PllhbmFnaXNhd2EsIEEuPC9hdXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjxhdXRoLWFk

ZHJlc3M+RGl2aXNpb24gb2YgSGVhZCBhbmQgTmVjaywgQ2FuY2VyIEluc3RpdHV0ZSBIb3NwaXRh

bCwgMS0zNy0xIEthbWktaWtlYnVrdXJvLCBUb3NoaW1hLWt1LCBUb2t5byAxNzAtODQ1NSwgSmFw

YW4uIGl3YW8tc3VnQHRjNC5zby1uZXQubmUuanA8L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRs

ZT5Qcm9nbm9zdGljIGZhY3RvcnMgYW5kIHRoZXJhcGV1dGljIHN0cmF0ZWd5IGZvciBhbmFwbGFz

dGljIGNhcmNpbm9tYSBvZiB0aGUgdGh5cm9pZDwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5Xb3Js

ZCBKIFN1cmc8L3NlY29uZGFyeS10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRs

ZT5Xb3JsZCBKIFN1cmc8L2Z1bGwtdGl0bGU+PC9wZXJpb2RpY2FsPjxwYWdlcz42MTctMjI8L3Bh

Z2VzPjx2b2x1bWU+MjU8L3ZvbHVtZT48bnVtYmVyPjU8L251bWJlcj48ZWRpdGlvbj4yMDAxLzA1

LzIzPC9lZGl0aW9uPjxrZXl3b3Jkcz48a2V5d29yZD5BZHVsdDwva2V5d29yZD48a2V5d29yZD5B

Z2VkPC9rZXl3b3JkPjxrZXl3b3JkPkFnZWQsIDgwIGFuZCBvdmVyPC9rZXl3b3JkPjxrZXl3b3Jk

PkNvbWJpbmVkIE1vZGFsaXR5IFRoZXJhcHk8L2tleXdvcmQ+PGtleXdvcmQ+RmVtYWxlPC9rZXl3

b3JkPjxrZXl3b3JkPkh1bWFuczwva2V5d29yZD48a2V5d29yZD5NYWxlPC9rZXl3b3JkPjxrZXl3

b3JkPk1pZGRsZSBBZ2VkPC9rZXl3b3JkPjxrZXl3b3JkPlByb2dub3Npczwva2V5d29yZD48a2V5

d29yZD5Qcm9wb3J0aW9uYWwgSGF6YXJkcyBNb2RlbHM8L2tleXdvcmQ+PGtleXdvcmQ+UmlzayBG

YWN0b3JzPC9rZXl3b3JkPjxrZXl3b3JkPlN1cnZpdmFsIEFuYWx5c2lzPC9rZXl3b3JkPjxrZXl3

b3JkPlRoeXJvaWQgTmVvcGxhc21zLyptb3J0YWxpdHkvKnRoZXJhcHk8L2tleXdvcmQ+PC9rZXl3

b3Jkcz48ZGF0ZXM+PHllYXI+MjAwMTwveWVhcj48cHViLWRhdGVzPjxkYXRlPk1heTwvZGF0ZT48

L3B1Yi1kYXRlcz48L2RhdGVzPjxpc2JuPjAzNjQtMjMxMyAoUHJpbnQpJiN4RDswMzY0LTIzMTMg

KExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Npb24tbnVtPjExMzY5OTg5PC9hY2Nlc3Npb24tbnVtPjx1

cmxzPjxyZWxhdGVkLXVybHM+PHVybD5odHRwOi8vd3d3Lm5jYmkubmxtLm5paC5nb3YvcHVibWVk

LzExMzY5OTg5PC91cmw+PC9yZWxhdGVkLXVybHM+PC91cmxzPjxlbGVjdHJvbmljLXJlc291cmNl

LW51bT4xMC4xMDA3L3MwMDI2ODAwMjAxNjY8L2VsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjxsYW5n

dWFnZT5lbmc8L2xhbmd1YWdlPjwvcmVjb3JkPjwvQ2l0ZT48Q2l0ZT48QXV0aG9yPkFsZGluZ2Vy

PC9BdXRob3I+PFllYXI+MTk3ODwvWWVhcj48UmVjTnVtPjI0PC9SZWNOdW0+PHJlY29yZD48cmVj

LW51bWJlcj4yNDwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9

InBzMnd3ZHNmcmEycjVlZTl6YXN4czV0OHp3ZHd4cnN3ZTV4YSIgdGltZXN0YW1wPSIxNDczMTE3

MTM4Ij4yNDwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGlj

bGUiPjE3PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+QWxkaW5nZXIs

IEsuIEEuPC9hdXRob3I+PGF1dGhvcj5TYW1hYW4sIE4uIEEuPC9hdXRob3I+PGF1dGhvcj5JYmFu

ZXosIE0uPC9hdXRob3I+PGF1dGhvcj5IaWxsLCBDLiBTLiwgSnIuPC9hdXRob3I+PC9hdXRob3Jz

PjwvY29udHJpYnV0b3JzPjx0aXRsZXM+PHRpdGxlPkFuYXBsYXN0aWMgY2FyY2lub21hIG9mIHRo

ZSB0aHlyb2lkOiBhIHJldmlldyBvZiA4NCBjYXNlcyBvZiBzcGluZGxlIGFuZCBnaWFudCBjZWxs

IGNhcmNpbm9tYSBvZiB0aGUgdGh5cm9pZDwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5DYW5jZXI8

L3NlY29uZGFyeS10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5DYW5jZXI8

L2Z1bGwtdGl0bGU+PC9wZXJpb2RpY2FsPjxwYWdlcz4yMjY3LTc1PC9wYWdlcz48dm9sdW1lPjQx

PC92b2x1bWU+PG51bWJlcj42PC9udW1iZXI+PGVkaXRpb24+MTk3OC8wNi8wMTwvZWRpdGlvbj48

a2V5d29yZHM+PGtleXdvcmQ+QWdlZDwva2V5d29yZD48a2V5d29yZD5BbmFwbGFzaWEvcGF0aG9s

b2d5PC9rZXl3b3JkPjxrZXl3b3JkPkNhcmNpbm9tYS9ldGlvbG9neS8qcGF0aG9sb2d5L3RoZXJh

cHk8L2tleXdvcmQ+PGtleXdvcmQ+Q2VsbCBEaWZmZXJlbnRpYXRpb248L2tleXdvcmQ+PGtleXdv

cmQ+RmVtYWxlPC9rZXl3b3JkPjxrZXl3b3JkPkh1bWFuczwva2V5d29yZD48a2V5d29yZD5NYWxl

PC9rZXl3b3JkPjxrZXl3b3JkPk1pZGRsZSBBZ2VkPC9rZXl3b3JkPjxrZXl3b3JkPlByb2dub3Np

czwva2V5d29yZD48a2V5d29yZD5UaHlyb2lkIE5lb3BsYXNtcy9ldGlvbG9neS8qcGF0aG9sb2d5

L3RoZXJhcHk8L2tleXdvcmQ+PC9rZXl3b3Jkcz48ZGF0ZXM+PHllYXI+MTk3ODwveWVhcj48cHVi

LWRhdGVzPjxkYXRlPkp1bjwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxpc2JuPjAwMDgtNTQz

WCAoUHJpbnQpJiN4RDswMDA4LTU0M1ggKExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Npb24tbnVtPjY1

NzA5MTwvYWNjZXNzaW9uLW51bT48dXJscz48cmVsYXRlZC11cmxzPjx1cmw+aHR0cDovL3d3dy5u

Y2JpLm5sbS5uaWguZ292L3B1Ym1lZC82NTcwOTE8L3VybD48L3JlbGF0ZWQtdXJscz48L3VybHM+

PGxhbmd1YWdlPmVuZzwvbGFuZ3VhZ2U+PC9yZWNvcmQ+PC9DaXRlPjxDaXRlPjxBdXRob3I+Tmlr

aWZvcm92PC9BdXRob3I+PFllYXI+MjAxMjwvWWVhcj48UmVjTnVtPjIyPC9SZWNOdW0+PHJlY29y

ZD48cmVjLW51bWJlcj4yMjwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIg

ZGItaWQ9InBzMnd3ZHNmcmEycjVlZTl6YXN4czV0OHp3ZHd4cnN3ZTV4YSIgdGltZXN0YW1wPSIx

NDczMTE3MTM3Ij4yMjwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJCb29rIFNl

Y3Rpb24iPjU8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5OaWtpZm9y

b3YsIFkuIEUuPC9hdXRob3I+PGF1dGhvcj5TZWV0aGFsYSwgUi4gUi48L2F1dGhvcj48L2F1dGhv

cnM+PHNlY29uZGFyeS1hdXRob3JzPjxhdXRob3I+TmlraWZvcm92LCBZLiBFLjwvYXV0aG9yPjxh

dXRob3I+QmlkZGluZ2VyLCBQLlcuPC9hdXRob3I+PGF1dGhvcj5UaG9tcHNvbiwgTC5ELlIuPC9h

dXRob3I+PC9zZWNvbmRhcnktYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48dGl0bGVzPjx0aXRsZT5B

bmFwbGFzdGljICh1bmRpZmZlcmVudGlhdGVkKSBjYXJjaW5vbWE8L3RpdGxlPjxzZWNvbmRhcnkt

dGl0bGU+RGlhZ25vc3RpYyBwYXRob2xvZ3kgYW5kIG1vbGVjdWxhciBnZW5ldGljcyBvZiB0aGUg

dGh5cm9pZDwvc2Vjb25kYXJ5LXRpdGxlPjwvdGl0bGVzPjxwYWdlcz4yNjMtMjg0PC9wYWdlcz48

ZWRpdGlvbj4ybmQ8L2VkaXRpb24+PHNlY3Rpb24+MTA8L3NlY3Rpb24+PGRhdGVzPjx5ZWFyPjIw

MTI8L3llYXI+PC9kYXRlcz48cHViLWxvY2F0aW9uPlBoaWxhZGVscGhpYTwvcHViLWxvY2F0aW9u

PjxwdWJsaXNoZXI+TGlwcGluY290dCBXaWxsaWFtcyBhbmQgV2lsa2luczwvcHVibGlzaGVyPjx1

cmxzPjwvdXJscz48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPgB=

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5TdWdpdGFuaTwvQXV0aG9yPjxZZWFyPjIwMDE8L1llYXI+

PFJlY051bT4yMzwvUmVjTnVtPjxEaXNwbGF5VGV4dD48c3R5bGUgZmFjZT0ic3VwZXJzY3JpcHQi

PjIzLTI1PC9zdHlsZT48L0Rpc3BsYXlUZXh0PjxyZWNvcmQ+PHJlYy1udW1iZXI+MjM8L3JlYy1u

dW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRiLWlkPSJwczJ3d2RzZnJhMnI1ZWU5

emFzeHM1dDh6d2R3eHJzd2U1eGEiIHRpbWVzdGFtcD0iMTQ3MzExNzEzNyI+MjM8L2tleT48L2Zv

cmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5cGU+

PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPlN1Z2l0YW5pLCBJLjwvYXV0aG9yPjxhdXRo

b3I+S2FzYWksIE4uPC9hdXRob3I+PGF1dGhvcj5GdWppbW90bywgWS48L2F1dGhvcj48YXV0aG9y

PllhbmFnaXNhd2EsIEEuPC9hdXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjxhdXRoLWFk

ZHJlc3M+RGl2aXNpb24gb2YgSGVhZCBhbmQgTmVjaywgQ2FuY2VyIEluc3RpdHV0ZSBIb3NwaXRh

bCwgMS0zNy0xIEthbWktaWtlYnVrdXJvLCBUb3NoaW1hLWt1LCBUb2t5byAxNzAtODQ1NSwgSmFw

YW4uIGl3YW8tc3VnQHRjNC5zby1uZXQubmUuanA8L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRs

ZT5Qcm9nbm9zdGljIGZhY3RvcnMgYW5kIHRoZXJhcGV1dGljIHN0cmF0ZWd5IGZvciBhbmFwbGFz

dGljIGNhcmNpbm9tYSBvZiB0aGUgdGh5cm9pZDwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5Xb3Js

ZCBKIFN1cmc8L3NlY29uZGFyeS10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRs

ZT5Xb3JsZCBKIFN1cmc8L2Z1bGwtdGl0bGU+PC9wZXJpb2RpY2FsPjxwYWdlcz42MTctMjI8L3Bh

Z2VzPjx2b2x1bWU+MjU8L3ZvbHVtZT48bnVtYmVyPjU8L251bWJlcj48ZWRpdGlvbj4yMDAxLzA1

LzIzPC9lZGl0aW9uPjxrZXl3b3Jkcz48a2V5d29yZD5BZHVsdDwva2V5d29yZD48a2V5d29yZD5B

Z2VkPC9rZXl3b3JkPjxrZXl3b3JkPkFnZWQsIDgwIGFuZCBvdmVyPC9rZXl3b3JkPjxrZXl3b3Jk

PkNvbWJpbmVkIE1vZGFsaXR5IFRoZXJhcHk8L2tleXdvcmQ+PGtleXdvcmQ+RmVtYWxlPC9rZXl3

b3JkPjxrZXl3b3JkPkh1bWFuczwva2V5d29yZD48a2V5d29yZD5NYWxlPC9rZXl3b3JkPjxrZXl3

b3JkPk1pZGRsZSBBZ2VkPC9rZXl3b3JkPjxrZXl3b3JkPlByb2dub3Npczwva2V5d29yZD48a2V5

d29yZD5Qcm9wb3J0aW9uYWwgSGF6YXJkcyBNb2RlbHM8L2tleXdvcmQ+PGtleXdvcmQ+UmlzayBG

YWN0b3JzPC9rZXl3b3JkPjxrZXl3b3JkPlN1cnZpdmFsIEFuYWx5c2lzPC9rZXl3b3JkPjxrZXl3

b3JkPlRoeXJvaWQgTmVvcGxhc21zLyptb3J0YWxpdHkvKnRoZXJhcHk8L2tleXdvcmQ+PC9rZXl3

b3Jkcz48ZGF0ZXM+PHllYXI+MjAwMTwveWVhcj48cHViLWRhdGVzPjxkYXRlPk1heTwvZGF0ZT48

L3B1Yi1kYXRlcz48L2RhdGVzPjxpc2JuPjAzNjQtMjMxMyAoUHJpbnQpJiN4RDswMzY0LTIzMTMg

KExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Npb24tbnVtPjExMzY5OTg5PC9hY2Nlc3Npb24tbnVtPjx1

cmxzPjxyZWxhdGVkLXVybHM+PHVybD5odHRwOi8vd3d3Lm5jYmkubmxtLm5paC5nb3YvcHVibWVk

LzExMzY5OTg5PC91cmw+PC9yZWxhdGVkLXVybHM+PC91cmxzPjxlbGVjdHJvbmljLXJlc291cmNl

LW51bT4xMC4xMDA3L3MwMDI2ODAwMjAxNjY8L2VsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjxsYW5n

dWFnZT5lbmc8L2xhbmd1YWdlPjwvcmVjb3JkPjwvQ2l0ZT48Q2l0ZT48QXV0aG9yPkFsZGluZ2Vy

PC9BdXRob3I+PFllYXI+MTk3ODwvWWVhcj48UmVjTnVtPjI0PC9SZWNOdW0+PHJlY29yZD48cmVj

LW51bWJlcj4yNDwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9

InBzMnd3ZHNmcmEycjVlZTl6YXN4czV0OHp3ZHd4cnN3ZTV4YSIgdGltZXN0YW1wPSIxNDczMTE3

MTM4Ij4yNDwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGlj

bGUiPjE3PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+QWxkaW5nZXIs

IEsuIEEuPC9hdXRob3I+PGF1dGhvcj5TYW1hYW4sIE4uIEEuPC9hdXRob3I+PGF1dGhvcj5JYmFu

ZXosIE0uPC9hdXRob3I+PGF1dGhvcj5IaWxsLCBDLiBTLiwgSnIuPC9hdXRob3I+PC9hdXRob3Jz

PjwvY29udHJpYnV0b3JzPjx0aXRsZXM+PHRpdGxlPkFuYXBsYXN0aWMgY2FyY2lub21hIG9mIHRo

ZSB0aHlyb2lkOiBhIHJldmlldyBvZiA4NCBjYXNlcyBvZiBzcGluZGxlIGFuZCBnaWFudCBjZWxs

IGNhcmNpbm9tYSBvZiB0aGUgdGh5cm9pZDwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5DYW5jZXI8

L3NlY29uZGFyeS10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5DYW5jZXI8

L2Z1bGwtdGl0bGU+PC9wZXJpb2RpY2FsPjxwYWdlcz4yMjY3LTc1PC9wYWdlcz48dm9sdW1lPjQx

PC92b2x1bWU+PG51bWJlcj42PC9udW1iZXI+PGVkaXRpb24+MTk3OC8wNi8wMTwvZWRpdGlvbj48

a2V5d29yZHM+PGtleXdvcmQ+QWdlZDwva2V5d29yZD48a2V5d29yZD5BbmFwbGFzaWEvcGF0aG9s

b2d5PC9rZXl3b3JkPjxrZXl3b3JkPkNhcmNpbm9tYS9ldGlvbG9neS8qcGF0aG9sb2d5L3RoZXJh

cHk8L2tleXdvcmQ+PGtleXdvcmQ+Q2VsbCBEaWZmZXJlbnRpYXRpb248L2tleXdvcmQ+PGtleXdv

cmQ+RmVtYWxlPC9rZXl3b3JkPjxrZXl3b3JkPkh1bWFuczwva2V5d29yZD48a2V5d29yZD5NYWxl

PC9rZXl3b3JkPjxrZXl3b3JkPk1pZGRsZSBBZ2VkPC9rZXl3b3JkPjxrZXl3b3JkPlByb2dub3Np

czwva2V5d29yZD48a2V5d29yZD5UaHlyb2lkIE5lb3BsYXNtcy9ldGlvbG9neS8qcGF0aG9sb2d5

L3RoZXJhcHk8L2tleXdvcmQ+PC9rZXl3b3Jkcz48ZGF0ZXM+PHllYXI+MTk3ODwveWVhcj48cHVi

LWRhdGVzPjxkYXRlPkp1bjwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxpc2JuPjAwMDgtNTQz

WCAoUHJpbnQpJiN4RDswMDA4LTU0M1ggKExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Npb24tbnVtPjY1

NzA5MTwvYWNjZXNzaW9uLW51bT48dXJscz48cmVsYXRlZC11cmxzPjx1cmw+aHR0cDovL3d3dy5u

Y2JpLm5sbS5uaWguZ292L3B1Ym1lZC82NTcwOTE8L3VybD48L3JlbGF0ZWQtdXJscz48L3VybHM+

PGxhbmd1YWdlPmVuZzwvbGFuZ3VhZ2U+PC9yZWNvcmQ+PC9DaXRlPjxDaXRlPjxBdXRob3I+Tmlr

aWZvcm92PC9BdXRob3I+PFllYXI+MjAxMjwvWWVhcj48UmVjTnVtPjIyPC9SZWNOdW0+PHJlY29y

ZD48cmVjLW51bWJlcj4yMjwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIg

ZGItaWQ9InBzMnd3ZHNmcmEycjVlZTl6YXN4czV0OHp3ZHd4cnN3ZTV4YSIgdGltZXN0YW1wPSIx

NDczMTE3MTM3Ij4yMjwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJCb29rIFNl

Y3Rpb24iPjU8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5OaWtpZm9y

b3YsIFkuIEUuPC9hdXRob3I+PGF1dGhvcj5TZWV0aGFsYSwgUi4gUi48L2F1dGhvcj48L2F1dGhv

cnM+PHNlY29uZGFyeS1hdXRob3JzPjxhdXRob3I+TmlraWZvcm92LCBZLiBFLjwvYXV0aG9yPjxh

dXRob3I+QmlkZGluZ2VyLCBQLlcuPC9hdXRob3I+PGF1dGhvcj5UaG9tcHNvbiwgTC5ELlIuPC9h

dXRob3I+PC9zZWNvbmRhcnktYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48dGl0bGVzPjx0aXRsZT5B

bmFwbGFzdGljICh1bmRpZmZlcmVudGlhdGVkKSBjYXJjaW5vbWE8L3RpdGxlPjxzZWNvbmRhcnkt

dGl0bGU+RGlhZ25vc3RpYyBwYXRob2xvZ3kgYW5kIG1vbGVjdWxhciBnZW5ldGljcyBvZiB0aGUg

dGh5cm9pZDwvc2Vjb25kYXJ5LXRpdGxlPjwvdGl0bGVzPjxwYWdlcz4yNjMtMjg0PC9wYWdlcz48

ZWRpdGlvbj4ybmQ8L2VkaXRpb24+PHNlY3Rpb24+MTA8L3NlY3Rpb24+PGRhdGVzPjx5ZWFyPjIw

MTI8L3llYXI+PC9kYXRlcz48cHViLWxvY2F0aW9uPlBoaWxhZGVscGhpYTwvcHViLWxvY2F0aW9u

PjxwdWJsaXNoZXI+TGlwcGluY290dCBXaWxsaWFtcyBhbmQgV2lsa2luczwvcHVibGlzaGVyPjx1

cmxzPjwvdXJscz48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPgB=

ADDIN EN.CITE.DATA 23-25 These tumors are treatable surgically and will have a more favorable prognosis than a predominantly anaplastic carcinoma. Thus, tumors with only focal anaplastic areas and no extrathyroidal extension should be delineated from the more common and overtly anaplastic tumors. The maximum percentage of tumor that is allowable by the term focal in this context is unclear at this point, however, and will require judgment on a case-by-case basis.I. MarginsBy convention, margin status is a required data element in association with thyroid cancers. The “margin” is defined as the surface of the thyroid specimen, usually the outer aspect of the thyroid gland and/or inked edge of the specimen. The evaluation of the relationship of tumor to the inked edge of the tissue represents determination of margin status. It should be noted that the thyroid “capsule” is not an anatomically defined structure. Evidence has shown that microscopically the capsule is focally incomplete or absent in a majority of thyroid glands evaluated at autopsy. ADDIN EN.CITE <EndNote><Cite><Author>Komorowski</Author><Year>1988</Year><RecNum>13</RecNum><DisplayText><style face="superscript">14</style></DisplayText><record><rec-number>13</rec-number><foreign-keys><key app="EN" db-id="ps2wwdsfra2r5ee9zasxs5t8zwdwxrswe5xa" timestamp="1473117137">13</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Komorowski, R. A.</author><author>Hanson, G. A.</author></authors></contributors><auth-address>Department of Pathology, Medical College of Wisconsin, Milwaukee 53226.</auth-address><titles><title>Occult thyroid pathology in the young adult: an autopsy study of 138 patients without clinical thyroid disease</title><secondary-title>Hum Pathol</secondary-title></titles><periodical><full-title>Hum Pathol</full-title></periodical><pages>689-96</pages><volume>19</volume><number>6</number><edition>1988/06/01</edition><keywords><keyword>Adenoma/diagnosis/pathology</keyword><keyword>Adult</keyword><keyword>Carcinoma, Papillary/diagnosis/pathology</keyword><keyword>Female</keyword><keyword>Fibrosis/pathology</keyword><keyword>Humans</keyword><keyword>Lymphocytes/pathology</keyword><keyword>Male</keyword><keyword>Thyroid Diseases/diagnosis/*pathology</keyword><keyword>Thyroid Gland/*pathology</keyword><keyword>Thyroid Neoplasms/diagnosis/pathology/secondary</keyword></keywords><dates><year>1988</year><pub-dates><date>Jun</date></pub-dates></dates><isbn>0046-8177 (Print)&#xD;0046-8177 (Linking)</isbn><accession-num>3378788</accession-num><urls><related-urls><url> Further, unlike hollow organs such as the gastrointestinal tract where there is continuity of the entire viscera such that a real surgical and pathologic margin exists, the same does not hold true for the thyroid gland such that tumor at the margin (ie, capsule and/or ink) does not correlate to incomplete excision. Few published studies have addressed the influence of margin status and patient outcome. Most surgeons, endocrinologists, and nuclear medicine specialists request information on margin status. While this makes intuitive sense, and it is recommended that a positive margin be mentioned in the final pathology report, meticulous studies on the effect of positive margins and outcome in large series of patients with long-term follow-up are lacking. Indeed, there is no data to date on the prognostic value of close margins as an independent or co-variable.J. Angioinvasion (Vascular Invasion) and Lymphatic InvasionAngiolymphatic invasion is an important parameter for both papillary and follicular carcinomas. Given the preferential spread of papillary carcinoma via lymphatics and follicular carcinoma via hematogenous routes, the vessels invaded by papillary carcinoma are usually lymphatic spaces and those in follicular carcinoma are usually blood vessels. However, papillary carcinomas can involve vascular spaces, as indicated by occasional hematogenous spread. Thus, the distinction between vascular and lymphatic invasion may be helpful in that the former is a predictor of a more aggressive pattern of spread. Criteria for Angioinvasion As noted above, papillary thyroid carcinomas tend to spread via lymphatics. In addition to tumor deposits within lymphatic spaces, this form of spread may manifest as psammoma bodies alone within these spaces, which are the equivalent of lymphatic invasion for reporting purposes.For encapsulated follicular carcinomas, criteria are designed to identify venous vascular invasion, as this is the typical means of spread for these tumors. Vascular invasion can be a diagnostic criterion for follicular carcinoma and appears to correlate with poor outcome. As with capsular invasion, vascular invasion, though conceptually straightforward, is controversial and challenging. For vascular invasion, the blood vessels should be located outside the tumor, within the capsule, or outside the capsule. ADDIN EN.CITE <EndNote><Cite><Author>Rosai</Author><Year>1992</Year><RecNum>25</RecNum><DisplayText><style face="superscript">26</style></DisplayText><record><rec-number>25</rec-number><foreign-keys><key app="EN" db-id="ps2wwdsfra2r5ee9zasxs5t8zwdwxrswe5xa" timestamp="1473117138">25</key></foreign-keys><ref-type name="Book">6</ref-type><contributors><authors><author>Rosai, J.</author><author>Carcangiu, M.L.</author><author>DeLellis, R.A.</author></authors></contributors><titles><title>Atlas of tumor pathology. Tumors of the thyroid gland.</title></titles><volume>Fascicle 5</volume><edition>3rd</edition><dates><year>1992</year></dates><pub-location>Washington D.C.</pub-location><publisher>Armed Forces Institute of Pathology</publisher><urls></urls></record></Cite></EndNote>26 The involved spaces should include capsular or extracapsular vessels. While angioinvasion of a venous caliber space is fairly easily recognized, occasionally separating capillary sized vascular spaces from lymphatics may be difficult. Morphologically smaller vascular spaces will still have red blood cells within. In challenging cases, markers selective for vascular and lymphatic endothelium, such as CD31 and podoplanin (D2-40), respectively, may be useful. ADDIN EN.CITE <EndNote><Cite><Author>Mete</Author><Year>2011</Year><RecNum>22</RecNum><DisplayText><style face="superscript">27</style></DisplayText><record><rec-number>26</rec-number><foreign-keys><key app="EN" db-id="ps2wwdsfra2r5ee9zasxs5t8zwdwxrswe5xa" timestamp="1473117138">26</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Mete, O.</author><author>Asa, S. L.</author></authors></contributors><auth-address>Department of Pathology, University Health Network, Toronto, Ontario, Canada. Ozgur.Mete2@uhn.on.ca</auth-address><titles><title>Pathological definition and clinical significance of vascular invasion in thyroid carcinomas of follicular epithelial derivation</title><secondary-title>Mod Pathol</secondary-title></titles><periodical><full-title>Mod Pathol</full-title></periodical><pages>1545-52</pages><volume>24</volume><number>12</number><edition>2011/08/02</edition><keywords><keyword>Adenocarcinoma, Follicular</keyword><keyword>Artifacts</keyword><keyword>Autopsy</keyword><keyword>Biopsy</keyword><keyword>Blood Vessels/*pathology</keyword><keyword>Carcinoma</keyword><keyword>Cell Differentiation</keyword><keyword>Epithelial Cells/*pathology</keyword><keyword>Humans</keyword><keyword>Immunohistochemistry</keyword><keyword>Neoplasm Invasiveness</keyword><keyword>Predictive Value of Tests</keyword><keyword>Prognosis</keyword><keyword>Retrospective Studies</keyword><keyword>Thyroid Neoplasms/*pathology/secondary</keyword><keyword>Time Factors</keyword></keywords><dates><year>2011</year><pub-dates><date>Dec</date></pub-dates></dates><isbn>1530-0285 (Electronic)&#xD;0893-3952 (Linking)</isbn><accession-num>21804527</accession-num><urls><related-urls><url> [pii]</electronic-resource-num><language>eng</language></record></Cite></EndNote>27 Figure 3 depicts the various histologic appearances of vascular invasion. ADDIN EN.CITE <EndNote><Cite><Author>Chan</Author><Year>2007</Year><RecNum>4</RecNum><DisplayText><style face="superscript">4</style></DisplayText><record><rec-number>4</rec-number><foreign-keys><key app="EN" db-id="ps2wwdsfra2r5ee9zasxs5t8zwdwxrswe5xa" timestamp="1473117136">4</key></foreign-keys><ref-type name="Book Section">5</ref-type><contributors><authors><author>Chan, J. K.</author></authors><secondary-authors><author>Fletcher, C.D.M.</author></secondary-authors></contributors><titles><title>The thyroid gland</title><secondary-title>Diagnostic histopathology of tumours</secondary-title></titles><pages>1018</pages><dates><year>2007</year></dates><pub-location>Edinburgh</pub-location><publisher>Churchill Livingstone Elsevier</publisher><urls></urls></record></Cite></EndNote>4 The minimal requirements for clinically meaningful vascular invasion are currently a point of controversy. Historically, the presence of endothelialized tumor alone has been the minimal criterion to identify vascular space invasion, a finding supported in the literature. ADDIN EN.CITE <EndNote><Cite><Author>Rosai</Author><Year>1992</Year><RecNum>25</RecNum><DisplayText><style face="superscript">26</style></DisplayText><record><rec-number>25</rec-number><foreign-keys><key app="EN" db-id="ps2wwdsfra2r5ee9zasxs5t8zwdwxrswe5xa" timestamp="1473117138">25</key></foreign-keys><ref-type name="Book">6</ref-type><contributors><authors><author>Rosai, J.</author><author>Carcangiu, M.L.</author><author>DeLellis, R.A.</author></authors></contributors><titles><title>Atlas of tumor pathology. Tumors of the thyroid gland.</title></titles><volume>Fascicle 5</volume><edition>3rd</edition><dates><year>1992</year></dates><pub-location>Washington D.C.</pub-location><publisher>Armed Forces Institute of Pathology</publisher><urls></urls></record></Cite></EndNote>26 More recently, however, 1 group has raised the caveat that tumor cells within vascular lumina unassociated with thrombus, and tumor cells underlying intact endothelium could represent “pseudoinvasion” given the fenestrated endothelial network of endocrine organs. ADDIN EN.CITE <EndNote><Cite><Author>Mete</Author><Year>2011</Year><RecNum>22</RecNum><DisplayText><style face="superscript">27</style></DisplayText><record><rec-number>26</rec-number><foreign-keys><key app="EN" db-id="ps2wwdsfra2r5ee9zasxs5t8zwdwxrswe5xa" timestamp="1473117138">26</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Mete, O.</author><author>Asa, S. L.</author></authors></contributors><auth-address>Department of Pathology, University Health Network, Toronto, Ontario, Canada. Ozgur.Mete2@uhn.on.ca</auth-address><titles><title>Pathological definition and clinical significance of vascular invasion in thyroid carcinomas of follicular epithelial derivation</title><secondary-title>Mod Pathol</secondary-title></titles><periodical><full-title>Mod Pathol</full-title></periodical><pages>1545-52</pages><volume>24</volume><number>12</number><edition>2011/08/02</edition><keywords><keyword>Adenocarcinoma, Follicular</keyword><keyword>Artifacts</keyword><keyword>Autopsy</keyword><keyword>Biopsy</keyword><keyword>Blood Vessels/*pathology</keyword><keyword>Carcinoma</keyword><keyword>Cell Differentiation</keyword><keyword>Epithelial Cells/*pathology</keyword><keyword>Humans</keyword><keyword>Immunohistochemistry</keyword><keyword>Neoplasm Invasiveness</keyword><keyword>Predictive Value of Tests</keyword><keyword>Prognosis</keyword><keyword>Retrospective Studies</keyword><keyword>Thyroid Neoplasms/*pathology/secondary</keyword><keyword>Time Factors</keyword></keywords><dates><year>2011</year><pub-dates><date>Dec</date></pub-dates></dates><isbn>1530-0285 (Electronic)&#xD;0893-3952 (Linking)</isbn><accession-num>21804527</accession-num><urls><related-urls><url> [pii]</electronic-resource-num><language>eng</language></record></Cite></EndNote>27 Using more rigorous criteria, namely invasion of tumor cells through a vessel wall as well as thrombus formation in association with tumor, this group demonstrated that over one-third of tumors that fulfilled these criteria had distant metastases. ADDIN EN.CITE <EndNote><Cite><Author>Mete</Author><Year>2011</Year><RecNum>22</RecNum><DisplayText><style face="superscript">27</style></DisplayText><record><rec-number>26</rec-number><foreign-keys><key app="EN" db-id="ps2wwdsfra2r5ee9zasxs5t8zwdwxrswe5xa" timestamp="1473117138">26</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Mete, O.</author><author>Asa, S. L.</author></authors></contributors><auth-address>Department of Pathology, University Health Network, Toronto, Ontario, Canada. Ozgur.Mete2@uhn.on.ca</auth-address><titles><title>Pathological definition and clinical significance of vascular invasion in thyroid carcinomas of follicular epithelial derivation</title><secondary-title>Mod Pathol</secondary-title></titles><periodical><full-title>Mod Pathol</full-title></periodical><pages>1545-52</pages><volume>24</volume><number>12</number><edition>2011/08/02</edition><keywords><keyword>Adenocarcinoma, Follicular</keyword><keyword>Artifacts</keyword><keyword>Autopsy</keyword><keyword>Biopsy</keyword><keyword>Blood Vessels/*pathology</keyword><keyword>Carcinoma</keyword><keyword>Cell Differentiation</keyword><keyword>Epithelial Cells/*pathology</keyword><keyword>Humans</keyword><keyword>Immunohistochemistry</keyword><keyword>Neoplasm Invasiveness</keyword><keyword>Predictive Value of Tests</keyword><keyword>Prognosis</keyword><keyword>Retrospective Studies</keyword><keyword>Thyroid Neoplasms/*pathology/secondary</keyword><keyword>Time Factors</keyword></keywords><dates><year>2011</year><pub-dates><date>Dec</date></pub-dates></dates><isbn>1530-0285 (Electronic)&#xD;0893-3952 (Linking)</isbn><accession-num>21804527</accession-num><urls><related-urls><url> [pii]</electronic-resource-num><language>eng</language></record></Cite></EndNote>27 These rigid criteria are also highly predictive of aggressive disease in medullary thyroid carcinoma.PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Fcm92aWM8L0F1dGhvcj48WWVhcj4yMDEyPC9ZZWFyPjxS

ZWNOdW0+Mjc8L1JlY051bT48RGlzcGxheVRleHQ+PHN0eWxlIGZhY2U9InN1cGVyc2NyaXB0Ij4y

ODwvc3R5bGU+PC9EaXNwbGF5VGV4dD48cmVjb3JkPjxyZWMtbnVtYmVyPjI3PC9yZWMtbnVtYmVy

Pjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0icHMyd3dkc2ZyYTJyNWVlOXphc3hz

NXQ4endkd3hyc3dlNXhhIiB0aW1lc3RhbXA9IjE0NzMxMTcxMzgiPjI3PC9rZXk+PC9mb3JlaWdu

LWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxjb250

cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5Fcm92aWMsIEIuIE0uPC9hdXRob3I+PGF1dGhvcj5L

aW0sIEQuPC9hdXRob3I+PGF1dGhvcj5DYXNzb2wsIEMuPC9hdXRob3I+PGF1dGhvcj5Hb2xkc3Rl

aW4sIEQuIFAuPC9hdXRob3I+PGF1dGhvcj5JcmlzaCwgSi4gQy48L2F1dGhvcj48YXV0aG9yPkFz

YSwgUy4gTC48L2F1dGhvcj48YXV0aG9yPk1ldGUsIE8uPC9hdXRob3I+PC9hdXRob3JzPjwvY29u

dHJpYnV0b3JzPjxhdXRoLWFkZHJlc3M+RGVwYXJ0bWVudCBvZiBPdG9sYXJ5bmdvbG9neS1IZWFk

IGFuZCBOZWNrIFN1cmdlcnkvU3VyZ2ljYWwgT25jb2xvZ3ksIFVuaXZlcnNpdHkgSGVhbHRoIE5l

dHdvcmssIFRvcm9udG8sIE9OLCBDYW5hZGEuPC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48dGl0bGU+

UHJvZ25vc3RpYyBhbmQgcHJlZGljdGl2ZSBtYXJrZXJzIGluIG1lZHVsbGFyeSB0aHlyb2lkIGNh

cmNpbm9tYTwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5FbmRvY3IgUGF0aG9sPC9zZWNvbmRhcnkt

dGl0bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+RW5kb2NyIFBhdGhvbDwvZnVs

bC10aXRsZT48L3BlcmlvZGljYWw+PHBhZ2VzPjIzMi00MjwvcGFnZXM+PHZvbHVtZT4yMzwvdm9s

dW1lPjxudW1iZXI+NDwvbnVtYmVyPjxlZGl0aW9uPjIwMTIvMTEvMTU8L2VkaXRpb24+PGtleXdv

cmRzPjxrZXl3b3JkPkFkZW5vY2FyY2lub21hLyptZXRhYm9saXNtL21vcnRhbGl0eS8qc2Vjb25k

YXJ5PC9rZXl3b3JkPjxrZXl3b3JkPkFkb2xlc2NlbnQ8L2tleXdvcmQ+PGtleXdvcmQ+QWR1bHQ8

L2tleXdvcmQ+PGtleXdvcmQ+QWdlZDwva2V5d29yZD48a2V5d29yZD5BZ2VkLCA4MCBhbmQgb3Zl

cjwva2V5d29yZD48a2V5d29yZD5DYW5hZGEvZXBpZGVtaW9sb2d5PC9rZXl3b3JkPjxrZXl3b3Jk

PkRpc2Vhc2UtRnJlZSBTdXJ2aXZhbDwva2V5d29yZD48a2V5d29yZD5GZW1hbGU8L2tleXdvcmQ+

PGtleXdvcmQ+SHVtYW5zPC9rZXl3b3JkPjxrZXl3b3JkPkluZGl2aWR1YWxpemVkIE1lZGljaW5l

PC9rZXl3b3JkPjxrZXl3b3JkPkx5bXBoIE5vZGVzL3BhdGhvbG9neTwva2V5d29yZD48a2V5d29y

ZD5MeW1waGF0aWMgTWV0YXN0YXNpczwva2V5d29yZD48a2V5d29yZD5NYWxlPC9rZXl3b3JkPjxr

ZXl3b3JkPk1pZGRsZSBBZ2VkPC9rZXl3b3JkPjxrZXl3b3JkPk5lb3BsYXNtIEludmFzaXZlbmVz

czwva2V5d29yZD48a2V5d29yZD5OZW9wbGFzbSBQcm90ZWlucy9tZXRhYm9saXNtPC9rZXl3b3Jk

PjxrZXl3b3JkPk5lb3BsYXNtIFJlY3VycmVuY2UsIExvY2FsPC9rZXl3b3JkPjxrZXl3b3JkPlBh

dGllbnQgU2VsZWN0aW9uPC9rZXl3b3JkPjxrZXl3b3JkPlN1cnZpdmFsIFJhdGU8L2tleXdvcmQ+

PGtleXdvcmQ+VGh5cm9pZCBHbGFuZC9ibG9vZCBzdXBwbHk8L2tleXdvcmQ+PGtleXdvcmQ+VGh5

cm9pZCBOZW9wbGFzbXMvKm1ldGFib2xpc20vbW9ydGFsaXR5LypwYXRob2xvZ3k8L2tleXdvcmQ+

PGtleXdvcmQ+VGlzc3VlIEFycmF5IEFuYWx5c2lzPC9rZXl3b3JkPjxrZXl3b3JkPlR1bW9yIE1h

cmtlcnMsIEJpb2xvZ2ljYWwvKm1ldGFib2xpc208L2tleXdvcmQ+PGtleXdvcmQ+WW91bmcgQWR1

bHQ8L2tleXdvcmQ+PC9rZXl3b3Jkcz48ZGF0ZXM+PHllYXI+MjAxMjwveWVhcj48cHViLWRhdGVz

PjxkYXRlPkRlYzwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxpc2JuPjE1NTktMDA5NyAoRWxl

Y3Ryb25pYykmI3hEOzEwNDYtMzk3NiAoTGlua2luZyk8L2lzYm4+PGFjY2Vzc2lvbi1udW0+MjMx

NTAwMjk8L2FjY2Vzc2lvbi1udW0+PHVybHM+PHJlbGF0ZWQtdXJscz48dXJsPmh0dHA6Ly93d3cu

bmNiaS5ubG0ubmloLmdvdi9wdWJtZWQvMjMxNTAwMjk8L3VybD48L3JlbGF0ZWQtdXJscz48L3Vy

bHM+PGVsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjEwLjEwMDcvczEyMDIyLTAxMi05MjI1LTg8L2Vs

ZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjxsYW5ndWFnZT5lbmc8L2xhbmd1YWdlPjwvcmVjb3JkPjwv

Q2l0ZT48L0VuZE5vdGU+

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Fcm92aWM8L0F1dGhvcj48WWVhcj4yMDEyPC9ZZWFyPjxS

ZWNOdW0+Mjc8L1JlY051bT48RGlzcGxheVRleHQ+PHN0eWxlIGZhY2U9InN1cGVyc2NyaXB0Ij4y

ODwvc3R5bGU+PC9EaXNwbGF5VGV4dD48cmVjb3JkPjxyZWMtbnVtYmVyPjI3PC9yZWMtbnVtYmVy

Pjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0icHMyd3dkc2ZyYTJyNWVlOXphc3hz

NXQ4endkd3hyc3dlNXhhIiB0aW1lc3RhbXA9IjE0NzMxMTcxMzgiPjI3PC9rZXk+PC9mb3JlaWdu

LWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxjb250

cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5Fcm92aWMsIEIuIE0uPC9hdXRob3I+PGF1dGhvcj5L

aW0sIEQuPC9hdXRob3I+PGF1dGhvcj5DYXNzb2wsIEMuPC9hdXRob3I+PGF1dGhvcj5Hb2xkc3Rl

aW4sIEQuIFAuPC9hdXRob3I+PGF1dGhvcj5JcmlzaCwgSi4gQy48L2F1dGhvcj48YXV0aG9yPkFz

YSwgUy4gTC48L2F1dGhvcj48YXV0aG9yPk1ldGUsIE8uPC9hdXRob3I+PC9hdXRob3JzPjwvY29u

dHJpYnV0b3JzPjxhdXRoLWFkZHJlc3M+RGVwYXJ0bWVudCBvZiBPdG9sYXJ5bmdvbG9neS1IZWFk

IGFuZCBOZWNrIFN1cmdlcnkvU3VyZ2ljYWwgT25jb2xvZ3ksIFVuaXZlcnNpdHkgSGVhbHRoIE5l

dHdvcmssIFRvcm9udG8sIE9OLCBDYW5hZGEuPC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48dGl0bGU+

UHJvZ25vc3RpYyBhbmQgcHJlZGljdGl2ZSBtYXJrZXJzIGluIG1lZHVsbGFyeSB0aHlyb2lkIGNh

cmNpbm9tYTwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5FbmRvY3IgUGF0aG9sPC9zZWNvbmRhcnkt

dGl0bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+RW5kb2NyIFBhdGhvbDwvZnVs

bC10aXRsZT48L3BlcmlvZGljYWw+PHBhZ2VzPjIzMi00MjwvcGFnZXM+PHZvbHVtZT4yMzwvdm9s

dW1lPjxudW1iZXI+NDwvbnVtYmVyPjxlZGl0aW9uPjIwMTIvMTEvMTU8L2VkaXRpb24+PGtleXdv

cmRzPjxrZXl3b3JkPkFkZW5vY2FyY2lub21hLyptZXRhYm9saXNtL21vcnRhbGl0eS8qc2Vjb25k

YXJ5PC9rZXl3b3JkPjxrZXl3b3JkPkFkb2xlc2NlbnQ8L2tleXdvcmQ+PGtleXdvcmQ+QWR1bHQ8

L2tleXdvcmQ+PGtleXdvcmQ+QWdlZDwva2V5d29yZD48a2V5d29yZD5BZ2VkLCA4MCBhbmQgb3Zl

cjwva2V5d29yZD48a2V5d29yZD5DYW5hZGEvZXBpZGVtaW9sb2d5PC9rZXl3b3JkPjxrZXl3b3Jk

PkRpc2Vhc2UtRnJlZSBTdXJ2aXZhbDwva2V5d29yZD48a2V5d29yZD5GZW1hbGU8L2tleXdvcmQ+

PGtleXdvcmQ+SHVtYW5zPC9rZXl3b3JkPjxrZXl3b3JkPkluZGl2aWR1YWxpemVkIE1lZGljaW5l

PC9rZXl3b3JkPjxrZXl3b3JkPkx5bXBoIE5vZGVzL3BhdGhvbG9neTwva2V5d29yZD48a2V5d29y

ZD5MeW1waGF0aWMgTWV0YXN0YXNpczwva2V5d29yZD48a2V5d29yZD5NYWxlPC9rZXl3b3JkPjxr

ZXl3b3JkPk1pZGRsZSBBZ2VkPC9rZXl3b3JkPjxrZXl3b3JkPk5lb3BsYXNtIEludmFzaXZlbmVz

czwva2V5d29yZD48a2V5d29yZD5OZW9wbGFzbSBQcm90ZWlucy9tZXRhYm9saXNtPC9rZXl3b3Jk

PjxrZXl3b3JkPk5lb3BsYXNtIFJlY3VycmVuY2UsIExvY2FsPC9rZXl3b3JkPjxrZXl3b3JkPlBh

dGllbnQgU2VsZWN0aW9uPC9rZXl3b3JkPjxrZXl3b3JkPlN1cnZpdmFsIFJhdGU8L2tleXdvcmQ+

PGtleXdvcmQ+VGh5cm9pZCBHbGFuZC9ibG9vZCBzdXBwbHk8L2tleXdvcmQ+PGtleXdvcmQ+VGh5

cm9pZCBOZW9wbGFzbXMvKm1ldGFib2xpc20vbW9ydGFsaXR5LypwYXRob2xvZ3k8L2tleXdvcmQ+

PGtleXdvcmQ+VGlzc3VlIEFycmF5IEFuYWx5c2lzPC9rZXl3b3JkPjxrZXl3b3JkPlR1bW9yIE1h

cmtlcnMsIEJpb2xvZ2ljYWwvKm1ldGFib2xpc208L2tleXdvcmQ+PGtleXdvcmQ+WW91bmcgQWR1

bHQ8L2tleXdvcmQ+PC9rZXl3b3Jkcz48ZGF0ZXM+PHllYXI+MjAxMjwveWVhcj48cHViLWRhdGVz

PjxkYXRlPkRlYzwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxpc2JuPjE1NTktMDA5NyAoRWxl

Y3Ryb25pYykmI3hEOzEwNDYtMzk3NiAoTGlua2luZyk8L2lzYm4+PGFjY2Vzc2lvbi1udW0+MjMx

NTAwMjk8L2FjY2Vzc2lvbi1udW0+PHVybHM+PHJlbGF0ZWQtdXJscz48dXJsPmh0dHA6Ly93d3cu

bmNiaS5ubG0ubmloLmdvdi9wdWJtZWQvMjMxNTAwMjk8L3VybD48L3JlbGF0ZWQtdXJscz48L3Vy

bHM+PGVsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjEwLjEwMDcvczEyMDIyLTAxMi05MjI1LTg8L2Vs

ZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjxsYW5ndWFnZT5lbmc8L2xhbmd1YWdlPjwvcmVjb3JkPjwv

Q2l0ZT48L0VuZE5vdGU+

ADDIN EN.CITE.DATA 28 While these more rigid criteria require validation from additional studies, they set the framework for the minimal criteria for unequivocal and meaningful vascular invasion, to reiterate: invasion of tumor through a vessel wall accompanied by fibrin thrombus. It is acknowledged that the risk of metastasis when these criteria are not fulfilled by a focus in vessels is not entirely absentPEVuZE5vdGU+PENpdGU+PEF1dGhvcj5UaG9tcHNvbjwvQXV0aG9yPjxZZWFyPjIwMDE8L1llYXI+

PFJlY051bT40NzwvUmVjTnVtPjxEaXNwbGF5VGV4dD48c3R5bGUgZmFjZT0ic3VwZXJzY3JpcHQi

PjI5PC9zdHlsZT48L0Rpc3BsYXlUZXh0PjxyZWNvcmQ+PHJlYy1udW1iZXI+Mjg8L3JlYy1udW1i

ZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRiLWlkPSJwczJ3d2RzZnJhMnI1ZWU5emFz

eHM1dDh6d2R3eHJzd2U1eGEiIHRpbWVzdGFtcD0iMTQ3MzExNzEzOCI+Mjg8L2tleT48L2ZvcmVp

Z24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5cGU+PGNv

bnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPlRob21wc29uLCBMLiBELjwvYXV0aG9yPjxhdXRo

b3I+V2llbmVrZSwgSi4gQS48L2F1dGhvcj48YXV0aG9yPlBhYWwsIEUuPC9hdXRob3I+PGF1dGhv

cj5Gcm9tbWVsdCwgUi4gQS48L2F1dGhvcj48YXV0aG9yPkFkYWlyLCBDLiBGLjwvYXV0aG9yPjxh

dXRob3I+SGVmZmVzcywgQy4gUy48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PGF1

dGgtYWRkcmVzcz5EZXBhcnRtZW50IG9mIEVuZG9jcmluZSBhbmQgT3Rvcmhpbm9sYXJ5bmdpYy1I

ZWFkICZhbXA7IE5lY2sgUGF0aG9sb2d5LCBBcm1lZCBGb3JjZXMgSW5zdGl0dXRlIG9mIFBhdGhv

bG9neSwgQnVpbGRpbmcgNTQsIFJvb20gRzA2Ni0xMSwgNjgyNSAxNnRoIFN0LiBOVywgV2FzaGlu

Z3RvbiwgREMgMjAzMDYtNjAwMCwgVVNBLiB0aG9tcHNvbmxAYWZpcC5vc2QubWlsPC9hdXRoLWFk

ZHJlc3M+PHRpdGxlcz48dGl0bGU+QSBjbGluaWNvcGF0aG9sb2dpYyBzdHVkeSBvZiBtaW5pbWFs

bHkgaW52YXNpdmUgZm9sbGljdWxhciBjYXJjaW5vbWEgb2YgdGhlIHRoeXJvaWQgZ2xhbmQgd2l0

aCBhIHJldmlldyBvZiB0aGUgRW5nbGlzaCBsaXRlcmF0dXJlPC90aXRsZT48c2Vjb25kYXJ5LXRp

dGxlPkNhbmNlcjwvc2Vjb25kYXJ5LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRp

dGxlPkNhbmNlcjwvZnVsbC10aXRsZT48L3BlcmlvZGljYWw+PHBhZ2VzPjUwNS0yNDwvcGFnZXM+

PHZvbHVtZT45MTwvdm9sdW1lPjxudW1iZXI+MzwvbnVtYmVyPjxlZGl0aW9uPjIwMDEvMDIvMTU8

L2VkaXRpb24+PGtleXdvcmRzPjxrZXl3b3JkPkFkZW5vY2FyY2lub21hLCBGb2xsaWN1bGFyL21v

cnRhbGl0eS8qcGF0aG9sb2d5L3JhZGlvdGhlcmFweS9zdXJnZXJ5PC9rZXl3b3JkPjxrZXl3b3Jk

PkFkdWx0PC9rZXl3b3JkPjxrZXl3b3JkPkFnZSBGYWN0b3JzPC9rZXl3b3JkPjxrZXl3b3JkPkFn

ZWQ8L2tleXdvcmQ+PGtleXdvcmQ+QWdlZCwgODAgYW5kIG92ZXI8L2tleXdvcmQ+PGtleXdvcmQ+

RGVtb2dyYXBoeTwva2V5d29yZD48a2V5d29yZD5EaWFnbm9zaXMsIERpZmZlcmVudGlhbDwva2V5

d29yZD48a2V5d29yZD5GZW1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+Rm9sbG93LVVwIFN0dWRpZXM8

L2tleXdvcmQ+PGtleXdvcmQ+SHVtYW5zPC9rZXl3b3JkPjxrZXl3b3JkPk1hbGU8L2tleXdvcmQ+

PGtleXdvcmQ+TWlkZGxlIEFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+TmVvcGxhc20gSW52YXNpdmVu

ZXNzPC9rZXl3b3JkPjxrZXl3b3JkPk5lb3BsYXNtIFJlY3VycmVuY2UsIExvY2FsPC9rZXl3b3Jk

PjxrZXl3b3JkPk91dGNvbWUgQXNzZXNzbWVudCAoSGVhbHRoIENhcmUpPC9rZXl3b3JkPjxrZXl3

b3JkPlJhZGlvdGhlcmFweTwva2V5d29yZD48a2V5d29yZD5TZXggRmFjdG9yczwva2V5d29yZD48

a2V5d29yZD5UaHlyb2lkIEdsYW5kL3BhdGhvbG9neTwva2V5d29yZD48a2V5d29yZD5UaHlyb2lk

IE5lb3BsYXNtcy9tb3J0YWxpdHkvKnBhdGhvbG9neS9yYWRpb3RoZXJhcHkvc3VyZ2VyeTwva2V5

d29yZD48L2tleXdvcmRzPjxkYXRlcz48eWVhcj4yMDAxPC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+

RmViIDE8L2RhdGU+PC9wdWItZGF0ZXM+PC9kYXRlcz48aXNibj4wMDA4LTU0M1ggKFByaW50KSYj

eEQ7MDAwOC01NDNYIChMaW5raW5nKTwvaXNibj48YWNjZXNzaW9uLW51bT4xMTE2OTkzMzwvYWNj

ZXNzaW9uLW51bT48dXJscz48cmVsYXRlZC11cmxzPjx1cmw+aHR0cDovL3d3dy5uY2JpLm5sbS5u

aWguZ292L3B1Ym1lZC8xMTE2OTkzMzwvdXJsPjwvcmVsYXRlZC11cmxzPjwvdXJscz48ZWxlY3Ry

b25pYy1yZXNvdXJjZS1udW0+MTAuMTAwMi8xMDk3LTAxNDIoMjAwMTAyMDEpOTE6MyZsdDs1MDU6

OkFJRC1DTkNSMTAyOSZndDszLjAuQ087Mi02IFtwaWldPC9lbGVjdHJvbmljLXJlc291cmNlLW51

bT48bGFuZ3VhZ2U+ZW5nPC9sYW5ndWFnZT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPn==

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5UaG9tcHNvbjwvQXV0aG9yPjxZZWFyPjIwMDE8L1llYXI+

PFJlY051bT40NzwvUmVjTnVtPjxEaXNwbGF5VGV4dD48c3R5bGUgZmFjZT0ic3VwZXJzY3JpcHQi

PjI5PC9zdHlsZT48L0Rpc3BsYXlUZXh0PjxyZWNvcmQ+PHJlYy1udW1iZXI+Mjg8L3JlYy1udW1i

ZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRiLWlkPSJwczJ3d2RzZnJhMnI1ZWU5emFz

eHM1dDh6d2R3eHJzd2U1eGEiIHRpbWVzdGFtcD0iMTQ3MzExNzEzOCI+Mjg8L2tleT48L2ZvcmVp

Z24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5cGU+PGNv

bnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPlRob21wc29uLCBMLiBELjwvYXV0aG9yPjxhdXRo

b3I+V2llbmVrZSwgSi4gQS48L2F1dGhvcj48YXV0aG9yPlBhYWwsIEUuPC9hdXRob3I+PGF1dGhv

cj5Gcm9tbWVsdCwgUi4gQS48L2F1dGhvcj48YXV0aG9yPkFkYWlyLCBDLiBGLjwvYXV0aG9yPjxh

dXRob3I+SGVmZmVzcywgQy4gUy48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PGF1

dGgtYWRkcmVzcz5EZXBhcnRtZW50IG9mIEVuZG9jcmluZSBhbmQgT3Rvcmhpbm9sYXJ5bmdpYy1I

ZWFkICZhbXA7IE5lY2sgUGF0aG9sb2d5LCBBcm1lZCBGb3JjZXMgSW5zdGl0dXRlIG9mIFBhdGhv

bG9neSwgQnVpbGRpbmcgNTQsIFJvb20gRzA2Ni0xMSwgNjgyNSAxNnRoIFN0LiBOVywgV2FzaGlu

Z3RvbiwgREMgMjAzMDYtNjAwMCwgVVNBLiB0aG9tcHNvbmxAYWZpcC5vc2QubWlsPC9hdXRoLWFk

ZHJlc3M+PHRpdGxlcz48dGl0bGU+QSBjbGluaWNvcGF0aG9sb2dpYyBzdHVkeSBvZiBtaW5pbWFs

bHkgaW52YXNpdmUgZm9sbGljdWxhciBjYXJjaW5vbWEgb2YgdGhlIHRoeXJvaWQgZ2xhbmQgd2l0

aCBhIHJldmlldyBvZiB0aGUgRW5nbGlzaCBsaXRlcmF0dXJlPC90aXRsZT48c2Vjb25kYXJ5LXRp

dGxlPkNhbmNlcjwvc2Vjb25kYXJ5LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRp

dGxlPkNhbmNlcjwvZnVsbC10aXRsZT48L3BlcmlvZGljYWw+PHBhZ2VzPjUwNS0yNDwvcGFnZXM+

PHZvbHVtZT45MTwvdm9sdW1lPjxudW1iZXI+MzwvbnVtYmVyPjxlZGl0aW9uPjIwMDEvMDIvMTU8

L2VkaXRpb24+PGtleXdvcmRzPjxrZXl3b3JkPkFkZW5vY2FyY2lub21hLCBGb2xsaWN1bGFyL21v

cnRhbGl0eS8qcGF0aG9sb2d5L3JhZGlvdGhlcmFweS9zdXJnZXJ5PC9rZXl3b3JkPjxrZXl3b3Jk

PkFkdWx0PC9rZXl3b3JkPjxrZXl3b3JkPkFnZSBGYWN0b3JzPC9rZXl3b3JkPjxrZXl3b3JkPkFn

ZWQ8L2tleXdvcmQ+PGtleXdvcmQ+QWdlZCwgODAgYW5kIG92ZXI8L2tleXdvcmQ+PGtleXdvcmQ+

RGVtb2dyYXBoeTwva2V5d29yZD48a2V5d29yZD5EaWFnbm9zaXMsIERpZmZlcmVudGlhbDwva2V5

d29yZD48a2V5d29yZD5GZW1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+Rm9sbG93LVVwIFN0dWRpZXM8

L2tleXdvcmQ+PGtleXdvcmQ+SHVtYW5zPC9rZXl3b3JkPjxrZXl3b3JkPk1hbGU8L2tleXdvcmQ+

PGtleXdvcmQ+TWlkZGxlIEFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+TmVvcGxhc20gSW52YXNpdmVu

ZXNzPC9rZXl3b3JkPjxrZXl3b3JkPk5lb3BsYXNtIFJlY3VycmVuY2UsIExvY2FsPC9rZXl3b3Jk

PjxrZXl3b3JkPk91dGNvbWUgQXNzZXNzbWVudCAoSGVhbHRoIENhcmUpPC9rZXl3b3JkPjxrZXl3

b3JkPlJhZGlvdGhlcmFweTwva2V5d29yZD48a2V5d29yZD5TZXggRmFjdG9yczwva2V5d29yZD48

a2V5d29yZD5UaHlyb2lkIEdsYW5kL3BhdGhvbG9neTwva2V5d29yZD48a2V5d29yZD5UaHlyb2lk

IE5lb3BsYXNtcy9tb3J0YWxpdHkvKnBhdGhvbG9neS9yYWRpb3RoZXJhcHkvc3VyZ2VyeTwva2V5

d29yZD48L2tleXdvcmRzPjxkYXRlcz48eWVhcj4yMDAxPC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+

RmViIDE8L2RhdGU+PC9wdWItZGF0ZXM+PC9kYXRlcz48aXNibj4wMDA4LTU0M1ggKFByaW50KSYj

eEQ7MDAwOC01NDNYIChMaW5raW5nKTwvaXNibj48YWNjZXNzaW9uLW51bT4xMTE2OTkzMzwvYWNj

ZXNzaW9uLW51bT48dXJscz48cmVsYXRlZC11cmxzPjx1cmw+aHR0cDovL3d3dy5uY2JpLm5sbS5u

aWguZ292L3B1Ym1lZC8xMTE2OTkzMzwvdXJsPjwvcmVsYXRlZC11cmxzPjwvdXJscz48ZWxlY3Ry

b25pYy1yZXNvdXJjZS1udW0+MTAuMTAwMi8xMDk3LTAxNDIoMjAwMTAyMDEpOTE6MyZsdDs1MDU6

OkFJRC1DTkNSMTAyOSZndDszLjAuQ087Mi02IFtwaWldPC9lbGVjdHJvbmljLXJlc291cmNlLW51

bT48bGFuZ3VhZ2U+ZW5nPC9sYW5ndWFnZT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPn==

ADDIN EN.CITE.DATA 29 Additionally, some investigators have suggested that the number of foci of vascular invasion has prognostic impact as well.PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Db2xsaW5pPC9BdXRob3I+PFllYXI+MjAwNDwvWWVhcj48

UmVjTnVtPjI5PC9SZWNOdW0+PERpc3BsYXlUZXh0PjxzdHlsZSBmYWNlPSJzdXBlcnNjcmlwdCI+

MzAtMzI8L3N0eWxlPjwvRGlzcGxheVRleHQ+PHJlY29yZD48cmVjLW51bWJlcj4yOTwvcmVjLW51

bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9InBzMnd3ZHNmcmEycjVlZTl6

YXN4czV0OHp3ZHd4cnN3ZTV4YSIgdGltZXN0YW1wPSIxNDczMTE3MTM4Ij4yOTwva2V5PjwvZm9y

ZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9yZWYtdHlwZT48

Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+Q29sbGluaSwgUC48L2F1dGhvcj48YXV0aG9y

PlNhbXBpZXRybywgRy48L2F1dGhvcj48YXV0aG9yPlBpbG90dGksIFMuPC9hdXRob3I+PC9hdXRo

b3JzPjwvY29udHJpYnV0b3JzPjxhdXRoLWFkZHJlc3M+RGVwYXJ0bWVudCBvZiBQYXRob2xvZ3ks

IElzdGl0dXRvIE5hemlvbmFsZSBUdW1vcmksIE1pbGFuLCBJdGFseS4gcGFvbGEuY29sbGluaUBp

c3RpdHV0b3R1bW9yaS5taS5pdDwvYXV0aC1hZGRyZXNzPjx0aXRsZXM+PHRpdGxlPkV4dGVuc2l2

ZSB2YXNjdWxhciBpbnZhc2lvbiBpcyBhIG1hcmtlciBvZiByaXNrIG9mIHJlbGFwc2UgaW4gZW5j

YXBzdWxhdGVkIG5vbi1IdXJ0aGxlIGNlbGwgZm9sbGljdWxhciBjYXJjaW5vbWEgb2YgdGhlIHRo

eXJvaWQgZ2xhbmQ6IGEgY2xpbmljb3BhdGhvbG9naWNhbCBzdHVkeSBvZiAxOCBjb25zZWN1dGl2

ZSBjYXNlcyBmcm9tIGEgc2luZ2xlIGluc3RpdHV0aW9uIHdpdGggYSAxMS15ZWFyIG1lZGlhbiBm

b2xsb3ctdXA8L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+SGlzdG9wYXRob2xvZ3k8L3NlY29uZGFy

eS10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5IaXN0b3BhdGhvbG9neTwv

ZnVsbC10aXRsZT48L3BlcmlvZGljYWw+PHBhZ2VzPjM1LTk8L3BhZ2VzPjx2b2x1bWU+NDQ8L3Zv

bHVtZT48bnVtYmVyPjE8L251bWJlcj48ZWRpdGlvbj4yMDA0LzAxLzE0PC9lZGl0aW9uPjxrZXl3

b3Jkcz48a2V5d29yZD5BZGVub2NhcmNpbm9tYSwgRm9sbGljdWxhci9ibG9vZCBzdXBwbHkvKnNl

Y29uZGFyeS9zdXJnZXJ5PC9rZXl3b3JkPjxrZXl3b3JkPkFkZW5vbWEsIE94eXBoaWxpYy8qcGF0

aG9sb2d5PC9rZXl3b3JkPjxrZXl3b3JkPkFkb2xlc2NlbnQ8L2tleXdvcmQ+PGtleXdvcmQ+QWR1

bHQ8L2tleXdvcmQ+PGtleXdvcmQ+QWdlZDwva2V5d29yZD48a2V5d29yZD5CbG9vZCBWZXNzZWxz

L3BhdGhvbG9neTwva2V5d29yZD48a2V5d29yZD5EaXNlYXNlLUZyZWUgU3Vydml2YWw8L2tleXdv

cmQ+PGtleXdvcmQ+RmVtYWxlPC9rZXl3b3JkPjxrZXl3b3JkPkZvbGxvdy1VcCBTdHVkaWVzPC9r

ZXl3b3JkPjxrZXl3b3JkPkh1bWFuczwva2V5d29yZD48a2V5d29yZD5NYWxlPC9rZXl3b3JkPjxr

ZXl3b3JkPk1pZGRsZSBBZ2VkPC9rZXl3b3JkPjxrZXl3b3JkPk5lb3BsYXNtIEludmFzaXZlbmVz

czwva2V5d29yZD48a2V5d29yZD5UaHlyb2lkIE5lb3BsYXNtcy9ibG9vZCBzdXBwbHkvKnBhdGhv

bG9neS9zdXJnZXJ5PC9rZXl3b3JkPjwva2V5d29yZHM+PGRhdGVzPjx5ZWFyPjIwMDQ8L3llYXI+

PHB1Yi1kYXRlcz48ZGF0ZT5KYW48L2RhdGU+PC9wdWItZGF0ZXM+PC9kYXRlcz48aXNibj4wMzA5

LTAxNjcgKFByaW50KSYjeEQ7MDMwOS0wMTY3IChMaW5raW5nKTwvaXNibj48YWNjZXNzaW9uLW51

bT4xNDcxNzY2NzwvYWNjZXNzaW9uLW51bT48dXJscz48cmVsYXRlZC11cmxzPjx1cmw+aHR0cDov

L3d3dy5uY2JpLm5sbS5uaWguZ292L3B1Ym1lZC8xNDcxNzY2NzwvdXJsPjwvcmVsYXRlZC11cmxz

PjwvdXJscz48ZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+MTcyOSBbcGlpXTwvZWxlY3Ryb25pYy1y

ZXNvdXJjZS1udW0+PGxhbmd1YWdlPmVuZzwvbGFuZ3VhZ2U+PC9yZWNvcmQ+PC9DaXRlPjxDaXRl

PjxBdXRob3I+R2hvc3NlaW48L0F1dGhvcj48WWVhcj4yMDA2PC9ZZWFyPjxSZWNOdW0+MzA8L1Jl

Y051bT48cmVjb3JkPjxyZWMtbnVtYmVyPjMwPC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtl

eSBhcHA9IkVOIiBkYi1pZD0icHMyd3dkc2ZyYTJyNWVlOXphc3hzNXQ4endkd3hyc3dlNXhhIiB0

aW1lc3RhbXA9IjE0NzMxMTcxMzgiPjMwPC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5h

bWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+

PGF1dGhvcj5HaG9zc2VpbiwgUi4gQS48L2F1dGhvcj48YXV0aG9yPkhpbHR6aWssIEQuIEguPC9h

dXRob3I+PGF1dGhvcj5DYXJsc29uLCBELiBMLjwvYXV0aG9yPjxhdXRob3I+UGF0ZWwsIFMuPC9h

dXRob3I+PGF1dGhvcj5TaGFoYSwgQS48L2F1dGhvcj48YXV0aG9yPlNoYWgsIEouIFAuPC9hdXRo

b3I+PGF1dGhvcj5UdXR0bGUsIFIuIE0uPC9hdXRob3I+PGF1dGhvcj5TaW5naCwgQi48L2F1dGhv

cj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PGF1dGgtYWRkcmVzcz5EZXBhcnRtZW50IG9mIFBh

dGhvbG9neSBNZW1vcmlhbCBTbG9hbi1LZXR0ZXJpbmcgQ2FuY2VyIENlbnRlciwgTmV3IFlvcmss

IE5ldyBZb3JrIDEwMDIxLCBVU0EuIGdob3NzZWlyQG1za2NjLm9yZzwvYXV0aC1hZGRyZXNzPjx0

aXRsZXM+PHRpdGxlPlByb2dub3N0aWMgZmFjdG9ycyBvZiByZWN1cnJlbmNlIGluIGVuY2Fwc3Vs

YXRlZCBIdXJ0aGxlIGNlbGwgY2FyY2lub21hIG9mIHRoZSB0aHlyb2lkIGdsYW5kOiBhIGNsaW5p

Y29wYXRob2xvZ2ljIHN0dWR5IG9mIDUwIGNhc2VzPC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkNh

bmNlcjwvc2Vjb25kYXJ5LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkNh

bmNlcjwvZnVsbC10aXRsZT48L3BlcmlvZGljYWw+PHBhZ2VzPjE2NjktNzY8L3BhZ2VzPjx2b2x1

bWU+MTA2PC92b2x1bWU+PG51bWJlcj44PC9udW1iZXI+PGVkaXRpb24+MjAwNi8wMy8xNTwvZWRp

dGlvbj48a2V5d29yZHM+PGtleXdvcmQ+QWRlbm9tYSwgT3h5cGhpbGljLypwYXRob2xvZ3kvKnNl

Y29uZGFyeS90aGVyYXB5PC9rZXl3b3JkPjxrZXl3b3JkPkNvbWJpbmVkIE1vZGFsaXR5IFRoZXJh

cHk8L2tleXdvcmQ+PGtleXdvcmQ+RmVtYWxlPC9rZXl3b3JkPjxrZXl3b3JkPkh1bWFuczwva2V5

d29yZD48a2V5d29yZD5NYWxlPC9rZXl3b3JkPjxrZXl3b3JkPk1pZGRsZSBBZ2VkPC9rZXl3b3Jk

PjxrZXl3b3JkPipOZW9wbGFzbSBSZWN1cnJlbmNlLCBMb2NhbDwva2V5d29yZD48a2V5d29yZD5Q

cm9nbm9zaXM8L2tleXdvcmQ+PGtleXdvcmQ+VGh5cm9pZCBOZW9wbGFzbXMvKnBhdGhvbG9neS90

aGVyYXB5PC9rZXl3b3JkPjxrZXl3b3JkPlRoeXJvaWRlY3RvbXk8L2tleXdvcmQ+PC9rZXl3b3Jk

cz48ZGF0ZXM+PHllYXI+MjAwNjwveWVhcj48cHViLWRhdGVzPjxkYXRlPkFwciAxNTwvZGF0ZT48

L3B1Yi1kYXRlcz48L2RhdGVzPjxpc2JuPjAwMDgtNTQzWCAoUHJpbnQpJiN4RDswMDA4LTU0M1gg

KExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Npb24tbnVtPjE2NTM0Nzk2PC9hY2Nlc3Npb24tbnVtPjx1

cmxzPjxyZWxhdGVkLXVybHM+PHVybD5odHRwOi8vd3d3Lm5jYmkubmxtLm5paC5nb3YvcHVibWVk

LzE2NTM0Nzk2PC91cmw+PC9yZWxhdGVkLXVybHM+PC91cmxzPjxlbGVjdHJvbmljLXJlc291cmNl

LW51bT4xMC4xMDAyL2NuY3IuMjE4MjU8L2VsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjxsYW5ndWFn

ZT5lbmc8L2xhbmd1YWdlPjwvcmVjb3JkPjwvQ2l0ZT48Q2l0ZT48QXV0aG9yPlN0b2phZGlub3Zp

YzwvQXV0aG9yPjxZZWFyPjIwMDE8L1llYXI+PFJlY051bT4zMTwvUmVjTnVtPjxyZWNvcmQ+PHJl

Yy1udW1iZXI+MzE8L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRiLWlk

PSJwczJ3d2RzZnJhMnI1ZWU5emFzeHM1dDh6d2R3eHJzd2U1eGEiIHRpbWVzdGFtcD0iMTQ3MzEx

NzEzOCI+MzE8L2tleT48L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRp

Y2xlIj4xNzwvcmVmLXR5cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPlN0b2phZGlu

b3ZpYywgQS48L2F1dGhvcj48YXV0aG9yPkdob3NzZWluLCBSLiBBLjwvYXV0aG9yPjxhdXRob3I+

SG9vcywgQS48L2F1dGhvcj48YXV0aG9yPlVyaXN0LCBNLiBKLjwvYXV0aG9yPjxhdXRob3I+U3Bp

cm8sIFIuIEguPC9hdXRob3I+PGF1dGhvcj5TaGFoLCBKLiBQLjwvYXV0aG9yPjxhdXRob3I+QnJl

bm5hbiwgTS4gRi48L2F1dGhvcj48YXV0aG9yPlNoYWhhLCBBLiBSLjwvYXV0aG9yPjxhdXRob3I+

U2luZ2gsIEIuPC9hdXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjxhdXRoLWFkZHJlc3M+

RGVwYXJ0bWVudCBvZiBTdXJnZXJ5LCBNZW1vcmlhbCBTbG9hbi1LZXR0ZXJpbmcgQ2FuY2VyIENl

bnRlciwgTmV3IFlvcmssIE5ZIDEwMDIxLCBVU0EuPC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48dGl0

bGU+SHVydGhsZSBjZWxsIGNhcmNpbm9tYTogYSBjcml0aWNhbCBoaXN0b3BhdGhvbG9naWMgYXBw

cmFpc2FsPC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkogQ2xpbiBPbmNvbDwvc2Vjb25kYXJ5LXRp

dGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkogQ2xpbiBPbmNvbDwvZnVsbC10

aXRsZT48L3BlcmlvZGljYWw+PHBhZ2VzPjI2MTYtMjU8L3BhZ2VzPjx2b2x1bWU+MTk8L3ZvbHVt

ZT48bnVtYmVyPjEwPC9udW1iZXI+PGVkaXRpb24+MjAwMS8wNS8xNjwvZWRpdGlvbj48a2V5d29y

ZHM+PGtleXdvcmQ+Q2FyY2lub21hL2NsYXNzaWZpY2F0aW9uL21vcnRhbGl0eS8qcGF0aG9sb2d5

L3RoZXJhcHk8L2tleXdvcmQ+PGtleXdvcmQ+Q29tYmluZWQgTW9kYWxpdHkgVGhlcmFweTwva2V5

d29yZD48a2V5d29yZD5EYXRhYmFzZXMsIEZhY3R1YWw8L2tleXdvcmQ+PGtleXdvcmQ+RmVtYWxl

PC9rZXl3b3JkPjxrZXl3b3JkPkh1bWFuczwva2V5d29yZD48a2V5d29yZD5NYWxlPC9rZXl3b3Jk

PjxrZXl3b3JkPk1pZGRsZSBBZ2VkPC9rZXl3b3JkPjxrZXl3b3JkPk5lb3BsYXNtIE1ldGFzdGFz

aXM8L2tleXdvcmQ+PGtleXdvcmQ+UHJvZ25vc2lzPC9rZXl3b3JkPjxrZXl3b3JkPlJlZ2lzdHJp

ZXM8L2tleXdvcmQ+PGtleXdvcmQ+UmV0cm9zcGVjdGl2ZSBTdHVkaWVzPC9rZXl3b3JkPjxrZXl3

b3JkPlRoeXJvaWQgTmVvcGxhc21zL2NsYXNzaWZpY2F0aW9uL21vcnRhbGl0eS8qcGF0aG9sb2d5

L3RoZXJhcHk8L2tleXdvcmQ+PC9rZXl3b3Jkcz48ZGF0ZXM+PHllYXI+MjAwMTwveWVhcj48cHVi

LWRhdGVzPjxkYXRlPk1heSAxNTwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxpc2JuPjA3MzIt

MTgzWCAoUHJpbnQpJiN4RDswNzMyLTE4M1ggKExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Npb24tbnVt

PjExMzUyOTUzPC9hY2Nlc3Npb24tbnVtPjx1cmxzPjxyZWxhdGVkLXVybHM+PHVybD5odHRwOi8v

d3d3Lm5jYmkubmxtLm5paC5nb3YvcHVibWVkLzExMzUyOTUzPC91cmw+PC9yZWxhdGVkLXVybHM+

PC91cmxzPjxsYW5ndWFnZT5lbmc8L2xhbmd1YWdlPjwvcmVjb3JkPjwvQ2l0ZT48L0VuZE5vdGU+

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Db2xsaW5pPC9BdXRob3I+PFllYXI+MjAwNDwvWWVhcj48

UmVjTnVtPjI5PC9SZWNOdW0+PERpc3BsYXlUZXh0PjxzdHlsZSBmYWNlPSJzdXBlcnNjcmlwdCI+

MzAtMzI8L3N0eWxlPjwvRGlzcGxheVRleHQ+PHJlY29yZD48cmVjLW51bWJlcj4yOTwvcmVjLW51

bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9InBzMnd3ZHNmcmEycjVlZTl6

YXN4czV0OHp3ZHd4cnN3ZTV4YSIgdGltZXN0YW1wPSIxNDczMTE3MTM4Ij4yOTwva2V5PjwvZm9y

ZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9yZWYtdHlwZT48

Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+Q29sbGluaSwgUC48L2F1dGhvcj48YXV0aG9y

PlNhbXBpZXRybywgRy48L2F1dGhvcj48YXV0aG9yPlBpbG90dGksIFMuPC9hdXRob3I+PC9hdXRo

b3JzPjwvY29udHJpYnV0b3JzPjxhdXRoLWFkZHJlc3M+RGVwYXJ0bWVudCBvZiBQYXRob2xvZ3ks

IElzdGl0dXRvIE5hemlvbmFsZSBUdW1vcmksIE1pbGFuLCBJdGFseS4gcGFvbGEuY29sbGluaUBp

c3RpdHV0b3R1bW9yaS5taS5pdDwvYXV0aC1hZGRyZXNzPjx0aXRsZXM+PHRpdGxlPkV4dGVuc2l2

ZSB2YXNjdWxhciBpbnZhc2lvbiBpcyBhIG1hcmtlciBvZiByaXNrIG9mIHJlbGFwc2UgaW4gZW5j

YXBzdWxhdGVkIG5vbi1IdXJ0aGxlIGNlbGwgZm9sbGljdWxhciBjYXJjaW5vbWEgb2YgdGhlIHRo

eXJvaWQgZ2xhbmQ6IGEgY2xpbmljb3BhdGhvbG9naWNhbCBzdHVkeSBvZiAxOCBjb25zZWN1dGl2

ZSBjYXNlcyBmcm9tIGEgc2luZ2xlIGluc3RpdHV0aW9uIHdpdGggYSAxMS15ZWFyIG1lZGlhbiBm

b2xsb3ctdXA8L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+SGlzdG9wYXRob2xvZ3k8L3NlY29uZGFy

eS10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5IaXN0b3BhdGhvbG9neTwv

ZnVsbC10aXRsZT48L3BlcmlvZGljYWw+PHBhZ2VzPjM1LTk8L3BhZ2VzPjx2b2x1bWU+NDQ8L3Zv

bHVtZT48bnVtYmVyPjE8L251bWJlcj48ZWRpdGlvbj4yMDA0LzAxLzE0PC9lZGl0aW9uPjxrZXl3

b3Jkcz48a2V5d29yZD5BZGVub2NhcmNpbm9tYSwgRm9sbGljdWxhci9ibG9vZCBzdXBwbHkvKnNl

Y29uZGFyeS9zdXJnZXJ5PC9rZXl3b3JkPjxrZXl3b3JkPkFkZW5vbWEsIE94eXBoaWxpYy8qcGF0

aG9sb2d5PC9rZXl3b3JkPjxrZXl3b3JkPkFkb2xlc2NlbnQ8L2tleXdvcmQ+PGtleXdvcmQ+QWR1

bHQ8L2tleXdvcmQ+PGtleXdvcmQ+QWdlZDwva2V5d29yZD48a2V5d29yZD5CbG9vZCBWZXNzZWxz

L3BhdGhvbG9neTwva2V5d29yZD48a2V5d29yZD5EaXNlYXNlLUZyZWUgU3Vydml2YWw8L2tleXdv

cmQ+PGtleXdvcmQ+RmVtYWxlPC9rZXl3b3JkPjxrZXl3b3JkPkZvbGxvdy1VcCBTdHVkaWVzPC9r

ZXl3b3JkPjxrZXl3b3JkPkh1bWFuczwva2V5d29yZD48a2V5d29yZD5NYWxlPC9rZXl3b3JkPjxr

ZXl3b3JkPk1pZGRsZSBBZ2VkPC9rZXl3b3JkPjxrZXl3b3JkPk5lb3BsYXNtIEludmFzaXZlbmVz

czwva2V5d29yZD48a2V5d29yZD5UaHlyb2lkIE5lb3BsYXNtcy9ibG9vZCBzdXBwbHkvKnBhdGhv

bG9neS9zdXJnZXJ5PC9rZXl3b3JkPjwva2V5d29yZHM+PGRhdGVzPjx5ZWFyPjIwMDQ8L3llYXI+

PHB1Yi1kYXRlcz48ZGF0ZT5KYW48L2RhdGU+PC9wdWItZGF0ZXM+PC9kYXRlcz48aXNibj4wMzA5

LTAxNjcgKFByaW50KSYjeEQ7MDMwOS0wMTY3IChMaW5raW5nKTwvaXNibj48YWNjZXNzaW9uLW51

bT4xNDcxNzY2NzwvYWNjZXNzaW9uLW51bT48dXJscz48cmVsYXRlZC11cmxzPjx1cmw+aHR0cDov

L3d3dy5uY2JpLm5sbS5uaWguZ292L3B1Ym1lZC8xNDcxNzY2NzwvdXJsPjwvcmVsYXRlZC11cmxz

PjwvdXJscz48ZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+MTcyOSBbcGlpXTwvZWxlY3Ryb25pYy1y

ZXNvdXJjZS1udW0+PGxhbmd1YWdlPmVuZzwvbGFuZ3VhZ2U+PC9yZWNvcmQ+PC9DaXRlPjxDaXRl

PjxBdXRob3I+R2hvc3NlaW48L0F1dGhvcj48WWVhcj4yMDA2PC9ZZWFyPjxSZWNOdW0+MzA8L1Jl

Y051bT48cmVjb3JkPjxyZWMtbnVtYmVyPjMwPC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtl

eSBhcHA9IkVOIiBkYi1pZD0icHMyd3dkc2ZyYTJyNWVlOXphc3hzNXQ4endkd3hyc3dlNXhhIiB0

aW1lc3RhbXA9IjE0NzMxMTcxMzgiPjMwPC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5h

bWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+

PGF1dGhvcj5HaG9zc2VpbiwgUi4gQS48L2F1dGhvcj48YXV0aG9yPkhpbHR6aWssIEQuIEguPC9h

dXRob3I+PGF1dGhvcj5DYXJsc29uLCBELiBMLjwvYXV0aG9yPjxhdXRob3I+UGF0ZWwsIFMuPC9h

dXRob3I+PGF1dGhvcj5TaGFoYSwgQS48L2F1dGhvcj48YXV0aG9yPlNoYWgsIEouIFAuPC9hdXRo

b3I+PGF1dGhvcj5UdXR0bGUsIFIuIE0uPC9hdXRob3I+PGF1dGhvcj5TaW5naCwgQi48L2F1dGhv

cj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PGF1dGgtYWRkcmVzcz5EZXBhcnRtZW50IG9mIFBh

dGhvbG9neSBNZW1vcmlhbCBTbG9hbi1LZXR0ZXJpbmcgQ2FuY2VyIENlbnRlciwgTmV3IFlvcmss

IE5ldyBZb3JrIDEwMDIxLCBVU0EuIGdob3NzZWlyQG1za2NjLm9yZzwvYXV0aC1hZGRyZXNzPjx0

aXRsZXM+PHRpdGxlPlByb2dub3N0aWMgZmFjdG9ycyBvZiByZWN1cnJlbmNlIGluIGVuY2Fwc3Vs

YXRlZCBIdXJ0aGxlIGNlbGwgY2FyY2lub21hIG9mIHRoZSB0aHlyb2lkIGdsYW5kOiBhIGNsaW5p

Y29wYXRob2xvZ2ljIHN0dWR5IG9mIDUwIGNhc2VzPC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkNh

bmNlcjwvc2Vjb25kYXJ5LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkNh

bmNlcjwvZnVsbC10aXRsZT48L3BlcmlvZGljYWw+PHBhZ2VzPjE2NjktNzY8L3BhZ2VzPjx2b2x1

bWU+MTA2PC92b2x1bWU+PG51bWJlcj44PC9udW1iZXI+PGVkaXRpb24+MjAwNi8wMy8xNTwvZWRp

dGlvbj48a2V5d29yZHM+PGtleXdvcmQ+QWRlbm9tYSwgT3h5cGhpbGljLypwYXRob2xvZ3kvKnNl

Y29uZGFyeS90aGVyYXB5PC9rZXl3b3JkPjxrZXl3b3JkPkNvbWJpbmVkIE1vZGFsaXR5IFRoZXJh

cHk8L2tleXdvcmQ+PGtleXdvcmQ+RmVtYWxlPC9rZXl3b3JkPjxrZXl3b3JkPkh1bWFuczwva2V5

d29yZD48a2V5d29yZD5NYWxlPC9rZXl3b3JkPjxrZXl3b3JkPk1pZGRsZSBBZ2VkPC9rZXl3b3Jk

PjxrZXl3b3JkPipOZW9wbGFzbSBSZWN1cnJlbmNlLCBMb2NhbDwva2V5d29yZD48a2V5d29yZD5Q

cm9nbm9zaXM8L2tleXdvcmQ+PGtleXdvcmQ+VGh5cm9pZCBOZW9wbGFzbXMvKnBhdGhvbG9neS90

aGVyYXB5PC9rZXl3b3JkPjxrZXl3b3JkPlRoeXJvaWRlY3RvbXk8L2tleXdvcmQ+PC9rZXl3b3Jk

cz48ZGF0ZXM+PHllYXI+MjAwNjwveWVhcj48cHViLWRhdGVzPjxkYXRlPkFwciAxNTwvZGF0ZT48

L3B1Yi1kYXRlcz48L2RhdGVzPjxpc2JuPjAwMDgtNTQzWCAoUHJpbnQpJiN4RDswMDA4LTU0M1gg

KExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Npb24tbnVtPjE2NTM0Nzk2PC9hY2Nlc3Npb24tbnVtPjx1

cmxzPjxyZWxhdGVkLXVybHM+PHVybD5odHRwOi8vd3d3Lm5jYmkubmxtLm5paC5nb3YvcHVibWVk

LzE2NTM0Nzk2PC91cmw+PC9yZWxhdGVkLXVybHM+PC91cmxzPjxlbGVjdHJvbmljLXJlc291cmNl

LW51bT4xMC4xMDAyL2NuY3IuMjE4MjU8L2VsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjxsYW5ndWFn

ZT5lbmc8L2xhbmd1YWdlPjwvcmVjb3JkPjwvQ2l0ZT48Q2l0ZT48QXV0aG9yPlN0b2phZGlub3Zp

YzwvQXV0aG9yPjxZZWFyPjIwMDE8L1llYXI+PFJlY051bT4zMTwvUmVjTnVtPjxyZWNvcmQ+PHJl

Yy1udW1iZXI+MzE8L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRiLWlk

PSJwczJ3d2RzZnJhMnI1ZWU5emFzeHM1dDh6d2R3eHJzd2U1eGEiIHRpbWVzdGFtcD0iMTQ3MzEx

NzEzOCI+MzE8L2tleT48L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRp

Y2xlIj4xNzwvcmVmLXR5cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPlN0b2phZGlu

b3ZpYywgQS48L2F1dGhvcj48YXV0aG9yPkdob3NzZWluLCBSLiBBLjwvYXV0aG9yPjxhdXRob3I+

SG9vcywgQS48L2F1dGhvcj48YXV0aG9yPlVyaXN0LCBNLiBKLjwvYXV0aG9yPjxhdXRob3I+U3Bp

cm8sIFIuIEguPC9hdXRob3I+PGF1dGhvcj5TaGFoLCBKLiBQLjwvYXV0aG9yPjxhdXRob3I+QnJl

bm5hbiwgTS4gRi48L2F1dGhvcj48YXV0aG9yPlNoYWhhLCBBLiBSLjwvYXV0aG9yPjxhdXRob3I+

U2luZ2gsIEIuPC9hdXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjxhdXRoLWFkZHJlc3M+

RGVwYXJ0bWVudCBvZiBTdXJnZXJ5LCBNZW1vcmlhbCBTbG9hbi1LZXR0ZXJpbmcgQ2FuY2VyIENl

bnRlciwgTmV3IFlvcmssIE5ZIDEwMDIxLCBVU0EuPC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48dGl0

bGU+SHVydGhsZSBjZWxsIGNhcmNpbm9tYTogYSBjcml0aWNhbCBoaXN0b3BhdGhvbG9naWMgYXBw

cmFpc2FsPC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkogQ2xpbiBPbmNvbDwvc2Vjb25kYXJ5LXRp

dGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkogQ2xpbiBPbmNvbDwvZnVsbC10

aXRsZT48L3BlcmlvZGljYWw+PHBhZ2VzPjI2MTYtMjU8L3BhZ2VzPjx2b2x1bWU+MTk8L3ZvbHVt

ZT48bnVtYmVyPjEwPC9udW1iZXI+PGVkaXRpb24+MjAwMS8wNS8xNjwvZWRpdGlvbj48a2V5d29y

ZHM+PGtleXdvcmQ+Q2FyY2lub21hL2NsYXNzaWZpY2F0aW9uL21vcnRhbGl0eS8qcGF0aG9sb2d5

L3RoZXJhcHk8L2tleXdvcmQ+PGtleXdvcmQ+Q29tYmluZWQgTW9kYWxpdHkgVGhlcmFweTwva2V5

d29yZD48a2V5d29yZD5EYXRhYmFzZXMsIEZhY3R1YWw8L2tleXdvcmQ+PGtleXdvcmQ+RmVtYWxl

PC9rZXl3b3JkPjxrZXl3b3JkPkh1bWFuczwva2V5d29yZD48a2V5d29yZD5NYWxlPC9rZXl3b3Jk

PjxrZXl3b3JkPk1pZGRsZSBBZ2VkPC9rZXl3b3JkPjxrZXl3b3JkPk5lb3BsYXNtIE1ldGFzdGFz

aXM8L2tleXdvcmQ+PGtleXdvcmQ+UHJvZ25vc2lzPC9rZXl3b3JkPjxrZXl3b3JkPlJlZ2lzdHJp

ZXM8L2tleXdvcmQ+PGtleXdvcmQ+UmV0cm9zcGVjdGl2ZSBTdHVkaWVzPC9rZXl3b3JkPjxrZXl3

b3JkPlRoeXJvaWQgTmVvcGxhc21zL2NsYXNzaWZpY2F0aW9uL21vcnRhbGl0eS8qcGF0aG9sb2d5

L3RoZXJhcHk8L2tleXdvcmQ+PC9rZXl3b3Jkcz48ZGF0ZXM+PHllYXI+MjAwMTwveWVhcj48cHVi

LWRhdGVzPjxkYXRlPk1heSAxNTwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxpc2JuPjA3MzIt

MTgzWCAoUHJpbnQpJiN4RDswNzMyLTE4M1ggKExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Npb24tbnVt

PjExMzUyOTUzPC9hY2Nlc3Npb24tbnVtPjx1cmxzPjxyZWxhdGVkLXVybHM+PHVybD5odHRwOi8v

d3d3Lm5jYmkubmxtLm5paC5nb3YvcHVibWVkLzExMzUyOTUzPC91cmw+PC9yZWxhdGVkLXVybHM+

PC91cmxzPjxsYW5ndWFnZT5lbmc8L2xhbmd1YWdlPjwvcmVjb3JkPjwvQ2l0ZT48L0VuZE5vdGU+

ADDIN EN.CITE.DATA 30-32 In some studies, encapsulated follicular carcinoma, oncocytic variant with 4 or more foci of vascular invasion, has a significant recurrence rate (47%) even if the foci of angioinvasion are microscopic. ADDIN EN.CITE <EndNote><Cite><Author>Ghossein</Author><Year>2006</Year><RecNum>30</RecNum><DisplayText><style face="superscript">31</style></DisplayText><record><rec-number>30</rec-number><foreign-keys><key app="EN" db-id="ps2wwdsfra2r5ee9zasxs5t8zwdwxrswe5xa" timestamp="1473117138">30</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Ghossein, R. A.</author><author>Hiltzik, D. H.</author><author>Carlson, D. L.</author><author>Patel, S.</author><author>Shaha, A.</author><author>Shah, J. P.</author><author>Tuttle, R. M.</author><author>Singh, B.</author></authors></contributors><auth-address>Department of Pathology Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA. ghosseir@</auth-address><titles><title>Prognostic factors of recurrence in encapsulated Hurthle cell carcinoma of the thyroid gland: a clinicopathologic study of 50 cases</title><secondary-title>Cancer</secondary-title></titles><periodical><full-title>Cancer</full-title></periodical><pages>1669-76</pages><volume>106</volume><number>8</number><edition>2006/03/15</edition><keywords><keyword>Adenoma, Oxyphilic/*pathology/*secondary/therapy</keyword><keyword>Combined Modality Therapy</keyword><keyword>Female</keyword><keyword>Humans</keyword><keyword>Male</keyword><keyword>Middle Aged</keyword><keyword>*Neoplasm Recurrence, Local</keyword><keyword>Prognosis</keyword><keyword>Thyroid Neoplasms/*pathology/therapy</keyword><keyword>Thyroidectomy</keyword></keywords><dates><year>2006</year><pub-dates><date>Apr 15</date></pub-dates></dates><isbn>0008-543X (Print)&#xD;0008-543X (Linking)</isbn><accession-num>16534796</accession-num><urls><related-urls><url> On the other hand, another study showed that follicular oncocytic (Hürthle cell) carcinomas with a total of 2 foci of capsular/vascular invasion did not recur after a long follow-up. ADDIN EN.CITE <EndNote><Cite><Author>Stojadinovic</Author><Year>2001</Year><RecNum>31</RecNum><DisplayText><style face="superscript">32</style></DisplayText><record><rec-number>31</rec-number><foreign-keys><key app="EN" db-id="ps2wwdsfra2r5ee9zasxs5t8zwdwxrswe5xa" timestamp="1473117138">31</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Stojadinovic, A.</author><author>Ghossein, R. A.</author><author>Hoos, A.</author><author>Urist, M. J.</author><author>Spiro, R. H.</author><author>Shah, J. P.</author><author>Brennan, M. F.</author><author>Shaha, A. R.</author><author>Singh, B.</author></authors></contributors><auth-address>Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.</auth-address><titles><title>Hurthle cell carcinoma: a critical histopathologic appraisal</title><secondary-title>J Clin Oncol</secondary-title></titles><periodical><full-title>J Clin Oncol</full-title></periodical><pages>2616-25</pages><volume>19</volume><number>10</number><edition>2001/05/16</edition><keywords><keyword>Carcinoma/classification/mortality/*pathology/therapy</keyword><keyword>Combined Modality Therapy</keyword><keyword>Databases, Factual</keyword><keyword>Female</keyword><keyword>Humans</keyword><keyword>Male</keyword><keyword>Middle Aged</keyword><keyword>Neoplasm Metastasis</keyword><keyword>Prognosis</keyword><keyword>Registries</keyword><keyword>Retrospective Studies</keyword><keyword>Thyroid Neoplasms/classification/mortality/*pathology/therapy</keyword></keywords><dates><year>2001</year><pub-dates><date>May 15</date></pub-dates></dates><isbn>0732-183X (Print)&#xD;0732-183X (Linking)</isbn><accession-num>11352953</accession-num><urls><related-urls><url> Moreover, in a series of 4000 thyroid carcinomas of follicular epithelial origin, angioinvasive differentiated thyroid carcinomas that developed distant metastases revealed predominantly a single focus of angioinvasion, and there were no more than 2 foci of vascular invasion. ADDIN EN.CITE <EndNote><Cite><Author>Mete</Author><Year>2011</Year><RecNum>22</RecNum><DisplayText><style face="superscript">27</style></DisplayText><record><rec-number>26</rec-number><foreign-keys><key app="EN" db-id="ps2wwdsfra2r5ee9zasxs5t8zwdwxrswe5xa" timestamp="1473117138">26</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Mete, O.</author><author>Asa, S. L.</author></authors></contributors><auth-address>Department of Pathology, University Health Network, Toronto, Ontario, Canada. Ozgur.Mete2@uhn.on.ca</auth-address><titles><title>Pathological definition and clinical significance of vascular invasion in thyroid carcinomas of follicular epithelial derivation</title><secondary-title>Mod Pathol</secondary-title></titles><periodical><full-title>Mod Pathol</full-title></periodical><pages>1545-52</pages><volume>24</volume><number>12</number><edition>2011/08/02</edition><keywords><keyword>Adenocarcinoma, Follicular</keyword><keyword>Artifacts</keyword><keyword>Autopsy</keyword><keyword>Biopsy</keyword><keyword>Blood Vessels/*pathology</keyword><keyword>Carcinoma</keyword><keyword>Cell Differentiation</keyword><keyword>Epithelial Cells/*pathology</keyword><keyword>Humans</keyword><keyword>Immunohistochemistry</keyword><keyword>Neoplasm Invasiveness</keyword><keyword>Predictive Value of Tests</keyword><keyword>Prognosis</keyword><keyword>Retrospective Studies</keyword><keyword>Thyroid Neoplasms/*pathology/secondary</keyword><keyword>Time Factors</keyword></keywords><dates><year>2011</year><pub-dates><date>Dec</date></pub-dates></dates><isbn>1530-0285 (Electronic)&#xD;0893-3952 (Linking)</isbn><accession-num>21804527</accession-num><urls><related-urls><url> [pii]</electronic-resource-num><language>eng</language></record></Cite></EndNote>27 Thus, the use of appropriate criteria seems to be more critical than the number of involved vessels. ADDIN EN.CITE <EndNote><Cite><Author>Mete</Author><Year>2011</Year><RecNum>22</RecNum><DisplayText><style face="superscript">27</style></DisplayText><record><rec-number>26</rec-number><foreign-keys><key app="EN" db-id="ps2wwdsfra2r5ee9zasxs5t8zwdwxrswe5xa" timestamp="1473117138">26</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Mete, O.</author><author>Asa, S. L.</author></authors></contributors><auth-address>Department of Pathology, University Health Network, Toronto, Ontario, Canada. Ozgur.Mete2@uhn.on.ca</auth-address><titles><title>Pathological definition and clinical significance of vascular invasion in thyroid carcinomas of follicular epithelial derivation</title><secondary-title>Mod Pathol</secondary-title></titles><periodical><full-title>Mod Pathol</full-title></periodical><pages>1545-52</pages><volume>24</volume><number>12</number><edition>2011/08/02</edition><keywords><keyword>Adenocarcinoma, Follicular</keyword><keyword>Artifacts</keyword><keyword>Autopsy</keyword><keyword>Biopsy</keyword><keyword>Blood Vessels/*pathology</keyword><keyword>Carcinoma</keyword><keyword>Cell Differentiation</keyword><keyword>Epithelial Cells/*pathology</keyword><keyword>Humans</keyword><keyword>Immunohistochemistry</keyword><keyword>Neoplasm Invasiveness</keyword><keyword>Predictive Value of Tests</keyword><keyword>Prognosis</keyword><keyword>Retrospective Studies</keyword><keyword>Thyroid Neoplasms/*pathology/secondary</keyword><keyword>Time Factors</keyword></keywords><dates><year>2011</year><pub-dates><date>Dec</date></pub-dates></dates><isbn>1530-0285 (Electronic)&#xD;0893-3952 (Linking)</isbn><accession-num>21804527</accession-num><urls><related-urls><url> [pii]</electronic-resource-num><language>eng</language></record></Cite></EndNote>27 Figure 3. Vascular invasion (VI): Schematic drawing for the interpretation of the presence or absence of significant VI. The diagram depicts a follicular neoplasm (green) surrounded by a fibrous capsule (tan). The driving concepts behind significant VI are penetration through the vessel wall and a reaction to the vascular deposit, namely thrombus formation, which may range from subtle and fibrinoid in nature to large and heavily organized. ADDIN EN.CITE <EndNote><Cite><Author>Mete</Author><Year>2011</Year><RecNum>22</RecNum><DisplayText><style face="superscript">27</style></DisplayText><record><rec-number>26</rec-number><foreign-keys><key app="EN" db-id="ps2wwdsfra2r5ee9zasxs5t8zwdwxrswe5xa" timestamp="1473117138">26</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Mete, O.</author><author>Asa, S. L.</author></authors></contributors><auth-address>Department of Pathology, University Health Network, Toronto, Ontario, Canada. Ozgur.Mete2@uhn.on.ca</auth-address><titles><title>Pathological definition and clinical significance of vascular invasion in thyroid carcinomas of follicular epithelial derivation</title><secondary-title>Mod Pathol</secondary-title></titles><periodical><full-title>Mod Pathol</full-title></periodical><pages>1545-52</pages><volume>24</volume><number>12</number><edition>2011/08/02</edition><keywords><keyword>Adenocarcinoma, Follicular</keyword><keyword>Artifacts</keyword><keyword>Autopsy</keyword><keyword>Biopsy</keyword><keyword>Blood Vessels/*pathology</keyword><keyword>Carcinoma</keyword><keyword>Cell Differentiation</keyword><keyword>Epithelial Cells/*pathology</keyword><keyword>Humans</keyword><keyword>Immunohistochemistry</keyword><keyword>Neoplasm Invasiveness</keyword><keyword>Predictive Value of Tests</keyword><keyword>Prognosis</keyword><keyword>Retrospective Studies</keyword><keyword>Thyroid Neoplasms/*pathology/secondary</keyword><keyword>Time Factors</keyword></keywords><dates><year>2011</year><pub-dates><date>Dec</date></pub-dates></dates><isbn>1530-0285 (Electronic)&#xD;0893-3952 (Linking)</isbn><accession-num>21804527</accession-num><urls><related-urls><url> [pii]</electronic-resource-num><language>eng</language></record></Cite></EndNote>27 A through C represent scenarios where tumor in vessels are not counted as VI. A. Free-floating irregular tumor fragments often result from artifactual displacement. B. Tumor bulging and indenting the vessel wall does not count as VI. C. Endothelialized tumor floating in an intracapsular vessel may result from tangential sectioning of tumor bulging into a vessel, often at a branch or bifurcation. These findings can however prompt deeper levels (at least by 3) to exclude definitive VI (see E through G).**** D represents a common but contentious scenario among experts, in light of these new proposed criteria for significant VI. This endothelialized tumor deposit is juxtaposed to the vessel wall. As this is somewhat similar to C, and there is no obvious thrombus, technically this would not count as significant VI. One counterargument is that the endothelialized appearance represents “organization” of a tumor thrombus and is thus still significant. While deeper levels may help, this scenario may still be considered a “judgment call” based on current level of evidence. E through G represent unequivocal VI. E. Tumor is juxtaposed to vessel wall and is associated with a thrombus. F.?Tumor penetrating vessel wall also demonstrating thrombus formation at its neck. G. Tumor fragments in intermingled with an organized thrombus and adherent to vessel wall. Note: While there is no standard definition of “deeper levels,” generally, each level is at a certain interval (ie, 3 serial sections deeper or 15-micron intervals) below the original H&E rather than an immediate serial section. Original concept for schematic from Fletcher CDM, ed. Diagnostic Histopathology of Tumours. 3rd ed. Edinburgh; Churchill Livingstone Elsevier; 2007. Modified with permission. ? Elsevier.K. Extrathyroidal ExtensionExtrathyroidal extension refers to involvement of the perithyroidal tissues by a primary thyroid cancer. Since the thyroid gland does not have a well-defined capsule, ADDIN EN.CITE <EndNote><Cite><Author>Mete</Author><Year>2010</Year><RecNum>32</RecNum><DisplayText><style face="superscript">33</style></DisplayText><record><rec-number>32</rec-number><foreign-keys><key app="EN" db-id="ps2wwdsfra2r5ee9zasxs5t8zwdwxrswe5xa" timestamp="1473117138">32</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Mete, O.</author><author>Rotstein, L.</author><author>Asa, S. L.</author></authors></contributors><auth-address>Department of Pathology, University Health Network, University of Toronto, Toronto, ON, Canada.</auth-address><titles><title>Controversies in thyroid pathology: thyroid capsule invasion and extrathyroidal extension</title><secondary-title>Ann Surg Oncol</secondary-title></titles><periodical><full-title>Ann Surg Oncol</full-title></periodical><pages>386-91</pages><volume>17</volume><number>2</number><edition>2009/12/02</edition><keywords><keyword>Connective Tissue/*pathology</keyword><keyword>Humans</keyword><keyword>Neoplasm Invasiveness</keyword><keyword>Neoplasm Staging</keyword><keyword>Prognosis</keyword><keyword>Thyroid Gland/anatomy &amp; histology</keyword><keyword>Thyroid Neoplasms/*pathology</keyword></keywords><dates><year>2010</year><pub-dates><date>Feb</date></pub-dates></dates><isbn>1534-4681 (Electronic)&#xD;1068-9265 (Linking)</isbn><accession-num>19949881</accession-num><urls><related-urls><url> the definition of extrathyroidal extension has been problematic and subjective. On gross examination, the capsule may appear complete, but evidence has shown that microscopically the capsule is focally incomplete or absent in a majority of thyroid glands evaluated at autopsy. ADDIN EN.CITE <EndNote><Cite><Author>Komorowski</Author><Year>1988</Year><RecNum>13</RecNum><DisplayText><style face="superscript">14</style></DisplayText><record><rec-number>13</rec-number><foreign-keys><key app="EN" db-id="ps2wwdsfra2r5ee9zasxs5t8zwdwxrswe5xa" timestamp="1473117137">13</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Komorowski, R. A.</author><author>Hanson, G. A.</author></authors></contributors><auth-address>Department of Pathology, Medical College of Wisconsin, Milwaukee 53226.</auth-address><titles><title>Occult thyroid pathology in the young adult: an autopsy study of 138 patients without clinical thyroid disease</title><secondary-title>Hum Pathol</secondary-title></titles><periodical><full-title>Hum Pathol</full-title></periodical><pages>689-96</pages><volume>19</volume><number>6</number><edition>1988/06/01</edition><keywords><keyword>Adenoma/diagnosis/pathology</keyword><keyword>Adult</keyword><keyword>Carcinoma, Papillary/diagnosis/pathology</keyword><keyword>Female</keyword><keyword>Fibrosis/pathology</keyword><keyword>Humans</keyword><keyword>Lymphocytes/pathology</keyword><keyword>Male</keyword><keyword>Thyroid Diseases/diagnosis/*pathology</keyword><keyword>Thyroid Gland/*pathology</keyword><keyword>Thyroid Neoplasms/diagnosis/pathology/secondary</keyword></keywords><dates><year>1988</year><pub-dates><date>Jun</date></pub-dates></dates><isbn>0046-8177 (Print)&#xD;0046-8177 (Linking)</isbn><accession-num>3378788</accession-num><urls><related-urls><url> The perithyroidal tissues include sizable blood vessels as well as small peripheral nerves and are continuous with the pretracheal fascia. ADDIN EN.CITE <EndNote><Cite><Author>Standring</Author><Year>2005</Year><RecNum>33</RecNum><DisplayText><style face="superscript">34</style></DisplayText><record><rec-number>33</rec-number><foreign-keys><key app="EN" db-id="ps2wwdsfra2r5ee9zasxs5t8zwdwxrswe5xa" timestamp="1473117139">33</key></foreign-keys><ref-type name="Book Section">5</ref-type><contributors><authors><author>Standring, S.</author></authors><secondary-authors><author>Standring, S.</author></secondary-authors></contributors><titles><title>Thyroid gland</title><secondary-title>Gray&apos;s anatomy: the anatomical basis of clinical practice</secondary-title></titles><pages>560-564</pages><dates><year>2005</year></dates><pub-location>Edinburgh</pub-location><publisher>Elsevieer Churchill Livingstone</publisher><urls></urls></record></Cite></EndNote>34 Extension into adipose tissue is a problematic criterion if used alone, given the fact that adipose tissue can be found within the thyroid gland proper under normal conditions and also may be a component of a variety of thyroid lesions including carcinomas.PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5HbmVwcDwvQXV0aG9yPjxZZWFyPjE5ODk8L1llYXI+PFJl

Y051bT4zNDwvUmVjTnVtPjxEaXNwbGF5VGV4dD48c3R5bGUgZmFjZT0ic3VwZXJzY3JpcHQiPjI2

LDM1PC9zdHlsZT48L0Rpc3BsYXlUZXh0PjxyZWNvcmQ+PHJlYy1udW1iZXI+MzQ8L3JlYy1udW1i

ZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRiLWlkPSJwczJ3d2RzZnJhMnI1ZWU5emFz

eHM1dDh6d2R3eHJzd2U1eGEiIHRpbWVzdGFtcD0iMTQ3MzExNzEzOSI+MzQ8L2tleT48L2ZvcmVp

Z24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5cGU+PGNv

bnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPkduZXBwLCBELiBSLjwvYXV0aG9yPjxhdXRob3I+

T2dvcnphbGVrLCBKLiBNLjwvYXV0aG9yPjxhdXRob3I+SGVmZmVzcywgQy4gUy48L2F1dGhvcj48

L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PGF1dGgtYWRkcmVzcz5EZXBhcnRtZW50IG9mIFBhdGhv

bG9neSwgU3QuIExvdWlzIFVuaXZlcnNpdHkgU2Nob29sIG9mIE1lZGljaW5lLCBNaXNzb3VyaS48

L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5GYXQtY29udGFpbmluZyBsZXNpb25zIG9mIHRo

ZSB0aHlyb2lkIGdsYW5kPC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkFtIEogU3VyZyBQYXRob2w8

L3NlY29uZGFyeS10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5BbSBKIFN1

cmcgUGF0aG9sPC9mdWxsLXRpdGxlPjwvcGVyaW9kaWNhbD48cGFnZXM+NjA1LTEyPC9wYWdlcz48

dm9sdW1lPjEzPC92b2x1bWU+PG51bWJlcj43PC9udW1iZXI+PGVkaXRpb24+MTk4OS8wNy8wMTwv

ZWRpdGlvbj48a2V5d29yZHM+PGtleXdvcmQ+QWRpcG9zZSBUaXNzdWUvKnBhdGhvbG9neTwva2V5

d29yZD48a2V5d29yZD5BZG9sZXNjZW50PC9rZXl3b3JkPjxrZXl3b3JkPkFkdWx0PC9rZXl3b3Jk

PjxrZXl3b3JkPkFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+Q2hpbGQ8L2tleXdvcmQ+PGtleXdvcmQ+

RmVtYWxlPC9rZXl3b3JkPjxrZXl3b3JkPkdvaXRlci9wYXRob2xvZ3k8L2tleXdvcmQ+PGtleXdv

cmQ+SHVtYW5zPC9rZXl3b3JkPjxrZXl3b3JkPk1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+TWlkZGxl

IEFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+VGh5cm9pZCBEaXNlYXNlcy8qcGF0aG9sb2d5PC9rZXl3

b3JkPjxrZXl3b3JkPlRoeXJvaWQgR2xhbmQvKnBhdGhvbG9neTwva2V5d29yZD48a2V5d29yZD5U

aHlyb2lkIE5lb3BsYXNtcy9wYXRob2xvZ3k8L2tleXdvcmQ+PC9rZXl3b3Jkcz48ZGF0ZXM+PHll

YXI+MTk4OTwveWVhcj48cHViLWRhdGVzPjxkYXRlPkp1bDwvZGF0ZT48L3B1Yi1kYXRlcz48L2Rh

dGVzPjxpc2JuPjAxNDctNTE4NSAoUHJpbnQpJiN4RDswMTQ3LTUxODUgKExpbmtpbmcpPC9pc2Ju

PjxhY2Nlc3Npb24tbnVtPjI2NjA2MTE8L2FjY2Vzc2lvbi1udW0+PHVybHM+PHJlbGF0ZWQtdXJs

cz48dXJsPmh0dHA6Ly93d3cubmNiaS5ubG0ubmloLmdvdi9wdWJtZWQvMjY2MDYxMTwvdXJsPjwv

cmVsYXRlZC11cmxzPjwvdXJscz48bGFuZ3VhZ2U+ZW5nPC9sYW5ndWFnZT48L3JlY29yZD48L0Np

dGU+PENpdGU+PEF1dGhvcj5Sb3NhaTwvQXV0aG9yPjxZZWFyPjE5OTI8L1llYXI+PFJlY051bT4y

NTwvUmVjTnVtPjxyZWNvcmQ+PHJlYy1udW1iZXI+MjU8L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5

cz48a2V5IGFwcD0iRU4iIGRiLWlkPSJwczJ3d2RzZnJhMnI1ZWU5emFzeHM1dDh6d2R3eHJzd2U1

eGEiIHRpbWVzdGFtcD0iMTQ3MzExNzEzOCI+MjU8L2tleT48L2ZvcmVpZ24ta2V5cz48cmVmLXR5

cGUgbmFtZT0iQm9vayI+NjwvcmVmLXR5cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9y

PlJvc2FpLCBKLjwvYXV0aG9yPjxhdXRob3I+Q2FyY2FuZ2l1LCBNLkwuPC9hdXRob3I+PGF1dGhv

cj5EZUxlbGxpcywgUi5BLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48dGl0bGVz

Pjx0aXRsZT5BdGxhcyBvZiB0dW1vciBwYXRob2xvZ3kuIFR1bW9ycyBvZiB0aGUgdGh5cm9pZCBn

bGFuZC48L3RpdGxlPjwvdGl0bGVzPjx2b2x1bWU+RmFzY2ljbGUgNTwvdm9sdW1lPjxlZGl0aW9u

PjNyZDwvZWRpdGlvbj48ZGF0ZXM+PHllYXI+MTk5MjwveWVhcj48L2RhdGVzPjxwdWItbG9jYXRp

b24+V2FzaGluZ3RvbiBELkMuPC9wdWItbG9jYXRpb24+PHB1Ymxpc2hlcj5Bcm1lZCBGb3JjZXMg

SW5zdGl0dXRlIG9mIFBhdGhvbG9neTwvcHVibGlzaGVyPjx1cmxzPjwvdXJscz48L3JlY29yZD48

L0NpdGU+PC9FbmROb3RlPn==

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5HbmVwcDwvQXV0aG9yPjxZZWFyPjE5ODk8L1llYXI+PFJl

Y051bT4zNDwvUmVjTnVtPjxEaXNwbGF5VGV4dD48c3R5bGUgZmFjZT0ic3VwZXJzY3JpcHQiPjI2

LDM1PC9zdHlsZT48L0Rpc3BsYXlUZXh0PjxyZWNvcmQ+PHJlYy1udW1iZXI+MzQ8L3JlYy1udW1i

ZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRiLWlkPSJwczJ3d2RzZnJhMnI1ZWU5emFz

eHM1dDh6d2R3eHJzd2U1eGEiIHRpbWVzdGFtcD0iMTQ3MzExNzEzOSI+MzQ8L2tleT48L2ZvcmVp

Z24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5cGU+PGNv

bnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPkduZXBwLCBELiBSLjwvYXV0aG9yPjxhdXRob3I+

T2dvcnphbGVrLCBKLiBNLjwvYXV0aG9yPjxhdXRob3I+SGVmZmVzcywgQy4gUy48L2F1dGhvcj48

L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PGF1dGgtYWRkcmVzcz5EZXBhcnRtZW50IG9mIFBhdGhv

bG9neSwgU3QuIExvdWlzIFVuaXZlcnNpdHkgU2Nob29sIG9mIE1lZGljaW5lLCBNaXNzb3VyaS48

L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5GYXQtY29udGFpbmluZyBsZXNpb25zIG9mIHRo

ZSB0aHlyb2lkIGdsYW5kPC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkFtIEogU3VyZyBQYXRob2w8

L3NlY29uZGFyeS10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5BbSBKIFN1

cmcgUGF0aG9sPC9mdWxsLXRpdGxlPjwvcGVyaW9kaWNhbD48cGFnZXM+NjA1LTEyPC9wYWdlcz48

dm9sdW1lPjEzPC92b2x1bWU+PG51bWJlcj43PC9udW1iZXI+PGVkaXRpb24+MTk4OS8wNy8wMTwv

ZWRpdGlvbj48a2V5d29yZHM+PGtleXdvcmQ+QWRpcG9zZSBUaXNzdWUvKnBhdGhvbG9neTwva2V5

d29yZD48a2V5d29yZD5BZG9sZXNjZW50PC9rZXl3b3JkPjxrZXl3b3JkPkFkdWx0PC9rZXl3b3Jk

PjxrZXl3b3JkPkFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+Q2hpbGQ8L2tleXdvcmQ+PGtleXdvcmQ+

RmVtYWxlPC9rZXl3b3JkPjxrZXl3b3JkPkdvaXRlci9wYXRob2xvZ3k8L2tleXdvcmQ+PGtleXdv

cmQ+SHVtYW5zPC9rZXl3b3JkPjxrZXl3b3JkPk1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+TWlkZGxl

IEFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+VGh5cm9pZCBEaXNlYXNlcy8qcGF0aG9sb2d5PC9rZXl3

b3JkPjxrZXl3b3JkPlRoeXJvaWQgR2xhbmQvKnBhdGhvbG9neTwva2V5d29yZD48a2V5d29yZD5U

aHlyb2lkIE5lb3BsYXNtcy9wYXRob2xvZ3k8L2tleXdvcmQ+PC9rZXl3b3Jkcz48ZGF0ZXM+PHll

YXI+MTk4OTwveWVhcj48cHViLWRhdGVzPjxkYXRlPkp1bDwvZGF0ZT48L3B1Yi1kYXRlcz48L2Rh

dGVzPjxpc2JuPjAxNDctNTE4NSAoUHJpbnQpJiN4RDswMTQ3LTUxODUgKExpbmtpbmcpPC9pc2Ju

PjxhY2Nlc3Npb24tbnVtPjI2NjA2MTE8L2FjY2Vzc2lvbi1udW0+PHVybHM+PHJlbGF0ZWQtdXJs

cz48dXJsPmh0dHA6Ly93d3cubmNiaS5ubG0ubmloLmdvdi9wdWJtZWQvMjY2MDYxMTwvdXJsPjwv

cmVsYXRlZC11cmxzPjwvdXJscz48bGFuZ3VhZ2U+ZW5nPC9sYW5ndWFnZT48L3JlY29yZD48L0Np

dGU+PENpdGU+PEF1dGhvcj5Sb3NhaTwvQXV0aG9yPjxZZWFyPjE5OTI8L1llYXI+PFJlY051bT4y

NTwvUmVjTnVtPjxyZWNvcmQ+PHJlYy1udW1iZXI+MjU8L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5

cz48a2V5IGFwcD0iRU4iIGRiLWlkPSJwczJ3d2RzZnJhMnI1ZWU5emFzeHM1dDh6d2R3eHJzd2U1

eGEiIHRpbWVzdGFtcD0iMTQ3MzExNzEzOCI+MjU8L2tleT48L2ZvcmVpZ24ta2V5cz48cmVmLXR5

cGUgbmFtZT0iQm9vayI+NjwvcmVmLXR5cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9y

PlJvc2FpLCBKLjwvYXV0aG9yPjxhdXRob3I+Q2FyY2FuZ2l1LCBNLkwuPC9hdXRob3I+PGF1dGhv

cj5EZUxlbGxpcywgUi5BLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48dGl0bGVz

Pjx0aXRsZT5BdGxhcyBvZiB0dW1vciBwYXRob2xvZ3kuIFR1bW9ycyBvZiB0aGUgdGh5cm9pZCBn

bGFuZC48L3RpdGxlPjwvdGl0bGVzPjx2b2x1bWU+RmFzY2ljbGUgNTwvdm9sdW1lPjxlZGl0aW9u

PjNyZDwvZWRpdGlvbj48ZGF0ZXM+PHllYXI+MTk5MjwveWVhcj48L2RhdGVzPjxwdWItbG9jYXRp

b24+V2FzaGluZ3RvbiBELkMuPC9wdWItbG9jYXRpb24+PHB1Ymxpc2hlcj5Bcm1lZCBGb3JjZXMg

SW5zdGl0dXRlIG9mIFBhdGhvbG9neTwvcHVibGlzaGVyPjx1cmxzPjwvdXJscz48L3JlY29yZD48

L0NpdGU+PC9FbmROb3RlPn==

ADDIN EN.CITE.DATA 26,35 Given this state of variability, microscopic extrathyroidal extension that is not grossly evident is no longer a criterion for upstaging. The T stages, pT3b, pT4a, pT4b, are now defined by extrathyroidal extension into at least skeletal muscle, which then necessitates review of macroscopic, intraoperative, and radiologic findings. As such, a thorough gross examination and review of the operative and radiologic findings are now essentially required to document the “gross” extrathyroidal extension required to upstage a tumor. L. Lymph NodesRegional Lymph NodesRegional lymph node spread from thyroid cancer is common but of less prognostic significance in patients with well-differentiated tumors (papillary) than in medullary cancers. The adverse prognostic influence of lymph node metastasis in patients with differentiated carcinomas is observed only in the older age group. ADDIN EN.CITE <EndNote><Cite><Author>Tuttle</Author><Year>2017</Year><RecNum>1</RecNum><DisplayText><style face="superscript">1</style></DisplayText><record><rec-number>1</rec-number><foreign-keys><key app="EN" db-id="ps2wwdsfra2r5ee9zasxs5t8zwdwxrswe5xa" timestamp="1473117135">1</key></foreign-keys><ref-type name="Book Section">5</ref-type><contributors><authors><author>Tuttle, R.M.</author><author>Morris, L.F.</author><author>Haugen, B.R. </author><author>Shah, J.P </author><author>Sosa, J.A.</author><author>Rohren, E.</author><author>Subramaniam, R. M.</author><author>Hunt, J.L.</author><author>Perrier, N.D</author></authors><secondary-authors><author>Amin, M.B.</author></secondary-authors></contributors><titles><title>Thyroid- differentiated and anaplastic carcinoma</title><secondary-title>AJCC Cancer Staging Manual</secondary-title></titles><edition>8th</edition><dates><year>2017</year></dates><pub-location>New York, NY</pub-location><publisher>Springer</publisher><urls></urls></record></Cite></EndNote>1 In comparison to macrometastatic disease, micrometastases in thyroid cancer of follicular cell differentiation are of even less clinical value. Based on a few studies to date, micrometastasis does not appear to confer an increased risk of locoregional recurrence as compared to node-negative patients and does not likely warrant more aggressive intervention.36,37 HYPERLINK \l "_ENREF_40" \o "Urken, 2013 #39" The same holds true for isolated tumor cells and psammomatous calcifications (psammoma bodies) only in lymph nodes. Reporting of “psammoma bodies only” in lymph nodes is not well defined. While indolent, they do indicate capacity for lymphatic spread and are considered pN1a. On the other end of the spectrum, larger size of lymph node metastases can confer a higher risk of locoregional recurrence, and the American Thyroid Association thus advocates reporting of the size of the largest metastatic focus.38 Currently no established cut-offs for size on for macro- or micrometastases. ADDIN EN.CITE <EndNote><Cite><Author>Rosen</Author><Year>2017</Year><RecNum>46</RecNum><DisplayText><style face="superscript">1,2</style></DisplayText><record><rec-number>46</rec-number><foreign-keys><key app="EN" db-id="ps2wwdsfra2r5ee9zasxs5t8zwdwxrswe5xa" timestamp="1473120927">46</key></foreign-keys><ref-type name="Book Section">5</ref-type><contributors><authors><author>Rosen, J.E.</author><author>Lloyd, R.V.</author><author>Brierley, J.D.</author><author>Grogan, R.H.</author><author>Haddad, R.</author><author>Hunt, J.L.</author><author>Ridge, J.A.</author><author>Seethala, R.R.</author><author>Sosa, J.A.</author><author>Subramaniam, R.M.</author><author>Wang, T.S.</author><author>Wirth, L.J. </author><author>Perrier, N.D.</author></authors><secondary-authors><author>Amin, M.B.</author></secondary-authors></contributors><titles><title>Thyroid- Medullary</title><secondary-title>AJCC Cancer Staging Manual</secondary-title></titles><edition>8th</edition><dates><year>2017</year></dates><pub-location>New York, NY</pub-location><publisher>Springer</publisher><urls></urls></record></Cite><Cite><Author>Tuttle</Author><Year>2017</Year><RecNum>1</RecNum><record><rec-number>1</rec-number><foreign-keys><key app="EN" db-id="ps2wwdsfra2r5ee9zasxs5t8zwdwxrswe5xa" timestamp="1473117135">1</key></foreign-keys><ref-type name="Book Section">5</ref-type><contributors><authors><author>Tuttle, R.M.</author><author>Morris, L.F.</author><author>Haugen, B.R. </author><author>Shah, J.P </author><author>Sosa, J.A.</author><author>Rohren, E.</author><author>Subramaniam, R. M.</author><author>Hunt, J.L.</author><author>Perrier, N.D</author></authors><secondary-authors><author>Amin, M.B.</author></secondary-authors></contributors><titles><title>Thyroid- differentiated and anaplastic carcinoma</title><secondary-title>AJCC Cancer Staging Manual</secondary-title></titles><edition>8th</edition><dates><year>2017</year></dates><pub-location>New York, NY</pub-location><publisher>Springer</publisher><urls></urls></record></Cite></EndNote>1,2Classification of Neck Dissection1.Radical neck dissection2.Modified radical neck dissection, internal jugular vein and/or sternocleidomastoid muscle spared3.Selective neck dissection (SND), as specified by the surgeon, with levels and sublevels designated (see Figure 3),39,40 such as:a.Supraomohyoid neck dissectionb.Posterolateral neck dissectionc.Lateral neck dissectiond.Central compartment neck dissection4.Superselecteive neck dissection, as specific by the surgeon5. Extended radical neck dissection, as specified by the surgeonThe first echelon of nodal metastasis consists of the paralaryngeal, paratracheal, and prelaryngeal (Delphian) nodes adjacent to the thyroid gland in the central compartment of the neck, generally described as level VI. ADDIN EN.CITE <EndNote><Cite><Author>Tuttle</Author><Year>2017</Year><RecNum>1</RecNum><DisplayText><style face="superscript">1</style></DisplayText><record><rec-number>1</rec-number><foreign-keys><key app="EN" db-id="ps2wwdsfra2r5ee9zasxs5t8zwdwxrswe5xa" timestamp="1473117135">1</key></foreign-keys><ref-type name="Book Section">5</ref-type><contributors><authors><author>Tuttle, R.M.</author><author>Morris, L.F.</author><author>Haugen, B.R. </author><author>Shah, J.P </author><author>Sosa, J.A.</author><author>Rohren, E.</author><author>Subramaniam, R. M.</author><author>Hunt, J.L.</author><author>Perrier, N.D</author></authors><secondary-authors><author>Amin, M.B.</author></secondary-authors></contributors><titles><title>Thyroid- differentiated and anaplastic carcinoma</title><secondary-title>AJCC Cancer Staging Manual</secondary-title></titles><edition>8th</edition><dates><year>2017</year></dates><pub-location>New York, NY</pub-location><publisher>Springer</publisher><urls></urls></record></Cite></EndNote>1 Metastases secondarily involve the mid- and lower jugular, the supraclavicular, and (much less commonly) the upper deep jugular and spinal accessory lymph nodes. ADDIN EN.CITE <EndNote><Cite><Author>Tuttle</Author><Year>2017</Year><RecNum>1</RecNum><DisplayText><style face="superscript">1</style></DisplayText><record><rec-number>1</rec-number><foreign-keys><key app="EN" db-id="ps2wwdsfra2r5ee9zasxs5t8zwdwxrswe5xa" timestamp="1473117135">1</key></foreign-keys><ref-type name="Book Section">5</ref-type><contributors><authors><author>Tuttle, R.M.</author><author>Morris, L.F.</author><author>Haugen, B.R. </author><author>Shah, J.P </author><author>Sosa, J.A.</author><author>Rohren, E.</author><author>Subramaniam, R. M.</author><author>Hunt, J.L.</author><author>Perrier, N.D</author></authors><secondary-authors><author>Amin, M.B.</author></secondary-authors></contributors><titles><title>Thyroid- differentiated and anaplastic carcinoma</title><secondary-title>AJCC Cancer Staging Manual</secondary-title></titles><edition>8th</edition><dates><year>2017</year></dates><pub-location>New York, NY</pub-location><publisher>Springer</publisher><urls></urls></record></Cite></EndNote>1 Lymph node metastasis to submandibular and submental lymph nodes is very rare. Upper mediastinal (level VII) nodal spread occurs frequently both anteriorly and posteriorly. Retropharyngeal nodal metastasis may be seen, usually in the presence of extensive lateral cervical metastasis. ADDIN EN.CITE <EndNote><Cite><Author>Tuttle</Author><Year>2017</Year><RecNum>1</RecNum><DisplayText><style face="superscript">1</style></DisplayText><record><rec-number>1</rec-number><foreign-keys><key app="EN" db-id="ps2wwdsfra2r5ee9zasxs5t8zwdwxrswe5xa" timestamp="1473117135">1</key></foreign-keys><ref-type name="Book Section">5</ref-type><contributors><authors><author>Tuttle, R.M.</author><author>Morris, L.F.</author><author>Haugen, B.R. </author><author>Shah, J.P </author><author>Sosa, J.A.</author><author>Rohren, E.</author><author>Subramaniam, R. M.</author><author>Hunt, J.L.</author><author>Perrier, N.D</author></authors><secondary-authors><author>Amin, M.B.</author></secondary-authors></contributors><titles><title>Thyroid- differentiated and anaplastic carcinoma</title><secondary-title>AJCC Cancer Staging Manual</secondary-title></titles><edition>8th</edition><dates><year>2017</year></dates><pub-location>New York, NY</pub-location><publisher>Springer</publisher><urls></urls></record></Cite></EndNote>1 Bilateral nodal spread is common. The components of the N category are described as follows: first echelon (perithyroidal/central compartment/level VI and/or superior mediastinal/level VII), or N1a; and lateral cervical/level I-V, or N1b. Commonly utilized surgical techniques for compartmental dissection often result in varying portions of the central compartment being resected en bloc with the thyroidectomy specimen, thus “perithyroidal” lymph nodes seen here are counted towards the N status of the patient (in addition to other parts formally labeled as central compartment or level VI).41 The lymph node metastasis should also be described according to the level of the neck that is involved. In comparison to metastatic head and neck squamous cell carcinoma, the risk for increased locoregional disease and distant metastasis in the presence of extranodal extension of thyroid cancer is not as widely validated, although several studies have shown an increase risk for distant metastases and death in the presence of extranodal extension.38,42,43 Therefore, as a recommendation, the pathologist should comment on the presence or absence of extranodal extension. Nodal metastases from medullary thyroid cancer carry a much more ominous prognosis, although they follow a similar pattern of spread. For purposes of pathologic evaluation, lymph nodes are organized by levels as shown in Figure 4.44Figure 4. The 6 sublevels of the neck for describing the location of lymph nodes within levels I, II, and V. Level IA, submental group; level IB, submandibular group; level IIA, upper jugular nodes along the carotid sheath, including the subdigastric group; level IIB, upper jugular nodes in the submuscular recess; level VA, spinal accessory nodes; and level VB, the supraclavicular and transverse cervical nodes. From Flint PW, et al, eds. Cummings Otolaryngology: Head and Neck Surgery. 5th ed. Philadelphia, PA; Saunders: 2010. Reproduced with permission. ??Elsevier.In order for pathologists to properly identify these nodes, they must be familiar with the terminology of the regional lymph node groups and with the relationships of those groups to the regional anatomy. Which lymph node groups surgeons submit for histopathologic evaluation depends on the type of neck dissection they perform. Therefore, surgeons must supply information on the types of neck dissections that they perform and on the details of the local anatomy in the specimens they submit for examination, or in other ways orient those specimens for pathologists.PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Sb2JiaW5zPC9BdXRob3I+PFllYXI+MTk5MTwvWWVhcj48

UmVjTnVtPjM2PC9SZWNOdW0+PERpc3BsYXlUZXh0PjxzdHlsZSBmYWNlPSJzdXBlcnNjcmlwdCI+

MzcsMzg8L3N0eWxlPjwvRGlzcGxheVRleHQ+PHJlY29yZD48cmVjLW51bWJlcj4zNjwvcmVjLW51

bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9InBzMnd3ZHNmcmEycjVlZTl6

YXN4czV0OHp3ZHd4cnN3ZTV4YSIgdGltZXN0YW1wPSIxNDczMTE3MTM5Ij4zNjwva2V5PjwvZm9y

ZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9yZWYtdHlwZT48

Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+Um9iYmlucywgSy4gVC48L2F1dGhvcj48YXV0

aG9yPk1lZGluYSwgSi4gRS48L2F1dGhvcj48YXV0aG9yPldvbGZlLCBHLiBULjwvYXV0aG9yPjxh

dXRob3I+TGV2aW5lLCBQLiBBLjwvYXV0aG9yPjxhdXRob3I+U2Vzc2lvbnMsIFIuIEIuPC9hdXRo

b3I+PGF1dGhvcj5QcnVldCwgQy4gVy48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+

PGF1dGgtYWRkcmVzcz5TYW4gRGllZ28gQ2FuY2VyIENlbnRlciwgVW5pdmVyc2l0eSBvZiBDYWxp

Zm9ybmlhIDkyMTAzLjwvYXV0aC1hZGRyZXNzPjx0aXRsZXM+PHRpdGxlPlN0YW5kYXJkaXppbmcg

bmVjayBkaXNzZWN0aW9uIHRlcm1pbm9sb2d5LiBPZmZpY2lhbCByZXBvcnQgb2YgdGhlIEFjYWRl

bXkmYXBvcztzIENvbW1pdHRlZSBmb3IgSGVhZCBhbmQgTmVjayBTdXJnZXJ5IGFuZCBPbmNvbG9n

eTwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5BcmNoIE90b2xhcnluZ29sIEhlYWQgTmVjayBTdXJn

PC9zZWNvbmRhcnktdGl0bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+QXJjaCBP

dG9sYXJ5bmdvbCBIZWFkIE5lY2sgU3VyZzwvZnVsbC10aXRsZT48L3BlcmlvZGljYWw+PHBhZ2Vz

PjYwMS01PC9wYWdlcz48dm9sdW1lPjExNzwvdm9sdW1lPjxudW1iZXI+NjwvbnVtYmVyPjxlZGl0

aW9uPjE5OTEvMDYvMDE8L2VkaXRpb24+PGtleXdvcmRzPjxrZXl3b3JkPkhlYWQgYW5kIE5lY2sg

TmVvcGxhc21zL3N1cmdlcnk8L2tleXdvcmQ+PGtleXdvcmQ+SHVtYW5zPC9rZXl3b3JkPjxrZXl3

b3JkPkx5bXBoIE5vZGUgRXhjaXNpb24vY2xhc3NpZmljYXRpb248L2tleXdvcmQ+PGtleXdvcmQ+

THltcGggTm9kZXMvYW5hdG9teSAmYW1wOyBoaXN0b2xvZ3k8L2tleXdvcmQ+PGtleXdvcmQ+TmVj

ay9hbmF0b215ICZhbXA7IGhpc3RvbG9neTwva2V5d29yZD48a2V5d29yZD5OZWNrIERpc3NlY3Rp

b24vKmNsYXNzaWZpY2F0aW9uPC9rZXl3b3JkPjxrZXl3b3JkPipUZXJtaW5vbG9neSBhcyBUb3Bp

Yzwva2V5d29yZD48L2tleXdvcmRzPjxkYXRlcz48eWVhcj4xOTkxPC95ZWFyPjxwdWItZGF0ZXM+

PGRhdGU+SnVuPC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+MDg4Ni00NDcwIChQcmlu

dCkmI3hEOzA4ODYtNDQ3MCAoTGlua2luZyk8L2lzYm4+PGFjY2Vzc2lvbi1udW0+MjAzNjE4MDwv

YWNjZXNzaW9uLW51bT48dXJscz48cmVsYXRlZC11cmxzPjx1cmw+aHR0cDovL3d3dy5uY2JpLm5s

bS5uaWguZ292L3B1Ym1lZC8yMDM2MTgwPC91cmw+PC9yZWxhdGVkLXVybHM+PC91cmxzPjxsYW5n

dWFnZT5lbmc8L2xhbmd1YWdlPjwvcmVjb3JkPjwvQ2l0ZT48Q2l0ZT48QXV0aG9yPlJvYmJpbnM8

L0F1dGhvcj48WWVhcj4yMDA4PC9ZZWFyPjxSZWNOdW0+Mzc8L1JlY051bT48cmVjb3JkPjxyZWMt

bnVtYmVyPjM3PC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0i

cHMyd3dkc2ZyYTJyNWVlOXphc3hzNXQ4endkd3hyc3dlNXhhIiB0aW1lc3RhbXA9IjE0NzMxMTcx

MzkiPjM3PC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNs

ZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5Sb2JiaW5zLCBL

LiBULjwvYXV0aG9yPjxhdXRob3I+U2hhaGEsIEEuIFIuPC9hdXRob3I+PGF1dGhvcj5NZWRpbmEs

IEouIEUuPC9hdXRob3I+PGF1dGhvcj5DYWxpZmFubywgSi4gQS48L2F1dGhvcj48YXV0aG9yPldv

bGYsIEcuIFQuPC9hdXRob3I+PGF1dGhvcj5GZXJsaXRvLCBBLjwvYXV0aG9yPjxhdXRob3I+U29t

LCBQLiBNLjwvYXV0aG9yPjxhdXRob3I+RGF5LCBULiBBLjwvYXV0aG9yPjwvYXV0aG9ycz48L2Nv

bnRyaWJ1dG9ycz48YXV0aC1hZGRyZXNzPkRpdmlzaW9uIG9mIE90b2xhcnluZ29sb2d5LCBTb3V0

aGVybiBJbGxpbm9pcyBVbml2ZXJzaXR5IFNjaG9vbCBvZiBNZWRpY2luZSwgU3ByaW5nZmllbGQs

IElMIDYyNzk0LTk2NzcsIFVTQS4gdHJvYmJpbnNAc2l1bWVkLmVkdTwvYXV0aC1hZGRyZXNzPjx0

aXRsZXM+PHRpdGxlPkNvbnNlbnN1cyBzdGF0ZW1lbnQgb24gdGhlIGNsYXNzaWZpY2F0aW9uIGFu

ZCB0ZXJtaW5vbG9neSBvZiBuZWNrIGRpc3NlY3Rpb248L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+

QXJjaCBPdG9sYXJ5bmdvbCBIZWFkIE5lY2sgU3VyZzwvc2Vjb25kYXJ5LXRpdGxlPjwvdGl0bGVz

PjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkFyY2ggT3RvbGFyeW5nb2wgSGVhZCBOZWNrIFN1cmc8

L2Z1bGwtdGl0bGU+PC9wZXJpb2RpY2FsPjxwYWdlcz41MzYtODwvcGFnZXM+PHZvbHVtZT4xMzQ8

L3ZvbHVtZT48bnVtYmVyPjU8L251bWJlcj48ZWRpdGlvbj4yMDA4LzA1LzIxPC9lZGl0aW9uPjxr

ZXl3b3Jkcz48a2V5d29yZD5IZWFkIGFuZCBOZWNrIE5lb3BsYXNtcy9wYXRob2xvZ3kvKnN1cmdl

cnk8L2tleXdvcmQ+PGtleXdvcmQ+SHVtYW5zPC9rZXl3b3JkPjxrZXl3b3JkPkx5bXBoYXRpYyBN

ZXRhc3Rhc2lzL3BhdGhvbG9neTwva2V5d29yZD48a2V5d29yZD5NZWRpYXN0aW51bTwva2V5d29y

ZD48a2V5d29yZD5OZWNrIERpc3NlY3Rpb24vKmNsYXNzaWZpY2F0aW9uPC9rZXl3b3JkPjxrZXl3

b3JkPlJlZmVyZW5jZSBTdGFuZGFyZHM8L2tleXdvcmQ+PGtleXdvcmQ+U3BlY2ltZW4gSGFuZGxp

bmc8L2tleXdvcmQ+PGtleXdvcmQ+KlRlcm1pbm9sb2d5IGFzIFRvcGljPC9rZXl3b3JkPjxrZXl3

b3JkPlVuaXRlZCBTdGF0ZXM8L2tleXdvcmQ+PC9rZXl3b3Jkcz48ZGF0ZXM+PHllYXI+MjAwODwv

eWVhcj48cHViLWRhdGVzPjxkYXRlPk1heTwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxpc2Ju

PjE1MzgtMzYxWCAoRWxlY3Ryb25pYykmI3hEOzA4ODYtNDQ3MCAoTGlua2luZyk8L2lzYm4+PGFj

Y2Vzc2lvbi1udW0+MTg0OTA1Nzc8L2FjY2Vzc2lvbi1udW0+PHVybHM+PHJlbGF0ZWQtdXJscz48

dXJsPmh0dHA6Ly93d3cubmNiaS5ubG0ubmloLmdvdi9wdWJtZWQvMTg0OTA1Nzc8L3VybD48L3Jl

bGF0ZWQtdXJscz48L3VybHM+PGVsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjEwLjEwMDEvYXJjaG90

b2wuMTM0LjUuNTM2JiN4RDsxMzQvNS81MzYgW3BpaV08L2VsZWN0cm9uaWMtcmVzb3VyY2UtbnVt

PjxsYW5ndWFnZT5lbmc8L2xhbmd1YWdlPjwvcmVjb3JkPjwvQ2l0ZT48L0VuZE5vdGU+

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Sb2JiaW5zPC9BdXRob3I+PFllYXI+MTk5MTwvWWVhcj48

UmVjTnVtPjM2PC9SZWNOdW0+PERpc3BsYXlUZXh0PjxzdHlsZSBmYWNlPSJzdXBlcnNjcmlwdCI+

MzcsMzg8L3N0eWxlPjwvRGlzcGxheVRleHQ+PHJlY29yZD48cmVjLW51bWJlcj4zNjwvcmVjLW51

bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9InBzMnd3ZHNmcmEycjVlZTl6

YXN4czV0OHp3ZHd4cnN3ZTV4YSIgdGltZXN0YW1wPSIxNDczMTE3MTM5Ij4zNjwva2V5PjwvZm9y

ZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9yZWYtdHlwZT48

Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+Um9iYmlucywgSy4gVC48L2F1dGhvcj48YXV0

aG9yPk1lZGluYSwgSi4gRS48L2F1dGhvcj48YXV0aG9yPldvbGZlLCBHLiBULjwvYXV0aG9yPjxh

dXRob3I+TGV2aW5lLCBQLiBBLjwvYXV0aG9yPjxhdXRob3I+U2Vzc2lvbnMsIFIuIEIuPC9hdXRo

b3I+PGF1dGhvcj5QcnVldCwgQy4gVy48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+

PGF1dGgtYWRkcmVzcz5TYW4gRGllZ28gQ2FuY2VyIENlbnRlciwgVW5pdmVyc2l0eSBvZiBDYWxp

Zm9ybmlhIDkyMTAzLjwvYXV0aC1hZGRyZXNzPjx0aXRsZXM+PHRpdGxlPlN0YW5kYXJkaXppbmcg

bmVjayBkaXNzZWN0aW9uIHRlcm1pbm9sb2d5LiBPZmZpY2lhbCByZXBvcnQgb2YgdGhlIEFjYWRl

bXkmYXBvcztzIENvbW1pdHRlZSBmb3IgSGVhZCBhbmQgTmVjayBTdXJnZXJ5IGFuZCBPbmNvbG9n

eTwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5BcmNoIE90b2xhcnluZ29sIEhlYWQgTmVjayBTdXJn

PC9zZWNvbmRhcnktdGl0bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+QXJjaCBP

dG9sYXJ5bmdvbCBIZWFkIE5lY2sgU3VyZzwvZnVsbC10aXRsZT48L3BlcmlvZGljYWw+PHBhZ2Vz

PjYwMS01PC9wYWdlcz48dm9sdW1lPjExNzwvdm9sdW1lPjxudW1iZXI+NjwvbnVtYmVyPjxlZGl0

aW9uPjE5OTEvMDYvMDE8L2VkaXRpb24+PGtleXdvcmRzPjxrZXl3b3JkPkhlYWQgYW5kIE5lY2sg

TmVvcGxhc21zL3N1cmdlcnk8L2tleXdvcmQ+PGtleXdvcmQ+SHVtYW5zPC9rZXl3b3JkPjxrZXl3

b3JkPkx5bXBoIE5vZGUgRXhjaXNpb24vY2xhc3NpZmljYXRpb248L2tleXdvcmQ+PGtleXdvcmQ+

THltcGggTm9kZXMvYW5hdG9teSAmYW1wOyBoaXN0b2xvZ3k8L2tleXdvcmQ+PGtleXdvcmQ+TmVj

ay9hbmF0b215ICZhbXA7IGhpc3RvbG9neTwva2V5d29yZD48a2V5d29yZD5OZWNrIERpc3NlY3Rp

b24vKmNsYXNzaWZpY2F0aW9uPC9rZXl3b3JkPjxrZXl3b3JkPipUZXJtaW5vbG9neSBhcyBUb3Bp

Yzwva2V5d29yZD48L2tleXdvcmRzPjxkYXRlcz48eWVhcj4xOTkxPC95ZWFyPjxwdWItZGF0ZXM+

PGRhdGU+SnVuPC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+MDg4Ni00NDcwIChQcmlu

dCkmI3hEOzA4ODYtNDQ3MCAoTGlua2luZyk8L2lzYm4+PGFjY2Vzc2lvbi1udW0+MjAzNjE4MDwv

YWNjZXNzaW9uLW51bT48dXJscz48cmVsYXRlZC11cmxzPjx1cmw+aHR0cDovL3d3dy5uY2JpLm5s

bS5uaWguZ292L3B1Ym1lZC8yMDM2MTgwPC91cmw+PC9yZWxhdGVkLXVybHM+PC91cmxzPjxsYW5n

dWFnZT5lbmc8L2xhbmd1YWdlPjwvcmVjb3JkPjwvQ2l0ZT48Q2l0ZT48QXV0aG9yPlJvYmJpbnM8

L0F1dGhvcj48WWVhcj4yMDA4PC9ZZWFyPjxSZWNOdW0+Mzc8L1JlY051bT48cmVjb3JkPjxyZWMt

bnVtYmVyPjM3PC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0i

cHMyd3dkc2ZyYTJyNWVlOXphc3hzNXQ4endkd3hyc3dlNXhhIiB0aW1lc3RhbXA9IjE0NzMxMTcx

MzkiPjM3PC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNs

ZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5Sb2JiaW5zLCBL

LiBULjwvYXV0aG9yPjxhdXRob3I+U2hhaGEsIEEuIFIuPC9hdXRob3I+PGF1dGhvcj5NZWRpbmEs

IEouIEUuPC9hdXRob3I+PGF1dGhvcj5DYWxpZmFubywgSi4gQS48L2F1dGhvcj48YXV0aG9yPldv

bGYsIEcuIFQuPC9hdXRob3I+PGF1dGhvcj5GZXJsaXRvLCBBLjwvYXV0aG9yPjxhdXRob3I+U29t

LCBQLiBNLjwvYXV0aG9yPjxhdXRob3I+RGF5LCBULiBBLjwvYXV0aG9yPjwvYXV0aG9ycz48L2Nv

bnRyaWJ1dG9ycz48YXV0aC1hZGRyZXNzPkRpdmlzaW9uIG9mIE90b2xhcnluZ29sb2d5LCBTb3V0

aGVybiBJbGxpbm9pcyBVbml2ZXJzaXR5IFNjaG9vbCBvZiBNZWRpY2luZSwgU3ByaW5nZmllbGQs

IElMIDYyNzk0LTk2NzcsIFVTQS4gdHJvYmJpbnNAc2l1bWVkLmVkdTwvYXV0aC1hZGRyZXNzPjx0

aXRsZXM+PHRpdGxlPkNvbnNlbnN1cyBzdGF0ZW1lbnQgb24gdGhlIGNsYXNzaWZpY2F0aW9uIGFu

ZCB0ZXJtaW5vbG9neSBvZiBuZWNrIGRpc3NlY3Rpb248L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+

QXJjaCBPdG9sYXJ5bmdvbCBIZWFkIE5lY2sgU3VyZzwvc2Vjb25kYXJ5LXRpdGxlPjwvdGl0bGVz

PjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkFyY2ggT3RvbGFyeW5nb2wgSGVhZCBOZWNrIFN1cmc8

L2Z1bGwtdGl0bGU+PC9wZXJpb2RpY2FsPjxwYWdlcz41MzYtODwvcGFnZXM+PHZvbHVtZT4xMzQ8

L3ZvbHVtZT48bnVtYmVyPjU8L251bWJlcj48ZWRpdGlvbj4yMDA4LzA1LzIxPC9lZGl0aW9uPjxr

ZXl3b3Jkcz48a2V5d29yZD5IZWFkIGFuZCBOZWNrIE5lb3BsYXNtcy9wYXRob2xvZ3kvKnN1cmdl

cnk8L2tleXdvcmQ+PGtleXdvcmQ+SHVtYW5zPC9rZXl3b3JkPjxrZXl3b3JkPkx5bXBoYXRpYyBN

ZXRhc3Rhc2lzL3BhdGhvbG9neTwva2V5d29yZD48a2V5d29yZD5NZWRpYXN0aW51bTwva2V5d29y

ZD48a2V5d29yZD5OZWNrIERpc3NlY3Rpb24vKmNsYXNzaWZpY2F0aW9uPC9rZXl3b3JkPjxrZXl3

b3JkPlJlZmVyZW5jZSBTdGFuZGFyZHM8L2tleXdvcmQ+PGtleXdvcmQ+U3BlY2ltZW4gSGFuZGxp

bmc8L2tleXdvcmQ+PGtleXdvcmQ+KlRlcm1pbm9sb2d5IGFzIFRvcGljPC9rZXl3b3JkPjxrZXl3

b3JkPlVuaXRlZCBTdGF0ZXM8L2tleXdvcmQ+PC9rZXl3b3Jkcz48ZGF0ZXM+PHllYXI+MjAwODwv

eWVhcj48cHViLWRhdGVzPjxkYXRlPk1heTwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxpc2Ju

PjE1MzgtMzYxWCAoRWxlY3Ryb25pYykmI3hEOzA4ODYtNDQ3MCAoTGlua2luZyk8L2lzYm4+PGFj

Y2Vzc2lvbi1udW0+MTg0OTA1Nzc8L2FjY2Vzc2lvbi1udW0+PHVybHM+PHJlbGF0ZWQtdXJscz48

dXJsPmh0dHA6Ly93d3cubmNiaS5ubG0ubmloLmdvdi9wdWJtZWQvMTg0OTA1Nzc8L3VybD48L3Jl

bGF0ZWQtdXJscz48L3VybHM+PGVsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjEwLjEwMDEvYXJjaG90

b2wuMTM0LjUuNTM2JiN4RDsxMzQvNS81MzYgW3BpaV08L2VsZWN0cm9uaWMtcmVzb3VyY2UtbnVt

PjxsYW5ndWFnZT5lbmc8L2xhbmd1YWdlPjwvcmVjb3JkPjwvQ2l0ZT48L0VuZE5vdGU+

ADDIN EN.CITE.DATA 39,40 If it is not possible to assess the levels of lymph nodes (for instance, when the anatomic landmarks in the excised specimens are not specified), then the lymph node levels may be estimated as follows: level II, upper third of internal jugular (IJ) vein or neck specimen; level III, middle third of IJ vein or neck specimen; level IV, lower third of IJ vein or neck specimen, all anterior to the sternocleidomastoid muscle.Level I. Submental Group (Sublevel IA) Lymph nodes within the triangular boundary of the anterior belly of the digastric muscles and the hyoid bone.Submandibular Group (Sublevel IB) Lymph nodes within the boundaries of the anterior and posterior bellies of the digastric muscle and the body of the mandible. The submandibular gland is included in the specimen when the lymph nodes within this triangle are removed.Level II. Upper Jugular Group (Sublevels IIA and IIB)Lymph nodes located around the upper third of the internal jugular vein and adjacent spinal accessory nerve extending from the level of the carotid bifurcation (surgical landmark) or hyoid bone (clinical landmark) to the skull base. The posterior boundary is the posterior border of the sternocleidomastoid muscle, and the anterior boundary is the lateral border of the sternohyoid muscle.Level III. Middle Jugular Group Lymph nodes located around the middle third of the internal jugular vein extending from the carotid bifurcation superiorly to the omohyoid muscle (surgical landmark), or cricothyroid notch (clinical landmark) inferiorly. The posterior boundary is the posterior border of the sternocleidomastoid muscle, and the anterior boundary is the lateral border of the sternohyoid muscle.Level IV. Lower Jugular Group Lymph nodes located around the lower third of the internal jugular vein extending from the omohyoid muscle superiorly to the clavicle inferiorly. The posterior boundary is the posterior border of the sternocleidomastoid muscle, and the anterior boundary is the lateral border of the sternohyoid muscle.Level V. Posterior Triangle Group (Sublevels VA and VB)This group comprises predominantly the lymph nodes located along the lower half of the spinal accessory nerve and the transverse cervical artery. The supraclavicular nodes are also included in this group. The posterior boundary of the posterior triangle is the anterior border of the trapezius muscle, the anterior boundary of the posterior triangle is the posterior border of the sternocleidomastoid muscle, and the inferior boundary of the posterior triangle is the clavicle.Level VI. Anterior (Central) CompartmentLymph nodes in this compartment include the pre- and paratracheal nodes, precricoid (Delphian) node, and the perithyroidal nodes, including the lymph nodes along the recurrent laryngeal nerve. The superior boundary is the hyoid bone, the inferior boundary is the suprasternal notch, the lateral boundaries are the common carotid arteries, and the posterior boundary by the prevertebral fascia. Level VII. Superior Mediastinal Lymph NodesMetastases at level VII are considered regional lymph node metastases; all other mediastinal lymph node metastases are considered distant metastases. Lymph node groups removed from areas not included in the above levels, eg, scalene, suboccipital, and retropharyngeal, should be identified and reported from all levels separately. Midline nodes are considered ipsilateral nodes.Lymph Node NumberHistologic examination of a selective neck dissection specimen will ordinarily include 6 or more lymph nodes. Histologic examination of a radical or modified radical neck dissection specimen will ordinarily include 10 or more lymph nodes in the untreated neck. ADDIN EN.CITE <EndNote><Cite><Author>Tuttle</Author><Year>2017</Year><RecNum>1</RecNum><DisplayText><style face="superscript">1</style></DisplayText><record><rec-number>1</rec-number><foreign-keys><key app="EN" db-id="ps2wwdsfra2r5ee9zasxs5t8zwdwxrswe5xa" timestamp="1473117135">1</key></foreign-keys><ref-type name="Book Section">5</ref-type><contributors><authors><author>Tuttle, R.M.</author><author>Morris, L.F.</author><author>Haugen, B.R. </author><author>Shah, J.P </author><author>Sosa, J.A.</author><author>Rohren, E.</author><author>Subramaniam, R. M.</author><author>Hunt, J.L.</author><author>Perrier, N.D</author></authors><secondary-authors><author>Amin, M.B.</author></secondary-authors></contributors><titles><title>Thyroid- differentiated and anaplastic carcinoma</title><secondary-title>AJCC Cancer Staging Manual</secondary-title></titles><edition>8th</edition><dates><year>2017</year></dates><pub-location>New York, NY</pub-location><publisher>Springer</publisher><urls></urls></record></Cite></EndNote>1 Special Procedures for Lymph NodesAt the current time, no additional special techniques should be used other than routine histology for the assessment of nodal metastases (ie, sentinel lymph node-type protocols are not advocated). However, confirmation by immunohistochemical staining, including thyroglobulin for papillary carcinoma and calcitonin and neuroendocrine markers (eg, chromogranins, synaptophysin, CD56) for medullary carcinoma, may be required.M. TNM and Stage GroupingsAccording to the American Joint Committee on Cancer (AJCC) ADDIN EN.CITE <EndNote><Cite><Author>Tuttle</Author><Year>2017</Year><RecNum>1</RecNum><DisplayText><style face="superscript">1</style></DisplayText><record><rec-number>1</rec-number><foreign-keys><key app="EN" db-id="ps2wwdsfra2r5ee9zasxs5t8zwdwxrswe5xa" timestamp="1473117135">1</key></foreign-keys><ref-type name="Book Section">5</ref-type><contributors><authors><author>Tuttle, R.M.</author><author>Morris, L.F.</author><author>Haugen, B.R. </author><author>Shah, J.P </author><author>Sosa, J.A.</author><author>Rohren, E.</author><author>Subramaniam, R. M.</author><author>Hunt, J.L.</author><author>Perrier, N.D</author></authors><secondary-authors><author>Amin, M.B.</author></secondary-authors></contributors><titles><title>Thyroid- differentiated and anaplastic carcinoma</title><secondary-title>AJCC Cancer Staging Manual</secondary-title></titles><edition>8th</edition><dates><year>2017</year></dates><pub-location>New York, NY</pub-location><publisher>Springer</publisher><urls></urls></record></Cite></EndNote>1 the TNM stage groupings for papillary and follicular carcinomas and variants thereof are stratified by age, including patients under 55 years of age and patients 55 years and older, as well as the individual TNM parameters. Age is not used to stratify medullary thyroid carcinoma into stage groups. ADDIN EN.CITE <EndNote><Cite><Author>Rosen</Author><Year>2017</Year><RecNum>46</RecNum><DisplayText><style face="superscript">2</style></DisplayText><record><rec-number>46</rec-number><foreign-keys><key app="EN" db-id="ps2wwdsfra2r5ee9zasxs5t8zwdwxrswe5xa" timestamp="1473120927">46</key></foreign-keys><ref-type name="Book Section">5</ref-type><contributors><authors><author>Rosen, J.E.</author><author>Lloyd, R.V.</author><author>Brierley, J.D.</author><author>Grogan, R.H.</author><author>Haddad, R.</author><author>Hunt, J.L.</author><author>Ridge, J.A.</author><author>Seethala, R.R.</author><author>Sosa, J.A.</author><author>Subramaniam, R.M.</author><author>Wang, T.S.</author><author>Wirth, L.J. </author><author>Perrier, N.D.</author></authors><secondary-authors><author>Amin, M.B.</author></secondary-authors></contributors><titles><title>Thyroid- Medullary</title><secondary-title>AJCC Cancer Staging Manual</secondary-title></titles><edition>8th</edition><dates><year>2017</year></dates><pub-location>New York, NY</pub-location><publisher>Springer</publisher><urls></urls></record></Cite></EndNote>2Undifferentiated (anaplastic) carcinoma is always assigned stage IV and subgrouped into IVA, IVB, IVC by TNM parameters. ADDIN EN.CITE <EndNote><Cite><Author>Tuttle</Author><Year>2017</Year><RecNum>1</RecNum><DisplayText><style face="superscript">1</style></DisplayText><record><rec-number>1</rec-number><foreign-keys><key app="EN" db-id="ps2wwdsfra2r5ee9zasxs5t8zwdwxrswe5xa" timestamp="1473117135">1</key></foreign-keys><ref-type name="Book Section">5</ref-type><contributors><authors><author>Tuttle, R.M.</author><author>Morris, L.F.</author><author>Haugen, B.R. </author><author>Shah, J.P </author><author>Sosa, J.A.</author><author>Rohren, E.</author><author>Subramaniam, R. M.</author><author>Hunt, J.L.</author><author>Perrier, N.D</author></authors><secondary-authors><author>Amin, M.B.</author></secondary-authors></contributors><titles><title>Thyroid- differentiated and anaplastic carcinoma</title><secondary-title>AJCC Cancer Staging Manual</secondary-title></titles><edition>8th</edition><dates><year>2017</year></dates><pub-location>New York, NY</pub-location><publisher>Springer</publisher><urls></urls></record></Cite></EndNote>1 All categories may be subdivided: (a) solitary tumor, (b) multifocal tumor. With multifocal tumors, the most aggressive (typically the largest) one is used for classification. The multifocal designation may be used for tumors of different histologies (ie, a follicular and papillary carcinoma, not just multiple papillary carcinomas). The lymph nodes must be specifically identified to classify regional node involvement.Stage GroupingsPapillary or Follicular CarcinomaUnder 55 Years of AgeStage I Any TAny NM0Stage IIAny TAny NM155 Years or OlderStage I T1-2N0M0Stage IIT1-2N1M0T3a/b Any N M0Stage IIIT4aAny NM0Stage IVAT4bAny NM0Stage IVBAny TAny NM1Medullary Carcinoma (All Age Groups)Stage IT1N0M0Stage IIT2-3N0M0Stage IIIT1-3N1aM0Stage IVAT4aAny NM0T4aN1aM0T1-3N1bM0Stage IVBT4bAny NM0Stage IVCAny TAny NM1Undifferentiated (Anaplastic) Carcinoma All undifferentiated carcinomas are considered Stage IVStage IVAT1-3aN0M0Stage IVBT1-3aN1M0T3b,T4Any NM0 Stage IVCAny TAny N M1TNM DescriptorsFor identification of special cases of TNM or pTNM classifications, the “m” suffix and “y,” “r,” and “a” prefixes are used. Although they do not affect the stage grouping, they indicate cases needing separate analysis.The “m” suffix indicates the presence of multiple primary tumors in a single site and is recorded in parentheses: pT(m)NM.The “y” prefix indicates those cases in which classification is performed during or following initial multimodality therapy (ie, neoadjuvant chemotherapy, radiation therapy, or both chemotherapy and radiation therapy). The cTNM or pTNM category is identified by a “y” prefix. The ycTNM or ypTNM categorizes the extent of tumor actually present at the time of that examination. The “y” categorization is not an estimate of tumor prior to multimodality therapy (ie, before initiation of neoadjuvant therapy).The “r” prefix indicates a recurrent tumor when staged after a documented disease-free interval, and is identified by the “r” prefix: rTNM.The “a” prefix designates the stage determined at autopsy: aTNM.Additional DescriptorsResidual Tumor (R)In the thyroid gland, residual tumor mainly applicable to anaplastic carcinoma. Residual tumor is tumor remaining in a patient after therapy with curative intent (eg, surgical resection for cure) is categorized by a system known as R classification, shown below.RXPresence of residual tumor cannot be assessedR0No residual tumorR1Microscopic residual tumorR2Macroscopic residual tumorFor the surgeon, the R classification may be useful to indicate the known or assumed status of the completeness of a surgical excision. For the pathologist, the R classification is relevant to the status of the margins of a surgical resection specimen. That is, tumor involving the resection margin on pathologic examination may be assumed to correspond to residual tumor in the patient and may be classified as macroscopic or microscopic according to the findings at the specimen margin(s).45.References ADDIN EN.REFLIST 1.Tuttle RM, Morris LF, Haugen BR, et al. Thyroid- differentiated and anaplastic carcinoma. In: Amin MB, ed. AJCC Cancer Staging Manual. 8th ed. New York, NY: Springer; 2017.2.Rosen JE, Lloyd RV, Brierley JD, et al. Thyroid-medullary. In: Amin MB, Edge SB, Greene FL, et al, eds. AJCC Cancer Staging Manual. 8th ed. New York, NY: Springer; 2017.3.DeLellis RA, Lloyd RV, Heitz PU, Eng C, eds. Pathology and Genetics of Tumours of the Endocrine Organs. Lyons: IARC PRess; 2004. World Health Organization Classification of Tumours.4.Chan JK. The thyroid gland. In: Fletcher CDM, ed. Diagnostic Histopathology of Tumours. Edinburgh: Churchill Livingstone Elsevier; 2007:1018.5.Kazaure HS, Roman SA, Sosa JA. Medullary thyroid microcarcinoma: a population-level analysis of 310 patients. Cancer. 2012;118(3):620-627.6.Morris LG, Shaha AR, Tuttle RM, Sikora AG, Ganly I. Tall-cell variant of papillary thyroid carcinoma: a matched-pair analysis of survival. Thyroid. 2010;20(2):153-158.7.Nikiforov YE, Nikiforova MN. Molecular genetics and diagnosis of thyroid cancer. Nat Rev Endocrinol. 2011;7(10):569-580.8.Rivera M, Ghossein RA, Schoder H, Gomez D, Larson SM, Tuttle RM. Histopathologic characterization of radioactive iodine-refractory fluorodeoxyglucose-positron emission tomography-positive thyroid carcinoma. Cancer. 2008;113(1):48-56.9.Cameselle-Teijeiro J, Chan JK. Cribriform-morular variant of papillary carcinoma: a distinctive variant representing the sporadic counterpart of familial adenomatous polyposis-associated thyroid carcinoma? Mod Pathol. 1999;12(4):400-411.10.Regalbuto C, Malandrino P, Tumminia A, Le Moli R, Vigneri R, Pezzino V. A diffuse sclerosing variant of papillary thyroid carcinoma: clinical and pathologic features and outcomes of 34 consecutive cases. Thyroid. 2011;21(4):383-389.11.Rivera M, Tuttle RM, Patel S, Shaha A, Shah JP, Ghossein RA. Encapsulated papillary thyroid carcinoma: a clinico-pathologic study of 106 cases with emphasis on its morphologic subtypes (histologic growth pattern). Thyroid. 2009;19(2):119-127.12.Liu J, Singh B, Tallini G, et al. Follicular variant of papillary thyroid carcinoma: a clinicopathologic study of a problematic entity. Cancer. 2006;107(6):1255-1264.13.Nikiforov YE, Seethala RR, Tallini G, et al. Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma: a paradigm shift to reduce overtreatment of indolent tumors. JAMA oncology. 2016;2(8):1023-1029.14.Komorowski RA, Hanson GA. Occult thyroid pathology in the young adult: an autopsy study of 138 patients without clinical thyroid disease. Hum Pathol. 1988;19(6):689-696.15.Fink A, Tomlinson G, Freeman JL, Rosen IB, Asa SL. Occult micropapillary carcinoma associated with benign follicular thyroid disease and unrelated thyroid neoplasms. Mod Pathol. 1996;9(8):816-820.16.Niemeier LA, Kuffner Akatsu H, Song C, et al. A combined molecular-pathologic score improves risk stratification of thyroid papillary microcarcinoma. Cancer. 2012;118(8):2069-2077.17.Nikiforov YE, Ohori NP. Follicular carcinoma. In: Nikiforov YE, Biddinger PW, Thompson LDR, eds. Diagnostic Pathology and Molecular Genetics of the Thyroid. 2nd ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2012:152-182.18.van Heerden JA, Hay ID, Goellner JR, et al. Follicular thyroid carcinoma with capsular invasion alone: a nonthreatening malignancy. Surgery. 1992;112(6):1130-1136; discussion 1136-1138.19.Volante M, Collini P, Nikiforov YE, et al. Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach. Am J Surg Pathol. 2007;31(8):1256-1264.20.Dettmer M, Schmitt A, Steinert H, et al. Poorly differentiated thyroid carcinomas: how much poorly differentiated is needed? Am J Surg Pathol. 2011;35(12):1866-1872.21.Hiltzik D, Carlson DL, Tuttle RM, et al. Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients. Cancer. 2006;106(6):1286-1295.22.Rivera M, Ricarte-Filho J, Patel S, et al. Encapsulated thyroid tumors of follicular cell origin with high grade features (high mitotic rate/tumor necrosis): a clinicopathologic and molecular study. Hum Pathol. 2010;41(2):172-180.23.Nikiforov YE, Seethala RR. Anaplastic (undifferentiated) carcinoma. In: Nikiforov YE, Biddinger PW, Thompson LDR, eds. Diagnostic Pathology and Molecular Genetics of the Thyroid. 2nd ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2012:263-284.24.Sugitani I, Kasai N, Fujimoto Y, Yanagisawa A. Prognostic factors and therapeutic strategy for anaplastic carcinoma of the thyroid. World J Surg. 2001;25(5):617-622.25.Aldinger KA, Samaan NA, Ibanez M, Hill CS, Jr. Anaplastic carcinoma of the thyroid: a review of 84 cases of spindle and giant cell carcinoma of the thyroid. Cancer. 1978;41(6):2267-2275.26.Rosai J, Carcangiu ML, DeLellis RA. Atlas of Tumor Pathology. Tumors of the Thyroid Gland. Vol 5. 3rd ed. Washington DC: Armed Forces Institute of Pathology; 1992.27.Mete O, Asa SL. Pathological definition and clinical significance of vascular invasion in thyroid carcinomas of follicular epithelial derivation. Mod Pathol. 2011;24(12):1545-1552.28.Erovic BM, Kim D, Cassol C, et al. Prognostic and predictive markers in medullary thyroid carcinoma. Endocr Pathol. 2012;23(4):232-242.29.Thompson LD, Wieneke JA, Paal E, Frommelt RA, Adair CF, Heffess CS. A clinicopathologic study of minimally invasive follicular carcinoma of the thyroid gland with a review of the English literature. Cancer. 2001;91(3):505-524.30.Collini P, Sampietro G, Pilotti S. Extensive vascular invasion is a marker of risk of relapse in encapsulated non-Hurthle cell follicular carcinoma of the thyroid gland: a clinicopathological study of 18 consecutive cases from a single institution with a 11-year median follow-up. Histopathology. 2004;44(1):35-39.31.Ghossein RA, Hiltzik DH, Carlson DL, et al. Prognostic factors of recurrence in encapsulated Hurthle cell carcinoma of the thyroid gland: a clinicopathologic study of 50 cases. Cancer. 2006;106(8):1669-1676.32.Stojadinovic A, Ghossein RA, Hoos A, et al. Hurthle cell carcinoma: a critical histopathologic appraisal. J Clin Oncol. 2001;19(10):2616-2625.33.Mete O, Rotstein L, Asa SL. Controversies in thyroid pathology: thyroid capsule invasion and extrathyroidal extension. Ann Surg Oncol. 2010;17(2):386-391.34.Standring S. Thyroid gland. In: Standring S, ed. Gray's Anatomy: The Anatomical Basis of Clinical Practice. Edinburgh: Elsevieer Churchill Livingstone; 2005:560-564.35.Gnepp DR, Ogorzalek JM, Heffess CS. Fat-containing lesions of the thyroid gland. Am J Surg Pathol. 1989;13(7):605-612.36.Cranshaw IM, Carnaille B. Micrometastases in thyroid cancer: an important finding? Surg Oncol. 2008;17(3):253-258.37.Urken ML, Mechanick JI, Sarlin J, Scherl S, Wenig BM. Pathologic reporting of lymph node metastases in differentiated thyroid cancer: a call to action for the College of American Pathologists. Endocr Pathol. 2014;25(3):214-218.38.Randolph GW, Duh QY, Heller KS, et al. The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension. Thyroid. 2012;22(11):1144-1152.39.Robbins KT, Medina JE, Wolfe GT, Levine PA, Sessions RB, Pruet CW. Standardizing neck dissection terminology. Official report of the Academy's Committee for Head and Neck Surgery and Oncology. Arch Otolaryngol Head Neck Surg. 1991;117(6):601-605.40.Robbins KT, Shaha AR, Medina JE, et al. Consensus statement on the classification and terminology of neck dissection. Arch Otolaryngol Head Neck Surg. 2008;134(5):536-538.41.Carty SE, Cooper DS, Doherty GM, et al. Consensus statement on the terminology and classification of central neck dissection for thyroid cancer. Thyroid. 2009;19(11):1153-1158.42.Yamashita H, Noguchi S, Murakami N, et al. Extracapsular invasion of lymph node metastasis: a good indicator of disease recurrence and poor prognosis in patients with thyroid microcarcinoma. Cancer. 1999;86(5):842-849.43.Lango M, Flieder D, Arrangoiz R, et al. Extranodal extension of metastatic papillary thyroid carcinoma: correlation with biochemical endpoints, nodal persistence, and systemic disease progression. Thyroid. 2013;23(9):1099-1105.44.Robbins KT, Samant S, Ronen O. Neck Dissection. In: Flint PW, Haughey BH, Lund VJ, et al, eds. Cummings Otolaryngology: Head and Neck Surgery. 5th ed. Philadelphia, PA: Saunders; 2005:1702-1725.45.Gress DM, Edge SB, Greene FL, et al. Principles of cancer staging. In: Amin MB, Edge SB, Greene FL, et al, eds. AJCC Cancer Staging Manual. 8th ed. New York, NY: Springer; 2017. ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download